UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

the Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted byRule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant tounder §240.14a-2240.14a-12

COMSCORE, INC.

(Name of Registrant as Specified In Itsin its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee computed on table below per Exchange ActRules 14a-6(i)(4) and0-11.
(1)

Title of each class of securities to which transaction applies:

(2)

Aggregate number of securities to which transaction applies:

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange ActRule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules Rule 0-11(a)(2)14a-6(i)(1) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

Amount Previously Paid:

(2)

Form, Schedule or Registration Statement No.:

(3)

Filing Party:

(4)

Date Filed:

0-11.

 

 

 


LOGOLOGO

PRELIMINARY COPY – SUBJECT TO COMPLETION – DATED APRIL 14, 2023

11950 Democracy Drive,

Suite 600

Reston, Virginia 20190

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON MAY 30, 2018

To the Stockholders of comScore, Inc.:JUNE 15, 2023

Notice is hereby given that the 2018 Annual Meeting2023 annual meeting of Stockholdersstockholders (the “2018“2023 Annual Meeting”) of comScore, Inc. (the “Company”“company,” “Comscore,” “we” or “our”) will be held at the Hyatt Regency Reston,Carr Workplaces, located at 1800 Presidents1818 Library Street, Suite 500, Reston, Virginia 20190 on Wednesday, May 30, 2018,June 15, 2023, at [•],10:00 a.m. Eastern Time for the following purposes:

 

 1)

to elect (A) three Class III directors to serve for terms expiring at our 2019 annual meeting of stockholders, (B) twothe four nominees named in this proxy statement as Class I directors to serve for terms expiring at our 20202026 annual meeting of stockholders, and (C) three Class II directors to serve for terms expiring at our 2021 annual meeting of stockholders, in each case, to hold office until their respective successors have been duly elected and qualified;

 

 2)

to approve, on anon-binding advisory basis, the compensation paid to our named executive officers;

 

 3)to recommend, on anon-binding advisory basis, whether the advisory vote on executive compensation should occur every year, every two years or every three years;

4)to approve our 2018 Equity and Incentive Compensation Plan;

5)to approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of shares of Common Stock authorized for issuance thereunder from 100,000,000 to 150,000,000;

6)to ratify the appointment of Deloitte & Touche LLP as the Company’sour independent registered public accounting firm for the fiscal year ending December 31, 2018; and2023;

4)

to approve an amendment to our Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of our common stock, par value $0.001 per share (the “Common Stock”) available for grant by 10,000,000;

5)

to adopt an amendment to the Certificate of Designations of our Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) to (i) permit us to pay annual dividends on the Series B Preferred Stock in the form of cash, shares of Common Stock, additional shares of Series B Preferred Stock, or a combination thereof, in each case in accordance with the amendment and as elected by members of our Board of Directors who have not been designated by, and are not affiliated with, any holder of Series B Preferred Stock (the “Disinterested Directors”), and (ii) make certain other clarifying and conforming changes to the Certificate of Designations, including with respect to intended tax treatment;

6)

to adopt an amendment to our Amended and Restated Certificate of Incorporation to authorize additional shares of preferred stock, par value $0.001 per share (“preferred stock”) in order to permit us to issue additional shares of Series B Preferred Stock and other preferred stock and pay annual dividends in the form of Series B Preferred Stock, in accordance with the Certificate of Designations amendment and if elected by the Disinterested Directors;

7)

to approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of Common Stock or Series B Preferred Stock as annual dividends on the Series B Preferred Stock, in accordance with the terms of the Certificate of Designations amendment and if elected by the Disinterested Directors; and

8)

to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.

Stockholders of record at the close of business on April 13, 201817, 2023 are entitled to notice of, and to vote at, the 20182023 Annual Meeting or any adjournment or postponement thereof. The presence, in person or represented by proxy, of a majority of shares of the Company’s Common Stock issued and outstanding shares of our Common Stock and Series B Preferred Stock (on an as-converted basis) on the record date will be required to establish a quorum at the 20182023 Annual Meeting. Where a separate vote


by a class or series of stock is required, the holders of a majority in voting power of issued and outstanding shares of such class or series entitled to vote on such matter, present in person or represented by proxy, shall constitute a quorum with respect to such matter.

We are furnishing our proxy materials to our stockholders over the Internet rather than in paper form. We believe that this delivery process reduces our environmental impact and lowers the costs of printing and distributing our proxy materials without affecting our stockholders’ timely access to this important information. Accordingly, stockholders of record at the close of business on April 13, 201817, 2023 will receive a Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability”) and will receive notice of any postponements or adjournments of the meeting. The Notice of Internet Availability is being distributed to stockholders beginning on or about April 20, 2018.[●], 2023.

Your vote is very important. Whether or not you plan to attend the 20182023 Annual Meeting, we encourage you to read the proxy statement and vote as soon as possible. For specific instructions on how to vote your shares, please refer to the section in the proxy statement entitled “Questions and Answers About the 20182023 Annual Meeting and Procedural Matters” and the instructions in the Notice of Internet Availability. If you are a stockholder of record of the Company’scompany’s Common Stock or Series B Preferred Stock, you may cast your vote by proxy or in person at the annual meeting.2023 Annual Meeting. If your shares are held by a bank, broker or other nominee, you should instruct such nominee on how to vote your shares.

Thank you for your continued support of comScore.Comscore.

 

Reston, Virginia

April [•], 2018

  

By Order of the Board of Directors,

 

April [●], 2023

 

Carol A. DiBattisteLOGO

General Counsel & Chief Compliance, Privacy and People OfficerAshley Wright

Secretary

Important Notice Regarding the Availability of Proxy Materials

for the Stockholder Meeting to Be Held on June 15, 2023

This proxy statement and our Annual Report on Form 10-K for the year ended December 31, 2022 are available at:

https://materials.proxyvote.com/[●]


COMSCORE, INC.

PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON MAY 30, 2018JUNE 15, 2023

Table of Contents

 

   Page 

QUESTIONS AND ANSWERS ABOUT THE 20182023 ANNUAL MEETING AND PROCEDURAL MATTERS

   12 

DIRECTORS, DIRECTOR NOMINEES, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

   910 

Directors, Director Nominees and Executive Officers

   910 

Board Structure, Composition and Leadership

   1213 

Standing Committees of the Board of Directors

   1215 

Risk Management

   1316 

Board of Directors and Committee Meeting Attendance

   1316 

Annual Meeting Attendance

   1316 

Director Nomination Process and Qualifications

   1317 

Director and Director Nominee Independence

   1418 

Compensation Committee Interlocks and Insider Participation

   1518 

Code of Business Conduct and Ethics

   1518

Reporting and Non-Retaliation Policy

18 

Corporate Governance Guidelines

   1518 

Stock Ownership Guidelines forNon-Employee Directors

15

DIRECTOR COMPENSATION

16

EXECUTIVE COMPENSATION

19

COMPENSATION DISCUSSION AND ANALYSISDirector Resignation Policy

   19 

COMPENSATION COMMITTEE REPORTBoard Diversity Policy

   3019 

COMPENSATION TABLESCompensation Policies

   3119

Insider Trading Policy and Preclearance Requirements

20

Political Activity Policy

20 

2017 Summary Compensation TableDIRECTOR COMPENSATION

   31

2017 Grants of Plan-Based Awards Table

32

Notes to 2017 Summary Compensation Table and 2017 Grants of Plan-Based Awards Table

33

2017 Outstanding Equity Awards at Fiscal Year End

33

2017 Option Exercises and Stock Vested

3421 

PAYMENTS UPON TERMINATION OR CHANGE IN CONTROLEXECUTIVE COMPENSATION

   35

PAY RATIO DISCLOSURE

4023 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

   4142 

Policies and Procedures for Transactions with Related Parties

   4142 

Transactions with Related Parties

   4142

Series B Preferred Stock Transactions

43 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

44

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

46

PRINCIPAL ACCOUNTING FEES AND SERVICESRELATED STOCKHOLDER MATTERS

   47 

AUDIT COMMITTEE REPORTPRINCIPAL ACCOUNTANT FEES AND SERVICES

   4950 

AUDIT COMMITTEE REPORT

51

PROPOSALS TO BE VOTED ON

   5052 

Proposal No. 1 – Election of Directors

   5052 

Proposal No.  2 – Advisory Vote to Approve Named Executive Officer Compensation

   5153 

Proposal No.  3 – Advisory Vote on Frequency of Vote to Approve Named Executive Officer Compensation

53

Proposal No.  4 – Approval of the comScore, Inc. 2018 Equity and Incentive Compensation Plan

54

i


Proposal No.  5 – Approval of an Amendment to the comScore, Inc. Amended and Restated Certificate of Incorporation to Increase the Number of Shares of Common Stock Authorized for Issuance Thereunder

67

Proposal No.  6 – Ratification of Appointment of Independent Registered Public Accounting Firm

   6954

Proposal No.  4 – Approval of an Amendment to the comScore, Inc. 2018 Equity and Incentive Compensation Plan (as Amended and Restated Effective as of July 9, 2020)

55

Proposal No.  5 – Adoption of the Certificate of Designations Amendment

70

Proposal No.  6 – Adoption of the Certificate of Incorporation Amendment

74

Proposal No. 7 – Approval of the Share Issuance

76 

OTHER INFORMATION

   7078 

Other Matters to be Presented at the Annual Meeting

   7078 

Security Holder Communication with Board Members

   7078

i


Page 

Annex A – Second Amendment to the comScore, Inc. Amended and Restated 2018 Equity and Incentive Compensation Plan

   A-1 

Annex B – FormAmendment to the Certificate of Designations of Series B Convertible Preferred Stock, Par Value $0.001, of comScore, Inc.

B-1

Annex C – Certificate of Amendment of the comScore, Inc. Amended and Restated Certificate of Incorporation of comScore, Inc.

   B-1C-1

Annex D – Reconciliation of Non-GAAP Financial Measure

D-1 

 

ii


COMSCORE, INC.

PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON MAY 30, 2018

This proxy statement and our Annual Report on Form10-K for the year ended December 31, 2017 are available at www.astproxyportal.com/ast/25890.JUNE 15, 2023

In accordance with rules and regulations adopted by the U.S. Securities and Exchange Commission (“SEC”), we are pleased to provide access to our proxy materials over the Internet to our stockholders rather than in paper form. Accordingly, a Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability”) has been mailed to our stockholders beginning on or about April 20, 2018.[●], 2023. Stockholders will have the ability to access the proxy materials on the website listed above, or to request that a printed set of the proxy materials be sent to them by following the instructions in the Notice of Internet Availability. By furnishing a Notice of Internet Availability and access to our proxy materials by the Internet, we are lowering the costs and reducing the environmental impact of our annual meeting.

The Notice of Internet Availability will also provide instructions on how you may request that we send future proxy materials to you electronically bye-mail or in printed form by mail. If you elect to receive future proxy materials bye-mail, you will receive ane-mail next year with instructions containing a link to those materials and a link to the proxy voting site. Your election to receive proxy materials bye-mail or printed form by mail will remain in effect until you terminate it. We encourage you to elect to receive future proxy materials bye-mail, which will allow us to provide you with the information you need in a more timely manner, will save us the cost of printing and mailing documents to you, and will conserve natural resources.

This proxy statement and accompanying proxy card and notice are being made available or distributed to stockholders beginning on or about April 20, 2018.[●], 2023.

QUESTIONS AND ANSWERS ABOUT THE 20182023 ANNUAL MEETING

AND PROCEDURAL MATTERS

 

Q:

Why am I receiving these proxy materials?

 

A:

The Board of Directors (the “Board”) of comScore, Inc. (the “Company,“company,“comScore,“Comscore,” “we,” “us” or “our”) has made these proxy materials available to you over the Internet, or is providing printed proxy materials to you, in connection with the Board’s solicitation of proxies for use at comScore’s 2018Comscore’s 2023 Annual Meeting of Stockholders (the “2018“2023 Annual Meeting”) to be held Wednesday, May 30, 2018,on June 15, 2023, at [•],10:00 a.m. Eastern Time, and at any adjournment or postponement thereof, for the purpose of considering and acting upon the matters set forth in this proxy statement. These proxy materials are being made available or distributed to you beginning on or about April 20, 2018.[●], 2023. As a stockholder, you are invited to attend the 20182023 Annual Meeting and are requested to vote on the proposals described in this proxy statement.

 

Q:

Where is the 20182023 Annual Meeting?

 

A:

The 20182023 Annual Meeting will be held at the Hyatt Regency Reston, located at 1800 Presidents1818 Library Street, Suite 500, Reston, Virginia 20190.

 

Q:

Can I attend the 20182023 Annual Meeting?

 

A:

You are invited to attend the 20182023 Annual Meeting if you were a stockholder of record or a beneficial owner as of April 13, 201817, 2023 (the “Record Date”). or if you are a proxy holder for a stockholder of record or beneficial owner as of the Record Date. You should bring photo identification and your Notice of Internet Availability, a statement from your bank, broker or other nominee or other proof of stock ownership as of the Record Date, for entrance to the 20182023 Annual Meeting. The meeting will begin promptly at [•],10:00 a.m. Eastern Time, and you should allow ample time forcheck-in procedures. We will not be able to accommodate guests who were not stockholders as of the Record Date (or proxy holders for such stockholders) at the 20182023 Annual Meeting.

Q:

Who is entitled to vote at the 20182023 Annual Meeting?

 

A:

You may vote your shares of comScoreComscore common stock, par value $0.001 per share (“Common Stock”), or Series B Convertible Preferred Stock, par value $0.001 per share (“Series B Preferred Stock”), if our records show that you owned your shares at the close of business on the Record Date. At the close of business on the Record Date, there were [•[●] shares of Common Stock and 82,527,609 shares of Series B Preferred Stock issued and outstanding and entitled to vote at the 20182023 Annual Meeting. YouHolders of Common Stock may cast one vote for each share of Common Stock held by you as of the Record Date on each matter presented. Holders of Series B Preferred Stock may vote their shares held as of the Record Date on an “as-converted basis” on each matter presented. Such holders will vote together as a single class. For those matters that require an additional, separate class vote by holders of Series B Preferred Stock, such holders may cast one vote for each share of Series B Preferred Stock held as of the Record Date.

 

Q:

What is the difference between holding shares as a stockholder of record and as a beneficial owner?

 

A:

If your shares are registered directly in your name with comScore’sComscore’s transfer agent, American Stock Transfer & Trust Company, you are considered, with respect to those shares, the “stockholder of record,” and the Notice of Internet Availability has been sent directly to you by comScore.Comscore. As the stockholder of record, you have the right to grant your voting proxy directly to comScoreComscore or to a third party, or to vote in person at the 20182023 Annual Meeting.

If you hold your shares are held bythrough a bank, broker or another nominee, you are considered the “beneficial owner” of shares held in “street name,” and the Notice of Internet Availability has been forwarded to you by your bank, broker or other nominee who is considered, with respect to those shares, the stockholder of record. As a beneficial owner, you have the right to direct your bank, broker or other nominee how to vote your shares. Please refer to the voting instruction card provided by your bank, broker or other nominee. You are also invited to attend the 20182023 Annual Meeting. However, because a beneficial owner is not the

stockholder of record, you may not vote these shares in person at the 20182023 Annual Meeting unless you obtain a “legal proxy” from the bank, broker or other nominee that holds your shares, giving you the right to vote the shares at the 20182023 Annual Meeting.

 

Q:

How can I vote my shares in person at the 20182023 Annual Meeting?

 

A:

Shares held in your name as the stockholder of record may be voted in person at the 20182023 Annual Meeting. Shares held beneficially in street name may be voted in person at the 20182023 Annual Meeting only if you obtain a “legal proxy” from the bank, broker or other nominee that holds your shares giving you the right to vote the shares. Even if you plan to attend the 20182023 Annual Meeting, we recommend that you also submit your vote as instructed on the Notice of Internet Availability and below, to ensure that your shares are represented and so that your vote will be counted even if you later decide not to attend the 20182023 Annual Meeting. If you attend the 20182023 Annual Meeting, any votes you cast at the meeting in person will supersede your proxy.

 

Q:

How can I vote my shares without attending the 20182023 Annual Meeting?

 

A:

Whether you hold shares directly as the stockholder of record or beneficially in street name, you may direct how your shares are voted without attending the 20182023 Annual Meeting. If you are a stockholder of record, you may vote by submitting a proxy. If you hold shares beneficially in street name, you may vote by submitting voting instructions to your bank, broker or other nominee. For instructions on how to vote, please refer to the instructions below and those included on the Notice of Internet Availability or, for shares held beneficially in street name, the voting instructions provided to you by your bank, broker or other nominee.

By Telephone or Internet – Stockholders of record may vote by telephone or the Internet by following the instructions on the Notice of Internet Availability.Availability to access the proxy materials. If you are a beneficial owner of Common Stock or Series B Preferred Stock held in street name, please check the voting instructions provided by your bank, broker or other nominee for telephone or Internet voting availability.

By mailMail – Stockholders of record may request a paper proxy card from comScoreComscore by following the procedures outlined in the Notice of Internet Availability. If you elect to vote by mail, please indicate your vote by completing, signing and dating the proxy card where indicated and by returning it in the prepaid envelope that will be included with the proxy card. Proxy cards submitted by mail must be received by the time of the meeting in order for your shares to be voted. comScoreComscore stockholders who hold shares beneficially in street name may vote by mail by completing, signing and dating the voting instructions provided by their bank, broker or other nominee and mailing them in the accompanyingpre-addressed envelopes.

Q:

How many shares must be present or represented by proxy to conduct business at the 20182023 Annual Meeting?

 

A:

The presence of the holders of a majority of theissued and outstanding shares of Common Stock issued and outstanding andSeries B Preferred Stock (on an as-converted basis) entitled to vote at the 20182023 Annual Meeting shall constitute a quorum at the 20182023 Annual Meeting. Such stockholders are counted as present atWhere a separate vote by a class or series of stock is required, the meeting if (1) they areholders of a majority in voting power of issued and outstanding shares of such class or series entitled to vote on such matter, present in person at the 2018 Annual Meeting or (2) they have properly submittedrepresented by proxy, shall constitute a proxy.quorum with respect to such matter.

AbstentionsStockholders are counted as present at the meeting if (1) they are present in person at the 2023 Annual Meeting or (2) they have properly submitted a proxy. In addition, cast abstentions and brokernon-votes (which are described below) are counted as present and entitled to vote for purposes of determining whether a quorum is present. At the close of business on the Record Date, there were [●] shares of Common Stock issued and outstanding and entitled to vote and 82,527,609 shares of Series B Preferred Stock issued and outstanding and entitled to vote (representing 80,952,378 shares of Common Stock on an as-converted voting basis) at the 2023 Annual Meeting. Therefore, the presence of the holders of at least [●] shares of Common Stock (on an as-converted basis) is required to establish a quorum at our 2023 Annual Meeting,

and the presence of the holders of at least 41,263,805 shares of Series B Preferred Stock is required to establish a quorum for matters that require an additional, separate class vote by holders of Series B Preferred Stock.

 

Q:

What proposals will be voted on at the 20182023 Annual Meeting?

 

A:

The proposals scheduled to be voted on at the 20182023 Annual Meeting are:

 

 1)

The election of (A) three Class III directors to serve for terms expiring at our 2019 annual meeting of stockholders, (B) twothe four nominees named in this proxy statement as Class I directors to serve for terms expiring at our 20202026 annual meeting of stockholders, and (C) three Class II directors to serve for terms expiring at our 2021 annual meeting of stockholders, in each case, to hold office until their respective successors have been duly elected and qualified;

 

 2)

The approval, on anon-binding advisory basis, of the compensation paid to our named executive officers (known as “Say on Pay”);

 

 3)The recommendation, on anon-binding advisory basis, of whether the advisory vote on executive compensation should occur every year, every two years or every three years (known as “Say on Frequency”);

4)The approval of our 2018 Equity and Incentive Compensation Plan;

5)The approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the number of shares of Common Stock authorized for issuance thereunder from 100,000,000 to 150,000,000; and

6)The ratification of the appointment of Deloitte & Touche LLP as the Company’sour independent registered public accounting firm for the fiscal year ending December 31, 2018.2023;

Q:

4)

The approval of an amendment to our Amended and Restated 2018 Equity and Incentive Compensation Plan (the “2018 Plan”) to increase the number of shares of our Common Stock available for grant by 10,000,000;

5)

The adoption of an amendment to the Certificate of Designations of the Series B Preferred Stock (the “Certificate of Designations Amendment”) to (i) permit us to pay annual dividends on the Series B Preferred Stock in the form of cash, shares of Common Stock, additional shares of Series B Preferred Stock, or a combination thereof, in each case in accordance with the Certificate of Designations Amendment and as elected by members of our Board who have not been designated by, and are not affiliated with, any holder of Series B Preferred Stock (the “Disinterested Directors”), and (ii) make certain other clarifying and conforming changes to the Certificate of Designations, including with respect to intended tax treatment;

6)

The adoption of an amendment to our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation Amendment”) to authorize additional shares of preferred stock, par value $0.001 per share (“preferred stock”) in order to permit us to issue additional shares of Series B Preferred Stock and other preferred stock and pay annual dividends in the form of Series B Preferred Stock, in accordance with the Certificate of Designations Amendment and if elected by the Disinterested Directors; and

7)

The approval, in accordance with Nasdaq Listing Rule 5635(d), of the issuance of Common Stock or Series B Preferred Stock as annual dividends on the Series B Preferred Stock, in accordance with the terms of the Certificate of Designations Amendment and if elected by the Disinterested Directors (the “Share Issuance”).

Q:

What is the vote required to approve each of the proposals?

 

A:

A: Proposal

  

Vote Required

  

Broker


Discretionary


Voting

Allowed

Proposal No. 1 – Election of Directors  Plurality of votes cast by the shares of capital stock present in person or represented by proxy at the meeting  No
Proposal No. 2 – Say on Pay Advisory Vote  Affirmative vote of a majority of shares of capital stock present in person or represented by proxy and entitled to vote  No
Proposal No. 3 – Say on Frequency Advisory VoteAffirmative vote of a majority of shares present in person or represented by proxy and entitled to voteNo

Proposal No. 4 – Approval of 2018 Equity and Incentive Compensation PlanAffirmative vote of a majority of shares present in person or represented by proxy and entitled to voteNo
Proposal No. 5 – Approval of Amendment to Amended and Restated Certificate of Incorporation to Increase Number of Shares of Common Stock Authorized for IssuanceAffirmative vote of a majority of shares outstanding and entitled to voteYes
Proposal No. 6 – Ratification of Appointment of Independent Registered Public Accounting Firm  Affirmative vote of a majority of shares of capital stock present in person or represented by proxy and entitled to vote  Yes

A: Proposal

Vote Required

Broker
Discretionary
Voting Allowed

Proposal No. 4 – Amendment to 2018 PlanAffirmative vote of a majority of shares of capital stock present in person or represented by proxy and entitled to voteNo
Proposal No. 5 – Certificate of Designations AmendmentAffirmative vote of (i) a majority of outstanding shares of capital stock entitled to vote and (ii) at least 75% of outstanding shares of Series B Preferred Stock entitled to voteNo
Proposal No. 6 – Certificate of Incorporation AmendmentAffirmative vote of (i) a majority of outstanding shares of capital stock entitled to vote and (ii) at least 75% of outstanding shares of Series B Preferred Stock entitled to voteNo
Proposal No. 7 – Share IssuanceAffirmative vote of a majority of shares of capital stock present in person or represented by proxy and entitled to voteNo

 

Q:

How are votes counted?

 

A:

You may vote “FOR” or “WITHHOLD” on each of the nominees for election as director (Proposal No. 1). The nominees for director receiving the highest number of affirmative votes with respect to each class will be elected as directors for their respective term of office.

You may vote “FOR,” “AGAINST” or “ABSTAIN” on the proposals to approve, bynon-binding advisory vote, executive compensation (Proposal No. 2), to approve the 2018 Equity and Incentive Compensation Plan (Proposal No. 4), to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of Common Stock authorized for issuance (Proposal No. 5), and to ratify the appointment of Deloitte & Touche LLP as the Company’sour independent registered public accounting firm (Proposal No. 3), to approve an amendment to the 2018 Plan (Proposal No. 4), to approve the Certificate of Designations Amendment (Proposal No 5), to approve the Certificate of Incorporation Amendment (Proposal No. 6) and to approve the Share Issuance (Proposal No. 7). An abstention has the same effect as a vote against these proposals.

You may vote “EVERY YEAR,” “EVERY 2 YEARS,” “EVERY 3 YEARS” or “ABSTAIN” on the proposal to recommend, bynon-binding advisory vote, whether the advisory vote on executive compensation should occur every year, every two years or every three years (Proposal No. 3). An abstention has the same effect as a vote against this proposal.

All shares entitled to vote and represented by properly executed proxies received prior to the 20182023 Annual Meeting (and not revoked) will be voted at the 20182023 Annual Meeting in accordance with the instructions indicated.

 

Q:

How does the company’s director resignation policy work?

A:

Our Board has adopted a director resignation policy, which provides that any nominee for director who receives a majority of “withhold” votes in an uncontested election of directors is expected to tender his or her resignation promptly following the certification of the election results. In such event, the Nominating and Governance Committee will promptly consider the tendered resignation and will recommend to the Board whether to accept or reject the resignation. The Board will act on the Nominating and Governance Committee’s recommendation no later than 90 days following the certification of the stockholder vote. The company will promptly disclose the Board’s decision (and, if the Board rejects the resignation, the Board’s reasons for doing so).

Q:

What if I do not specify how my shares are to be voted?

 

A:

If you are a stockholder of record and you submit a proxy, but you do not provide voting instructions, your shares will be voted as recommended by the Board of Directors.Board.

If you are a beneficial owner and you do not provide the bank, broker or other nominee that holds your shares with voting instructions, the bank, broker or other nominee will determine if it has the discretionary

authority to vote on the particular matter. Under applicable regulations, banks, brokers and other nominees have the discretion to vote on routine matters, such as Proposal No. 5 and Proposal No. 6,3, but do not have discretion to vote onnon-routine matters, such as Proposal No. 1, Proposal No. 2, Proposal No. 34, Proposal No. 5, Proposal No. 6 and Proposal No. 4.7, which results in a “broker non-vote.” Therefore, if you do not provide voting instructions to your bank, broker or other nominee, such nominee may only vote your shares on Proposal No. 5 and Proposal No. 63 and on any other routine matters properly presented for a vote at the 20182023 Annual Meeting.

 

Q:

What is the effect of a brokernon-vote?

 

A:

A brokernon-vote with respect to a proposal occurs when shares are held by a bank, broker or other nominee for a beneficial owner and the bank, broker or other nominee does not receive voting instructions from the beneficial owner as to how to vote such shares, and the bank, broker or other nominee does not have the authority to exercise discretion to vote on such proposal. Additionally, the bank, broker or other nominee may elect not to vote shares with respect to a proposal for which it does have discretionary authority to vote on such proposal, in which case such shares would also be treated as “brokernon-votes” with respect to that proposal.

Brokernon-votes will be counted for purposes of calculating whether a quorum is present at the 20182023 Annual Meeting, but they will not be counted for purposes of determining the number of votes present in person or represented by proxy and entitled to vote with respect to a particular proposal. Thus, brokernon-votes will not negatively impact our ability to obtain a quorum and will not otherwise affect the outcome of the vote on a proposal that requires a plurality of votes cast (Proposal No. 1) or the approval of a majority of the shares present in person or represented by proxy and entitled to vote (Proposal No. 2, Proposal No. 3, Proposal No. 4 and Proposal No. 6)7). With respect to Proposal No. 5 and Proposal No. 6, a brokernon-vote has the same effect ofas a vote against the proposal.

 

Q:

What is the effect of not casting a vote at the 20182023 Annual Meeting?

 

A:

If you are the stockholder of record of your shares and you do not vote by proxy card, via telephone, via the Internet or in person at the 20182023 Annual Meeting, your shares will not be voted at the 20182023 Annual Meeting. If you are a beneficial owner of shares held in street name, it is critical that you provide voting instructions if you want your vote to count in the election of directors (Proposal No. 1), the Say on Pay advisory vote (Proposal No. 2), the Say on Frequency advisory vote (Proposal No. 3) or the approval ofto approve an amendment to the 2018 Equity and Incentive Compensation Plan (Proposal No. 4), the vote to adopt the Certificate of Designations Amendment (Proposal No. 5) and the Certificate of Incorporation Amendment (Proposal No. 6), and the vote to approve the Share Issuance (Proposal No. 7).

In the past, if you held your shares in street name and you did not indicate how you wanted your shares voted in the election of directors, your bank, broker or other nominee was allowed to vote those shares on your behalf in the election of directors at their discretion. Under current applicable regulations, your bank, broker or other nominee does not have the ability to vote your uninstructed shares in the election of directors on a discretionary basis or to vote your uninstructed shares onnon-binding advisory proposals related to executive compensation. Thus, if you hold your shares in street name and you do not instruct your bank, broker or other nominee how to vote on these or othernon-routine matters, no votes will be cast on your behalf. Your bank, broker or other nominee will, however, continue to have discretion to vote any uninstructed shares on the ratification of the appointment of comScore’s As discussed above, banks, brokers and other nominees have the discretion to vote on routine matters, such as Proposal No. 3, but do not have discretion to vote on non-routine matters, such as the remaining proposals. Thus, if you hold your shares in street name and you do not instruct your bank, broker or other nominee how to vote on these or other non-routine matters, no votes will be cast on your behalf. Your bank, broker or other nominee will, however, continue to have discretion to vote any uninstructed shares on the ratification of the appointment of Comscore’s independent registered public accounting firm and other routine matters.

 

Q:

How does the Board of Directors recommend that I vote?

 

A:

The Board of Directors recommends that you vote your shares:

 

 1)

“FOR” each of the company’s nominees for election as Class I directors (Proposal No. 1);

 

 2)

“FOR” the approval, on a non-binding advisory basis, of the compensation of the named executive officers (Proposal No. 2);

 

 3)“EVERY YEAR” on the frequency of future advisory votes on executive compensation (Proposal No. 3);

4)“FOR” the approval of the 2018 Equity and Incentive Compensation Plan (Proposal No. 4);

5)“FOR” the approval of the amendment to our Amended and Restated Certificate of Incorporation to increase the number of shares of Common Stock authorized for issuance thereunder from 100,000,000 to 150,000,000 (Proposal No. 5); and

6)“FOR” the ratification of the appointment of Deloitte & Touche LLP as comScore’sour independent registered public accounting firm for the fiscal year ending December 31, 20182023 (Proposal No. 3);

4)

“FOR” the approval of an amendment to the 2018 Plan to increase the number of shares of our Common Stock available for grant by 10,000,000 (Proposal No. 4);

5)

“FOR” the adoption of the Certificate of Designations Amendment (Proposal No. 5);

6)

“FOR” the adoption of the Certificate of Incorporation Amendment (Proposal No. 6); and

7)

“FOR” the approval of the Share Issuance (Proposal No. 7).

 

Q:

What happens if additional matters are presented at the 20182023 Annual Meeting?

 

A.A:

If any other matters are properly presented for consideration at the 20182023 Annual Meeting, including, among other things, consideration of a motion to adjourn the 20182023 Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named as proxy holders, Gregory FinkMary Margaret Curry and Carol DiBattisteAshley Wright (each officers of the Company)company), or eitherany of them, will have discretion to vote on those matters in accordance with their best judgment. Other than the matters described in this proxy statement, comScoreComscore does not currently know of any other matters that will be raised at the 20182023 Annual Meeting.

Q:

Can I change my vote?

 

A:

If you are the stockholder of record, you may change your vote by (1) granting a new proxy bearing a later date (which automatically revokes the earlier proxy) using any of the voting methods described above (and until the applicable deadline for each voting method), (2) providing a written notice of revocation to comScore’sComscore’s Corporate Secretary at comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 prior to your shares being voted, or (3) attending the 20182023 Annual Meeting and voting in person.

If you are a beneficial owner of shares held in street name, you may change your vote, subject to any rules your bank, broker or other nominee may have, at any time before your proxy is voted at the 20182023 Annual Meeting, (1) by submitting new voting instructions to your bank, broker or other nominee or (2) if you have obtained a legal proxy from the bank, broker or other nominee that holds your shares giving you the right to vote your shares, by attending the 20182023 Annual Meeting and voting in person.

 

Q:

What happens if I decide to attend the 20182023 Annual Meeting, but I have already voted or submitted a proxy card covering my shares?

 

A:

You may attend the 20182023 Annual Meeting and vote in person even if you have already voted or submitted a proxy card. Any previous votes that were submitted by you by proxy will be superseded by the vote you cast in person at the 20182023 Annual Meeting. Please be aware that attendance at the 20182023 Annual Meeting will not, by itself, revoke a proxy.

If a bank, broker or other nominee beneficially holds your shares in street name and you wish to attend the 20182023 Annual Meeting and vote in person, you must obtain a legal proxy from the bank, broker or other nominee that holds your shares giving you the right to vote the shares.

 

Q:

Are any shares subject to voting restrictions?

A:

For so long as a holder of Series B Preferred Stock beneficially owns voting stock representing at least 5% of the outstanding shares of Common Stock of the company on an as-converted basis, each holder of Series B Preferred Stock agrees to vote, or provide a written consent or proxy with respect to, its shares in the same proportion as all other outstanding Common Stock of the company (excluding any and all voting stock beneficially owned, directly or indirectly, by certain holders of Series B Preferred Stock) (a “neutral manner”) in the election of any directors nominated by the Board, other than pursuant to any Series B Preferred Stock holder’s right to designate such directors pursuant to the terms of the SHA (as defined below). One of the director nominees standing for election at the 2023 Annual Meeting (Ms. Love) was not designated pursuant to a Series B Preferred Stock holder’s right under the SHA; therefore, the holders of the Series B Preferred Stock are required to vote their shares in a neutral manner with respect to her election under Proposal No. 1.

Similarly, if a holder of Series B Preferred Stock holds such shares that, in the aggregate, represent voting rights with respect to more than 16.66% of the company’s Common Stock (the “Voting Threshold”), such

holder will not be permitted to exercise the voting rights with respect to any shares of Series B Preferred Stock held by them in excess of the Voting Threshold and the company shall exercise the voting rights with respect to such shares of Series B Preferred Stock in excess of the Voting Threshold in a neutral manner.

Q:

What should I do if I receive more than one Notice of Internet Availability or set of proxy materials?

 

A:

You may receive more than one Notice of Internet Availability or set of proxy materials, including multiple copies of proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you may receive a separate Notice of Internet Availability or voting instruction card for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more than one Notice of Internet Availability or proxy card. Please complete, sign, date and return each comScoreComscore proxy card or voting instruction card that you receive to ensure that all your shares are voted.

 

Q:

Who will count the votes?

 

A:comScore’s

The Board of Directors has designated representatives of American Stock Transfer & Trust Company, LLC, the Company’s transfer agent,Broadridge Financial Solutions, Inc. to serve as inspector of election.

 

Q:

Where can I find the voting results of the 20182023 Annual Meeting?

 

A:

We intend to announce preliminary voting results at the 20182023 Annual Meeting and will publish final voting results in a Current Report on Form8-K, which will be filed with the SEC within four (4) business days following the 20182023 Annual Meeting.

 

Q:

Who will bear the cost of soliciting votes for the 20182023 Annual Meeting?

 

A:comScore

Comscore will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials and soliciting votes. The Companycompany has engaged Innisfree M&A Incorporated (“Innisfree”) to aid in the solicitation of proxies. The Companycompany will pay Innisfree a fee of $[•]$15,000 as compensation for its services and will reimburse Innisfree for its reasonableout-of-pocket expenses. Our directors, officers and employees may also solicit proxies in person or by other means of communication. Such directors, officers and employees will not be additionally compensated but may be reimbursed for reasonableout-of-pocket expenses in connection with such solicitation.

If you choose to access the proxy materials and/or vote over the Internet, you are responsible for any Internet access charges you may incur.

 

Q:

What is the deadline to propose actions for consideration at next year’s annual meeting of stockholders or to nominate individuals to serve as directors?

 

A:

You may submit proposals, including recommendations of director candidates, for consideration at future stockholder meetings. comScore’sComscore’s bylaws provide for advance notice procedures to recommend a person for nomination as a director or to propose business to be considered by stockholders at a meeting. For the 20192024 annual meeting of stockholders, such nominations or proposals, other than those made by or at the direction of the Board, of Directors, must be submitted in writing and received by our Corporate Secretary at our principal executive offices 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attn: Ashley Wright, no later than January 20, 2019,[●], 2024, which is 90 days prior to the anniversary of the expected first mailing date of notice of availability of this proxy statement, and no earlier than December [●], 2023, which is 120 days prior to the anniversary of the expected mailing date of the notice of availability of this proxy statement. If our 20192024 annual meeting of stockholders is moved more than 30 days before or after the anniversary date of our 20182023 Annual Meeting, then the deadline for such nominations or proposals to be received by our Corporate Secretary is the close of business on the tenth day following the day notice of the date of the meeting was mailed or first made public, whichever occurs first. Such proposals also must comply with all the information requirements contained in the bylaws and applicable requirements of the rules and regulations of the SEC. The chairperson of the stockholder meeting may refuse to acknowledge the introduction of your a

proposal if it is not made in compliance with the foregoing procedures or the applicable provisions of our bylaws. If a stockholder who has notified comScoreComscore of his or her intention to present a proposal at an annual meeting does not appear to present his or her proposal at such meeting, comScoreComscore need not present the proposal for vote at such meeting.

In addition, forFor a stockholder proposal to be considered for inclusion in our proxy statement for the 20192024 annual meeting of stockholders, the proposal must comply with all the requirements of Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and must be submitted in writing and received by our Corporate Secretary at our principal executive offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attn: Ashley Wright, no later than December 21, 2018,[●], 2023, which is 120 days prior to the anniversary of the expected mailing date of the notice of availability of this proxy statement.

A copy of the full text of the bylaw provisions discussed above may be obtained by writing to comScore’sComscore’s Corporate Secretary at our principal executive offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attn: Ashley Wright, or by accessing comScore’sComscore’s filings on the SEC’s website at www.sec.gov.www.sec.gov. All notices of proposals by stockholders, whether or not to be considered for inclusion in comScore’sComscore’s proxy materials, should be sent to comScore’sComscore’s Corporate Secretary at our principal executive offices.

Q:

Q:

How may I obtain a separate copy of the Notice of Internet Availability?

 

A:

If you share an address with another stockholder, each stockholder might not receive a separate copy of the Notice of Internet Availability.Availability, a practice known as “householding.” Stockholders may request to receive separate or additional copies of the Notice of Internet Availability by writing to comScore, Inc.,our Corporate Secretary at our principal executive offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Corporate Secretary.Attn: Ashley Wright or by calling our proxy solicitor, Innisfree, toll-free at (877) 825-8971. Stockholders who have multiple accounts in their names or who share an address with other stockholders can request “householding” and receiveauthorize your broker to discontinue mailings of multiple copiessets of the Notice of Internet Availability can also request to receive a single copyproxy materials by following the instructions above.contacting your broker.

 

Q:

How may I obtain comScore’s 2017Comscore’s 2022 Form10-K and other financial information?

 

A:Stockholders can access our

Our Annual Report on Form10-K for the year ended December 31, 20172022 (the “2017“2022 10-K”), is available at https://materials.proxyvote.com/[]. Stockholders can also access our 2022 10-K and other financial information on the Investor Relations section of our website at www.comscore.com or on the SEC’s website at www.sec.gov.www.sec.gov. Alternatively, current and prospective investors may request a free copy of our 20172022 10-K by writing to comScore, Inc.,our Corporate Secretary at our principal executive offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Corporate Secretary.Attn: Ashley Wright. We also will furnish any exhibit to the 20172022 10-K if specifically requested upon payment of charges that approximate our cost of reproduction.

Q:

Who can help answer my questions?

 

A:

Please contact Innisfree, our legal departmentproxy solicitor, by calling toll-free at (877) 703-438-2000825-8971. or by writing to comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Legal Department.

DIRECTORS, DIRECTOR NOMINEES, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors, Director Nominees and Executive Officers

The names of our directors and executive officers and directors and their ages, positions and biographies are set forth below. Also included for our directors is information regarding their service on other public company boards, and their specific experience, qualifications, attributes andor skills that led to the conclusion that each director should serve on our Board of Directors (“Board”).Board. This information is as of March 15, 2018.April [●], 2023.

 

Name

  Age   

Position

Executive Officers and Executive Director

Jonathan (Jon) Carpenter

47Chief Executive Officer

David Algranati

46Chief Innovation Officer

Mary Margaret Curry

44Chief Financial Officer and Treasurer

Gregory (Greg) Dale

53Chief Operating Officer

Non-Executive Directors

Nana Banerjee (2)(3)(4)

53Chairman of the Board and Class I Director

Itzhak Fisher (1)(5)

67Class III Director

Leslie Gillin (2)(4)

53Class II Director

David Kline (2)(4)

65Class I Director

Pierre Liduena (1)(3)(5)

45Class III Director

William (Bill) Livek

   6368   

President and Executive Vice Chairman and Class II Director

Gregory FinkKathleen (Kathi) Love (2)(3)

70Class I Director

Martin (Marty) Patterson (1)(3)

36Class III Director

Brent Rosenthal (1)(5)

   51   

Chief Financial OfficerLead Director and Treasurer

Class II Director

Carol DiBattisteBrian Wendling (2)(5)

   6650   

General Counsel & Chief Compliance, Privacy and People Officer

Christopher Wilson

51

Chief Revenue Officer

Daniel Hess

49

Chief Product Officer

Joseph Rostock

55

Chief Information and Technology Operations Officer

Non-Employee Directors

Gian Fulgoni*

70

Chairman Emeritus and Class III Director

Dale Fuller

59

Class III Director

Jacques Kerrest(1)(3)

71

Class III Director

Michelle McKenna-Doyle(3)

52

Class III Director

Wesley Nichols(2)

53

Class I Director

Paul Reilly(2)(3)

61

Class I Director

Brent Rosenthal(2)

46

Class II Director

Bryan Wiener(1)

47

Class II Director

*Not standing forre-election at the 2018 Annual Meeting.

 

(1)

Member of Nominating and Governance Committee

 

(2)

Member of Compensation Committee

 

(3)

Member of Audit Committee

(4)

Member of Growth Committee

(5)

Member of Finance and Acquisitions Committee

Executive Officers and Executive Director

William (Bill) LivekJonathan (Jon) Carpenter has served as our Chief Executive Officer since July 2022 and was our Chief Financial Officer and Treasurer from November 2021 to July 2022. Mr. Carpenter previously served as Chief Financial Officer of Publishers Clearing House, a direct marketing and media company, from June 2016 until November 2021. Prior to Publishers Clearing House, he served in divisional CFO roles for Nielsen Company, Sears Holdings and NBC Universal. He began his career with General Electric in the GE Financial Management Program. Mr. Carpenter holds a bachelor’s degree in economics from the University of Vermont.

David Algranati has served as our Chief Innovation Officer since August 2022. Dr. Algranati was our Chief Product Officer from May 2019 to August 2022 and our Senior Vice President, Product Management from January 2016 to May 2019. He previously served as Senior Vice President, Product Innovation and Custom Research at Rentrak Corporation from July 2011 until our merger with Rentrak in January 2016. Prior to Rentrak, he held various roles with Simmons Market Research and Experian. Dr. Algranati holds a bachelor’s degree in political science from The George Washington University, master’s degrees in statistics and public policy from Carnegie Mellon University, and a doctorate in statistics and public policy from Carnegie Mellon University.

Mary Margaret Curry has served as our Chief Financial Officer and Treasurer since July 2022 and as our Chief Accounting Officer since December 2021. Ms. Curry joined Comscore in 2011 and has served in roles of increasing scope and responsibility since then, including as Global Tax Director (August 2011 to July 2015),

Senior Director of Global Tax Compliance and Reporting (July 2015 to May 2018), Vice President of Tax and Treasury (May 2018 to November 2020) and Senior Vice President and Controller (November 2020 to December 2021). Prior to joining Comscore, she spent nine years with KPMG. Ms. Curry holds bachelor’s and master’s degrees in accounting from East Carolina University and is a Certified Public Accountant.

Gregory (Greg) Dale has served as our Chief Operating Officer since August 2022 and was our General Manager, Digital from December 2021 to August 2022. Mr. Dale previously served as Chief Operating Officer of Shareablee, Inc., a social media marketing analytics company, from July 2018 through our acquisition of Shareablee in December 2021. Prior to Shareablee, he was Chief Operating Officer of Persado, an artificial intelligence-based marketing content platform, from April 2016 to February 2018. Mr. Dale previously held senior roles with Comscore from 1999 to 2016, and prior to that, worked with data and analytics firm Information Resources, Inc. He holds a bachelor’s degree from Purdue University.

Non-Executive Directors

Nana Banerjee has served as Chairman of the Board since July 2022 and as a director since March 2021. Dr. Banerjee has served as a senior advisor to the CEO of Cerberus Capital Management, a private equity firm, since September 2021. He also serves on the Board of multiple Cerberus portfolio companies. From March 2020 to September 2021, he served as a Senior Managing Director of Cerberus Global Technology Solutions. Dr. Banerjee brings extensive experience in leading, innovating and scaling analytics and technology businesses globally. Prior to joining Cerberus, he served as the President and CEO of McGraw-Hill, an education solutions company, and a member of its board of directors from April 2018 to October 2019. From September 2012 to March 2018, he was Group President and an Executive Officer of Verisk Analytics, a data analytics company, with responsibility for its high-growth businesses as well as oversight responsibility for its joint data and development environment and its centralized AI and advanced analytics organizations. He joined Verisk as part of its acquisition of Argus Information and Advisory Services, where he was CEO, and co-president and chief operating officer in prior roles. In other prior roles, Dr. Banerjee served as head of Citibank’s credit card business in the United Kingdom and as vice president of marketing and analytics at GE Capital. Dr. Banerjee has a Ph.D. in applied mathematics from the State University of New York, a M.S. degree in mathematics from the Indian Institute of Technology, Delhi, and a B.S. degree with honors in mathematics from St. Stephens College, Delhi. Dr. Banerjee’s extensive experience in analytics and technology enable him to bring valuable perspective to our Board.

Itzhak Fisher has served as a director since March 2021. Mr. Fisher is the Chairman and founder (2014 to present) of Pereg Ventures, a venture capital fund that invests in B2B information services businesses across the United States and Israel. Previously, he served as the EVP of global product, strategy and business development at Nielsen, as founder and Executive Chairman of Trendum, and as President and CEO of RSL Communications, where he built a telecommunications company that operated in over 20 countries and generated more than $1.5 billion in revenues. Mr. Fisher received a B.S. in Computer Science from New York Institute of Technology and completed advanced studies in computer science at New York University. He served on the board of directors of SITO Mobile from June 2017 to July 2018. His other affiliations include the Strategic Advisory Group, Goldman Sachs; Advisory Board, NYU Courant Institute of Mathematical Sciences; and President’s Council, Tufts University. Mr. Fisher brings to our Board substantial experience in creating, operating and investing in digital, media and retail companies.

Leslie Gillin has served as a director since January 2023. Ms. Gillin is Chief Growth Officer of Pagaya Technologies, a financial technology company, where she oversees global growth strategy, business development, marketing, public relations and external communications. She joined Pagaya in October 2021 from JPMorgan Chase, where she served as Chief Marketing Officer of the firm (December 2019 to April 2021) and prior to that was President of Chase’s CoBrand Cards Services (February 2017 to December 2019). Ms. Gillin has also held senior executive leadership positions at Bank of America, Citi and MBNA, including leadership roles in Canada and Europe. She has been recognized as a Top 50 Women Leaders by Women We Admire in

2022, as one of 2022’s Top 25 Women Leaders in Financial Technology by The Financial Technology Report, honored as a Woman of the Year 2022 by The Stevie Awards’ Women in Business and a Top 25 CMO to Watch by Business Insider in 2020. Ms. Gillin serves on the board of directors of Establishment Labs, a Nasdaq-listed women’s biotech company, and has served on the board of The Ad Council, MasterCard UK Forum, the Philadelphia International Council of the Arts, The Please Touch Museum and the Delaware Bankers Association. She holds a degree in international relations and Spanish from the University of Delaware and also attended the University of Salamanca. Ms. Gillin brings a strong background in buy-side media analytics, marketing and financial services to our Board.

David Kline has served as a director since March 2021. Mr. Kline is Executive Vice President at Charter Communications, a communications and media company, and President of Spectrum Reach, the advertising sales division of Charter. Mr. Kline joined Charter in 2015 and provides strategic leadership to guide the company in both the traditional and advanced TV advertising space. Mr. Kline joined Charter from Visible World (now FreeWheel), where he served as President and COO directing their household addressable sales and programmatic advertising efforts. Earlier in his career, he served as President and COO of Cablevision Media Sales (now Altice Media Solutions) for more than 17 years. Mr. Kline serves on the board of directors for the Video Advertising Bureau and private companies Ampersand, Blockgraph (where he was appointed Chairman in April 2022) and Canoe. He received a B.A. in a personalized study program focusing on marketing, finance, accounting and management from Ohio State University. Mr. Kline is a pioneering leader in the traditional and advanced TV advertising space and brings valuable relationships and perspective to our Board.

Pierre Liduena has served as a director since April 2021. Mr. Liduena is Group Vice President, Business Development at Charter Communications, a communications and media company, where he manages strategic partnerships for Charter. Prior to this he was Vice President, Corporate Development at Charter, where he managed M&A and Corporate Ventures activities. Prior to joining Charter in 2012, Mr. Liduena worked at UBS in the Technology, Media & Telecom investment banking group, and at EY in the Audit and Transaction Advisory groups. Mr. Liduena holds a Master in Management from EDHEC Business School in France, and an M.B.A. from the Wharton School of the University of Pennsylvania. In addition, he is a graduate of the Cable Executive Management program at Harvard Business School. Mr. Liduena brings to our Board financial expertise and substantial M&A and industry experience.

William (Bill) Livek has served as our Vice Chairman since January 2016. Mr. Livek was our Chief Executive Officer from November 2019 to July 2022 and our President from January 2016 to May 2018. He previously served as Vice Chairman and Chief Executive Officer of Rentrak Corporation, a media measurement and consumer targeting company, from June 2009 until the Company’s acquisition ofour merger with Rentrak in January 2016. From December 2008 until June 2009,Prior to Rentrak, Mr. Livek was founder and Chief Executive Officer of Symmetrical Capital, an investment and consulting firm. From February 2007 until December 2008, he wasfirm; Senior Vice President, Strategic Alliances and International Expansion, of Experian Information Solutions, Inc., a provider of information, analytical and marketing services,services; and wasco-President of Experian’s subsidiary Experian Research Services from October 2004Services. Mr. Livek has served on the board of directors of the Advertising Research Foundation (“ARF”) since July 2022, and prior to February 2007.that was a member of the ARF board of trustees. He holds a B.S. degree in Communications Radio/Television from Southern Illinois University. Mr. Livek brings substantial industry experience and audience measurement expertise to our Board.

Gregory A. FinkKathleen (Kathi) Love has served as our Chief Financial Officer and Treasurer since October 2017 and previously served as our Executive Vice President, Finance since joining the Company earlier in October 2017. Prior to joining the Company, Mr. Fink was the Senior Vice President, Controller and Chief Accounting Officer at Fannie Mae, a government-sponsored enterprise in the mortgage industry, since 2011. Mr. Fink holds a B.S. in Business Administration with an accounting emphasis from San Diego State University and is a Certified Public Accountant.

Carol DiBattiste has served as our General Counsel & Chief Privacy and People Officer since January 2017 and as our Chief Compliance Officer since April 2017. Ms. DiBattiste previously held positions at the U.S. Department of Veterans Affairs with the Board of Veterans’ Appeals as Executive in Charge and Vice Chairman from August 2016 to January 2017, and Senior Advisor for Appeals Modernization, Office of the Secretary, from May 2016 to August 2016. Prior to that, Ms. DiBattiste served as Executive Vice President, Chief Legal, Privacy, Security, and Administrative Officer of Education Management Corporation, an operator offor-profit post-secondary educational institutions, from March 2013 through March 2016. She also served as Executive Vice President, General Counsel and Chief Administrative Officer of Geeknet, Inc., an online retailer, from April 2011 through March 2013. Ms. DiBattiste holds an L.L.M., Law from the Columbia University School of Law, a J.D. from Temple University School of Law, and a B.A., Sociology-Criminal Justice from LaSalle University.

Christopher Wilson has served as our Chief Revenue Officer since June 2017. Mr. Wilson previously served as our Executive Vice President, Commercial from January 2016 to June 2017. Prior to joining the Company, Mr. Wilson served as President, National Television at Rentrak Corporation from 2010 until the Company’s merger with Rentrak in January 2016. Mr. Wilson holds a Bachelor’s Degree in Broadcast Communications from Southern Illinois University, Carbondale.

Daniel Hess has served as our Chief Product Officer since January 2018. Mr. Hess previously served as our Executive Vice President, Products from September 2016 to December 2017. Prior to joining the Company, Mr. Hess served as an investor in and advisor tostart-ups in digital media and marketing, software service ande-commerce. Previously, Mr. Hess served as Chief Corporate Development Officer of Rewards Network, a loyalty marketing and financial services company, from January 2014 to December 2014. Prior to that, Mr. Hess was Chief Executive Officer, Director andCo-Founder of Local Offer Network, Inc., a technology and marketing services company, from January 2010 to October 2013. Mr. Hess holds a B.A., Psychology from the University of Rochester.

Joseph Rostock has served as our Chief Information Officer since September 2017, and as our Chief Information and Technology Operations Officer since January 2018. Mr. Rostock is also the Principal and Founder of AllosLogic, an advisory and executive management services provider founded in 2017. Prior to joining the Company, Mr. Rostock served as Chief Technology Officer of Inovalon, Inc., a cloud-based analytics platform provider, from 2013 to 2017. Mr. Rostock holds a B.A., Radio, Television and Film from Temple University and also completed graduate studies in Computer Science at St. Joseph’s University.

Non-Executive Directors

Gian M. Fulgoni, one of ourco-founders, has served as Chairman Emeritus of our Board since November 2017. Dr. Fulgoni previously served as our Chief Executive Officer from August 2016 to November 2017, Chairman Emeritus from March 2014 to August 2016, and Executive Chairman from September 1999 to March 2014. Dr. Fulgoni has served on the board of directors of PetMed Express, Inc., an online retailer, since 2002 and previously served on its board from August 1999 to November 2000. Dr. Fulgoni holds an honorary Doctor of Science and an M.A. in Marketing from the University of Lancaster and a B.Sc. in Physics from the University of Manchester. As aco-founder of the Company with substantial industry experience, Dr. Fulgoni is a valued asset to our Board.

Dale Fullerhas served as a director since March 2018. Mr. Fuller hasApril 2019. Ms. Love is currently the CEO of Motherwell Resources LLC, a company devoted to management consulting and executive coaching. Prior to founding Motherwell in 2013, Ms. Love served as Chairmanthe President and CEO of GFK MRI (formerly Mediamark Research). MRI produced audience ratings for the consumer magazine industry in the United States, along with offering a projectable database on the demographics, attitudes, activities and buying behaviors of the BoardU.S. consumer. MRI also developed and sold various software products. In 2018, Ms. Love was inducted into the Market Research Council Hall of DirectorsFame. Prior to joining MRI, Ms. Love held executive positions at The New York Times, EMAP Publishing and The Magazine Publishers of MobiSocial, Inc.,America. She has been an adjunct or guest instructor at Rutgers University, Brooklyn College and Queens College. Ms. Love holds a Stanford-based technology startup, since January 2013. He previously served on the Board of Directors of Quantum Corporation,B.A. degree from Douglass College, Rutgers – The State University, an M.A. from Michigan State University and an M.Phil. from The Graduate

Center, C.U.N.Y. She has advanced to candidacy for a data storagePh.D. in psychology and systems manufacturer, from 2014 to 2016, Chairmanis a professional certified executive coach (PCC) and a member of the Supervisory Board of AVG Technologies N.V., an Internet security and privacy software company, from 2009 to 2016, and President and Chief Executive Officer of MokaFive, a venture-backed software company, from 2008 to 2013. Mr. Fuller brings to our Board experience in the technology industry as both an executive officer and a director of private and publicly traded technology companies.

Jacques Kerrest has served as a director since June 2017. Mr. Kerrest has served as Executive Vice President and CFO of Intelsat S.A., a communications satellite services provider, since February 2016. Prior to his appointment at Intelsat, he held executive-level roles at numerous leading technology and communications companies, including ActivIdentity Corporation, Virgin Media Inc., Harte-Hanks Corporation and Chancellor Broadcasting Company. Previously, Mr. Kerrest served on the boards of directors of several public companies. Mr. Kerrest received his Master of Science Degree from Faculté des Sciences Économiques in Paris, France, and a Masters of Business Administration from Institut D’Etudes Politiques De Paris in Paris, France as well as the Thunderbird School of Global Management in Glendale, Arizona. Mr. Kerrest’s deep financial expertise and background enable him to bring valuable perspective to our Board.

Michelle McKenna-Doyle has served as a director since October 2017. Ms. McKenna-Doyle has served as Senior Vice President and Chief Information Officer of the National Football League since September 2012.International Coach Federation (ICF). She has served on the board of directors of RingCentral, Inc., a leading providerthe Advertising Research Foundation, The Media Behavior Institute and the Market Research Council, of global enterprise cloud communications and collaboration solutions, since March 2015, and Quotient Technology, a digital promotions and media company, since October 2017.which she is past President. She previously servedsits on the board of directorsthe Associate Alumnae of Insperity, Inc., a professional employer organization, from April 2015 to August 2017.    Ms. McKenna-Doyle holds a B.S. in Accounting from Auburn UniversityDouglass College and an MBA fromserves as the Crummer Graduatetreasurer and on the investment committee. She also uses her coaching skills during pro bono work at the Atlas School of Business at Rollins College. She was formerly licensed as a Certified Public Accountant in the State of Georgia. Ms. McKenna-Doyle brings global technology management and senior leadership experience to our Board.for Autism.

Wesley NicholsMartin (Marty) Patterson has served as a director since October 2017. Since January 2017, he has servedMarch 2021. Mr. Patterson currently serves as a Board Partner at Upfront Ventures, a venture capital firm. Mr. Nichols was the Senior Vice President, Strategy of Neustar, Inc., a global provider of real-time information services and analytics, from December 2015 until February 2017. Mr. Nicholsco-founded MarketShare, LLC, a provider of advanced analytic solutions and software, in 2005 and served as its Chief Executive Officer from January 2005 until its acquisition by Neustar in December 2015. Mr. Nichols has served on the board of directors of BJ’s Restaurants, Inc. since December 2013, and the board of directors of TrueCar, Inc., an automotive pricing and information website, since November 2016. He holds a B.A. from Randolph-Macon College and an M.A. from Johns Hopkins University. Mr. Nichols brings extensive experience in the technology and analytics industries to our Board.

Paul Reilly has served as a director since October 2017. Mr. Reilly served as an Executive Vice President of Arrow Electronics,Liberty Media Corporation, Qurate Retail, Inc. through his retirement in January 2017,, Liberty TripAdvisor Holdings, Inc. and previously had served as its Executive Vice President, Finance and Operations, and Chief Financial Officer from 2001 through May 2016, and Head of Global Operations from 2009 through May 2016.Liberty Broadband Corporation. He has servedbeen with Liberty Media Corporation, a media, communications and entertainment company, and its predecessors since 2010. Mr. Patterson currently serves as a director of Cabot Microelectronics Corporation,Skyhook Wireless, Inc. and was formerly a chemical mechanical planarization company, since March 2017, and Assurant, Inc., an insurance company, since June 2011.director of Ideiasnet S.A. He has a B.S. in Accountingreceived his B.A. from St. John’s UniversityColorado College and is a Certified Public Accountant.CFA Charterholder. Mr. ReillyPatterson brings financial expertise and operational experience to our Board.Board extensive experience identifying and evaluating investment opportunities in the technology, media and telecommunications sectors.

Brent D. Rosenthalhas served as Lead Director since July 2022 and as a director since January 2016. He served as Chairman of the Board from April 2018 to July 2022. Mr. Rosenthal is the Founder of Mountain Hawk Capital Partners, LLC.,LLC, an investment fund focused on small and microcap equities in the technology, media, telecom (TMT) and food industries. Mr. Rosenthal has been the Lead Independent Director/Non-Executive Chairman of the board of directors of RiceBran Technologies a food company, since July 2016.2016 and served as an advisor to the board of directors and executive management of FLYHT Aerospace from December 2019 to June 2020 and as a member of the FLYHT Aerospace board of directors since June 2020. He has alsoserved on the board of directors of OmniLit Acquisition Corp. since April 2023. He previously served on the board of directors of SITO Mobile, Ltd., a mobile location-based media platform, since from August 2016 to July 2018, and asNon-Executive Chairman of its board of directors sincefrom June 2017.2017 to July 2018. Previously, Mr. Rosenthal was a Partner in affiliates of W.R. Huff Asset Management where he worked from 2002 to 2016. Mr. Rosenthal served as theNon-Executive Chairman of Rentrak Corporation from 2011 to 2016. He was Special Advisor to the board of directors of Park City Group from November 2015 to February 2018. Mr. Rosenthal earned his B.S. from Lehigh University and MBAM.B.A. from the S.C. Johnson Graduate School of Management at Cornell University. He is an inactive Certified Public Accountant. Mr. Rosenthal brings to our Board financial expertise and experience in the media industry.and information industries.

Bryan WienerBrian Wendling has served as a director since October 2017.March 2021. Mr. Wendling is Chief Accounting Officer and Principal Financial Officer of Liberty Media Corporation, Qurate Retail, Inc. and Liberty Broadband Corporation. He currently serves as Executive Chairmanis also Senior Vice President and Chief Financial Officer of 360i, a digital marketing agency,Liberty TripAdvisor Holdings, Inc. Mr. Wendling has held various positions with these companies and their predecessors since 1999. Prior to joining these companies, he worked in the assurance practice of the accounting firm KPMG. Mr. Wendling has previously served as CEOon the boards of Fun Technologies Inc. and CommerceHub, Inc. He also serves on the board of Clothes to Kids of Colorado. He received his Bachelor of Science degree in accounting from 2005 to 2013. Prior to that,Indiana University. Mr. Wiener wasCo-CEOWendling brings over 25 years of Innovation Interactive, the privately held parent company of 360iaccounting, public reporting and digital media SaaS provider IgnitionOne, from 2004 until it was acquired by Dentsu in 2010. Mr. Wiener’s experience in the digital media and marketing industry allows him to bring valuable perspective and operationalcompliance experience to our Board.

Agreement with Starboard Value LP

Messrs. Nichols, Reilly and Wiener and Ms. McKenna-Doyle were each appointed to our Board in 2017 pursuant to an agreement we entered into on September 28, 2017 with Starboard Value LP and certain of its affiliates (collectively, “Starboard”). Pursuant to the agreement with Starboard and as previously disclosed, Messrs. Nichols, Reilly and Wiener and Ms. McKenna-Doyle have been nominated for election at the 2018 Annual Meeting.

Board Structure, Composition and Leadership

Our Board is presentlycurrently composed of nine10 directors and is divided into three classes (Class I, Class II and Class III) with staggered three-year terms. As previously announced, Gian Fulgoni is retiring fromAt the Board at the 2018 Annual Meeting and is not standing forre-election. Upon Dr. Fulgoni’s retirement, the size of the Board will be reduced from nine to eight directors. Because we have not held an annual meeting for the election of directors since our 2015 annual meeting, at the 20182023 Annual Meeting, our stockholders will elect: (A) three Class III directors to serve for terms expiring at our 2019 annual meeting of stockholders, (B) twoelect four Class I directors to serve for terms expiring at our 20202026 annual meeting of stockholders, and (C) three Class II directors to serve for terms expiring at our 2021 annual meeting of stockholders, in each case, to hold office until their respective successors have been duly elected and qualified.

As discussed in more detail below, the Board has determined that nine of our 10 current directors are independent under applicable standards. The Company’saverage Board tenure of our directors is approximately three years, and the average age of our directors is 56. We asked our directors to voluntarily disclose their race, ethnicity and gender identity. Of the responses we received, three of our current directors are considered diverse (one with respect to race/ethnicity and two with respect to gender).

The following matrix sets forth diversity statistics regarding the members of our Board.

 
Board Diversity Matrix (as of April [], 2023) 

Total Number of Directors

 

  10 
     
   Female  Male  Non-Binary  Did Not Disclose
Gender
 

Part I: Gender Identity

 

Directors

  2       8      0          0          

Part II: Demographic Background

 

African American or Black

  0       0      0          0          

Alaskan Native or Native American

  0       0      0          0          

Asian

  0       1      0          0          

Hispanic or Latinx

  0       0      0          0          

Native Hawaiian or Pacific Islander

  0       0      0          0          

White

  2       7      0          0          

Two or More Races or Ethnicities

  0       0      0          0          

LGBTQ+

          0 

Did Not Disclose Demographic Background

          0 

 
Board Diversity Matrix (as of April 19, 2022) 

Total Number of Directors

 

  10 
     
   Female  Male  Non-Binary  Did Not Disclose
Gender
 

Part I: Gender Identity

 

Directors

  1       9      0          0          

Part II: Demographic Background

 

African American or Black

  0       0      0          0          

Alaskan Native or Native American

  0       0      0          0          

Asian

  0       1      0          0          

Hispanic or Latinx

  0       0      0          0          

Native Hawaiian or Pacific Islander

  0       0      0          0          

White

  1       8      0          0          

Two or More Races or Ethnicities

  0       0      0          0          

LGBTQ+

          0 

Did Not Disclose Demographic Background

          0 

Stockholders Agreement

On March 10, 2021, we entered into a Stockholders Agreement (“SHA”) with Charter Communications Holding Company, LLC (“Charter”), Qurate Retail, Inc. (“Qurate”) and Pine Investor, LLC (“Pine,” and together with Charter and Qurate, the “Investors”) in connection with the Investors’ purchase of our Series B Preferred Stock. Under the SHA, we agreed to take all necessary action to ensure that our Board includes two designees of each Investor and that certain committees of the Board are constituted as set forth in the SHA. In accordance with the SHA, David Kline and Pierre Liduena were designated by Charter, Marty Patterson and Brian Wendling were designated by Qurate, and Nana Banerjee and Itzhak Fisher were designated by Pine. For the avoidance of doubt, it is our understanding that Dr. Banerjee, Mr. Liduena and Mr. Patterson, who serve on our Audit Committee, are not executive officers of Pine, Charter or Qurate, respectively. Pursuant to the SHA, we are

obligated to take all necessary action (to the extent not prohibited by applicable law) to cause the Board to nominate each Investor’s designee(s) for election until such time as such Investor beneficially owns a certain percentage of Series B Preferred Stock or Voting Stock (as defined in the SHA) as set forth in the SHA.

Board Leadership

Our governance framework provides the Board with flexibility to select the appropriate Board leadership structure for the Company.company. In making leadership structure determinations, our Board considers many factors, including the specific needs of the Companycompany and what is in the best interests of the Company’sour stockholders. The Company may have, at the discretion of the Board, a Chief Executive Officer and a Chairman of the Board. While the Board does not currently have a formal policy on whether the role of the Chief Executive Officer and Chairman of the Board should be separate, since 2016 the Board has selectedelected its Chairman from among the independent non-employee directors, and anticipates that if the Chairman is notdirectors.

Dr. Banerjee, an independent non-employee director, the Board would designate a lead independent director. As a result of recent retirements and departures, we do not currently have a Chief Executive Officer orserves as Chairman of the Board. However,Mr. Rosenthal, also an independent director and a Disinterested Director (as defined above), currently serves as Lead Director with responsibility for coordinating meetings and duties of the Board has formed a CEO Search Committee to directDisinterested Directors, among other things. We believe this structure is appropriate for the search for a new Chief Executive Officercompany at this time, based on the current composition of our Board and the Board anticipates appointing a Chairmandiverse interests of the Board from among its current directors concurrent with the conclusion of its search for a new Chief Executive Officer.our stockholders.

Standing Committees of the Board of Directors

Our Board has a standing Audit Committee, Compensation Committee and Nominating and Governance Committee. OurIn addition to the standing committees, the Board has appointed two special committees (the Finance and Acquisitions Committee and the Growth Committee) to identify and evaluate financing, M&A, business development and growth opportunities as delegated by the Board. The Board and its committees meet regularly throughout the year and also hold special meetings and act by written consent from time to time as appropriate. Our

The Board has determined that all standing committee members are independent within the meaning of the requirements of the Sarbanes-Oxley Act of 2002, The Nasdaq Stock Market (“Nasdaq”), and the rules and regulations of the SEC, as applicable. Each standing committee of our Board operates under a written charter approved by ourthe Board, each of which is available under “Corporate Governance” on the Investor Relations section of our website at www.comscore.com.www.comscore.com. Our Board has delegated various responsibilities and authority to its standing committees as generally described below.

Audit Committee.Committee. We have a separately-designatedseparately designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934.Act. The Audit Committee’s responsibilities include appointing and overseeing the work of our independent auditors, reviewing the adequacy and effectiveness of our system of internal controls, and reviewing and discussing with management and the independent auditors the Company’scompany’s annual audited financial statements and quarterly unaudited financial statements.statements, and overseeing the company’s enterprise risk management activities and legal and regulatory compliance programs. Among other things, the Audit Committee is charged with setting the overall corporate tone for quality financial reporting, sound business risk practices and ethical behavior.

Our Audit Committee met seven times (including telephonic meetings, but not including actions by written consent) during 2022. The Audit Committee is currently composed of Nana Banerjee (Chair), Pierre Liduena, Kathi Love and Marty Patterson. For the avoidance of doubt, it is our understanding that Dr. Banerjee, Mr. Liduena and Mr. Patterson are not executive officers of Pine, Charter or Qurate, respectively. The Board has determined that each member of Mr. Kerrest, Ms. McKenna-Doyle and Mr. Reilly arethe Audit Committee is an “audit committee financial experts”expert” as defined under SEC rules. Designation or identification of a person as an audit committee financial expert does not impose any duties, obligations or liability that are greater than the duties, obligations or liability imposed on such person as a member of the Audit Committee and the Board in the absence of such designation or identification. We believe that the composition and functioning of our Audit Committee complies with all applicable requirements of the Sarbanes-Oxley Act of 2002 and Nasdaq and SEC rules and regulations. Our Audit Committee met 23 times (including telephonic meetings) during 2017.

Compensation Committee.Committee. The Compensation Committee reviewsCommittee’s responsibilities include reviewing and approves and/approving or recommendsrecommending to our Board the compensation and benefits forof our executive officers administersand non-employee directors,

administering our incentive compensation and equity compensation plans, reviewing and establishesdiscussing with management our activities related to corporate culture and reviews generaltalent development, and making recommendations to the Board regarding compensation-related policies relating to compensation and benefits for our employees. Ourprocedures. The Compensation Committee may form and delegate authority to subcommittees when appropriate, including in connection with the allocation of equity awards (subject to conditions and limitations established by the Compensation Committee).

Our Compensation Committee met 10 times (including telephonic meetings, but not including actions by written consent) during 2022. The Compensation Committee is currently composed of Kathi Love (Chair), Nana Banerjee, Leslie Gillin, David Kline and Brian Wendling. We believe that the composition and functioning of our Compensation Committee complies with all applicable requirements of the Sarbanes-Oxley Act of 2002 and Nasdaq and SEC rules and regulations. Our Compensation Committee met 13 times (including telephonic meetings) during 2017.

Nominating and Governance Committee.Committee. The Nominating and Governance Committee is responsible for, among other things, reviewingCommittee’s responsibilities include evaluating the composition and size of theour Board, determining criteria for Board membership, identifying and recommending candidates for Board membership, overseeing annual Board and ensuring thatcommittee evaluations, recommending to the Company hasBoard a management succession plan, and follows appropriatereviewing and overseeing our corporate governance standards.policies and procedures.

Our Nominating and Governance Committee met 12 times (including telephonic meetings, but not including actions by written consent) during 2022. The Nominating and Governance Committee is currently composed of Itzhak Fisher (Chair), Pierre Liduena, Marty Patterson and Brent Rosenthal. We believe that the composition and functioning of our Nominating and Governance Committee complies with all applicable requirements of the Sarbanes-Oxley Act of 2002 and Nasdaq and SEC rules and regulations. The Nominating and Governance Committee met eight times (including telephonic meetings) during 2017.

Risk Management

Our Board has an active role, as a whole and also at the committee level, in overseeing management of our company’s risks. OurThe Board regularly reviews information regarding our credit, liquidity and operations, as well as the risks associated with each. Our Audit Committee oversees management of financial, regulatory, security (including cybersecurity) and compliance risks, including our enterprise risk management program, and receives quarterly reports from our Chief Compliance Officer regarding compliance and regulatory risks. Our Compensation Committee is responsible for overseeing management of risks relating to our executive compensation plans and arrangements. Our Audit Committee oversees management of financial risks. Our Nominating and Governance Committee evaluates risks associated with the independence and composition of our Board, our governance practices and potential conflicts of interest.management succession. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, our entire Board is regularly informed about such risks through committee reports, attendance at committee meetings and otherwise.

Board of Directors and Committee Meeting Attendance

Our Board met 3813 times (including telephonic meetings)meetings, but not including actions by written consent) during 2017.2022. Each of our current directors attended at least seventy-five percent (75%)75% of the aggregate of (i) the total number of meetings held by the Board during the period in 20172022 for which he or she was a director and (ii) the total number of meetings held by each standing committeeall committees of the Board on which such individual served during the period in 20172022 for which he or she served as a committee member.

IndependentThe independent and non-management members of theour Board regularly meet in executive session without management present.

Annual Meeting Attendance

We encourage, but do not require, our directorsDirectors are expected to attend our annual meeting of stockholders. Threestockholders absent extraordinary circumstances. All of our eight then-servingthen-current directors attended our 20152022 annual meeting of stockholders, which was the last annual meeting of stockholders held by the Company.stockholders.

Director Nomination Process and Qualifications

Our Nominating and Governance Committee identifies director nominees by first reviewing the appropriate skills, qualifications and experience required of directors, as well as the composition of the Board as a whole, taking into consideration our obligations under the SHA. While the Nominating and Governance Committee has not established specific minimum qualifications for director candidates, the committee’s assessment includes factors such as judgment, integrity, business acumen, leadership, experience with companies of comparable size or industry, the interplay of a candidate’s experience with the experience of other directors (which may include experience with operating management, public company governance, financing, strategy and marketing), the extent to which a candidate would be a desirable addition to the Board and any committees of the Board, a candidate’s commitment to promoting the long-term interests of our stockholders, his or her ability to devote adequate time to Board responsibilities, director independence and other attributes relevant to satisfying SEC and Nasdaq requirements, and any other factors that the Nominating and Governance Committee deems relevant to the needs of the Board.

Since 2019, our Board has also maintained a policy to promote diversity among the members nominated for election to the Board. The Board believes that a diverse membership with varying perspectives and breadth of experience is an important attribute of a well-functioning Board, and diversity (based on factors commonly associated with diversity such as race, ethnicity, nationality, gender identity and expression, sexual orientation, religion and disability, as well as on broader principles such as diversity of perspective and experience) is one of the elements the Nominating and Governance Committee considers when identifying and evaluating the composition of the Board. Pursuant to the Board diversity policy, when conducting a director candidate search or otherwise identifying potential director candidates to fill one or more vacancies or newly created directorships on the Board, the Nominating and Governance Committee has committed to include among the individuals it identifies as potential candidates at least one diverse candidate.

Within the framework described above, the Nominating and Governance Committee evaluates the current members of our Board who are willing to continue in service.service. Current members with skills and experience that are important to our business and who are willing to continue in service are considered for nomination.nomination. If any member of the Board does not wish to continue in service, or if the Nominating and Governance Committee or Board decides not to nominate a member forre-election, the committee identifies the desired skills and experience of a new nominee or, where appropriate, considers whether to reduce the size of the Board.Board. Current members of the Board and senior management are then asked for their recommendations. We have also engaged third-party search firms from time to time to identify and evaluate potential nominees.

As discussed under “Board Structure, Composition and Leadership – Stockholders Agreement,” the Investors have certain rights to designate director nominees in accordance with the SHA. The Nominating and Governance Committee has also considered (and will continue to consider)considers nominees recommended by other stockholders, and anyusing the same criteria described above. Any such recommendations should be forwarded to our Corporate Secretary in writing at our executive offices as identified in this proxy statement.statement. In accordance with our bylaws, such recommendations should include the following information:

 

the name, age, business address and residence address of the proposed candidate;

 

the principal occupation or employment of the proposed candidate;

 

the class and number of shares of our stock (or other rights with respect to our stock) that the proposed candidate beneficially owns;

 

a completed questionnaire (in a form provided by our Corporate Secretary upon written request) with respect to the identity, background and qualifications of the proposed candidate;

a description of all arrangements or understandings between the stockholder making the recommendations and each director nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder; and

any other information relating to such director candidate that is required to be disclosed in solicitations of proxies for elections of directors or is otherwise required pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (including without limitation such nominee’s written consent to being named in any proxy statement as a nominee and to serve as a director if elected).

While our Nominating and Governance Committee has not established specific minimum qualifications for director candidates, the committee evaluates individual director candidates based upon a number of criteria, including:

a high degree of personal and professional integrity;

commitment to promoting the long-term interests of our stockholders;

business experience and acumen, which may include experience in management, finance, marketing and/or accounting, with particular emphasis on technology companies;

adequate time to devote attention to the affairs of our company;

an ability to bring balance to our Board in light of our company’s current and anticipated needs and in light of the skills and attributes of the other Board members; and

other attributes relevant to satisfying the requirements imposed by the SEC and Nasdaq.

We believe that our Board represents a desirable mix of backgrounds, skills, and experience, and that our directors share the personal attributes of effective directors described above.While we do not have a formal written policy on director diversity, the Nominating and Governance Committee and our Board also consider diversity when reviewing the overall composition of our Board, and considering the slate of nominees for election to our Board and the appointment of individual directors to our Board.Diversity, in this context, includes factors such as experience, specialized expertise, geographic location, cultural background, gender and ethnicity.

Director and Director Nominee Independence

OurThe Board has determined that each of Messrs. Fuller, Kerrest, Nichols, Reilly,Nana Banerjee, Itzhak Fisher, Leslie Gillin, David Kline, Pierre Liduena, Kathi Love, Marty Patterson, Brent Rosenthal and Wiener and Ms. McKenna-DoyleBrian Wendling is independent under theSEC rules of the SEC and Nasdaq listing standards. Our Board also determined that each of William Engel, Russell Fradin, Lisa Gersh, Mark Harris, William Henderson, Ronald Korn, Joshua Peirez and Susan Riley was independent under the rules of the SEC and Nasdaq listing standards during his or her service as a director in 2017. Therefore, each member of the Audit Committee, Compensation Committee and Nominating and Governance Committee during 20172022 was, and each current member is, independent in accordance with those rules and standards.standards during the time that he or she served. In addition, our Board was composed of a majority of independent directors at all times during 2017.2022 and continues to be so composed. In determining the independence of our directors, our Board considered all transactions in which we and any director had any interest, including those involving payments made by us to or from companies in the ordinary course of business where any of our directors (oror their immediate family members)members serve on the board of directors or as a memberin management or advisory roles, payments made in connection with our acquisition of Shareablee, current and prior employment relationships of the executive management team.directors or their immediate family members, and compensation for service in Board leadership roles.

Compensation Committee Interlocks and Insider Participation

During 2017, Mr. HendersonIndependent directors Nana Banerjee, David Kline, Kathi Love and Mr. FradinBrian Wendling served as members of the Compensation Committee until their resignation as directors and members of the Compensation Committee in September 2017. The Compensation Committee was reconstituted in October 2017, with Paul Reilly, Wesley Nichols, Susan Riley and Brent Rosenthal appointed as members. Ms. Riley resigned as a director and member of the Compensation Committee in March 2018.

during 2022. No person who served as a member of the Compensation Committee during 20172022 was an officer or employee of the Companyour company during such year or a prior year. Mr. Fradin, who served on the Compensation Committee until September 2017, previously served as Executive Vice President, Corporate Development of the Company from June 2000 to June 2004.

In 2017,Moreover, none of our executive officers served on the board of directors or compensation committee of any entity that had one or more of its executive officers serving on our Board or Compensation Committee.Committee during 2022.

Mr. Wendling serves as an executive officer of Qurate. In 2022, we recognized revenue of approximately $0.9 million from transactions with Qurate and its affiliates in the normal course of business.

Code of Business Conduct and Ethics

We haveOur Board has adopted a Code of Business Conduct and Ethics that applies to all directors, officers and employees of the Company,company, including our principal executive officer, principal financial officer and principal accounting officer or controller.officer/controller, and persons performing similar functions. The full text of our Code of Business Conduct and Ethics is posted under “Corporate Governance” on the Investor Relations section onof our website at www.comscore.com. Wewww.comscore.com. To the extent permissible under Nasdaq rules, we intend to disclose any amendments to our Code of Business Conduct and Ethics or waivers thereto that apply to our principal executive officer, principal financial officer or principal accounting officer or officer/controller by posting such information on the same website.

Reporting and Non-Retaliation Policy

Our Board has adopted a reporting and non-retaliation policy to encourage employees and others to disclose wrongdoing or suspected wrongdoing that could adversely impact the company, our reputation, or our stockholders, customers, employees or other stakeholders, and to set forth the procedures by which reports should be made, investigated and addressed.

Corporate Governance Guidelines

Our Board has adopted written Corporate Governance Guidelinescorporate governance guidelines that set forth key principles thatto guide its actions, including:

the Board’s commitment to appropriate diversity among the candidates nominated for election to the Board;

limits on outside boards, including that directors who are executive officers of the rolecompany may serve on the board of any lead independent director appointed bydirectors of no more than two public companies, including our Board, and non-management directors should not serve on more than four public company boards, including our Board;

a requirement that a substantial majority of the members of our Board must be independent;

a commitment to appointing a Lead Independent Director should the roles of Chairman and Chief Executive Officer ever be combined; and

a commitment to an annual review of the performance of the Board. and its committees.

Stock Ownership Guidelines forNon-Employee DirectorsDirector Resignation Policy

Our Board has adopted written a director resignation policy, which provides that any nominee for director who receives a majority of “withhold” votes in an uncontested election of directors is expected to tender his or her resignation promptly following the certification of the election results. In such event, the Nominating and Governance Committee will promptly consider the tendered resignation and will recommend to the Board whether to accept or reject the resignation. The Board will act on the Nominating and Governance Committee’s recommendation no later than 90 days following the certification of the stockholder vote. The company will promptly disclose the Board’s decision (and, if the Board rejects the resignation, the Board’s reasons for doing so).

Board Diversity Policy

As described above, our Board has adopted a policy to promote diversity among the members nominated for election to the Board. Pursuant to this policy, when conducting a director candidate search or otherwise identifying potential director candidates to fill one or more vacancies or newly created directorships on the Board, the Nominating and Governance Committee has committed to include among the individuals it identifies as potential candidates at least one diverse candidate. The Nominating and Governance Committee reviews the Board diversity policy and its effectiveness annually.

Compensation Policies

Stock Ownership Guidelines forNon-Employee Directors

Our Board has adopted stock ownership guidelines to further align the interests of ournon-employee directors with thelong-term interests of our stockholders.Eachnon-employeedirectors and executive officers with those of our stockholders. Under the guidelines, each director on our Board is expected to hold a number ofown shares of our Common Stock with a value equal to at least twofive times the director’s annual cash retainer for service on the Board. For executive officers, the Chief Executive Officer is expected to own shares of Common Stock with a value equal to at least five times his or her annual retainerbase salary, and the Chief Financial Officer, Chief Operating Officer and other named executives are expected to own shares of Common Stock with a value equal to at least three times their respective annual base salaries. Equity award holdings that qualify toward satisfaction of the guidelines include shares underlying vested stock options (less the value of the aggregate exercise price), restricted stock and restricted stock units (“RSUs”), and deferred stock units. Awards subject to performance conditions are not counted until such awards are earned. A director or executive officer has five years from the date of becoming subject to the guidelines to achieve compliance and must hold 100% of the net shares acquired upon vesting or exercise of any equity award until he or she has satisfied the guidelines.

Clawback Policy

Our Board has adopted a clawback policy that provides for servicerecovery of executive compensation in the event of an accounting restatement, fraud, error or egregious conduct. Our clawback policy provides that, upon recommendation from the Compensation Committee, (i) if an accounting restatement occurs, the Board will seek to recover (a) any excess incentive-based compensation from an executive officer determined to have committed misconduct resulting in the restatement and (b) any compensation recoverable from the Chief Executive Officer

or Chief Financial Officer under Section 304 of the Sarbanes-Oxley Act of 2002; (ii) the Board will seek to recover any incentive-based compensation or other compensation from an executive officer if the compensation was determined to be based on our Board, exclusive of retainers for servingfinancial results or operating metrics that were satisfied as a memberresult of such executive officer’s knowing or chairintentional fraudulent or illegal conduct; (iii) the Board will seek to recover from an executive officer any incentive-based compensation it determines was awarded due to an error in the calculation of such compensation; and (iv) the Board will seek to recover from an executive officer who engages in egregious conduct (as defined below) any compensation that the Board reasonably deems appropriate. For purposes of part (iv), which was added in 2020 in response to stockholder feedback, “egregious conduct” includes an executive officer’s felony conviction, theft or embezzlement, illegal drug use, material breach of an employment agreement, gross negligence or willful misconduct, breach of fiduciary duty, willful refusal to perform assigned duties, or material breach of our code of conduct or other policies, including (but not limited to) conduct involving sexual harassment, prohibited relationships or unlawful discrimination.

Anti-Hedging and Pledging Policy

We maintain a robust anti-hedging and pledging policy, which prohibits our directors, executive officers, their family members and any entities they control from hedging and pledging Comscore equity securities as collateral for a loan or purchasing such securities on margin. More specifically, our policy prohibits covered persons from engaging in any type of hedging transaction with respect to Comscore equity securities, including but not limited to short sales, options (other than options pursuant to our incentive compensation plans), puts, calls, collars and other derivative securities, monetization transactions, prepaid variable forward contracts, equity swaps and exchange funds.

Insider Trading Policy and Preclearance Requirements

Our insider trading policy, which covers all directors, officers and employees of the company, prohibits the unauthorized disclosure of any nonpublic information acquired in the course of service with the company and the misuse of material nonpublic information in securities trading. The policy applies to all transactions involving Comscore securities or the securities of other companies as to which material nonpublic information is obtained in the course of service with Comscore. Moreover, the policy covers any arrangements that affect economic exposure to changes in the prices of these securities, including transactions in derivative securities (such as put or call options), hedging transactions and short sales. The policy also prohibits trading or tipping based on material nonpublic information. We maintain quarterly trading blackout periods for all directors, officers and designated employees, and we require our directors, officers and employees with access to sensitive information to obtain preclearance for any transaction in Comscore securities, even during open trading windows. These individuals are also prohibited from engaging in transactions in publicly traded options, such as puts and calls, and other derivative securities with respect to Comscore securities (other than options, appreciation rights and other securities issued pursuant to our benefit plans or compensatory arrangements). This prohibition extends to any hedging or similar transaction designed to decrease the risks associated with holding Comscore securities.

Political Activity Policy

Our Board committee,has adopted a political activity policy that gives the Nominating and Governance Committee oversight over any lobbying and political activities conducted by our company. The policy states that such activities will be conducted for the purpose of promoting the commercial interests of the company as a whole, be in furtherance of the interests of our stockholders, and be in compliance with applicable laws, rules and regulations. The policy further provides that employees may not make or commit to maintain this minimum amountmake political contributions on behalf of stock ownership throughoutthe company, and we will not reimburse or otherwise compensate an employee for his or her tenure on the Board. Directors are expected to achieve the applicable level of ownership within five years of joining the Board.personal political contributions.

DIRECTOR COMPENSATION

Cash Retainers

During 2017,2022, ournon-employee directors were eligible to receive an annual cash retainer of $30,000$50,000 for their service on the Board, of Directors. Until November 7, 2017,and our Board Chair (Mr. Henderson until September 10, 2017, and Ms. Riley from September 10, 2017 until March 25, 2018)Chairman was eligible to receivefor an additional annual cash retainer of $120,000. On November 7, 2017,$150,000. Effective July 6, 2022, the Board approved a monthly cash stipend of $33,500 for the then-Board Chair (Ms. Riley), which temporarily replaced theappointed Mr. Rosenthal as Lead Director and established an additional annual cash retainer of $150,000 for such position. The Board’s approval of the temporary cash stipend was in consideration of the significant increase in responsibilities, heightened oversight and time commitment required of the Board Chair due to our then-ongoing audit process, efforts to regain compliance with SEC periodic reporting requirements, and CEO transition.

role. Non-employee directors were also eligible to receive annual cash retainers for their service on certain Board committees, in 2017, as set forth below. Cash retainers were paid quarterly in arrears. The Special Committee was constituted on August 29, 2017,arrears and were prorated for directors who joined or left the CEO Search Committee was constituted on October 24, 2017. Annual cash retainers forBoard, a leadership role, or relevant committees during the Compensation Committee Chair and the Nominating and Governance Committee Chair were increased on November 7, 2017.year.

 

Committee

  Chair
(pre-Nov. 7)
   Chair
(post-Nov. 7)
   Member         Chair           Other Members   

Audit

  $18,000   $N/A   $10,000    $        30,000    $        15,000 

Compensation

   10,000    15,000    5,000    15,000    7,500 

Nominating and Governance

   7,500    10,000    3,000    10,000    5,000 

Special

   40,000    40,000    40,000 

CEO Search

   10,000    10,000    10,000 

Finance

   15,000    7,500 

Growth

   N/A   5,000 

On

Equity Compensation

For the 2022-2023 director compensation term, which began on July 31, 2017, the Board approved a quarterly cash stipend of $50,000 for the then-Audit Committee Chair (Ms. Riley), which temporarily replaced the annual cash retainer for such position.

As described under Compensation Discussion and Analysis, we temporarily stopped granting equity awards to1, 2022, our directors and employees in 2016 as a result of our delay in filing periodic reports with the SEC. Furthermore, our 2007 Equity Incentive Plan expired by its terms in March 2017 and no new awards could be made thereunder. Consequently, ournon-employee directors did not receive any equity awards in 2017.

On November 7, 2017, the Board evaluated the compensation program fornon-employee directors and determined that it would be appropriate for eachwere eligiblenon-employee director to receive an annual restricted stock unit (“RSU”) awarda number of 8,320 RSUs which is equal to $250,000 divided by the closing market price of our Common Stock on November 7, 2017the date of grant. In light of declines in our stock price, however, our directors elected to reduce their compensation and use a price of $2.50 to determine the number of RSUs to award, rather than using the closing price on the date of grant ($30.05),2.04). This resulted in a significant reduction in the number of RSUs otherwise due to each director for the term. The Board elected to use the higher price in order to further align directors’ interests with those of our stockholders. The 2022-2023 RSUs, which were granted on July 6, 2022, will vest in full on the earliest of (i) June 30, 2023, (ii) the date of our 2023 Annual Meeting, and (iii) the date of a change in control of the company, subject to continued service on the Company having an effective equity planBoard through the applicable vesting date. Once vested, the RSUs will be deferred and settled in place and being able to make such awardsshares of Common Stock upon the earlier of a director’s separation from service or a change in accordance with applicable rules and regulationscontrol of the SECcompany.

As previously disclosed, in 2022 Mr. Rosenthal also received the remainder of his RSU award for a prior compensation term. This award, which was granted on March 15, 2022, vested in full on the date of our 2022 annual meeting of stockholders and will be settled in shares of Common Stock upon the termsearlier of Mr. Rosenthal’s separation from service or a change in control of the company.

Additional Compensation Reduction (after December 31, 2022)

On February 22, 2023, in furtherance of our previously announced efforts to improve cost efficiency and conditionsalign resources with strategic priorities, the Board determined to implement an additional reduction in director compensation effective March 1, 2023. The Board’s action included a reduction of any applicable Companymore than 30% in the target value of annual equity plan. The RSU awards would be prorated for directors who joined(from $250,000 to $170,000), as well as a 50% reduction in the Lead Director retainer (from $150,000 to $75,000) and reductions in Audit Committee and Finance Committee retainers. On an annualized basis, the new program provides for a 26% reduction in total target compensation for the Board after July 1, 2017.relative to the previous program.

OtherDirector Compensation

On September 10, 2017, we entered into the following arrangements in connection with the resignation of Messrs. Engel, Fradin, Henderson and Korn (the “Resigning Directors”) from our Board:

Upon the Company regaining compliance with SEC periodic reporting requirements and having an effective equity plan in place, the issuance and immediate vesting of RSUs with a value of $125,000 at the time of grant, as compensation for each Resigning Director’s service for the 2016-2017 Board term (consistent with our director compensation program for such term);

As compensation for each Resigning Director’s service during the 2017-2018 Board term (through the resignation date), and in consideration for such Resigning Director’s agreement to be available to assist the Company with litigation and other matters through June 30, 2018, (a) payment of $30,000 in cash to each Resigning Director on or prior to September 30, 2017, and (b) issuance of an additional $125,000 in immediately vested RSUs to each Resigning Director upon the Company regaining compliance with SEC periodic reporting requirements and having an effective equity plan in place; and

Acceleration and immediate vesting of 13,503 RSUs previously granted to Mr. Engel for his prior service to Rentrak.

The following table sets forth summary information concerning compensation for thenon-employee members of our Board in 2017. Employee directors were not compensated2022. Mr. Livek’s compensation for Board service in addition to their regular employee compensation.as a non-employee director following his retirement as our Chief Executive Officer is included under “Executive Compensation – Summary Compensation Table”

below. We reimbursedreimburse all of our directors for reasonableout-of-pocket expenses incurred in the performance of their duties as directors. Such expense reimbursements are not included as a component of compensation in the table below.

 

Name

  Fees Earned
or Paid in
Cash

($)
   Stock
Awards
($)
  Option
Awards
($)
  All Other
Compensation

($)
  Total
($)
 

William Engel (1)

   17,609    —  (2)   304,881 (3)   30,000 (4)   352,490 

Russell Fradin (5)

   21,087    —     —     30,000 (6)   51,087 

Lisa Gersh (7)

   9,096    —     —     —     9,096 

Mark Harris (8)

   10,237    —     —     —     10,237 

William Henderson (9)

   114,478    —     —     30,000 (10)   144,478 

Jacques Kerrest (11)

   27,119    —     —     —     27,119 

Ronald Korn (12)

   26,609    —     —     30,000 (13)   56,609 

Michelle McKenna-Doyle (14)

   10,245    —     —     —     10,245 

Wesley Nichols (15)

   20,217    —     —     —     20,217 

Joshua Peirez (16)

   9,096    —     —     —     9,096 

Paul Reilly (17)

   12,976    —     —     —     12,976 

Susan Riley (18)

   188,227    —     —     —     188,227 

Brent Rosenthal

   47,826    —     
—  
 
(19) 
  —     47,826 

Bryan Wiener (20)

   17,853    —     —     —     17,853 

Name

  Fees Earned or
Paid in Cash
($)
   Stock Awards
($) (1)
     Total
($)
 

Nana Banerjee (2)

                 164,212                204,000   (3          368,212 

Itzhak Fisher

   67,500    204,000   (4  271,500 

Irwin Gotlieb (5)

   28,247       (6  28,247 

David Kline

   62,500    204,000   (7  266,500 

Pierre Liduena

   85,000    204,000   (8  289,000 

Kathi Love

   80,000    204,000   (9  284,000 

Marty Patterson

   70,000    204,000   (10  274,000 

Brent Rosenthal (11)

   212,500    353,999   (12  566,499 

Brian Wendling

   65,000    204,000   (13  269,000 

 

(1)Mr. Engel resigned from

Amounts reflected in this column represent the aggregate grant date fair value of stock awards computed in accordance with Financial Accounting Standards Board effective September 10, 2017.

(2)In connection with Mr. Engel’s resignation, we agreed to the acceleration and immediate vesting of 13,503 RSUs previously granted to Mr. Engel for his prior service to Rentrak. We did not recognize incremental expense in connection with the acceleration.
(3)Amount represents incremental expense recognized in the year of termination of service for awards granted in prior years, in connection with an extension of option exercisability for option holders who ceased providing services to the Company prior to our regaining compliance with SEC filing requirements.(FASB) Accounting Standards Codification Topic 718, or ASC Topic 718. Assumptions used in the calculation of this amountthese amounts are described in Note 135 to the consolidated financial statements included in Item 8our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

(2)

Dr. Banerjee was appointed Chairman of the 201710-K.Board effective July 6, 2022.

(3)

Amount reflects an RSU award for the 2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2017,2022, Dr. Banerjee held vested, deferred stock units with respect to 77,069 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock. The company understands that Dr. Banerjee has assigned his interests in 77,069 shares to Cerberus Capital Management, L.P.

(4)

Amount reflects an RSU award for the 2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2022, Mr. EngelFisher held vested, deferred stock units with respect to 77,069 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock. He also held exercisable options with respect to 23,000133,986 shares of our Common Stock.

(4)Amount represents cash payment madeStock and unvested options with respect to 23,643 shares of our Common Stock, in September 2017each case assumed in connection with Mr. Engel’s resignation from the Board.our acquisition of Shareablee in 2021.

(5)

Mr. Fradin resigned fromGotlieb left the Board effective September 10, 2017. on July 5, 2022.

(6)

As of December 31, 2017,2022, Mr. FradinGotlieb did not hold any outstanding awards with respect to our Common Stock.

(6)Amount represents cash payment made in September 2017 in connection with Mr. Fradin’s resignation from the Board.

(7)Ms. Gersh joined

Amount reflects an RSU award for the Board on June 9, 2017 and resigned from the Board effective September 10, 2017.2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2017, Ms. Gersh did not hold any outstanding awards2022, Mr. Kline held vested, deferred stock units with respect to 77,069 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock. The company understands that Mr. Kline has assigned his interests in these shares to Charter.

(8)Mr. Harris joined

Amount reflects an RSU award for the Board on June 9, 2017 and resigned from the Board effective September 10, 2017.2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2017,2022, Mr. Harris did not hold any outstanding awardsLiduena held vested, deferred stock units with respect to 67,177 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock. The company understands that Mr. Liduena has assigned his interests in these shares to Charter.

(9)Mr. Henderson resigned from

Amount reflects an RSU award for the Board effective September 10, 2017.2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2017, Mr. Henderson did not hold any outstanding awards2022, Ms. Love held vested, deferred stock units with respect to 181,431 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock.

(10)

Amount represents cash payment made in September 2017 in connectionreflects an RSU award for the 2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2022, Mr. Henderson’s resignation from the Board.Patterson held vested, deferred stock units with respect to 77,069 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock.

(11)

Mr. Kerrest joinedRosenthal served as Chairman of the Board on June 9, 2017.through July 5, 2022 and was appointed Lead Director effective July 6, 2022.

(12)

Amount reflects (i) an RSU award representing partial compensation for the 2021-2022 term with a grant date fair value of $149,999, awarded March 15, 2022, and (ii) an RSU award for the 2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2017,2022, Mr. Kerrest did not hold any outstanding awardsRosenthal held vested, deferred stock units with respect to 685,285 shares of our Common Stock.

(12)Mr. Korn resigned from the Board effective September 10, 2017. As of December 31, 2017, Mr. Korn did not hold any outstanding awardsStock, unvested RSUs with respect to 100,000 shares of our Common Stock.
(13)Amount represents cash payment made in September 2017 in connection with Mr. Korn’s resignation from the Board.
(14)Ms. McKenna-Doyle joined the Board on October 16, 2017. As of December 31, 2017, Ms. McKenna-Doyle did not hold any outstanding awards with respect to our Common Stock.
(15)Mr. Nichols joined the Board on October 3, 2017. As of December 31, 2017, Mr. Nichols did not hold any outstanding awards with respect to our Common Stock.
(16)Mr. Peirez joined the Board on June 9, 2017Stock, and resigned from the Board effective September 10, 2017. As of December 31, 2017, Mr. Peirez did not hold any outstanding awards with respect to our Common Stock.
(17)Mr. Reilly joined the Board on October 3, 2017. As of December 31, 2017, Mr. Reilly did not hold any outstanding awards with respect to our Common Stock.
(18)Ms. Riley joined the Board on June 9, 2017. As of December 31, 2017, Ms. Riley did not hold any outstanding awards with respect to our Common Stock.
(19)As of December 31, 2017, Mr. Rosenthal held exercisable options with respect to 86,97419,425 shares of our Common Stock.

(20)(13)Mr. Wiener joined

Amount reflects an RSU award for the Board on October 3, 2017.2022-2023 term with a grant date fair value of $204,000, awarded July 6, 2022. As of December 31, 2017,2022, Mr. Wiener did not hold any outstanding awardsWendling held vested, deferred stock units with respect to 77,069 shares of our Common Stock and unvested RSUs with respect to 100,000 shares of our Common Stock.

EXECUTIVE COMPENSATION

COMPENSATION DISCUSSION AND ANALYSIS

The following Compensation Discussion and Analysis (“CD&A”) provides information regarding ourWe are currently considered a “smaller reporting company” for purposes of the SEC’s executive compensation philosophy,disclosure rules. In accordance with such rules, we have opted to comply with the elementsscaled executive compensation disclosure rules applicable to smaller reporting companies due to the significant burden and expense that would be imposed on us by the new pay-versus-performance disclosure requirements applicable to regular filing companies under Item 402 of Regulation S-K. As a result, we have provided more limited narrative and tabular disclosures regarding executive compensation. Further, our reporting obligations generally extend only to the individuals who served as our principal executive officer during 2022, our next two most highly compensated executive officers who were serving as of December 31, 2022, and up to two additional individuals each of whom would have been one of our executive compensation program, and the factors that were considered in the compensation actions and decisions for our namedtwo most highly compensated executive officers during 2017. This CD&A should be read togetherbut for the fact that the individual was not serving as an executive officer as of December 31, 2022 (such individuals, our “named executive officers”). In accordance with the compensation tables and related disclosures set forth elsewhere in this proxy statement, as well asforegoing, the historical compensation disclosures set forth in the 201710-K.

Given the extraordinary circumstances we faced during 2016 and 2017, this CD&A, to a certain extent, does not contain information regarding the overarching philosophy, policies and practices that ordinarily would influence the design of our executive compensation program and the decisions affectingfollowing individuals are our named executive officers for 2017.

Named Executive Officers

Our named executive officers for the year ended December 31, 2017 were:2022:

 

William Livek,

Jon Carpenter, our PresidentChief Executive Officer (from July 6, 2022) and Executive Vice Chairman;previously our Chief Financial Officer;

 

Gian Fulgoni,

Bill Livek, our former Chief Executive Officer (until November 13, 2017)July 6, 2022);

 

Gregory Fink,

Mary Margaret Curry, our Chief Financial Officer (as of October 17, 2017);(from July 6, 2022) and previously our Chief Accounting Officer; and

 

David Kay,

Greg Dale, our former Interim Chief FinancialOperating Officer (from September 10, 2017 until October 16, 2017);

David Chemerow, our former Chief Financial Officer (until September 8, 2017);

Carol DiBattiste,August 23, 2022) and previously our General Counsel & Chief Compliance, PrivacyManager, Digital.

Information regarding the composition and People Officer (asresponsibilities of January 23, 2017);

our Compensation Committee is set forth under “Directors, Director Nominees, Executive Officers and Corporate Governance — Standing Committees of the Board of Directors” above. Information regarding certain compensation policies, including our stock ownership guidelines for directors and executive officers, clawback policy, and anti-hedging and pledging policy, is set forth under “Directors, Director Nominees, Executive Officers and Corporate Governance — Compensation Policies” above. Information regarding our executive compensation practices is set forth under “Executive Compensation – Narrative to Summary Compensation Table” below.

2022 Summary Compensation Table

The following table sets forth summary information concerning compensation for our named executive officers. The following table includes all compensation earned by the named executive officers for the respective periods, regardless of whether such amounts were actually paid during the period.

 

Name and Principal Position

      Year           Salary
     ($)
       Bonus    
($)(1)
   Stock
    Awards    
($)(2)
   Option
    Awards    
($)(3)
   Non-Equity
Incentive Plan
  Compensation  
($)(4)
   All Other
  Compensation  
($)(5)
   Total
($)
 

Jon Carpenter (6)

Chief Executive Officer

   2022    572,808    300,000    595,779    585,769    440,710    2,007    2,497,073 
   2021    29,712        1,599,999            17    1,629,728 

Bill Livek (7)

   2022    334,849        1,113,500        263,747    576,151    2,288,247 

Former Chief Executive Officer

   2021    650,000        991,140        507,000    3,513    2,151,653 

Mary Margaret Curry (8)

Chief Financial Officer

   2022    327,794        163,839    187,446    156,509    2,729    838,317 

Greg Dale (9)

Chief Operating Officer

   2022    312,517    100,000    164,891    188,441    254,021    2,506    1,022,376 

(1)

The amount reported for Mr. Carpenter in this column for 2022 reflects a signing bonus granted to Mr. Carpenter in connection with his appointment as our Chief Financial Officer in 2021 that was earned based on continued service through November 29, 2022. The amount reported for Mr. Dale in this column for 2022 reflects a transaction bonus related to our 2021 acquisition of Shareablee that was earned based on continued service through April 14, 2022.

(2)

Amounts reflected in this column represent the aggregate grant date fair value of stock awards computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are described in Note 5 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. As described under “Narrative to 2022 Summary Compensation Table” below, while Mr. Livek did not receive an equity award for his

Christiana Lin,
service as an executive officer during 2022, the 2022 amount reported in this column for Mr. Livek reflects the incremental fair value related to an award modification in connection with his separation from employment in 2022.
(3)

Amounts reflected in this column represent the aggregate grant date fair value of stock option awards computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are described in Note 5 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

(4)

Amounts reflected in this column represent annual incentive awards granted with respect to 2022, determined based on achievement of the applicable performance metrics. See “Narrative to 2022 Summary Compensation Table — Annual Incentive Awards” below for additional information regarding these awards.

(5)

Amounts for 2022 include (a) matching contributions made by us to the named executive officers’ 401(k) plan accounts, (b) payment of life insurance and accidental death and dismemberment premiums on behalf of the named executive officers, (c) medical loss ratio rebates pursuant to the Affordable Care Act of 2010, and (d) for Mr. Livek, (i) cash severance of $325,000 and continuation healthcare benefits of $19,633 paid in 2022 in connection with his separation from employment on July 6, 2022, and (ii) cash retainers of $24,185 and an RSU award with a grant date fair value of $204,000 granted in 2022, in each case in connection with his service as a non-employee director following his separation from employment. For a description of the full severance payments and benefits Mr. Livek is eligible to receive, see “Payments Upon Termination or Change in Control” below.

(6)

Mr. Carpenter served as our Chief Financial Officer through July 5, 2022 and as our Chief Executive Officer starting July 6, 2022.

(7)

Mr. Livek retired as our Chief Executive Officer on July 6, 2022. He continues to serve on our Board as a non-employee director. For the avoidance of doubt, the amount of compensation reported herein for Mr. Livek for 2022 includes compensation received by him for services as a non-employee director from July 6, 2022 to December 31, 2022.

(8)

Ms. Curry served as our Chief Accounting Officer through July 5, 2022 and as our Chief Financial Officer starting July 6, 2022.

(9)

Mr. Dale served as our General Manager, Digital through August 22, 2022 and as our Chief Operating Officer starting August 23, 2022.

Narrative to 2022 Summary Compensation Table

As a “smaller reporting company,” we are not required to publish a Compensation Discussion and Analysis section in this proxy statement like most larger companies, but we have included additional commentary within this “Narrative to 2022 Summary Compensation Table” regarding our former Executive Vice President, General Counsel and Chief Privacy Officer (until January 23, 2017); and

Michael Brown,executive compensation practices to provide transparency to our former Chief Technology Officer (until July 7, 2017).
stockholders.

Overview

Investigation and Restatement

As discussed in the 201710-K, in February 2016 the Audit Committee of our Board commenced an internal investigation, with the assistance of outside advisors, into certain of our accounting practices, disclosures and internal control matters. The Audit Committee subsequently concluded that (i) our previously issued, unaudited financial statements for the quarters ended March 31, June 30, and September 30, 2015, (ii) our previously issued, audited financial statements for the years ended December 31, 2014 and 2013, and (iii) our preliminary, unaudited financial statements for the quarter and year ended December 31, 2015, should no longer be relied upon.

As a result of our delay in filing periodic reports with the SEC, we temporarily stopped granting equity awards to our directors and employees (including our executive officers) in 2016, and our equity incentive plan expired in March 2017. We also restricted our directors and employees (including our executive officers) from trading in our Common Stock during our delay in filing periodic reports with the SEC. Our inability to grant equity awards and set targets for the financial measures used in our incentive compensation plans directly affected our compensation decisions for executive officers in 2017. Our 2017 compensation decisions were also impacted by the significant changes in our executive team described below. These changes led to a more individualized, situational approach to executive compensation in 2017, with decisions driven more by specific hiring and retention needs than by a holistic evaluation of our executive compensation program and corporate performance for the year.

Senior Executive Changes During 2017

Effective January 23, 2017, our Board of Directors appointed Carol DiBattiste as our General Counsel and Chief Privacy and People Officer (later expanded to General Counsel and Chief Compliance, Privacy and People Officer). Christiana Lin resigned as our Executive Vice President, General Counsel and Chief Privacy Officer on the same date. Michael Brown departed as our Chief Technology Officer on July 7, 2017.

On September 8, 2017, Mr. Chemerow resigned as our Chief Financial Officer. Our Board of Directors appointed David Kay of CrossCountry Consulting LLC (“CrossCountry”) (our accounting consultant) to serve as our Interim Chief Financial Officer following Mr. Chemerow’s departure. Mr. Kay served as Interim Chief Financial Officer until the appointment of Gregory Fink as our Chief Financial Officer effective October 17, 2017. Mr. Fink also assumed the role of principal accounting officer on December 5, 2017.

On October 25, 2017, we announced that Dr. Fulgoni would retire as our Chief Executive Officer on January 31, 2018. Dr. Fulgoni later accelerated his retirement date to November 13, 2017. Since Dr. Fulgoni’s retirement, Mr. Livek has acted as principal executive officer of the Company.

Compensation Committee Composition During 2017

During 2017, William Henderson and Russell Fradin served as members of the Compensation Committee until their resignation as directors and members of the Compensation Committee on September 10, 2017. The Compensation Committee was reconstituted on October 3, 2017, with Paul Reilly appointed as Chairman and Wesley Nichols, Susan Riley and Brent Rosenthal appointed as members. Ms. Riley resigned as a director and member of the Compensation Committee in March 2018. The Compensation Committee is currently composed of Mr. Reilly, Mr. Nichols and Mr. Rosenthal.

Our Executive Compensation Philosophy

The objective of our compensation programs for our employees, including our executive officers, is to attract and retain top talent and to ensure that the total compensation paid is fair and reasonable relative to the competitive nature of our industry. Our compensation programs are designed to motivate and reward employees for achievement of positive business results and to promote and enforce accountability.

Prior to the Audit Committee investigation in 2016,In 2022, our Compensation Committee was guided by certain core compensation principles, including aligning our executive officers’ interests with those of our stockholders and promoting achievement of our strategic and operational objectives. At the following goalssame time, our 2022 compensation decisions were significantly impacted by changes in our executive team, as described below. Our decisions were also impacted by declines in our stock price, which diminished the effectiveness of our equity awards as a means to recruit and principlesretain key personnel. Finally, although our financial performance improved over the course of the year (resulting in establishing compensation arrangementsgrowth over 2021), we were unable to fully achieve the targets our Compensation Committee established at the beginning of the year, leading to below-target annual incentive awards for our executive officers:

Further Align Stockholder Interests and Promote Achievement of Strategic Objectives. To further align our executive officers’ interests with those of our stockholders, the Compensation Committee believed that compensation arrangements should be tied to Company performance and growth in the value of our Common Stock.

Promote Achievement of Financial Goals.The Compensation Committee believed that executive compensation should be dependent on the achievement of our financial goals. Historically the Compensation Committee sought to establish target levels for our performance-based incentive compensation opportunities that were aligned with the financial targets we disclosed to stockholders.

Reward Superior Performance. The Compensation Committee believed that total compensation for an executive officer should be both competitive and tied topre-established financial goals and strategic objectives, and performance exceeding target levels should be appropriately rewarded.

Attract and Retain Top Talent. The Compensation Committee believed that compensation arrangements should be sufficient to allow us to attract, retain and motivate executive officers with the skills and talent needed to manage our business successfully. To this end, the Compensation Committee took into consideration factors such as market analyses, experience, alternative market opportunities, and consistency with the compensation paid to others within our organization.

While the Compensation Committee continued to be guided by these principles when addressing executive compensation matters during the Audit Committee investigation and subsequent restatement and audit process, the unique and challenging circumstances we encountered in 2017 also influenced the design of compensation arrangements for our executive officers as we sought to maintain normal business operations during a period of significant uncertainty.

Following the Audit Committee investigation, our Board of Directors and the Compensation Committee determined that ensuring our executive officers prioritize and maintain a “tone at the top” that emphasizes a strong, ethical corporate culture – as well as rigorous compliance and internal controls – is an additional principle that should guide our executive compensation actions and decisions. The Compensation Committee included these objectives in its evaluation of our executive compensation program for 2017.officers.

Compensation-Setting Process

Our Compensation Committee is committed to ensuring that our executive compensation programs align executive and stockholder interests, motivate achievement of key performance objectives, attract and retain top talent, and prioritize a strong, ethical corporate culture. Guided by our compensationthis philosophy, our Compensation Committee hasseeks to provide total compensation packages that are fair, reasonable and consistent with market practice. We generally sought to:

aim to compensate our executive officers at levels at or nearin a range around the median of the competitive market (as represented by our compensation peer group and published compensation survey data for the relevant period), with individual exceptions based on acase-by-case basis;

appropriately link executive officers’ compensation to our performancecircumstances and using the value we deliver to our stockholders; and

ensure that executive officers’ compensation is equitable relative to the compensation paid to other professionals within the Company.

Compensation Committee’s judgment. Overall, we seek to maintain a performance-oriented culture with compensation opportunities that reward our executive

officers when we achieve or exceed our goals, and objectives, while putting a significant portion of their target total direct compensation opportunities at risk in the event thatof underperformance.

In 2022, as discussed above, our goals and objectives are not achieved.

Compensation-Setting Process in 2017

The Compensation Committee’s 2017 executive compensation actions and decisions were dramatically impactedcompensation-setting process was also influenced by our inability to grant equity awards and set targets for the financial measures used in our incentive compensation plans during the Audit Committee investigation and subsequent restatement and audit process, as well as the significant changes in our executive team as described above. As a result, 2017and declines in our stock price. During this period, certain compensation decisions were made largely on an individualized,a case-by-case basis, taking into considerationaccount the situation that confronted the Companycompany at the time that we needed to appoint a new executive officer, address the circumstances relating to a departing executive officer or respond to the incentive and retention challenges that were presented for continuing executive officers. At the same time, we sought to maintain a normalized compensation process, including by establishing performance targets for our annual incentive compensation program early in the year and adhering to those targets in determining final award amounts.

Our compensation programs are intended to be consistent with corporate governance best practices. This is demonstrated by our:

stock ownership guidelines for directors and executive officers;

anti-hedging and pledging policy;

insider trading policy and preclearance requirements;

compensation recovery (clawback) policy;

consideration of market data, input from stockholders and critiques from stockholder advisory firms;

independent Compensation Committee oversight;

annual Compensation Committee evaluation;

engagement of an outside compensation consultant;

long-term vesting and holding requirements for executive equity awards;

no automatic increases in executive salaries or lock-step changes in compensation based on peer group levels or metrics;

no executive pension plans or supplemental executive retirement plans;

limited perquisites; and

no repricing or buyout of underwater stock options without stockholder approval.

Additional information regarding our compensation policies is set forth under “Directors, Director Nominees, Executive Officers and Corporate Governance — Compensation Policies” above.

Role of Compensation Committee

The members of our Compensation Committee are appointed by our Board of Directors to oversee our executive compensation program.programs. At all times during 2017,2022, the Compensation Committee was composed entirely of directors who were “outside directors” for purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”),“non-employee directors” for purposes of Exchange ActRule 16b-3, and “independent directors” under theNasdaq listing standards of the Nasdaq Stock Market, which we continue to elect to follow.

standards. Pursuant to its charter, the Compensation Committee approves, oversees and interprets our executive compensation programprograms and related policies and practices, including our equity incentive program and other compensation and benefits programs. The Compensation Committee is also responsible for establishing the compensation packages of our executive officers and ensuring that our executive compensation program isprograms are consistent with our compensation philosophy and corporate governance guidelines.

policies.

Generally, each year the Compensation Committee takes the following actions in the discharge of its responsibilities:

 

reviews the corporate goals and objectives of, and performance of and total compensation earned by or awarded to, our principal executive officer,Chief Executive Officer, independent of input from our principal executive officer;Chief Executive Officer;

examines the performance of our other executive officers with assistance from our principal executive officerChief Executive Officer and approves total compensation packages for them that it believes to be appropriate and consistent with those generally found in the marketplace for executives in comparable positions;

 

regularly holds executive sessions without management present; and

 

engages aan outside compensation consultant to review our executive compensation policies and practices, provide analysis of the competitive market for executive compensation,as needed, and make recommendations regarding the elements of our executive officer compensation packages.

As part of its decision-making process, the Compensation Committee periodically evaluates comparative compensation data including base salary, short-term and long-term incentive compensation (including equity awards) and other compensation components from similarly situated companies. Historically, the Compensation Committee has determined the target total direct compensation opportunities for each executive officerofficers after considering the following key factors:factors, among others:

 

the scope and nature of the executive officer’s responsibilities;

how much the executive officer might otherwise command in the employment marketplace;

how much we would be willing to pay to retain the executive officer;

 

how much we would expect to pay in the marketplace to replace the executive officer;

 

how much the executive officer could otherwise command in the employment marketplace;

past performance, as well as the strategic value of the executive officer’s future contributions; and

 

internal parity.parity within the executive team.

In 2017, theThe Compensation Committee also consideredconsiders the recommendations of our then Chief Executive Officer, who periodically reviewed competitive market data, individualreviews the performance, and changes in roles orand responsibilities of our other executive officers and proposedproposes adjustments to their executive compensation packages based on this review. The Chief Executive Officer did not and does not participate in Compensation Committee discussions or make recommendations with respect to his or her own compensation. By evaluating the comparative compensation data in light of the foregoing factors, the Compensation Committee sought to tailor its compensation decisions to the specific needs and responsibilities of the particular position, and the unique qualifications of the individual executive officer.

Due to the commencement of the Audit Committee investigation in February 2016, the continuation of the restatement and audit process through 2017, and the significant executive team changes described above, the Compensation Committee did not undertake its regular annual review of our executive compensation program and each individual executive officer’s compensation during the first quarter of 2017. Instead, compensation actions and decisions for our named executive officers for 2017 were taken as described below.

Role of Compensation Consultant

The Compensation Committee is authorized to retain the services of one or more executive compensation advisors from time to time, as it determines in its discretion, in connection with the discharge of its responsibilities. The Compensation Committee retained the services of Compensia, Inc.Meridian Compensation Partners, LLC (“Meridian”), a national compensation consulting firm, (“Compensia”), for this purpose during 2017. Compensia served at the discretion of and reported directly to the Compensation Committee. Compensia did not provide any services to us or our management in 2017 other than those provided to the Compensation Committee and Board of Directors as described below.

In 2017, Compensia assisted the Compensation Committee by providing the following services:

reviewing our compensation peer group;

reviewing and analyzing market data related to the base salaries, short-term incentives, and long-term incentive compensation levels of our then Chief Executive Officer and other executive officers;

reviewing and analyzing severance and post-employment compensation arrangements for certain executive officers;

evaluating equity plan design, metrics and pending equity award value and share usage; and

reviewing our Compensation Discussion and Analysis.

Compensia ceased providing services to the Compensation Committee in September 2017, after which time the Compensation Committee retained Meridian Capital Partners, LLC (“Meridian”) to assist in the discharge of its responsibilities.2022. Meridian serves at the discretion of and reports directly to the Compensation Committee. Meridian did not provide any services to us or our management in 20172022 other than those provided to the Compensation Committee and Board of Directors as described below.

In 2017,2022, Meridian assisted the Compensation Committee and Board of Directors by providing the following services:

 

reviewing key considerations for the

participating in Compensation Committee in overseeing our executive compensation program;meetings;

 

providing market analyses of executive officers’ compensation relative to peer group and survey data;

evaluating long-term incentive program design;

advising on equity plan modeling and share usage;

reviewing our compensation disclosures; and

analyzing market data and other considerations related to the base salaries, short-term incentives, and long-term incentive compensation levelsof members of our executive officers;Board.

reviewing the compensation of our then-Board Chair and the Board of Directors, as well as the compensation paid to directors for Board committee service; and

evaluating equity plan design and metrics for future years.

The prior Compensation Committee (serving until September 2017) considered all relevant factors relating to the independence of Compensia, including but not limited to applicable SEC rules and Nasdaq listing standards on compensation consultant independence, and concluded that the work performed by Compensia did not raise any conflict of interest in 2017. The Compensation Committee as reconstituted in October 2017 considered all relevant factors relating to the independence of Meridian, including but not limited to applicable SEC rules and Nasdaq listing standards on compensation consultant independence, and concluded that the work performed by Meridian did not raise any conflict of interest in 2017.2022.

Competitive Market Data

In February 2017, the Compensation Committee requested that Compensia review our compensation peer group and recommend any appropriate updates, including the replacement of peer companies that had been acquired or were no longer appropriate from a size or business focus perspective. After discussions with the Compensation Committee and management, as well as its own analysis, Compensia recommended and the Compensation Committee selected the following compensation peer group for use in 2017. At the time the Compensation Committee evaluated the 2017 peer group, our revenue approximated the median and our market capitalization approximated the 40th percentile of the peer group.

2UNew Relic
BroadSoftProgress Software
Cornerstone OnDemandProofpoint
CoStar GroupSynchronoss Technologies
Fair IsaacTiVo
ImpervaUltimate Software Group
j2 GlobalWeb.com Group
LogMeInWebMD Health
MicroStrategy

Using data collected from these companies, as well as data from Radford executive compensation surveys forsimilarly-sized companies (with revenues ranging from half to twice our revenues), Compensia, and later Meridian, prepared reports for the Compensation Committee in 2017 that analyzed the compensation levels of certain executive officers against the competitive market.

Stockholder Advisory Vote on Executive Compensation

We conducted anon-binding stockholder advisory vote on the compensation of our named executive officers (known as a“say-on-pay”say-on-pay vote) for the year ended December 31, 20142021 at the last annual meeting of stockholders that we held, which was in July 2015. While ourJune 2022. Our stockholders expressed strong support for the 20142021 compensation of our named executive officers, with approximately 67 percent99% of votes cast in favor of the votes cast for approval of this proposal, this result was lower than the support for our named executive compensation for the prior year.

Due to the Audit Committee investigation and subsequent restatement and audit process, we did not hold an annual meeting of stockholders or conduct asay-on-pay vote in 2016 or 2017, nor did theproposal. Our Compensation Committee conduct a comprehensive review of our executive officer compensation for those years in the context of thesay-on-pay vote results from 2015. In evaluating executive compensation for future years, the Compensation Committee intends to considerconsidered the results of upcomingthe say-on-pay votesvote and other feedback from our stockholders, as well as critiques from stockholder advisory firms.

Executive Compensation Elements

Our executivefirms, in designing our compensation program has historically consisted of three primary elements: base salary, annual incentive compensation opportunities and long-term incentive compensation opportunities. We also offer health and welfare benefits and certain separation-related benefits. Although we have not had a formal policyprograms for allocating executive compensation among the primary compensation elements,2022. In particular, the Compensation Committee has soughtconsidered investor input in establishing challenging targets for performance-based RSUs (“PRSUs”) awarded to provide compensation opportunities that were consistent with our compensation philosophy of further aligning executive and stockholder interests, promoting achievement of our financial goals and strategic objectives, rewarding superior performance, and attracting and retaining top talent.

To this end, base salary decisions in 2017 were guided primarily by our objective of attracting and retaining top executive talent. As in prior years, we used base salary to recognize the experience, skills, knowledge and responsibilities required of each executive officer, as well as to reflect competitive market practice. In contrast to base salary, our other direct compensation elements (both annual and long-term incentives) were historically distributed in the form of equity awards. The Compensation Committee believed that by using equity to compensate our executive officers for completing the objectives in our annual operating plan, and then by positioning them to share in the long-term results of their efforts, we could further align their interests with our stockholders and promote achievement of our strategic and financial goals. The Compensation Committee is evaluating the appropriate vehicles and metrics for incentive compensation in 2018 and future years.

As discussed above, we temporarily stopped granting equity awards to our directors and employees, including our executive officers in 2016. This decision was due to our delay2022 and in filing periodic reports with the SECimplementing long-term vesting and was not the result of a change in our compensation philosophy at that time. Subsequently, ourholding requirements for executive equity incentive plan expired in March 2017, and we have not made any equity awards to directors or employees, including our executive

officers, since that plan’s expiration. The Compensation Committee intends to resume using equity to compensate our directors and employees, including our executive officers, after we have a new equity plan in place. This may include consideration of compensation opportunities lost during the period that we were unable to grant equity awards in 2016 and 2017.awards.

Executive Compensation Actions and Decisions for 20172022

Due to the ongoing restatement and audit process in 2017, the Compensation Committee did not establish formal annual or long-term incentive award opportunities for our executive officers for 2017. We also continued to experience significant changes to our executive team in 2017. As a result, except as described below, the Compensation Committee did not conduct a programmatic review of our executive compensation program for 2017 and instead based its executive compensation decisions on specific hiring and retention needs.

General Counsel TransitionLivek Retirement

Effective January 23, 2017, Ms. DiBattiste was appointedOn February 28, 2022, we announced that Mr. Livek would retire as our General CounselChief Executive Officer and Chief Privacy and People Officer (later expandedtransition to General Counsel and Chief Compliance, Privacy and People Officer).a non-executive Vice Chairman role after his successor was named. On the same date, Ms. Lin resignedwe entered into a Transition and Separation Agreement to facilitate Mr. Livek’s retirement as Chief Executive Officer. The Transition and Separation Agreement provided for salary continuation and a prorated annual incentive award (based on actual performance) for the portion of 2022 during which Mr. Livek served as Chief Executive Officer. The Transition and Separation Agreement also provides Mr. Livek with those post-employment severance and healthcare continuation coverage benefits set forth in his existing change of control and severance agreement, subject to his compliance with certain restrictive covenants and execution of a release of claims in favor of the company. Effective July 6, 2022, the Board appointed Mr. Carpenter to serve as our Executive Vice President, General Counsel andnew Chief PrivacyExecutive Officer, and transitionedMr. Livek retired and became our non-executive Vice Chairman.

In connection with Mr. Livek’s transition from Chief Executive Officer to a consulting role with the Company.

Ms. DiBattiste’s appointment included the following initial compensation arrangements:

An annual base salarynon-employee director, he received cash severance of $325,000 in 2022, which amount is reported in the amount“All Other Compensation” column of $350,000;

Athe 2022 Summary Compensation Table above. Mr. Livek’s outstanding equity awards have continued to vest (or be exercisable) by their terms during his service as a sign-onnon-employee bonusdirector, except that the PRSUs granted to Mr. Livek in 2019 were modified to provide that they (i) will not vest upon a change of control, and (ii) will vest in full upon Mr. Livek’s separation from service as a member of the Board, to the extent they have not already vested by their terms prior to such date. The incremental fair value related to this award modification is reflected in the amount“Stock Awards” column of $200,000, paid in equal installments in April 2017the 2022 Summary Compensation Table above. Mr. Livek also received cash retainers and July 2017;

Anan RSU award equal to $1,000,000, to be granted afterwith a grant date fair value of $204,000 for his service as a non-employee director in 2022, consistent with our standard director compensation program. Such amounts are reported in the Company regained compliance with its SEC reporting obligations“All Other Compensation” column of the 2022 Summary Compensation Table above.

For a full description of the Transition and has a valid equity plan in place;

Participation in our incentive compensation programs for our executive officers as approved from time to time by the Board of Directors;Separation Agreement and

A Change of Control and Severance Agreement with the Company, the material terms and conditions of which are described under related matters, see “Payments Upon Termination or Change in Control” below.

In connection with Ms. Lin’s resignation, we entered into For a Separation and General Release Agreement with Ms. Lin, pursuant to which she received payments equal to her then-current base salary for a periodfull description of 12 months, commencing on February 2, 2017,our director compensation program, see “Director Compensation” above.

Carpenter Appointment

Mr. Carpenter served as well as payment of premiums for eligible continuation healthcare coverage for the same period. These payments and benefits are consistent with the payments and benefits contemplated by Ms. Lin’s Change of Control and Severance Agreement.

We also entered into a Consulting Agreement with Ms. Lin, pursuant to which Ms. Lin agreed to assist the Company during a transition period and to be available for additional assistance and cooperation. Ms. Lin received a consulting fee of $83,333 per month during her consulting term, which began on February 2, 2017 and ended on August 2, 2017.

our Chief ExecutiveFinancial Officer Compensation

In February 2017, the Compensation Committee and Dr. Fulgoni agreed that Dr. Fulgoni would not receive any additional cash compensation forfrom November 29, 2021 until his serviceappointment as our Chief Executive Officer in 2016 and 2017. Instead, the Compensation Committee agreed that Dr. Fulgoni would receive a long-term equity incentive award equal to $3,000,000 in time-based RSUs, to be issued after the Company regained complianceon July 6, 2022. In connection with its SEC reporting obligations and has a valid equity plan in place. The Compensation Committee agreed to provide for annual vesting of the award over three years, retroactive to Dr. Fulgoni’shis appointment as Chief Executive Officer, we and Mr. Carpenter entered into a letter agreement providing for the following compensation:

an annualized base salary of $600,000 (increased from $515,000 as Chief Financial Officer);

eligibility to participate in August 2016,our annual incentive program with accelerateda target incentive equal to 100% of his base salary (equivalent to his target percentage as Chief Financial Officer);

beginning in 2023, eligibility to participate in our long-term incentive program subject to the terms and conditions of such program as in effect from time to time;

a one-time grant of 400,000 PRSUs, which will have the opportunity to vest quarterly from the date of grant (July 6, 2022) through the 10th anniversary of the date of grant or an earlier change of control of the company, subject to and in accordance with the achievement of certain stock-price hurdles ranging from $5.00 to $15.00 per share (which significantly exceeded the $2.04 closing price of our Common Stock on the date of grant);

a one-time grant of options to purchase 500,000 shares of our Common Stock, with a per-share exercise price of $2.50 (which significantly exceeded the $1.97 closing price of our Common Stock on the date of grant), vesting in equal annual installments on July 6, 2023, 2024, 2025 and 2026; and

reimbursement of up to $10,000 in reasonable attorneys’ fees incurred in connection with the negotiation of the letter agreement and related agreements.

In evaluating Mr. Carpenter’s compensation package as Chief Executive Officer, our Compensation Committee considered competitive market analyses prepared by its outside compensation consultant and sought to tie a significant portion of total compensation to performance. The Compensation Committee also took steps to further align Mr. Carpenter’s interests with those of our stockholders, including by conditioning the vesting of his PRSUs on the achievement of challenging stock-price hurdles, granting options with an exercise price that exceeded the then-market value of our Common Stock, and imposing long-term vesting and holding requirements for his equity awards. All of Mr. Carpenter’s full-value equity awards (including his 2022 PRSUs and the RSUs granted to him as Chief Financial Officer in the event of2021) include deferred settlement provisions, pursuant to which any vested shares will not be distributed to Mr. Carpenter until his separation from service or a change in control of the Company or if Dr. Fulgoni were not reelected as a director at the end of his current term. The Compensation Committee made these decisions after consideration of analyses prepared by, and discussions with, its compensation consultant.

Base Salary Changes

In April 2017, the Compensation Committee reviewed the base salaries of our executive officers (other than Dr. Fulgoni) in the context of competitive market data and the executive officers’ roles and responsibilities within the Company. After consideration of an analysis prepared by its compensation consultant, and the recommendations of Dr. Fulgoni, the Compensation Committee increased the annualized base salaries of certain named executive officers as follows:

Name

  Previous
Salary
   Percentage
Increase
  New
Salary
 

David Chemerow

  $345,780    4.0 $359,611 

Carol DiBattiste

   350,000    10.0  385,000 

Michael Brown

   306,000    8.0  330,480 

Chief Technology Officer Transition

In June 2017, we announced a reorganization of our technology and product team pursuant to which Mr. Brown, our Chief Technology Officer, transitioned from his executive officer role effective July 7, 2017 but continued to assist the Company as a consultant for three months to facilitate the reorganization.company.

In connection with the reorganization,Mr. Carpenter’s appointment as Chief Executive Officer, we entered intoalso amended his change of control and severance agreements to reflect terms similar to those of our departing Chief Executive Officer. For a Separation and General Release Agreement withfull description of Mr. Brown, pursuant to which he will receive payments equal to his then-current base salary for a period of 12 months from July 7, 2017, as well as payment of premiums for eligible continuation healthcare coverage for the same period. These payments andCarpenter’s potential termination benefits, are consistent with the payments and benefits contemplated by Mr. Brown’s Change of Control and Severance Agreement.

We also entered into a Consulting Agreement with Mr. Brown, pursuant to which Mr. Brown agreed to assist the Company during a transition period from July 10, 2017 until October 13, 2017. Mr. Brown received a consulting fee of $50,000 per month during his consulting term.

Chief Financial Officer Transition

On September 8, 2017, Mr. Chemerow resigned as our Chief Financial Officer. We entered into a Separation and General Release Agreement with Mr. Chemerow, pursuant to which he will receive payments totaling approximately $650,000, payable over a17-month period, as well as payment of premiums for eligible continuation healthcare coverage for up to 18 months and continued vesting of his outstanding RSU awards through August 2020.

Following Mr. Chemerow’s resignation, our Board of Directors appointed Mr. Kay to serve as our Interim Chief Financial Officer effective September 10, 2017. Mr. Kay received no direct compensation for serving as Interim Chief Financial Officer. Instead, the Company entered into an interim services agreement with CrossCountry, of which Mr. Kay is a managing partner, to pay CrossCountry $60,000 per month during the term of the interim services agreement. Mr. Kay’s term as Interim Chief Financial Officer ended on October 16, 2017, after which he has continued to provide consulting services to the Company on behalf of CrossCountry.

Our Board of Directors appointed Mr. Fink as our Chief Financial Officer effective October 17, 2017. In connection with Mr. Fink’s appointment, the Compensation Committee approved the following compensation arrangements for him:

An annual base salary in the amount of $390,000;

Asign-on bonus in the amount of $800,000 in RSUs, to be granted after the Company regained compliance with its SEC reporting obligations and has a valid equity plan in place;

A prorated bonus for 2017 based on a target of 75% of his base salary for 2017;

Beginning in 2018, participation in our incentive compensation programs for our executive officers as approved from time to time by the Board of Directors; and

A Change of Control and Severance Agreement with the Company, the material terms and conditions of which are described undersee “Payments Upon Termination or Change in Control” below.

Special BonusCurry Appointment

On September 26, 2017, our Board of Directors approved a special performance and retention bonus in the amount of $1,500,000 for Ms. DiBattiste, our General Counsel and Chief Compliance, Privacy and People Officer, in recognition of her extraordinary efforts in reaching settlement terms in certain of our outstanding litigation. The first $500,000 installment of the special bonus was paid in October 2017, and the second was paid in January 2018. The final installment will be paid in September 2018, subject to Ms. DiBattiste’s continued employment through the payment date.

Chief Executive Officer Retirement

On October 25, 2017, we announced that Dr. Fulgoni would retireCurry served as our Chief ExecutiveAccounting Officer (“CEO”)from December 2021 until her appointment as our Chief Financial Officer on January 31, 2018July 6, 2022. In connection with her appointment as Chief Financial Officer, we and wouldMs. Curry entered into a letter agreement providing for the following compensation:

an annualized base salary of $375,000 (increased from $295,000 as Chief Accounting Officer);

eligibility to participate in our annual incentive program with a target incentive equal to 75% of her base salary (increased from 40% as Chief Accounting Officer);

beginning in 2023, eligibility to participate in our long-term incentive program subject to the terms and conditions of such program as in effect from time to time;

a one-time grant of 110,000 PRSUs, which will have the opportunity to vest quarterly from the date of grant (July 6, 2022) through the 10th anniversary of the date of grant or an earlier change of control of the company, subject to and in accordance with the achievement of certain stock-price hurdles ranging from $5.00 to $15.00 per share (which significantly exceeded the $2.04 closing price of our Common Stock on the date of grant); and

a one-time grant of options to purchase 160,000 shares of our Common Stock, with a per-share exercise price of $2.50 (which significantly exceeded the $1.97 closing price of our Common Stock on the date of grant), vesting in equal annual installments on July 6, 2023, 2024, 2025 and 2026.

In evaluating Ms. Curry’s compensation package as Chief Financial Officer, our Compensation Committee considered factors similar to those considered for Mr. Carpenter, including competitive market analyses, a focus on performance-based compensation, and alignment with stockholder interests, as well as internal parity within the executive team. Like Mr. Carpenter’s full-value awards, Ms. Curry’s PRSUs include a deferred settlement

provision, pursuant to which any vested shares will not stand for reelectionbe distributed to our Boardher until her separation from service or a change in control of Directors when his current term ends. Dr. Fulgoni later accelerated his CEO retirement date to November 13, 2017.the company.

In connection with Dr. Fulgoni’s retirement,Ms. Curry’s appointment as Chief Financial Officer, we entered into change of control and severance agreements with her reflecting terms similar to our other executive officers’ agreements. For a Retirementfull description of Ms. Curry’s potential termination benefits, see “Payments Upon Termination or Change in Control” below.

Dale Appointment

Mr. Dale served as our General Manager, Digital from December 2021 until his appointment as our Chief Operating Officer on August 23, 2022. In connection with his appointment as Chief Operating Officer, we and Transition Services AgreementMr. Dale entered into a letter agreement providing for the following compensation:

an annualized base salary of $335,000 (increased from $300,000 as General Manager, Digital);

eligibility to participate in our annual incentive program with a target incentive equal to 75% of his base salary (increased from 40% as General Manager, Digital);

beginning in 2023, eligibility to participate in our long-term incentive program subject to the terms and conditions of such program as in effect from time to time;

a one-time grant of 110,000 PRSUs, which will have the opportunity to vest quarterly from the date of grant (August 24, 2022) through the 10th anniversary of the date of grant or an earlier change of control of the company, subject to and in accordance with the achievement of certain stock-price hurdles ranging from $5.00 to $15.00 per share (which significantly exceeded the $1.97 closing price of our Common Stock on the date of grant); and

a one-time grant of options to purchase 160,000 shares of our Common Stock, with a per-share exercise price of $2.50 (which significantly exceeded the $1.97 closing price of our Common Stock on the date of grant), vesting in equal annual installments on August 23, 2023, 2024, 2025 and 2026.

In evaluating Mr. Dale’s compensation package as Chief Operating Officer, our Compensation Committee considered factors similar to those considered for Mr. Carpenter and Ms. Curry. Also like Mr. Carpenter and Ms. Curry, Mr. Dale’s PRSUs include a deferred settlement provision, pursuant to which Dr. Fulgoniany vested shares will continuenot be distributed to servehim until his separation from service or a change in control of the company.

In connection with Mr. Dale’s appointment as Chief Operating Officer, we entered into change of control and severance agreements with him reflecting terms similar to our other executive officers’ agreements. For a full description of Mr. Dale’s potential termination benefits, see “Payments Upon Termination or Change in Control” below.

Annual Incentive Compensation

In February 2022, our Compensation Committee established performance goals and targets for annual incentive awards that our executive officers were eligible to earn for the year. Target awards for the named executive officers, presented as a memberpercentage of base salary, were as follows:

Name

  Target Award
in Prior Role
(% of Base Salary) (1)
  Target Award
in Current Role
(% of Base Salary) (2)

Jon Carpenter

  100%  100%

Bill Livek

  100%  

Mary Margaret Curry

    40%    75%

Greg Dale

    40%    75%

(1)

This column reflects target award levels set in February 2022, prior to the executive team changes described above.

(2)

This column reflects target award levels set in July and August 2022 in connection with the executive team changes described above.

For each of our Board of Directors until the earlier of a permanent, full-time successor CEO taking office or our 2018 annual meeting of our stockholders. Dr. Fulgoni was also named Chairman Emeritus, and he will serve as Special Advisor to the Chairexecutive officers, 90% of the Boardtarget award for 2022 was based on achievement of goals relating to revenue and adjusted EBITDA1 performance, weighted equally. The remaining 10% of each executive officer’s target award was based on achievement of corporate culture objectives, including employee satisfaction and engagement and implementation of programs and actions to strengthen corporate culture. The Compensation Committee believed these performance measures were appropriate for our business because they provided a balance between generating growth, managing our expenses, and maintaining a strong corporate culture – factors the CEO followingCompensation Committee believed would enhance long-term stockholder value. Actual amounts payable under the conclusionannual incentive plan could range from 0% to 200% of his servicethe target award depending on the Boardlevel of Directors. As Special Advisor, Dr. Fulgoni will provide assistance and cooperation to the Company, our Board of Directors, and our senior management team until November 13, 2018.

The Board of Directors agreed to provide Dr. Fulgoni with the following compensation and benefits pursuant to the Retirement and Transition Services Agreement:

All accrued salary and accrued and unused paid time off earned through his retirement date;

Payment of premiums for eligible continuation healthcare coverage for up to 18 months from his retirement date;

Vesting in full (on his retirement date) of all outstanding RSU awards previously granted under our equity incentive plan; and

Issuance of $4,000,000 in fully vested RSUsachievement, as compensation for his services as CEO from August 2016 through his retirement date (for which he had not otherwise been separately compensated), subject to the Company’s compliance with SEC reporting requirements.

In approving this arrangement, the Board of Directors considered the previous analyses and deliberationsdetermined by the Compensation Committee.

The threshold, target and maximum performance levels for each measure were as follows, with linear interpolation for achievement between levels:

Component

  Below
Threshold
 Threshold
Performance
 Target
Performance
 Maximum
Performance

Revenue

  <$375 million $375 million $402 million $420 million

Adjusted EBITDA

  <$33 million $33 million $36 million $46 million

Culture

  (a) (a) (a) (a)

Payout Level

  0% 50% 100% 200%

(a)

Attainment of corporate culture objectives would be determined by the Compensation Committee based on improvements in employee satisfaction and engagement and implementation of programs and actions to strengthen corporate culture.

The Compensation Committee describedestablished performance targets at levels that it believed to be challenging but achievable through the successful execution of our annual operating plan, taking into account ongoing macroeconomic conditions, increased costs under “Chief Executive Officer Compensation” above.

Cash Bonusesour data license agreements and other business factors. In addition, each performance level was assigned a payment amount that the Compensation Committee believed was reasonable and appropriate for those results.

In March 2018,February 2023, the Compensation Committee reviewed our financial and operating results for 2022 and determined that the preestablished objectives had been achieved as follows:

Component

  Weight  Target
Performance
  Actual
Performance
 Payout Level
(Interpolated)
  Payout
Level
(Weighted)

Revenue

  45%  $402 million  $376.4 million   52.6%  23.7%

Adjusted EBITDA

  45%  $  36 million  $  37.0 million 110.0%  49.5%

Culture

  10%    (a) 60.0%    6.0%
         

 

         79.2%

(a)

In evaluating achievement of corporate culture objectives, the Compensation Committee considered employee survey indicators, attrition trends, enhanced employee onboarding processes, strategy alignment, improvements in employee communications and training, implementation of an employee volunteerism program, and expanded diversity programming under the leadership of a new Director of Diversity and Inclusion.

1

We define adjusted EBITDA as net income (loss) plus or minus interest, taxes, depreciation, amortization, stock-based compensation expense, loss on extinguishment of debt, non-cash impairment charges, restructuring expense, loss on asset disposition, and changes in the fair value of financing derivatives, warrants liability and contingent consideration. A reconciliation of non-GAAP adjusted EBITDA to its most directly comparable GAAP financial measure, net income (loss), is set forth on Annex D to this proxy statement.

Based on these results, the Compensation Committee approved cash bonusthe following annual incentive awards for certainthe named executive officers as set forth below:

Name

  Bonus
Amount
 

William Livek

  $444,000 

Gregory Fink

   73,125 

Carol DiBattiste

   308,000 

for 2022, which awards were paid in cash in March 2023. Each named executive officer’s bonus was determined by the Compensation Committee based on an evaluation of that individual’s performance during 2017. In the case of Mr. Livek, the Compensation Committee considered his leadership and contributions in maintaining normal business operations during a time of great change for the Company, particularly following Dr. Fulgoni’s retirement in 2017. For Mr. Fink, the Compensation Committee considered his effectiveness in managing our finance/accounting organization and driving to completion of our multi-year audit process. (Mr. Fink’s bonusaward was prorated for the adjusted salary levels and targets described above, and Mr. Livek’s award was prorated through his October 2017 startemployment termination date.) Finally,

Name

  Award   Award vs.
Target
 

Jon Carpenter

  $440,710    79.2% 

Bill Livek

  $263,747    79.2% 

Mary Margaret Curry

  $156,509    79.2% 

Greg Dale

  $134,021    79.2% 

In addition to the annual incentive award described above, Mr. Dale was eligible for Ms. DiBattiste,an additional performance-based incentive for 2022 pursuant to his offer letter from December 2021, when he joined the Compensation Committee considered her contributions and leadershipcompany as General Manager, Digital. Under this arrangement, Mr. Dale could receive up to $120,000 in addressingcash based on achievement of the litigation, compliance and governance matters we facedsame adjusted EBITDA goal (at the target performance level) used in 2017.our annual incentive program for 2022. As described above, this goal was fully achieved in 2022, resulting in a payment of $120,000 to Mr. Dale for his additional performance-based incentive in March 2023.

Other Compensation Elements

Benefits and Perquisites

We provide the following health and welfare benefits to our executive officers on the same basis as our other U.S. employees:

 

medical and dental insurance;

 

life insurance;

 

short-term and long-term disability insurance; and

 

a 401(k) plan with a company matching feature.

TheseWe believe these benefits are consistent with those offered by other companies, including those with whom we compete for executive talent.

In general, we do not provide significant perquisites or other personal benefits to our executive officers, and we do not view perquisites and personal benefits as a material element of our executive compensation program. We occasionally provide benefits, however, for retention purposes orpurposes; to accommodate specific, and usually temporary, circumstances of executives who do not reside near their work locations.locations; or to primarily serve a business purpose that may result in ancillary personal benefit to the executive. Moreover, we have provided for reimbursement of attorneys’ fees in certain cases, including in connection with the negotiation of employment or separation terms.

Change of Control and Severance Agreements

Our executive officers are parties to agreements that provide for certain payments and benefits to them in the event of a termination of their employment or a change in control of the Company.company. We believe these arrangements are valuable retention tools that are particularly necessary in an industry, such as ours, where there is frequent market consolidation. We recognize that it is possible that we may be subject to a change in control, and that this possibility could result in a sudden departure or distraction of our key executive officers to the detriment of our business. We believe that these arrangements help to encourage and maintain the continued focus and dedication of our executive officers to their assigned duties to maximize stockholder value, notwithstanding the possibility or occurrence of a change in control of the Company.company. We also believe that these arrangements are competitive with arrangements offered to senior executives at companies with whom we compete for executive talent and are necessary to attract and retain critical members of management. These arrangements do not contain any tax reimbursement or tax “gross up” provisions for our executive officers.

The material terms and conditions of our executive change of control and severance agreements are discussed under “Payments Upon Termination or Change in Control” below.

Other Compensation Policies

Hedging Prohibition

We have adopted and maintain a formal policy that prohibits hedging and similar transactions to ensure that the members of our leadership team (including our executive officers) and thenon-employee members of our Board of Directors bear the full risks of ownership of our Common Stock.

Pledging Prohibition

We have adopted and maintain a formal policy that prohibits the pledging of our equity securities as collateral for loans to ensure that a foreclosure on such securities would not trigger inadvertent insider trading violations.

Compensation Risk Assessment

Our Compensation Committee and management have considered whether our current compensation programs for employees create incentives for excessive or unreasonable risks that could have a material adverse effect on the Company. This has included consideration of the Audit Committee investigation findings and the internal control weaknesses identified by management as of December 31, 2017, as described in Item 9A of the 201710-K, as well as our plans to specify maximum payouts for incentive compensation, use multiple performance metrics and measurement periods, and require Compensation Committee review and validation of results and payouts for 2018 and future years. We believe that our compensation programs, as currently designed, are consistent with practices for our industry and that risks arising from our compensation policies and practices are not reasonably likely to have a material adverse effect on the Company. In structuring future compensation programs and decisions, the Compensation Committee will continue to monitor whether our risk management objectives are being met with respect to incentivizing our employees.

Tax and Accounting Implications

Deductibility of Executive Compensation

Generally, Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), disallows public companies a tax deduction for federal income tax purposes of remuneration in excess of $1 million paid to certain executive officers. Pursuant to tax law changes effective in 2018, these executive officers will include a public company’s chief executive officer, chief financial officer, and each of the three other most highly-compensated executive officers whose compensation is required to be disclosed to stockholders under the Securities Exchange Act of 1934 in any taxable year.employees. In making compensation decisions, theour Compensation Committee considersmay consider the potential effects of Section 162(m) on the compensation paid to our named executive officers.officers and others.

Accounting for Stock-Based Compensation

We follow Financial Accounting Standards BoardFASB Accounting Standards Codification Topic 718 (“ASC Topic 718”) for our stock-based compensation awards. ASC Topic 718 requires companies to measure the compensation expense for all share-based payment awards made to employees and directors, including stock options, RSU and RSUPRSU awards, based on the grant date fair value of these awards. ASC Topic 718 also requires companies to recognize the compensation cost of their stock-based compensation awards in their income statements over the period that an award recipient is required to render service in exchange for the award.

Consistent with ASC Topic 718, we recognized incremental In making compensation decisions, our Compensation Committee regularly considers the cost of stock-based compensation expense in 2016awards and 2017 in connection with an extension, approved byany proposed modifications to those awards.

Notwithstanding the foregoing discussion, our Board of Directors in April 2016, of the exercisability of outstanding stock options during our delay in filing periodic reports with the SEC.

COMPENSATION COMMITTEE REPORT

The Compensation Committee has reviewedbelieves that its primary responsibility is to provide a compensation program that is consistent with our compensation philosophy and discussedthat supports the Compensation Discussion and Analysis contained in this proxy statement with the Company’s management. Based its reviewachievement of and discussions with management with respect to, the Compensation Discussion and Analysis,our compensation objectives. Therefore, the Compensation Committee recommendedretains authority to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement.

Compensation Committee

Paul Reilly, Chairman

Wesley Nichols

Brent Rosenthal

The foregoing Compensation Committee report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933grant appropriate compensation items or the Securities Exchange Act of 1934, and shall not otherwise be deemed filed under these acts, except to the extent we specifically incorporate by reference into such filings.

COMPENSATION TABLES

2017 Summary Compensation Table

The following table sets forth summary information concerning compensation for the following persons: (i) all persons serving as our principal executive officer during 2017, (ii) all persons serving as our principal financial officer during 2017, (iii) the next most highly compensated executive officer who was serving as of December 31, 2017 (we had no other executive officers as of December 31, 2017), and (iv) two additional individuals who served as executive officers during 2017 but were not serving as of December 31, 2017. We refer to these persons as our “named executive officers” for 2017 elsewhere in this proxy statement. The following table includes all compensation earned by the named executive officers for the respective periods, regardless of whether such amounts were actually paid during the period.

Name and Principal Position

  Year   Salary ($)   Bonus ($)  Stock Awards
($)(1)
   Option Awards
($)(2)
   All Other
Compensation

($)(3)
   Total ($) 

William Livek (4)

President (Principal Executive Officer)

   

2017

2016

 

 

   

443,700

409,245

 

 

   

444,000

—  

 

(5) 

  

—  

356,000

 

 

   

—  

—  

 

 

   

3,090

4,655

 

 

   

890,790

769,900

 

 

Gian Fulgoni (6)

Former Chief Executive Officer

   

2017

2016

2015

 

 

 

   

191,186

220,000

220,082

 

 

 

   

—  

—  

—  

 

 

 

  

—  

—  

530,000

 

 

 

   

—  

—  

—  

 

 

 

   

703

3,919

345

 

 

 

   

191,889

223,919

750,427

 

 

 

Gregory Fink (7)

Chief Financial Officer

   2017    95,875    73,125 (8)   —      —      52    169,052 

David Kay (9)

Former Interim Chief Financial Officer

   2017    —      —     —      —      69,350    69,350 

David Chemerow (10)

Former Chief Financial Officer

   

2017

2016

 

 

   

244,456

318,260

 

 

   

100,000

64,834

 

 (11) 

  

—  

1,276,850

 

 

   

4,411,746

—  

 

 

   

139,502

19,099

 

 

   

4,895,704

1,679,043

 

 

Carol DiBattiste (12)

General Counsel & Chief Compliance,Privacy and People Officer

   2017    355,590    2,008,000 (13)   —      —      3,320    2,366,910 

Christiana Lin (14)

Former Executive Vice President, GeneralCounsel and Chief Privacy Officer

   

2017

2016

2015

 

 

 

   

30,317

347,985

346,299

 

 

 

   

—  

—  

—  

 

 

 

  

—  

—  

1,010,989

 

 

 

   

496,761

—  

—  

 

 

 

   

838,213

3,787

2,204

 

 

 

   

1,365,291

351,772

1,359,492

 

 

 

Michael Brown (15)

Former Chief Technology Officer

   

2017

2016

2015

 

 

 

   

166,005

306,000

305,983

 

 

 

   

100,000

45,900

—  

 

 

(16) 

  

—  

—  

829,500

 

 

 

   

191,086

—  

—  

 

 

 

   

330,060

4,230

2,630

 

 

 

   

787,151

356,130

1,138,113

 

 

 

(1)Amounts represent the aggregate grant date fair value of stock awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation – Stock Compensation (“FASB ASC Topic 718”). Assumptions used in the calculation of these amounts are described in Note 13 to the consolidated financial statements included in Item 8 of the 201710-K.
(2)Amounts represent incremental expense recognized in the year of termination of employment for awards granted in prior years, in connection with an extension of option exercisability for all employees who ceased employment prior to our regaining compliance with SEC filing requirements. Assumptions used in the calculation of these amounts are described in Note 13 to the consolidated financial statements included in Item 8 of the 201710-K.
(3)Amounts for 2017 consisted of (a) matching contributions by us to the named executive officers’ 401(k) plan accounts, (b) payment of life insurance premiums on behalf of the named executive officers, (c) severance benefits of $104,887 for Mr. Chemerow, $318,986 for Ms. Lin, and $165,240 for Mr. Brown, (d) COBRA benefits of $4,018 for Mr. Chemerow, $18,862 for Ms. Lin, and $9,510 for Mr. Brown, (e) attorneys’ fees of $27,474 for Mr. Chemerow in connection with his resignation; (f) consulting fees of $500,000 for Ms. Lin and $152,530 for Mr. Brown, and (g) fees of $69,350 paid to CrossCountry Consulting LLC pursuant to an interim services agreement in connection with Mr. Kay’s service as Interim Chief Financial Officer.
(4)Appointed President and Executive Vice Chairman effective January 29, 2016; has acted as our principal executive officer since Dr. Fulgoni’s retirement on November 13, 2017.
(5)Amount reflects a cash performance bonus awarded by the Compensation Committee on March 14, 2018 based on an evaluation of Mr. Livek’s contributions during 2017.

(6)Appointed Chief Executive Officer effective August 5, 2016 and retired effective November 13, 2017. 2015 and 2016 amounts include compensation from Dr. Fulgoni’s prior role with the Company.
(7)Appointed Chief Financial Officer effective October 17, 2017.
(8)Amount reflects a cash performance bonus awarded by the Compensation Committee on March 14, 2018 based on an evaluation of Mr. Fink’s contributions during 2017.
(9)Served as Interim Chief Financial Officer from September 10, 2017 to October 16, 2017.
(10)Appointed Chief Financial Officer effective August 5, 2016 and resigned effective September 8, 2017. 2016 amounts include compensation from Mr. Chemerow’s prior role with the Company.
(11)Amount reflects a cash bonus awarded by the Compensation Committee on March 20, 2017, designed to be consistent with the value of the time-based equity incentive awards granted in previous years.
(12)Appointed General Counsel & Chief Privacy and People Officer effective January 23, 2017 (later expanded to General Counsel & Chief Compliance, Privacy and People Officer).
(13)Amount reflects (a) a cashsign-on bonus of $200,000, paid in equal installments on April 2017 and July 2017, (b) a cash performance and retention bonus of $1,500,000, payable in equal installments in October 2017, January 2018 and September 2018 in recognition of Ms. DiBattiste’s efforts in reaching settlement terms in certain of our outstanding litigation, and (c) a cash performance bonus awarded by the Compensation Committee on March 14, 2018 based on an evaluation of Ms. DiBattiste’s contributions during 2017.
(14)Resigned as Executive Vice President, General Counsel and Chief Privacy Officer effective January 23, 2017; served as a consultant until August 2, 2017.
(15)Transitioned from Chief Technology Officer effective July 7, 2017; served as a consultant until October 13, 2017.
(16)Amount reflects a cash bonus awarded by the Compensation Committee on March 20, 2017, designed to be consistent with the value of the time-based equity incentive awards granted in previous years.

2017 Grants of Plan-Based Awards Table

The following table sets forth certain information concerning grants of plan-based awards to our named executive officers in 2017.service providers notwithstanding an adverse tax or accounting treatment for that compensation.

Approval
Date
Estimated Future
Payouts Under
Equity Incentive
Plan Awards (1)
All Other
Stock Awards:
Number of
Shares of Stock

(#)
All Other Option
Awards: Number
of Securities
Underlying
Options

(#)
Exercise or
Base Price of
Option Awards

($/Sh)
Grant Date Fair
Value of Stock
and Option
Awards

($) (1)

Name

Grant
Date
Target
(#)
Maximum
(#)

William Livek

—  —  —  —  —  —  —  —  

Gian Fulgoni

—  —  —  —  —  —  —  —  

Gregory Fink

—  —  —  —  —  —  —  —  

David Kay

—  —  —  —  —  —  —  —  

David Chemerow

—  —  —  —  —  —  —  4,411,746

Carol DiBattiste

—  —  —  —  —  —  —  —  

Christiana Lin

—  —  —  —  —  —  —  496,761

Michael Brown

—  —  —  —  —  —  —  191,086

(1)Amounts represent incremental expense recognized in the year of termination of employment for awards granted in prior years, in connection with an extension of option exercisability for all employees who ceased employment prior to our regaining compliance with SEC filing requirements. Mr. Chemerow’s employment ended on September 8, 2017; Ms. Lin’s service ended on August 2, 2017; and Mr. Brown’s service ended on October 13, 2017. Assumptions used in the calculation of these amounts are described in Note 13 to the consolidated financial statements included in Item 8 of the 201710-K.

Notes to 2017 Summary Compensation Table and 2017 Grants of Plan-Based Awards Table

As discussed under Compensation Discussion and Analysis, due to the ongoing restatement and audit process in 2017, the Compensation Committee did not establish formal annual or long-term incentive award opportunities for our executive officers for 2017. Instead, the compensation decisions reflected in the 2017 tables above were made largely on an individualized,case-by-case basis, taking into consideration the situation that confronted the Company at the time that we needed to appoint a new executive officer, address the circumstances involving a departing executive officer, or respond to the incentive and retention challenges that were presented for continuing executive officers. For additional information regarding the compensation of our named executive officers for 2017, see “Executive Compensation Actions and Decisions for 2017” under Compensation Discussion and Analysis.

20172022 Outstanding Equity Awards at Fiscal Year End

The following table sets forth certain information concerning outstanding equity awards held by the named executive officers as of December 31, 2017.2022.

 

   Option Awards  Stock Awards 

Name

  Number of Securities
Underlying Unexercised
and Exercisable Options
(#)
  Option Exercise
Price
($)
   Option Expiration
Date (1)
  Number of Shares
or Units of Stock
That Have Not
Vested (#) (2)
  Market Value of Shares or
Units of Stock That Have
Not Vested ($) (2)
 

William Livek

   316,250 (3)   12.61    6/15/2019   —     —   
   184,000 (3)   25.86    12/23/2020   —     —   
   102,350 (4)   11.56    11/6/2021   —     —   
   —     —      —     6,667 (5)   190,010 

Gian Fulgoni

   —     —      —     —     —   

Gregory Fink

   —     —      —     —     —   

David Kay

   —     —      —     —     —   

David Chemerow

   48,300 (4)   11.56    (1)   —     —   
   276,000 (3)   25.86    (1)   —     —   
   121,612 (3)   14.98    (1)   —     —   
   —     —      —     26,250 (6)   748,125 (6) 
   —     —      —     5,000 (7)   142,500 (7) 

Carol DiBattiste

   —     —      —     —     —   

Christiana Lin

   218,828   42.92    (1)   —     —   

Michael Brown

   103,089   42.92    (1)   —     —   
   Option Awards   Stock Awards 

Name

  Number of
Securities
Underlying
Unexercised
and
Exercisable
Options
(#)
      Number of
Securities
Underlying
Unexercised
and
Unexercisable
Options
(#)
      Option
Exercise
Price
($)
   Option
Expiration
Date
   Number
of Shares
or Units
of Stock
That
Have Not
Vested
(#) (1)
   Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($) (2)
   Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights
That Have
Not Vested
(#) (3)
   Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That
Have
Not Vested
($) (2)
 

Jon Carpenter

        500,000   (5)    2.50    8/24/2032                 
                     301,318    349,529    72,000    83,520 

Bill Livek

   300,000        (6)    3.21    11/7/2029                 
                     100,000    116,000    70,085    81,299 

Mary Margaret Curry

        160,000   (7)    2.50    8/24/2032                 
                             19,800    22,968 

Greg Dale

        160,000   (8)    2.50    8/24/2032                 
   26,161   (4)    39,927   (9)    0.97    5/26/2031                 
   62,073   (4)    10,954   (10)    1.45    7/18/2028                 
   2,809   (4)    496   (11)    0.57    4/13/2025                 
                             19,800    22,968 

 

(1)Option expiration dates

The awards reported in this column reflect time-based RSUs, which vest as set forth in the original expiration dates in effect as of December 31, 2017 for thosefollowing table, subject to the named executive officers who were still providing services to the Companyofficer’s continued employment or service through such vesting dates:

Name

Number of RSUsRemaining Vesting Schedule

Jon Carpenter

301,318       One-half on that date. On April 26, 2016, our Boardeach of Directors approved an extension of the exercisability of outstanding stock options for all of our employees in the event of a cessation of their employment prior to our regaining compliance with SEC filing requirements. As a result, any employees who left the Company while holding exercisable stock options prior to our regaining compliance with SEC filing obligations were given an additional 180 days following such compliance to exercise their options, subject to any earlier expiration date in their individual award agreements. Mr. Chemerow, Ms. LinNovember 29,
2023 and Mr. Brown left the Company with exercisable stock options in 2017 and are eligible to take advantage of this option extension.November 29, 2024

Bill Livek

100,000       June 15, 2023

Mary Margaret Curry

—       

Greg Dale

—       

(2)Market

Amounts in these columns reflect the market value of shares or units of stock reported in the preceding column that have not vested, is computed based on the closing bid price of our Common Stock as reported on the OTC Pink TierNasdaq on December 29, 2017,30, 2022, which was $28.50$1.16 per share.

(3)Award

The awards reported in this column reflect the threshold number of PRSUs granted in 2019 to Mr. Livek and 2022 to Messrs. Carpenter and Dale and Ms. Curry, which become eligible to be earned based on achievement of certain stock-price hurdles subject to the named executive officer’s continued employment or service through the date of achievement of the applicable stock-price hurdle during the applicable performance period. The awards are reported at threshold because the threshold level of performance had not been achieved as of December 31, 2022. The following table sets forth the end of the applicable performance period for each award with respect to the number of PRSUs reflected in this column. As described under “Payments Upon Termination or Change in Control” below, Mr. Livek’s PRSUs will vest in full with respect to 425,000 shares of Common Stock (to the extent not already vested) upon his separation from service as a member of the Board.

Name

Number of PRSUsPerformance Period End Date

Bill Livek

70,085       November 4, 2029

Jon Carpenter

72,000       July 6, 2032

Mary Margaret Curry

19,800       July 6, 2032

Greg Dale

19,800       August 24, 2032

(4)

Time-based stock option awards granted under the Rentrak Corporation 2005Shareablee, Inc. 2013 Stock IncentiveOption/Stock Issuance Plan (the “Shareablee Plan”) and assumed by the Companycompany on January 29, 2016December 16, 2021 in connection with the RentrakShareablee merger.

(4)(5)Award

Time-based stock option award granted under our 2018 Equity and Incentive Compensation Plan, as amended and restated effective as of July 9, 2020 (the “2018 Plan”) that vests and becomes exercisable as to one-fourth on each of July 6, 2023, July 6, 2024, July 6, 2025, and July 6, 2026.

(6)

Time-based stock option award granted under the Rentrak Corporation 2011 Stock Incentive2018 Plan and assumed by the Company on January 29, 2016 in connection with the Rentrak merger.

(5)RSUs with respect to 3,333 shareslast tranche of which vested on February 15, 2018. The remaining RSUs are scheduled to vest on February 15, 2019, subject toNovember 7, 2022 in light of Mr. Livek’s continued service as a member of the Board through thesuch vesting date.

(6)RSUs are scheduled to vest in equal installments on August 5, 2018, August 5, 2019 and August 5, 2020.

(7)RSUs with respect

Time-based stock option award granted under the 2018 Plan that vests and becomes exercisable as to 5,000 shares vestedone-fourth on February 15, 2018.each of July 6, 2023, July 6, 2024, July 6, 2025, and July 6, 2026.

2017 Option Exercises and Stock Vested

The following table sets forth certain information concerning the number of shares our named executive officers acquired and the value they realized upon vesting of stock awards during 2017. Values are shown before payment of any applicable withholding taxes or brokerage commissions. None of our named executive officers exercised options in 2017.

Name

  Option Awards   Stock Awards 
  Number of Shares
Acquired on

Exercise
(#)
   Value Realized on
Exercise

($)
   Number of Shares
Acquired on

Vesting
(#)
   Value Realized
on Vesting
($)(1)
 

William Livek

   —      —      3,333    74,959 

Gian Fulgoni

   —      —      14,855    375,100 

Gregory Fink

   —      —      —      —   

David Kay

   —      —      —      —   

David Chemerow

   —      —      13,750    373,200 

Carol DiBattiste

   —      —      —      —   

Christiana Lin

   —      —      22,352    528,703 

Michael Brown

   —      —      19,012    450,663 

 

(1)(8)The value realized

Time-based stock option award granted under the 2018 Plan that vests and becomes exercisable as to one-fourth on vesting is calculated by multiplying the numbereach of shares of stock or units by the market value of the underlying shares on the vesting date.August 23, 2023, August 23, 2024, August 23, 2025, and August 23, 2026.

(9)

Time-based stock option award granted under the Shareablee Plan that vests and becomes exercisable in substantially equal monthly installments.

(10)

Time-based stock option award granted under the Shareablee Plan that vests and becomes exercisable on June 15, 2023.

PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

(11)

Time-based stock option award granted under the Shareablee Plan that vests and becomes exercisable on June 15, 2023.

Current Named Executive OfficersPayments Upon Termination or Change in Control

Carpenter Change of Control and Severance Agreements

Each of our named executive officers serving at the end of 2017 (Mr. Livek, Mr. Fink and Ms. DiBattiste) has entered into our form ofCarpenter is party to a change of control agreement and a severance agreement, for executive officersas amended in connection with his appointment as our Chief Executive Officer in 2022 (the “Change of Control and Severance Agreement”“Carpenter Agreements”). The Change of Control and Severance Agreement hasCarpenter Agreements have a three-yeartwo-year initial term with automatic three-yearone-year renewals thereafter, and in the event of a change of control (as defined in the Change of Control and Severance Agreement), will continue in effect through the longer of the date that is 12 months following the effective date of the change of control or the remainder of the term then in effect. The Carpenter Agreements provide that

The Change of Control and Severance Agreement provides that

if the Company terminates an executive officer’s employmentwe terminate Mr. Carpenter without cause“cause” or an executive officerMr. Carpenter resigns for good reason“good reason” (each as defineddescribed below), then, subject to compliance with certain post-employment covenants and execution and non-revocation of a release of claims in favor of the executive officercompany, Mr. Carpenter would be eligible to receive (i) payment of all accrued but unpaid vacation, expense reimbursements, wages and other benefits due under our compensation plans, policies and arrangements;arrangements (the “Accrued Amounts”); (ii) reimbursement of continuation healthcare (COBRA)COBRA premiums (or an equivalent cash distribution if the severance period exceeds the permitted COBRA participation period) until the earlier of the expiration of the executive officer’s severance period or the date that he or she becomes covered under a similar plan;for 24 months; and (iii) the following severance payments, depending on the time of termination or resignation:

 

Time of Termination or Resignation

Severance Benefit

Prior to a Change of Control

  

Severance BenefitOn or Within 12 Months Following
a Change of Control

Prior to a change of controlCash Severance  If employed in executive role for less than two years, continuing payments at a rate equal to the executive officer’s24 months of Mr. Carpenter’s annual base salary thenas in effect for a specified period followingimmediately prior to the termination to bedate, paid periodicallyover 24 months in accordance with our normal payroll policies. For Mr. Livek, this period is 24 months. For Mr. Fink and Ms. DiBattiste, this period is six months.
practices.  If employed in executive role for two years or more, continuing payments at a rate equal to the executive officer’s24 months of Mr. Carpenter’s annual base salary then in effect, for a specified period following termination, to be paid periodically in accordance with our normal payroll policies. For Mr. Livek, this period is 24 months. For Mr. Fink, this period is 15 months. For Ms. DiBattiste, this period is 12 months.
On or within 12 months after a change of controlA lump sum payment (less applicable withholding taxes) equal to a specified multiple of the executive officer’s annual base salary in effect immediately prior to his or her termination date or, if greater, at the levelas in effect immediately prior to the termination date (or, if greater, the change of control. Forcontrol), paid 60 days following termination.
Current Year Short-Term Incentive AwardPro-rata portion based on actual performance through the end of the applicable year, paid at the time short-term incentive awards are paid to other senior executives.Pro-rata portion of the greater of (A) Mr. Livek, this multiple is 2.0 times annual base salary. For Mr. Fink, this multiple is 1.25 times annual base salary. For Ms. DiBattiste, this multiple is 1.0 times annual base salary.Carpenter’s target short- term incentive award for the year of termination and (B) the projected full-year short-term incentive award, paid 60 days following termination.
Time-Based Equity AccelerationNone (but see “Carpenter Equity Awards” below).Full acceleration.
Performance-Based Equity AccelerationNone.Acceleration as to the greater of (A) the target number of shares subject to the applicable equity award or (B) if 50% of the performance period has elapsed, the projected number of shares that would have been earned through the end of the performance period.

Further, if an executive officer is terminated without cause or resigns for good reason on or within 12 months after a change of control (a “Double-Trigger Change of Control Event”), or remains employed by or continues to provide services to the Company through theone-year anniversary of a change of control, the Change of Control and Severance Agreement provides that all of the executive officer’s outstanding and unvested equity awards held as of the date of the change of control will vest in full.

Under the Change of Control and Severance Agreement, “cause”Carpenter Agreements:

“cause” is generally defined as an executive officer’sMr. Carpenter’s indictment, plea of nolo contendere or conviction of any felony or any crime involving dishonesty; material breach of duties or a Company policy;company policy (that is not cured by Mr. Carpenter within 30 days following written notice); or commission of any act of dishonesty, embezzlement, theft, fraud or misconduct with respect to the Company,company, any of which in the good faith and reasonable determination of the Board or the Compensation Committee is materially detrimental to the Company,company, its business or its reputation. “Goodreputation;

“change of control” is generally defined as the occurrence of (i) a change in ownership of the company pursuant to the acquisition by any one person or any persons acting as a group of a number of shares of the company’s stock that, together with the stock already held by such person, represents more than 50% of the total voting power of the company’s stock (other than an acquisition of stock of the company as a result of a private financing that is approved by the Board), (ii) a change in the effective control of the company due to the majority of the members of the Board being replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election, or (iii) a change in the ownership of a substantial portion of the company’s assets which occurs on the date that any person acquires (or has acquired during the 12-month period preceding such acquisition) assets from the company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the company’s assets immediately prior to such acquisition (determined without regard to any liabilities associated with such assets); and

“good reason” is defined as an executive officer’sMr. Carpenter’s termination of employment within 90 days after the expiration of a specified cure period following the occurrence of one or more of the following, without the executive officer’s consent:following: (i) a material diminution in the executive officer’sMr. Carpenter’s base compensation (unless such reduction is done as part of a reduction program for all of our senior-level executives); or (ii) a material reductionrelocation of Mr. Carpenter’s primary workplace of over 50 miles.

Termination will not be considered for “good reason” if the compensation is subject to any clawback provisions, or if the executive’s termination is related in certain instances to the intentional and reckless conduct of the executive officer’s authority or responsibilities relative to his or her authority or responsibilities in effect immediately prior to such reduction, or, following a change of control, a change in the executive officer’s reporting position such that he or she no longer reports directly to the chief executive officer of the parent corporation in a group of controlled corporations; or (iii) the relocation of the executive officer’s primary workplace to a location more than 50 miles away from his or her workplace in effect immediately prior to such relocation.

Payments under the Change of Control and Severance Agreement are contingent upon the executive officer’s execution andnon-revocation of a release of claims in a form acceptable to the Company, as well as his or her continued compliance with certain post-employment covenants, includingnon-disclosure obligations (with appropriate exceptions for disclosures to government officials or attorneys in connection with a suspected violation of law or regulation) and obligations not to compete with the Company or to engage in solicitation during the12-month period following termination of employment.executive.

In the event that the payments or benefits under the Change of Control and Severance AgreementCarpenter Agreements (i) would constitute “parachute payments” within the meaning of Section 280G of the Code orand (ii) would subject an executive officerMr. Carpenter to the excise tax imposed by Section 4999 of the Code, then, depending on which method produces the executive officer would receive such payment as would entitle him or her to receive the greatestlargest net after-tax benefit.benefit for Mr. Carpenter, the payments shall either be: (a) reduced to the level at which no excise tax applies or (b) paid in full, which would subject Mr. Carpenter to the excise tax.

Potential PaymentsCarpenter Equity Awards

In connection with his appointment as our Chief Financial Officer in November 2021, Mr. Carpenter received an inducement award of Fiscal Year End 2017

The following tables show the valueRSUs with respect to 451,977 shares of our Common Stock. These RSUs vest as to one-third on each of the potential payments thatfirst three anniversaries of his start date (November 29, 2021). In addition to the severance benefits described above, if we terminate Mr. Livek,Carpenter’s service without cause or he resigns for good reason, in either case prior to a change in control, a portion of the RSU grant equal to 15 months of vesting (or the remaining term, if shorter) will vest upon termination.

In connection with his appointment as our Chief Executive Officer in July 2022, Mr. FinkCarpenter received one-time equity grants as follows: (i) 400,000 PRSUs, which will have the opportunity to vest quarterly from the date of grant (July 6, 2022) through the 10th anniversary of the date of grant or an earlier change of control of the company, subject to and Ms. DiBattiste would have received in various scenarios involvingaccordance with the achievement of certain stock-price hurdles (ranging from $5.00 to $15.00 per share) on or prior to such date; and (ii) options to purchase 500,000 shares of Common Stock, with aper-share exercise price equal to $2.50, which will vest in equal annual installments on July 6, 2023, 2024, 2025 and 2026. Each of these award agreements provides for certain treatment upon a qualifying termination of their employment service and/or change of control event, assumingcontrol. The award agreement evidencing the grant of PRSUs to Mr. Carpenter provides that (a) if we terminate Mr. Carpenter’s service without cause or if Mr. Carpenter resigns or terminates as a December 29, 2017 triggering date and, where applicable, aresult of death or disability (as defined in the Carpenter Agreements), the PRSUs will become vested based on actual achievement of the stock price per share for our Common Stock of $28.50 (the closing bid price of our Common Stockhurdles during the period beginning on the OTC Pink Tiermost recent vesting date preceding the date of termination and ending on December 29, 2017). December 29, 2017 was the last business daydate of 2017.

William Livek

Payments Upon Termination

  Voluntary
Termination

($)
   Termination by
Employee for Good
Reason

($)
  Involuntary
Termination without
Cause

($)
  Involuntary
Termination

for Cause
($)
   Double-Trigger
Change of Control
Event

($)
  Extended Service
after Change of
Control Event

($)
 

Severance Payments

   —      888,000   888,000   —      888,000 (1)   —   

COBRA Benefits

   —      32,245 (2)   32,245 (2)   —      32,245 (2)   —   

Restricted Stock Units

   —      —     —     —      190,010 (3)   190,010 (3) 
  

 

 

   

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

Total

   —      920,245   920,245   —      1,110,255   190,010 

(1)Represents the amount payable if Mr. Livek were terminated without cause or resigned for good reason on or within 12 months after a change of control.
(2)Represents the amount payable if Mr. Livek elected continuation healthcare coverage under COBRA for the full severance period.
(3)Represents the fair market value of RSU awards, the vesting of which would accelerate if Mr. Livek were terminated without cause or resigned for good reason on or within 12 months after a change of control, or if he remained employed by or continued to provide services to the Company through theone-year anniversary of a change of control.

Gregory Fink

Payments Upon Termination

  Voluntary
Termination

($)
   Termination by
Employee for
Good Reason

($)
  Involuntary
Termination
without
Cause

($)
  Involuntary
Termination

for Cause
($)
   Double-Trigger
Change of
Control Event

($)
  Extended Service
After Change of
Control Event

($)
 

Severance Payments

   —      195,000   195,000   —      487,500 (1)   —   

COBRA Benefits

   —      11,453 (2)   11,453 (2)   —      28,634 (2)   —   

Restricted Stock Units

   —      —     —     —      —     —   
  

 

 

   

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

Total

   —      206,453   206,453   —      516,134   —   

(1)Represents the amount payable if Mr. Fink were terminated without cause or resigned for good reason on or within 12 months after a change of control.
(2)Represents the amount payable if Mr. Fink elected continuation healthcare coverage under COBRA for the full severance period.

Carol DiBattiste

Payments Upon Termination

  Voluntary
Termination

($)
   Termination
by
Employee
for Good
Reason

($)
  Involuntary
Termination
without
Cause

($)
  Involuntary
Termination

for Cause
($)
   Double-Trigger
Change of
Control Event

($)
  Extended Service
after Change of
Control Event

($)
 

Severance Payments

   —      192,500   192,500   —      385,000 (1)   —   

COBRA Benefits

   —      3,335 (2)   3,335 (2)   —      6,670 (2)   —   

Restricted Stock Units

   —      —     —     —      —     —   
  

 

 

   

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

Total

   —      195,835   195,835   —      391,670   —   

(1)Represents the amount payable if Ms. DiBattiste were terminated without cause or resigned for good reason on or within 12 months after a change of control.
(2)Represents the amount payable if Ms. DiBattiste elected continuation healthcare coverage under COBRA for the full severance period.

Former Named Executive Officers

Our other named executive officers for 2017 (Ms. Lin, Mr. Brown, Mr. Chemerow, Mr. Kaysuch termination, and Dr. Fulgoni) were not serving as executive officers at(b) if a change of control occurs, the end of 2017. WithPRSUs will become vested by applying the exception of Mr. Kay, who provides services to us through CrossCountry and is not entitled to any termination benefits from the Company, the named executive officers who were not serving at the end of 2017 entered into separation agreementsper-share price paid in connection with the Companychange of control as follows.

Christiana Lin

Ms. Lin’s employmentthe stock price hurdle for purposes of determining attainment of performance goals. With respect to the option grant, if Mr. Carpenter’s service with the Company ended on February 1, 2017. As described under “Executive Compensation Actions and Decisionscompany is terminated by the company without cause or by Mr. Carpenter for 2017”good reason (each as defined in the Compensation Discussion and Analysis, we agreed to the following termination benefits for Ms. Lin: (i) payments equal to her then-current base salary for a period ofCarpenter Agreements), in either case within 12 months from her separationfollowing a change of control, then subject to Mr. Carpenter’s timely execution of a release of claims in favor of the company, any unvested portion of the options will fully vest upon such termination and Mr. Carpenter will have 90 days thereafter (or until the options’ 10-year expiration date, ($347,985if earlier) to exercise any vested options.

Livek Change of Control and Severance Agreement

Prior to his retirement as our Chief Executive Officer in total);July 2022, Mr. Livek was a party to a change of control and (ii) paymentseverance agreement (the “Livek Agreement”). The Livek Agreement provided that if Mr. Livek incurred a qualifying termination of premiums for eligible continuation healthcare coverage for the same period ($22,717). All payments wereemployment, then, subject to compliance with certain post-employment covenants and are contingent upon Ms. Lin’s execution andnon-revocation of a release of claims in favor of the company, he would be eligible to receive (i) all Accrued Amounts; (ii) reimbursement of COBRA premiums (or an equivalent cash distribution if the severance period exceeded the permitted COBRA participation period) for two years; and (iii) two times his annual base salary, payable over two years in accordance with our normal payroll practices (or if such

termination was on or within 12 months following a change of control, in a lump sum). In 2022, the Livek Agreement was modified as welldescribed under “Livek Transition Agreement” below.

Livek 2019 Equity Awards

In 2019, Mr. Livek was granted equity awards in the form of stock options, RSUs, and PRSUs. Each of these award agreements provided for certain treatment upon a qualifying termination of service and/or change of control. The award agreement evidencing the grant of PRSUs to Mr. Livek in 2019 provided that (a) if we terminated Mr. Livek’s service without cause or if Mr. Livek resigned or terminated as a result of death or disability (as defined in the Livek Agreement), the PRSUs would become vested based on actual achievement of the stock price hurdle during the period beginning on the most recent vesting date preceding the date of termination and ending on the date of such termination, and (b) if a change of control occurred, the PRSUs would become vested by applying the per-share price paid in connection with the change of control as the stock price hurdle for purposes of determining attainment of performance goals. In 2022, this PRSU award was modified as described under “Livek Transition Agreement” below.

Livek 2019 Letter Agreement

In connection with his appointment as our Chief Executive Officer, we and Mr. Livek entered into a letter agreement on November 4, 2019 (the “Livek 2019 Letter Agreement”) pursuant to which Mr. Livek was eligible to receive a one-time bonus of at least $1,000,000 upon the successful completion of a refinance of all or substantially all of our outstanding senior secured convertible notes. The refinance bonus was paid to Mr. Livek in the form of RSUs (the “2021 RSUs”) on March 10, 2021, upon the closing of our Series B Preferred Stock transactions. The 2021 RSUs vested in full on December 31, 2021. Mr. Livek was required to hold the net shares of Common Stock delivered to him under the 2021 RSUs over the three-year period following the closing of the transactions, with one-third of such shares being released from the hold on each anniversary of March 10, 2021. These holding requirements terminated upon Mr. Livek’s retirement as our Chief Executive Officer in 2022, as described under “Livek Transition Agreement” below.

Livek Transition Agreement

On February 28, 2022, we announced that Mr. Livek would retire as our Chief Executive Officer and transition to a non-executive Vice Chairman role after his successor was named. On the same date, we entered into a Transition and Separation Agreement (the “Transition Agreement”) to facilitate Mr. Livek’s retirement as Chief Executive Officer. Pursuant to the Transition Agreement, Mr. Livek agreed to continue to serve as Chief Executive Officer through the date on which we appointed a new Chief Executive Officer, at which time Mr. Livek’s employment would end. Effective July 6, 2022, the Board appointed Mr. Carpenter to serve as our new Chief Executive Officer, and Mr. Livek retired (such date, the “Separation Date”).

Mr. Livek’s annual incentive award for 2022 was prorated for his service as Chief Executive Officer through the Separation Date. This award was paid based on actual performance (as determined by the Compensation Committee and consistent with awards payable to other executive officers) at the same time such awards became payable to other executive officers in 2023. See “Narrative to 2022 Summary Compensation Table — Annual Incentive Awards” above for additional information about 2022 annual incentive awards.

Subject to Mr. Livek’s continued compliance with the terms of the Transition Agreement, which include certain non-competition, non-solicitation and other covenants, he is entitled to receive cash severance and healthcare continuation coverage consistent with the terms of the Livek Agreement (described above). Mr. Livek’s outstanding equity awards have remained outstanding and continued to vest or be exercisable (as applicable) in accordance with their terms following his transition to serving as non-executive Vice Chairman, provided that any outstanding PRSUs granted to Mr. Livek in 2019 (i) will not vest upon a change of control, and (ii) will vest in full upon Mr. Livek’s separation from service as a member of the Board, to the extent they have not already vested by their terms prior to such date. In addition, as described above, the holding requirements for the shares of Common Stock delivered to Mr. Livek under the 2021 RSUs terminated upon his retirement as Chief Executive Officer.

During his service as a non-employee director, Mr. Livek is entitled to receive standard non-employee director compensation payable on the same terms as applicable to our other non-employee directors. Finally, we agreed to reimburse up to $10,000 in attorneys’ fees incurred by Mr. Livek in connection with the Transition Agreement.

Curry Change of Control and Severance Agreements

Ms. Curry is party to a change of control agreement and a severance agreement entered into in connection with her continuedappointment as our Chief Financial Officer in 2022 (the “Curry Agreements”). The Curry Agreements have a two-year initial term with automatic one-year renewals thereafter, and in the event of a change of control will continue in effect through the longer of the date that is 12 months following the effective date of the change of control or the remainder of the term then in effect. The Curry Agreements provide that if we terminate Ms. Curry without “cause” or Ms. Curry resigns for “good reason” (each as described under the Carpenter Agreements, above), then, subject to compliance with certain post-employment covenants includingnon-disclosureandnon-disparagement obligations (with appropriate exceptions for disclosures to government officials or attorneys in connection with a suspected violation of law or regulation), obligations not to compete with the Company or to engage in solicitation during the12-month period following termination, and obligations to cooperate and assist the Company in any investigation into matters about which Ms. Lin has relevant knowledge.

During Ms. Lin’s consulting term, which began on February 2, 2017 and ended on August 2, 2017, Ms. Lin was paid $83,333 per month (totaling $500,000), and her outstanding equity awards continued to vest. The value upon vesting of these awards, based on the market value of the underlying shares on the relevant vesting dates, was $528,703.

Michael Brown

Mr. Brown’s employment with the Company ended on July 7, 2017. As described under “Executive Compensation Actions and Decisions for 2017” in the Compensation Discussion and Analysis, we agreed to the following termination benefits for Mr. Brown: (i) payments equal to his then-current base salary for a period of 12 months from his separation date ($330,480 in total); and (ii) payment of premiums for eligible continuation healthcare coverage for the same period ($22,907). All payments were and are contingent upon Mr. Brown’s execution andnon-revocation of a release of claims in favor of the company, Ms. Curry would be eligible to receive (i) all Accrued Amounts; (ii) reimbursement of COBRA premiums (or an equivalent cash distribution if the severance period exceeds the permitted COBRA participation period) for 15 months; and (iii) the following severance payments, depending on the time of termination or resignation:

Time of Termination or Resignation

Severance Benefit

Prior to a Change of Control

On or Within 12 Months Following
a Change of Control

Cash Severance15 months of Ms. Curry’s annual base salary as in effect immediately prior to the termination date, paid over 15 months in accordance with our normal payroll practices.15 months of Ms. Curry’s annual base salary as in effect immediately prior to the termination date (or, if greater, the change of control), paid 60 days following termination.
Current Year Short-Term Incentive AwardPro-rata portion based on actual performance through the end of the applicable year, paid at the time short-term incentive awards are paid to other senior executives.Pro-rata portion of the greater of (A) Ms. Curry’s target short-term incentive award for the year of termination and (B) the projected full-year short-term incentive award, paid 60 days following termination.
Time-Based Equity AccelerationNone (but see “Curry Equity Awards” below).Full acceleration.
Performance-Based Equity AccelerationNone.Acceleration as to the greater of (A) the target number of shares subject to the applicable equity award or (B) if 50% of the performance period has elapsed, the projected number of shares that would have been earned through the end of the performance period.

In the event that the payments or benefits under the Curry Agreements (i) would constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) would subject Ms. Curry to the excise tax imposed by Section 4999 of the Code, then, depending on which method produces the largest net after-tax benefit for Ms. Curry, the payments shall either be: (a) reduced to the level at which no excise tax applies or (b) paid in full, which would subject Ms. Curry to the excise tax.

Curry Equity Awards

In connection with her appointment as wellour Chief Financial Officer in July 2022, Ms. Curry received one-time equity grants as follows: (i) 110,000 PRSUs, which will have the opportunity to vest quarterly from the date of grant (July 6, 2022) through the 10th anniversary of the date of grant or an earlier change of control of the company, subject to and in accordance with the achievement of certain stock-price hurdles (ranging from $5.00 to $15.00 per share) on or prior to such date; and (ii) options to purchase 160,000 shares of Common Stock, with a per-share exercise price equal to $2.50, which will vest in equal annual installments on July 6, 2023, 2024, 2025 and 2026. Each of these award agreements provides for certain treatment upon a qualifying termination of

service and/or change of control. The award agreement evidencing the grant of PRSUs to Ms. Curry provides that (a) if we terminate Ms. Curry’s service without cause or if Ms. Curry resigns or terminates as a result of death or disability (as defined in the Curry Agreements), the PRSUs will become vested based on actual achievement of the stock price hurdles during the period beginning on the most recent vesting date preceding the date of termination and ending on the date of such termination, and (b) if a change of control occurs, the PRSUs will become vested by applying the per-share price paid in connection with the change of control as the stock price hurdle for purposes of determining attainment of performance goals. With respect to the option grant, if Ms. Curry’s service with the company is terminated by the company without cause or by Ms. Curry for good reason (each as defined in the Curry Agreements), in either case within 12 months following a change of control, then subject to Ms. Curry’s timely execution of a release of claims in favor of the company, any unvested portion of the options will fully vest upon such termination and Ms. Curry will have 90 days thereafter (or until the options’ 10-year expiration date, if earlier) to exercise any vested options.

Dale Change of Control and Severance Agreements

Mr. Dale is party to a change of control agreement and a severance agreement entered into in connection with his continuedappointment as our Chief Operating Officer in 2022 (the “Dale Agreements”). The Dale Agreements have a two-year initial term with automatic one-year renewals thereafter, and in the event of a change of control will continue in effect through the longer of the date that is 12 months following the effective date of the change of control or the remainder of the term then in effect. The Dale Agreements provide that if we terminate Mr. Dale without “cause” or Mr. Dale resigns for “good reason” (each as described under the Carpenter Agreements, above), then, subject to compliance with certain post-employment covenants includingnon-disclosureandnon-disparagement obligations (with appropriate exceptions for disclosures to government officials or attorneys in connection with a suspected violation of law or regulation), obligations not to compete with the Company or to engage in solicitation during the12-month period following termination, and obligations to cooperate and assist the Company in any investigation into matters about which Mr. Brown has relevant knowledge.

During Mr. Brown’s consulting term, which began on July 10, 2017 and ended on October 13, 2017, Mr. Brown was paid $50,000 per month (totaling $152,530).

David Chemerow

Mr. Chemerow’s employment with the Company ended on September 8, 2017. As described under “Executive Compensation Actions and Decisions for 2017” in the Compensation Discussion and Analysis, we agreed to the following termination benefits for Mr. Chemerow: (i) payments equal to his then-current base salary for a period of 15 months from his separation date ($449,514 in total); (ii) payment of premiums for eligible continuation healthcare coverage for up to 18 months ($24,158); (iii) a payment of $100,000 within 30 days after the first to occur of (A) the relisting of our Common Stock, the approval by our stockholders of a new equity plan, and the opening of our trading window for employees, or (B) any entity or person acquiring more than 50 percent of our Common Stock or more than 50 percent of our assets; (iv) a payment of $100,000 on February 1, 2019; and (v) payment of Mr. Chemerow’s attorney fees relating to his separation ($27,474). In addition, Mr. Chemerow is entitled to continued vesting of his outstanding equity awards through August 2020. The value upon vesting of these awards in 2017, based on the market value of the underlying shares on the relevant vesting dates, was $373,200. The potential value upon vesting of these awards in 2018, 2019 and 2020, assuming a value per share of $28.50 (the closing bid price of our Common Stock on the OTC Pink Tier on December 29, 2017), is $890,625.

All payments were and are contingent upon Mr. Chemerow’s execution andnon-revocation of a release of claims in favor of the company, Mr. Dale would be eligible to receive (i) all Accrued Amounts; (ii) reimbursement of COBRA premiums (or an equivalent cash distribution if the severance period exceeds the permitted COBRA participation period) for 12 months; and (iii) the following severance payments, depending on the time of termination or resignation:

Time of Termination or Resignation

Severance Benefit

Prior to a Change of Control

On or Within 12 Months Following
a Change of Control

Cash Severance12 months of Mr. Dale’s annual base salary as in effect immediately prior to the termination date, paid over 12 months in accordance with our normal payroll practices.12 months of Mr. Dale’s annual base salary as in effect immediately prior to the termination date (or, if greater, the change of control), paid 60 days following termination.
Current Year Short-Term Incentive AwardPro-rata portion based on actual performance through the end of the applicable year, paid at the time short-term incentive awards are paid to other senior executives.Pro-rata portion of the greater of (A) Mr. Dale’s target short-term incentive award for the year of termination and (B) the projected full-year short-term incentive award, paid 60 days following termination.
Time-Based Equity AccelerationNone.Full acceleration.
Performance-Based Equity AccelerationNone.Acceleration as to the greater of (A) the target number of shares subject to the applicable equity award or (B) if 50% of the performance period has elapsed, the projected number of shares that would have been earned through the end of the performance period.

In the event that the payments or benefits under the Dale Agreements (i) would constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) would subject Mr. Dale to the excise tax imposed by Section 4999 of the Code, then, depending on which method produces the largest net after-tax benefit for Mr. Dale, the payments shall either be: (a) reduced to the level at which no excise tax applies or (b) paid in full, which would subject Mr. Dale to the excise tax.

Dale Equity Awards

In connection with his appointment as wellour Chief Operating Officer in August 2022, Mr. Dale received one-time equity grants as his continued compliancefollows: (i) 110,000 PRSUs, which will have the opportunity to vest quarterly from the date of grant (August 24, 2022) through the 10th anniversary of the date of grant or an earlier change of control of the company, subject to and in accordance with the achievement of certain post-employment covenants, includingstock-price hurdles (ranging from $5.00 to $15.00 per share) on or prior to such date; and (ii) options to purchase 160,000 shares of Common Stock, with a non-disclosureper-share exercise price equal to $2.50, which will vest in equal annual installments on August 23, 2023, 2024, 2025 and 2026. Each of these award agreements provides for certain treatment upon a qualifying termination of service and/or change of control. The award agreement evidencing the grant of PRSUs to Mr. Dale provides that (a) if we terminate Mr. Dale’s service without cause or if Mr. Dale resigns or terminates as a result of death or disability (as defined in the Dale Agreements), the PRSUs will become vested based on actual achievement of the stock price hurdles during the period beginning on the most recent vesting date preceding the date of termination and ending on the date of such termination, and (b) if a change of control occurs, the PRSUs will become vested by applying the non-disparagementper-share obligations (with appropriate exceptions for disclosures to government officials or attorneysprice paid in connection with a suspected violationthe change of law or regulation), obligations notcontrol as the stock price hurdle for purposes of determining attainment of performance goals. With respect to competethe option grant, if Mr. Dale’s service with the Companycompany is terminated by the company without cause or to engage in solicitation during the12-month period following termination, and obligations to cooperate and assist the Company in any investigation into or litigation involving matters about whichby Mr. Chemerow has relevant knowledge.

Gian Fulgoni

Dr. Fulgoni’s employment with the Company ended on November 13, 2017. As described under “Executive Compensation Actions and DecisionsDale for 2017”good reason (each as defined in the Compensation Discussion and Analysis, we agreed to theDale Agreements), in either case within 12 months following termination benefits for Dr. Fulgoni: (i) paymenta change of premiums for eligible continuation healthcare coverage for up to 18 months ($24,180); (ii) vesting in full of all outstanding equity awards on his separation date; and (iii) the issuance of $4,000,000 in fully vested RSUs as compensation for his services as CEO from August 2016 through his separation date,control, then subject to the Company’s compliance with SEC reporting requirements. The value upon vesting of Dr. Fulgoni’s outstanding equity awards on his separation date (which did not include the RSUs described in clause (iii) above), based on the market value of the underlying shares on the relevant vesting date, was $107,230.

All payments were and are contingent upon Dr. Fulgoni’sMr. Dale’s timely execution andnon-revocation of a release of claims as well as his continued compliance with certain post-employment covenants, includingnon-disclosure andnon-disparagement obligations (with appropriate exceptions for disclosures to government officials or attorneys in connection with a suspected violationfavor of law or regulation), obligations not to compete with the Company or to engage in solicitation duringcompany, any unvested portion of the12-month period following options will fully vest upon such termination and obligationsMr. Dale will have 90 days thereafter (or until the options’ 10-year expiration date, if earlier) to cooperateexercise any vested options.

Pay Versus Performance

As required by Item 402(v) of Regulation S-K, we are providing the following information regarding the relationship between executive compensation and assist the Companycompany’s financial performance for each of the two years in any investigation into matters about which Dr. Fulgoni has relevant knowledge. In addition, the issuance of RSUs as compensation for Dr. Fulgoni’s services as CEO is contingent upon his continued serviceperiod ended December 31, 2022. As indicated above, we are permitted to report as a Special Advisor to the Chair of the Board and the CEO through the date of issuance. In the event that either (x) the Company, after regaining compliance with“smaller reporting company” under SEC reporting requirements (or Dr. Fulgoni’s earlier death or disability), is unable to issue the contemplated RSUs, or (y)rules. Accordingly, we have not issued such RSUs by June 30, 2018, then we are obligated to issue sharesincluded a tabular list of our Common Stock in an equivalent economic amount.

PAY RATIO DISCLOSURE

Forfinancial performance measures, and the 2017 fiscal year,table below (i) only includes the ratio of the annual total compensation of Mr. Livek, our President and Executive Vice Chairman (“PEO Compensation”), to the median of the annual total compensation of all of our employees other than our President and Executive Vice Chairman (“Median Annual Compensation”) was 11 to 1. This ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of RegulationS-K using the data and assumptions summarized below. In this summary, we refer to the employee who received such Median Annual Compensation as the “Median Employee.” For purposes of this disclosure, the date used to identify the Median Employee was December 31, 2017 (the “Determination Date”).

PEO Compensationrequisite information for purposes of this disclosure represents the total compensation reported for Mr. Livek under “2017 Summary Compensation Table” for the 2017 fiscal year, which was $890,790. For purposes of this disclosure, Median Annual Compensation was $77,792, and was calculated by totaling for our Median Employee all applicable elements of compensation for the 2017 fiscal year in accordance with Item 402(c)(2)(x) of RegulationS-K.

To identify the Median Employee, we first determined our employee population as of the Determination Date. We had 1989 employees, representing all full-time, part-time, seasonal and temporary employees of the Company and our consolidated subsidiaries as of the Determination Date. This numbertwo years, (ii) does not include any independent contractors or “leased” workers,information with respect to peer total stockholder return (“TSR”), and (iii) does not include a column for a Company-Selected Measure as permitted by thedefined in Item 402(v) of Regulation S-K. In accordance with applicable SEC rules. We then measuredrules, the adjustments described and quantified below were made to the values reported in the Summary Compensation Table for each applicable year to determine the “actual” compensation for the period beginning on January 1, 2017 and ending on December 31, 2017 for these employees usingyear-to-date Box 1 FormW-2 earnings (or, outside of the United States, a comparable local equivalent) as reflected in our U.S. and local payroll records for 2017. A portion of our employee workforce (full-time and part-time) worked for less than the full fiscal year due to commencing employment after the beginning of the fiscal year. In determining the Median Employee, we annualized the compensation for such individuals.

As a result of our delay in filing periodic reports with the SEC, we temporarily stopped granting equity awardspaid to our directorsprincipal executive officers (“PEOs”) and employees (including our executive officers) in 2016, and our equity incentive plan expired in March 2017. Our inability to grant equity awards to our President and Executive Vice Chairman affected the amount of PEO Compensation for 2017, and our inability to grant equity awardsaverage “actual” compensation paid to our other employees may have affected bothnamed executive officers (“NEOs”).

The following table summarizes compensation values reported in the identificationSummary Compensation Table for our PEOs and the average for our other NEOs, as compared to “compensation actually paid” and the company’s financial performance for the years ended December 31, 2022 and 2021:

Year

 Summary
Compensation
Table Total for
First PEO (1)
  Summary
Compensation
Table Total for
Second PEO (1)
  Compensation
Actually Paid to
First
PEO (1) (2)
  Compensation
Actually Paid to
Second PEO (1)
(2)
  Average Summary
Compensation
Table Total for
Non-PEO NEOs
(1)
  Average
Compensation
Actually Paid to
Non-PEO NEOs
(1) (2)
  Value of Initial
Fixed $100
Investment
Based On TSR
  Net
Income
(Loss) (in
thousands)
 

2022

 $2,288,247  $2,497,073  $74,509  $964,307  $930,347  $591,756  $46.59  ($66,561

2021

 $2,151,653     $3,084,410     $1,551,746  $1,491,691  $134.14  ($50,037

(1)

The first PEO and the second PEO in the table represent Bill Livek and Jon Carpenter, respectively. The non-PEO NEOs reflected in the table for each of 2022 and 2021 are as follows:

2022:

Mary Margaret Curry and Greg Dale

2021:

Jon Carpenter, Greg Fink and Chris Wilson

(2)

The company deducted from and added to the Summary Compensation Table total compensation the following amounts to calculate compensation actually paid in accordance with Item 402(v) of Regulation S-K as disclosed in columns (c) and (e) for our PEO and non-PEO NEOs in each respective year. Because the company’s NEOs do not participate in any defined benefit plans, no adjustments were required to amounts reported in the Summary Compensation Table totals related to the value of benefits under such plans.

   2022  2021 

FIRST PEO SUMMARY COMPENSATION TABLE TOTALS

  $2,288,247  $2,151,653 

Add (Subtract):

   

Fair value of equity awards granted during the year from the Summary Compensation Table

  $(1,317,500 $(991,140

Fair value at year end of equity awards granted during the year

  $116,000    

Change in fair value of equity awards granted in prior years that were unvested as of the end of the year

  $(731,611 $395,297 

Change in fair value of equity awards granted in current year that vested during the year

     $1,351,187 

Change in fair value of equity awards granted in prior years that vested during the year

  $(280,627 $177,413 

Equity awards granted in prior years that were forfeited during the year

       

Dividends or other earnings paid on equity awards during the year

       
  

 

 

  

 

 

 

Total Equity Award Related Adjustments

  $(2,213,738 $932,757 
  

 

 

  

 

 

 

COMPENSATION ACTUALLY PAID TOTALS

  $74,509  $3,084,410 
  

 

 

  

 

 

 

   2022 

SECOND PEO SUMMARY COMPENSATION TABLE TOTAL

  $2,497,073 

Add (Subtract):

  

Fair value of equity awards granted during the year from the Summary Compensation Table

  $(1,181,548

Fair value at year end of equity awards granted during the year

  $600,947 

Change in fair value of equity awards granted in prior years that were unvested as of the end of the year

  $(656,873

Change in fair value of equity awards granted in current year that vested during the year

    

Change in fair value of equity awards granted in prior years that vested during the year

  $(295,292

Equity awards granted in prior years that were forfeited during the year

    

Dividends or other earnings paid on equity awards during the year

    
  

 

 

 

Total Equity Award Related Adjustments

  $(1,532,766
  

 

 

 

COMPENSATION ACTUALLY PAID TOTAL

  $964,307 
  

 

 

 

   2022  2021 

NON-PEO NEOS SUMMARY COMPENSATION TABLE TOTALS

  $930,347  $1,551,746 

Add (Subtract):

   

Fair value of equity awards granted during the year from the Summary Compensation Table

  $(352,309 $(978,381

Fair value at year end of equity awards granted during the year

  $135,603  $660,840 

Change in fair value of equity awards granted in prior years that were unvested as of the end of the year

  $(50,438 $55,787 

Change in fair value of equity awards granted in current year that vested during the year

     $183,126 

Change in fair value of equity awards granted in prior years that vested during the year

  $(71,447 $28,218 

Equity awards granted in prior years that were forfeited during the year

     $(9,645

Dividends or other earnings paid on equity awards during the year

       
  

 

 

  

 

 

 

Total Equity Award Related Adjustments

  $(338,591 $(60,055
  

 

 

  

 

 

 

COMPENSATION ACTUALLY PAID TOTALS

  $591,756  $1,491,691 
  

 

 

  

 

 

 

Narrative Disclosure to Pay versus Performance Table

The illustrations below provide a graphical description of the Median Employeerelationship between compensation actually paid (“CAP”) and the amount of Median Annual Compensation for 2017.

following measures:

the company’s cumulative TSR; and

the company’s net income (loss).

CAP and Company Cumulative TSR

LOGO

CAP and Company Net Income (Loss)

LOGO

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Policies and Procedures for Transactions with Related Parties

Various comScoreComscore policies and procedures, including theour Code of Business Conduct and Ethics and annual questionnaires completed by all of the Company’sour directors and executive officers, require disclosure of transactions or relationships that may constitute conflicts of interest or otherwise require disclosure under applicable SEC rules. In addition, our Board has adopted a written policy and procedures for the review and approval of transactions in which the Companycompany is a participant, the amount involved exceeds $120,000, and one of our directors, director nominees, executive officers, or a holder of more than five percent5% of our Common Stock or Series B Preferred Stock, including any of their immediate family members and any entity owned or controlled by such persons (collectively, “related parties”), has or will have a direct or indirect material interest.

If any related party proposes to enter into any such transaction (a “related party transaction”), our Audit Committee shallwill consider all of the available material facts and circumstances of the transaction, including: the direct and indirect interests of the related party; the approximate dollar value of the amount involved in the transaction and the dollar value of such related person’s direct or indirect interest in the transaction; whether the transaction was undertaken in the ordinary course of business of the Company;company; whether the transaction is proposed to be entered into on terms no less favorable to the Companycompany than those reached with an unrelated third party; whether any alternative transactions or sources for comparable services or products are available; the purpose of the transaction and potential benefits, or potential risks or costs, to the Company;company; whether the transaction is in the best interests of the Company;company; any required public disclosure of the transaction; whether the transaction presents an improper conflict of interest for any Companycompany officer or director; in the event the related party is a director or nominee for director (or immediate family member of a director or nominee or an entity with which a director or nominee is affiliated), the impact that the transaction will have on that director’s or nominee’s independence; and any other information regarding the transaction that would be material to investors in light of the circumstances of such transaction.

Following such consideration and review, if deemed appropriate, the disinterested members of the Audit Committee shallwill approve the related party transaction (except that, if the transaction is proposed to be, or was, entered into on terms less favorable to the Companycompany than terms that could have been reached with an unrelated third party, approval shallwill be obtained by unanimous approval of the disinterested members of the Board). A related party transaction shallwill not be approved if the transaction would render a director no longer independent and would cause less than a majority of the Board to meet the Company’sour director independence requirements. Whenever practicable, the reporting, review and approval shallwill occur prior to entry into the related party transaction. If advance review is not practicable, our Audit Committee may ratify the related party transaction. Prior to the Board’s adoption of a written related party transaction policy, the Audit Committee previously reviewed and approved or ratified related party transactions pursuant to the Audit Committee charter.

Transactions with Related Parties

Other than compensation disclosed under “Director Compensation” or “Executive Compensation” in this proxy statement and the related party transactions described below, we believe there have not been anywere no other related party transactions (as defined above) during the yearyears ended December 31, 2017.2022 and December 31, 2021.

Transactions with WPP

As of DecemberMarch 31, 2017,2023, based on public filings, WPP plc (“WPP”) and its affiliates owned 19.7%approximately 12.3% of the Company’sour outstanding Common Stock. In the normal course of business, the Company provideswe provide WPP and its affiliates with services amongst itsour different product lines and receivesreceive services from WPP and its affiliates supporting the Company’sour data collection efforts. In 2017, the Company’s2022, our transactions with WPP and its affiliates resulted in $13.2approximately $11.7 million of revenue and $13.3$9.4 million of expense. In 2021, our transactions with WPP and its affiliates resulted in approximately $13.6 million of revenue and $12.5 million of expense.

Transactions with iHeartMediaCharter

On June 9, 2017, Lisa Gersh was appointedMarch 10, 2021, we entered into a Data License Agreement with Charter Communications Operating, LLC, an affiliate of Charter, in connection with the Series B Preferred Stock transactions described below. In addition to the Board. At that time, Richard Bressler, the husband of Ms. Gersh, served as President, Chief Operating Officer, Chief Financial OfficerData License Agreement, we also provide Charter and a member of the board of directors of iHeartMedia, Inc., a customer of the Company.its affiliates with services amongst our different product lines. In 2017, the Company recognized revenue of $0.4 million from2022, our commercial transactions with iHeartMedia, Inc.Charter and its affiliates resulted in the normal courseapproximately $2.3 million of business. Ms. Gersh resigned from the Board on September 10, 2017.revenue and $17.6 million of expense. In 2021, our commercial transactions with Charter and its affiliates resulted in approximately $1.8 million of revenue and $22.0 million of expense.

Transactions with CrossCountry ConsultingQurate

From September 10, 2017 through October 16, 2017, David Kay served as Interim Chief Financial Officer and Treasurer of the Company. Mr. Kay is aco-founder and managing partner of CrossCountry Consulting LLC (“CrossCountry”), which has been providing the Company with accounting advisory services, audit preparation support and process improvement services since July 2016. In 2017, the Company incurred expenses of $17.5 million payable to CrossCountry.    Mr. Kay ceased serving as Interim Chief Financial Officer and Treasurer effective October 16, 2017 and returned to providing advisory services to the Company through CrossCountry after that date.

Transactions with 360i and Vizeum

On October 3, 2017, Bryan Wiener was appointed to the Board. Mr. Wiener currentlyWendling serves as Executive Chairmanan executive officer of 360i Network, which includes 360i LLCQurate. In 2022 and its affiliate, Vizeum LLC, each of which are customers of the Company. In 2017, the Company2021, we recognized revenue of $0.4approximately $0.9 million and $0.8 million, respectively, from transactions with 360iQurate and Vizeumits affiliates in the normal course of business.

Compensation of Non-Executive Employees

Mr. Livek’s son has been a non-executive employee of the company since January 2016. During 2022 and 2021, he received salary and incentive compensation of approximately $109,000 and $106,000, respectively, in addition to the standard benefits that he received as an employee of the company.

Ms. Love’s son was a non-executive employee of the company from May 2017 until April 2022. During 2022 and 2021, he received salary and incentive compensation of approximately $80,000 and $169,000, respectively, in addition to the standard benefits that he received as an employee of the company.

Acquisition of Shareablee

On December 16, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Shareablee, pursuant to which we acquired Shareablee for a total purchase price of up to $45.0 million, subject to certain adjustments and conditions set forth in the Merger Agreement.

Mr. Fisher is a former director, stockholder (through Pereg Holdings, LLC) and equity award holder of Shareablee. Pursuant to the Merger Agreement, Mr. Fisher and Pereg Holdings, LLC received 89,888 shares of our Common Stock upon closing and were eligible to receive approximately $297,000 in deferred consideration, subject to certain adjustments and conditions set forth in the Merger Agreement. In addition, Mr. Fisher’s outstanding Shareablee options were converted into options to acquire 157,629 shares of our Common Stock, based on a conversion ratio set forth in the Merger Agreement.

Mr. Dale is a former officer and equity award holder of Shareablee. Pursuant to the Merger Agreement, Mr. Dale was eligible to receive approximately $171,000 in deferred consideration, subject to certain adjustments and conditions set forth in the Merger Agreement. In addition, Mr. Dale’s outstanding Shareablee options were converted into options to acquire 142,420 shares of our Common Stock, based on a conversion ratio set forth in the Merger Agreement.

Series B Preferred Stock Transactions

Charter, Qurate and Pine (the “Investors”) each own 33.3% of our outstanding Series B Preferred Stock. As of March 31, 2023, based on public filings, Pine also owned approximately 2.4% of our outstanding Common Stock.

During 2022 and 2021, in accordance with the National Football LeagueCertificate of Designations of the Series B Preferred Stock, we made cash dividend payments totaling $15.5 million and 4.8 million, respectively, to the Investors. Accrued dividends totaled $7.9 million as of December 31, 2022. The next scheduled dividend payment date for the Series B Preferred Stock is June 30, 2023.

In addition to the Charter Data License Agreement described above, we entered into the following agreements or transactions with the Investors in connection with their purchase of Series B Preferred Stock in 2021.

Stockholders Agreement

On October 16, 2017, Michelle McKenna-Doyle was appointedMarch 10, 2021 (the “Closing Date”), we and the Investors entered into the SHA, pursuant to which, among other things, immediately following the Board. Ms. McKenna-Doyle currently serves as Senior Vice Presidentconsummation of our issuance and sale of 27,509,203 shares of Series B Preferred Stock to each Investor in exchange for $68.0 million, with aggregate proceeds of $204.0 million (the “Transactions”), we were obligated to take all necessary action to ensure that the Board consisted of 10 total directors (two designees of each Investor, the Chief InformationExecutive Officer of the National Football League, a customercompany and three individuals who were directors of the Company. In 2017,company prior to the Company recognized revenueclosing of $0.4 million from transactions with the National Football LeagueTransactions). Under the SHA, we are obligated to take all necessary action (to the extent not prohibited by law) to cause the Board to nominate for election that number of individuals designated by an Investor that, if elected, would result in two designees of such Investor serving on the Board until the earlier of such time as such Investor (a) beneficially owns a number of shares of Series B Preferred Stock representing less than 50% of the number of shares of Series B Preferred Stock held by such Investor as of the Closing Date after giving effect to the Transactions (“Initial Preferred Stock Ownership”) as a result of such Investor’s Transfer (as defined in the normal courseSHA) of business.

Transactions with OKTA

On June 9, 2017, Jacques Kerrest was appointedsuch shares to any of the Board. At that time, Frederic Kerrest, the son of Mr. Kerrest, served as Chief Operating Officer of OKTA, Inc. which is a service provider to the Company. In 2017, the Company recognized expense of $0.2 million from transactions with OKTA, Inc.other Investors or (b) beneficially owns Voting Stock (as defined in the normal course of business.

Transactions with Starboard Value LP

On January 16, 2018, the Company entered into certain agreements with certain funds affiliated with or managed by Starboard Value LP (collectively, “Starboard”), then a beneficial owner of moreSHA) representing less than five percent10% of the Company’s outstanding common stock. shares of Common Stock (on an as-converted basis), after which time such Investor’s designation rights will be reduced to one designee until such time as such Investor beneficially owns Voting Stock representing less than 5% of the outstanding shares of Common Stock (on an as-converted basis), after which time such Investor will no longer have any rights to designate a nominee to serve on the Board thereunder.

Pursuant to the agreements,SHA, if one of the Company: (i) issuedInvestors (the “Buying Stockholder”) acquires from one of the other Investors (the “Selling Stockholder”) a number of shares of Series B Preferred Stock equal to (a) at least 50% (but less than 100%) or (b) 100% of the Selling Stockholder’s Initial Preferred Stock Ownership in accordance with the terms of the SHA, the Selling Stockholder will be obligated to cause one (in the case of clause (a)) or two (in the case of clause (b)) of its designated directors to resign, and soldwe will be obligated to Starboard $150.0 million in senior secured convertible notes (“Notes”) in exchange for $85.0 million in cash and $65.0 million intake all necessary action (to the extent not prohibited by applicable law) to cause the Board to appoint one or two, respectively, additional person(s) designated by the Buying Stockholder to fill such vacancy or vacancies, as applicable. If a Buying Stockholder acquires a number of shares of Common Stock; (ii) grantedStock equal to Starboard10% or more of the optionnumber of shares of outstanding Common Stock as of such time (determined on an as-converted basis) from a person other than another Investor and its Permitted Transferees (as defined in the SHA), we will be obligated to, purchase upamong other things, take all necessary action (to the extent not prohibited by applicable law) to cause the Board to (x) increase the size of the Board as required to enable the Buying Stockholder to designate one additional person to the Board, and (y) appoint such additional person designated by the Buying Stockholder to fill such newly created vacancy, in each case, on the terms and subject to the conditions set forth in the SHA. In no event will a single Investor be entitled to designate a number of directors to the Board that would constitute a majority of the Board.

Subject to compliance with applicable laws, stock exchange regulations and the Settlement (as defined in the SHA), for so long as an additional $50.0 million in senior secured convertible notes in exchange for a rangeInvestor beneficially owns Voting Stock representing at least 5% of $15.0 million to $35.0 millionthe outstanding shares of Common Stock (on an as-converted basis), we will take all necessary action (to the extent not prohibited by applicable law) to cause the Board to appoint (i) at Starboard’s option,least one of such Investor’s designees to serve on the Compensation Committee, (ii) at least one of such Investor’s designees to serve on the Nominating and Governance Committee, and (iii) at least one of such Investor’s designees to serve on the balance in cash; (iii) agreed to grant Starboard warrants to purchase 250,000Finance and Acquisitions Committee. For so long as an Investor beneficially owns Voting Stock representing at least 5% of the outstanding shares of Common Stock;Stock (on an as-converted basis), such Investor is entitled to appoint one observer on the Board or any committee thereof.

For so long as an Investor beneficially owns Voting Stock representing at least 5% of the outstanding shares of Common Stock (on an as-converted basis), such Investor (a) covenants to the company that it will vote, or provide a written consent or proxy with respect to, its Voting Stock in favor of each Investor’s director designees and (iv) has(b) agrees to vote, or provide a written consent or proxy with respect to, its Voting Stock in a neutral manner in the election of any directors nominated by the Board for election that are not designees of an Investor.

Pursuant to the SHA and subject to certain exceptions, each Investor agreed, for one year after the Closing Date, not to Transfer (as defined in the SHA) or enter into a cash-settled hedge with respect to any shares of Series B Preferred Stock held by such Investor, including any shares of Common Stock issued or issuable upon conversion of such shares of Series B Preferred Stock. Thereafter, until the second anniversary of the Closing Date, and subject to customary exceptions, each Investor agreed not to Transfer or enter into a cash-settled hedge with respect to more than 50% of such Investor’s Initial Preferred Stock Ownership, including any shares of Common Stock issued or issuable upon conversion of such Series B Preferred Stock. Each Investor agreed that any permitted Transfers will not be to a competitor of the company, an activist investor or certain other restricted persons as specified in the SHA.

Pursuant to the SHA, until such time as such Investor beneficially owns Voting Stock representing less than 5% of the outstanding shares of Common Stock (on an as-converted basis), each Investor is subject to customary standstill restrictions in accordance with which each Investor and its respective affiliates agreed not to, among other things, and subject to the exceptions set forth in the SHA, (a) for a period of 12 months following the Closing Date, acquire any equity securities of the company from any other Investor or any of its affiliates, (b) acquire any equity securities of the company such that after such acquisition such Investor and its affiliates would beneficially own 45% or more of the outstanding shares of Common Stock (on an as-converted basis), (c) publicly seek or encourage any offer or proposal for a merger or similar transaction involving the company, (d) make, or in any way participate in, directly or indirectly, any “solicitation” of “proxies” (within the meaning of Rule 14a-1 under the Exchange Act) to vote any Voting Stock of the company or its subsidiaries, or call or seek to call a meeting of our stockholders or initiate any stockholder proposal for action by our stockholders or seek the removal of any director from the Board, or (e) form, join or in any way participate in a “group” (as defined in Section 13(d)(3) of the Exchange Act) in connection with any Voting Stock of the company or its subsidiaries, including with any other Investor or its affiliates.

Pursuant to the SHA, in the event an Investor contemplates Transferring any shares of Series B Preferred Stock or Common Stock to another person, the other Investors will each have a right of first refusal to purchase any or all of their respective pro rata portions of such shares, subject to exceptions set forth in the SHA. Additionally, in the event we contemplate the sale or other disposition of any patents, Charter will have a right of first offer and a right of first refusal to acquire such patents, on the terms and subject to exceptions as more particularly set forth in the SHA.

Pursuant to the SHA, on a single occasion after January 1, 2022, upon any Investor’s request, subject to the conditions set forth in the SHA, we will (a) take all actions reasonably necessary to pay a one-time dividend on the Series B Preferred Stock (the “Special Dividend”) equal to the highest dividend that the Board determines can be paid at that time (or a lesser amount as may be unanimously agreed upon by the Investors), subject to the additional conditions and limitations as more particularly set forth in the SHA, (b) to the extent required based on our financial condition, reasonably promptly seek and obtain debt financing to effectuate such Special Dividend, and (c) declare and pay such Special Dividend, which, if debt financing is required, will be paid substantially contemporaneous with, or reasonably promptly after, the consummation of such debt financing.

Pursuant to the terms of the SHA, the prior written consent of each Investor is required for the company to effect or validate certain enumerated actions in the SHA for so long as such Investor beneficially owns Voting Stock representing at least 10% of the outstanding shares of Common Stock (on an as-converted basis).

The SHA will terminate with respect to any particular Investor upon the mutual agreement in writing among the company and such Investor. The SHA will terminate automatically as to any particular Investor and certain transferees at such time as such Investor no longer beneficially owns at least 5% of the outstanding shares of Common Stock (on an as-converted basis) at any time.

Registration Rights Agreement

On the Closing Date, we entered into a Registration Rights Agreement (the “RRA”) with the Investors (together with any other party that may become a party to the RRA, “Holders”), pursuant to which, among other things,

and on the terms and subject to certain limitations set forth therein, we were obligated to file a registration statement registering the sale or distribution of shares of Series B Preferred Stock or Common Stock held by any Holder, including any shares of Common Stock acquired by any Holder pursuant to the conversion of the Series B Preferred Stock, and any other securities issued or issuable with respect to any such shares of Common Stock or Series B Preferred Stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise (the “Registrable Securities”). We filed a registration statement on Form S-3 with respect to the Registrable Securities on August 30, 2021.

In addition, pursuant to the RRA, Holders have the right to conductrequire us, subject to certain limitations set forth therein, to effect a rightssale of any or all of their Registrable Securities by means of an underwritten offering openor an underwritten block trade or bought deal. We are not obligated to all stockholderseffect any underwritten offering or underwritten block trade or bought deal (a) subject to certain exceptions, unless the dollar amount of the Company, for upRegistrable Securities of Holder(s) demanding such underwritten offering or underwritten block trade or bought deal to $150.0be included therein is anticipated to result in gross sale proceeds of at least $25 million, (b) if three underwritten offerings or underwritten block trades or bought deals have already been launched at the request of Holder(s) within a 365-day period or (c) during the Quarterly Blackout Period (as defined in senior secured convertible notes,the RRA).

The RRA also provides Holders with certain customary piggyback registration rights. These registration rights are subject to certain conditions and Starboard agreed to enter into one or more backstop commitment agreements by which it would backstop up to $100.0 millionlimitations, including the right of the convertible notes offered in such a rights offering.

The Notes mature on January 16, 2022. Interest onunderwriters to limit the Notes accrues at 6.0% per year through January 30, 2019, and interest will thereafter accrue at a minimumnumber of 4.0% per year and a maximum of 12% per year, based upon the then-applicable conversion premium. The conversion price for the Notes (the “Conversion Price”) is equal to a 30% premium to the volume weighted average trading prices of the Common Stock on each trading day during the ten consecutive trading days commencing on January 16, 2018, subject to a Conversion Price floor of $28.00 per share. In accordance with the foregoing, the Conversion Price was set at $31.29.

As a result of the aforementioned agreements and transactions contemplated thereby, as of January 16, 2018, Starboard ceasedshares to be included in a beneficial owner of more than five percent of the Company’s outstanding Common Stock.

Indemnification Agreements with Directors and Executive Officers

We also have entered into an indemnification agreement with each of our directors and executive officers. The indemnification agreementsregistration or offering and our amended and restated certificate of incorporation and bylaws require usright to indemnify our directors and officers to the fullest extent permitted by Delaware law.delay or withdraw a registration statement under certain circumstances.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information with respect to beneficial ownership of our Common Stock and Series B Preferred Stock as of March 31, 2018,2023, by:

 

each beneficial owner of 5% or more of the outstanding shares of our Common Stock or Series B Preferred Stock;

 

each of our current directors and director-nominees;director nominees;

 

each of our named executive officers for 2017;2022; and

 

all of our current directors and executive officers as a group.

Beneficial ownership is determined in accordance with the rules of the SEC. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment power with respect to all shares of the Common Stock and Series B Preferred Stock that they beneficially own, subject to applicable community property laws.

In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of Common Stock and Series B Preferred Stock subject to options or other rights held by that person that are currently exercisable or exercisable within 60 days of March 31, 20182023 are deemed outstanding, but are not deemed outstanding for purposes of computing the percentage ownership of any other person. For example, the Common Stock “percentage of class outstanding” shown below for each holder of our Series B Preferred Stock assumes the conversion of such holder’s shares of Series B Preferred Stock to Common Stock as of March 31, 2022, but does not assume the conversion of the other holders’ shares of Series B Preferred Stock to Common Stock, resulting in Common Stock ownership percentages below that exceed the holders’ ownership percentages on a fully converted basis. On a fully converted basis, each holder’s Series B Preferred Stock would equate to approximately 16.2% of our Common Stock as of March 31, 2023.

Unless otherwise indicated, these shares do not include any stock or options awarded after March 31, 2018. A2023. As of March 31, 2023, a total of 55,017,67092,359,528 shares of our Common Stock and 82,527,609 shares of our Series B Preferred Stock were outstanding as of March 31, 2018.outstanding. Except as otherwise indicated, the address of each person in this table is c/o comScore, Inc.,Comscore, 11950 Democracy Drive, Suite 600, Reston, Virginia 20190.

 

Name and Address of Beneficial Owner

  Amount and
Nature of
Beneficial
Ownership (1)
   Percentage of
Common Stock
Outstanding
 

5% or Greater Stockholders:

    

WPP plc and affiliated entities (2)

   11,319,363    20.6

PRIMECAP Management Company (3)

   7,984,458    14.5

Directors and Named Executive Officers:

    

William Livek, President and Executive Vice Chairman (4)

   1,023,503    1.8

Gian Fulgoni, Chairman Emeritus and Former Chief Executive Officer

   109,553    * 

Gregory Fink, Chief Financial Officer and Treasurer

   —      * 

David Kay, Former Interim Chief Financial Officer

   —      * 

David Chemerow, Former Chief Financial Officer and Treasurer (5)

   699,573    1.3

Carol DiBattiste, General Counsel & Chief Compliance, Privacy and People Officer

   —      * 

Michael Brown, Former Chief Technology Officer (6)

   160,528    * 

Christiana Lin, Former General Counsel and Chief Privacy Officer (7)

   325,672    * 

Dale Fuller, Director

   —      * 

Jacques Kerrest, Director

   —      * 

Michelle McKenna-Doyle, Director

   —      * 

Wesley Nichols, Director

   3,000    * 

Paul Reilly, Director

   —      * 

Brent Rosenthal, Director (8)

   156,409    * 

Bryan Wiener, Director

   3,000    * 

All current directors and executive officers as a group (14 persons)(9)

   1,409,640    2.5
   Common Stock  Series B Preferred Stock 

Name and Address of Beneficial Owner

  Amount and
Nature of
Beneficial
Ownership (1)
   Percentage of
Class Outstanding
  Amount and
Nature of
Beneficial
Ownership (1)
   Percentage of
Class Outstanding
 

5% or Greater Stockholders:

       

Cerberus Capital Management, L.P. (2)

   31,355,408    25.8  27,509,203    33.3

Charter Communications, Inc. (3)

   29,229,497    24.0  27,509,203    33.3

Qurate SCOR, LLC (4)

   29,085,251    24.0  27,509,203    33.3

WPP plc and affiliated entities (5)

   11,319,363    12.3       

Weiss Multi-Strategy Advisers LLC (6)

   9,022,812    9.8       

180 Degree Capital Corp. (7)

   5,485,356    5.9       

Westerly Capital Management, LLC (8)

   4,945,000    5.4       

Directors and Named Executive Officers:

       

Nana Banerjee, Chairman of the Board (9)

   29,400    *        

Itzhak Fisher, Director (10)

   402,732    *        

Leslie Gillin, Director

               

David Kline, Director (11)

               

Pierre Liduena, Director (12)

   13,800    *        

Bill Livek, Vice Chairman of the Board (13)

   3,623,261    3.9       

   Common Stock  Series B Preferred Stock 

Name and Address of Beneficial Owner

  Amount and
Nature of
Beneficial
Ownership (1)
   Percentage of
Class Outstanding
  Amount and
Nature of
Beneficial
Ownership (1)
��  Percentage of
Class Outstanding
 

Kathi Love, Director (14)

   181,431    *        

Marty Patterson, Director (15)

   81,569    *        

Brent Rosenthal, Lead Director (16)

   849,124    *        

Brian Wendling, Director (17)

   117,069    *        

Jon Carpenter, Chief Executive Officer (18)

   169,159    *        

Mary Margaret Curry, Chief Financial Officer

   21,867    *        

Greg Dale, Chief Operating Officer (19)

   97,926    *        

All current directors and executive officers as a group (14 persons) (20)

   5,809,874    6.2       

*

Represents less than 1% of the outstanding shares of Common Stock.

(1)

The information provided in this table is based on Companycompany records, information supplied to us by our directors, executive officers directors and principal stockholders and information contained in Schedules 13D and 13G and Forms 4 filed with the SEC.

(2)

This information is derived in part from the Schedule 13D/A filed with the SEC on December 16, 2022. Cerberus Capital Management, L.P. and Pine have sole voting and dispositive power for 27,509,203 shares of Series B Preferred Stock, convertible at any time at the option of the holder into shares of Common Stock (shown on an as-converted basis including accrued dividends through March 31, 2023). Also reported are 2,193,088 shares of outstanding Common Stock and 77,069 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of the holder’s separation from service or a change in control of the company. These deferred stock units are currently held by Dr. Banerjee, who has assigned his rights and interests to Cerberus Capital Management, L.P. The address for Cerberus Capital Management, L.P. is 875 Third Avenue, 11th Floor, New York, NY 10022.

(3)

This information is derived in part from the Schedule 13D filed with the SEC on March 19, 2021 and the Form 4 filed with the SEC on June 17, 2022. Charter Communications, Inc., CCH II, LLC, Charter Communications Holdings, LLC, Spectrum Management Holding Company, and Charter Communications Holding Company, LLC have shared voting and dispositive power for 27,509,203 shares of Series B Preferred Stock, convertible at any time at the option of the holder into shares of Common Stock (shown on an as-converted basis including accrued dividends through March 31, 2023). Also reported are 144,246 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of the holder’s separation from service or a change in control of the company. These deferred stock units are currently held by Mr. Kline and Mr. Liduena, who have assigned their rights and interests to Charter. The address for Charter Communications, Inc., CCH II, LLC, Charter Communications Holdings, LLC, Spectrum Management Holding Company, and Charter Communications Holding Company, LLC is 400 Washington Blvd., Stamford, CT 06902.

(4)

This information is derived in part from the Schedule 13D filed with the SEC on March 16, 2021. Qurate SCOR, LLC (an affiliate of Qurate Retail, Inc.) has sole voting and dispositive power for 27,509,203 shares of Series B Preferred Stock, convertible at any time at the option of the holder into shares of Common Stock (shown on an as-converted basis including accrued dividends through March 31, 2023). The address for Qurate Retail, Inc. is 12300 Liberty Boulevard, Englewood, CO 80112.

(5)

This information is derived solely from the Schedule 13D/A filed with the SEC on April 6, 2018. Shares are owned directly by Cavendish Square Holding B.V. (“Cavendish”), which is a wholly-ownedwholly owned subsidiary of WPP plc that WPP plc owns indirectly through a series of holding companies. WPP plc is an indirect beneficial owner of the reported securities. The address for WPP plc is 27 Farm Street, London, United Kingdom W1J 5RJ. The address for Cavendish is Laan op Zuid 167, 3072 DB Rotterdam, Netherlands.

(3)(6)

This information is derived solely from the Schedule 13G/A filed with the SEC on April 10, 2018. PRIMECAP Management Company has soleFebruary 14, 2023. Weiss Multi-Strategy Advisers LLC and George A. Weiss have shared voting power for 6,807,790 shares and sole dispositive power for 7,984,458 shares.9,022,812 shares of Common Stock. The address for PRIMECAPWeiss Multi-Strategy Advisers LLC and George A. Weiss is 320 Park Avenue, 20th Floor, New York, NY 10020.

(7)

This information is derived solely from the Schedule 13D filed with the SEC on March 6, 2023. 180 Degree Capital Corp. has shared voting and dispositive power for 5,485,356 shares of Common Stock. The address for 180 Degree Capital Corp. is 7 N. Willow Street, Suite 4B, Montclair, NJ 07042.

(8)

This information is derived solely from the Schedule 13G filed with the SEC on March 20, 2023. Westerly Capital Management, CompanyLLC, Westerly Holdings, LLC and Christopher J. Galvin have shared voting and dispositive power for

4,945,000 shares of Common Stock held for the accounts of Westerly Partners, LP and Westerly Partners QP, LP. The address for Westerly Capital Management, LLC, Westerly Holdings, LLC and Christopher J. Galvin is 177 E. Colorado Blvd., 11th Floor, Pasadena,201 Mission Street, Suite 580, San Francisco, CA 91105.94105.

(4)(9)

Excludes 77,069 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Dr. Banerjee’s separation from service or a change in control of the company. Dr. Banerjee has assigned his rights and interests in these deferred stock units to Cerberus Capital Management, L.P.

(10)

Includes 602,600(i) 91,678 shares of Common Stock held indirectly through Pereg Holdings, LLC; (ii) 77,069 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Fisher’s separation from service or a change in control of the company; and (iii) 133,985 shares of Common Stock subject to options or SARs that are currently exercisable.

(5)(11)

Excludes 77,069 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Kline’s separation from service or a change in control of the company. Mr. Kline has assigned his rights and interests in these deferred stock units to Charter.

(12)

Excludes 67,177 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Liduena’s separation from service or a change in control of the company. Mr. Liduena has assigned his rights and interests in these deferred stock units to Charter.

(13)

Includes 445,912(i) 58,334 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled following Mr. Livek’s separation from service, and (ii) 300,000 shares of Common Stock subject to options or SARs that are currently exercisable.

(6)(14)

Represents 181,431 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Ms. Love’s separation from service or a change in control of the company.

(15)

Includes 103,08977,069 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Patterson’s separation from service or a change in control of the company.

(16)

Includes (i) 685,285 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Rosenthal’s separation from service or a change in control of the company, and (ii) 19,425 shares of Common Stock subject to options or SARs that are currently exercisable.

(7)(17)

Includes 218,82877,069 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Wendling’s separation from service or a change in control of the company.

(18)

Includes 150,659 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled on the earlier of Mr. Carpenter’s separation from service or a change in control of the company.

(19)

Represents (i) 95,172 shares of Common Stock subject to options or SARs that are currently exercisable.

(8)Includes 86,974exercisable, and (ii) 2,754 shares of Common Stock subject to options or SARsthat are scheduled to vest and become exercisable within 60 days of March 31, 2023.

(20)

Includes (i) 1,306,916 shares of Common Stock subject to vested, deferred stock units that are scheduled to be settled as described above, (ii) 548,582 shares of Common Stock subject to options that are currently exercisable.

(9)Includes 735,574exercisable, and (iii) 2,754 shares of Common Stock subject to options or SARs that are currently exercisable.scheduled to vest and become exercisable within 60 days of March 31, 2023.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires that certain of our executive officers and directors, and persons who beneficially own more than 10% of a registered class of our equity securities, file reports of ownership and changes in ownership (Forms 3, 4 and 5) with the SEC. Such executive officers, directors and greater than 10% beneficial owners are required to furnish us with copies of all of these forms that they file. Certain employees of our Company hold a power of attorney to enable such individuals to file ownership and change in ownership forms on behalf of our executive officers and directors.

Based solely on our review of these reports or written representations from certain reporting persons, we believe that during 2017, all filing requirements applicable to our executive officers, directors, greater than 10% beneficial owners and other persons subject to Section 16(a) of the Securities Exchange Act of 1934 were timely met, except for a Form 4 for Gian Fulgoni relating to one transaction occurring on November 13, 2017, which was filed on December 13, 2017.

PRINCIPAL ACCOUNTINGACCOUNTANT FEES AND SERVICES

Engagement of Deloitte & Touche LLP

As previously disclosed, effective September 28, 2017, the Audit Committee determined not to engage Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017 and instead to engage Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm for 2017. The Company’s decision to change its independent registered public accounting firm for 2017 was not the result of any disagreement with EY.

EY continued to serve as the Company’s auditor with respect to the Company’s financial statements for the fiscal years ended December 31, 2015 and 2016. EY had not previously issued an audit report or provided an audit opinion for the fiscal years ended December 31, 2015 and 2016.

During the fiscal years ended December 31, 2015 and 2016, and during the period subsequent to December 31, 2016 to the date of the decision not to engage EY for the fiscal year ending December 31, 2017, there were no disagreements with EY on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of EY, would have caused EY to make reference to the subject matter of the disagreement in connection with its reports.

Fees and Services

The following table sets forth a summary of the fees billed to us by Deloitte our independent auditors for professional services for the fiscal year ended 2017. Tax fees were principally for services related to consulting services.

(In thousands)        
Name  2017   2016 

Audit fees

  $9,500   $—   

Audit-related fees

   —      —   

Tax fees

   313    94 

All other fees

   —      —   
  

 

 

   

 

 

 

Total fees

  $9,813   $94 
  

 

 

   

 

 

 

The following table sets forth a summary of the fees billed to us by EY, our independent auditors for professional services for the fiscal years ended 2016December 31, 2022 and 2015. All other2021. Audit-related fees were for attestationservices in connection with foreign statutory audits and system organization control reports.our registration statements on Form S-3 and Form S-8. Tax fees were principally for tax consulting services.

 

(In thousands)        
Name  2017   2016 

Audit fees

  $—     $46,675 

Audit-related fees

   —      —   

Tax fees

   —      —   

All other fees

   68    171 
  

 

 

   

 

 

 

Total fees

  $68   $46,846 
  

 

 

   

 

 

 

Name

              2022                           2021         
   (In thousands) 

Audit Fees

  $3,017   $3,395 

Audit-Related Fees

   64    117 

Tax Fees

   6    7 

All Other Fees

        
  

 

 

   

 

 

 

Total Fees

  $3,087   $3,519 
  

 

 

   

 

 

 

All of the services described in the fee tables above were approved by the Audit Committee except for thenon-audit fees for Deloitte as these fees were incurred prior to engaging Deloitte as the Company’s independent auditors for the 2017 audit.Committee. The Audit Committee meets regularly with the independent auditorsauditor and reviews both audit andnon-audit services performed by EY and Deloitte as well as fees charged for such services. The Audit Committee has determined that the provision of the services described above is compatible with maintaining the relevant auditors’Deloitte’s independence in the conduct of theirits audit functions.

Pre-Approval Policies and Procedures

Our Audit Committee has adopted, and our Board has approved, procedures and conditions pursuant to which services proposed to be performed by our independent auditors should bepre-approved. Pursuant to its charter,Such procedures and conditions are set forth in the Audit Committee’s charter. The Audit Committee may delegatehas delegated pre-approval authority to one or more of its members.chairman for certain services other than the annual audit and quarterly reviews performed by Deloitte. The member to whom such authority is delegatedchairman must report for information purposes, anypre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committeepre-approved all audit, audit-related and other services rendered by EY for 2015 and 2016 and by Deloitte for 2017 in their capacitiesits capacity as our independent auditors.auditor for 2022 and 2021.

AUDIT COMMITTEE REPORT

The Audit Committee is composed of “independent” directors, as determined in accordance with Rule 5605(a)(2) of theapplicable Nasdaq Marketplace Rulesstandards and Rule10A-3 of the Securities Exchange Act of 1934. The Audit Committee operates pursuant to a written charter adopted by the Board, of Directors, a copy of which is available under “Corporate Governance” on the Investor Relations section of the Company’sour website at www.comscore.com.www.comscore.com.

As described more fully in its charter, the purpose of the Audit Committee is to assistoversee the Board with its oversight responsibilities regardingaccounting and financial reporting processes of the integritycompany and the audits of ourthe financial statements our compliance with legal and regulatory requirements, assessing our independent registered public accounting firm’s qualifications, independence and performance, and monitoringof the performance of our internal audit function.

company. Company management is responsible for the preparation, presentation and integrity of our financial statements as well as our financial reporting process, accounting policies, internal audit function, internal accounting controls and disclosure controls and procedures. Our independent registered public accounting firm is responsible for performing an independent audit of our consolidated financial statements in accordance with standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”) and issuing a report thereon. The Audit Committee’s responsibility is to monitor and oversee these processes. The following is the Audit Committee’s report submitted to the Board of Directors for 2017.2022.

The Audit Committee has:

 

reviewed and discussed the Company’scompany’s audited financial statements with management and each of Ernst & Young LLP and Deloitte & Touche LLP (“Deloitte”), the company’s independent registered public accounting firms;firm for 2022;

 

discussed with each of Ernst & Young LLP and Deloitte & Touche LLP the matters required to be discussed under the rules adopted byapplicable requirements of the PCAOB; and

 

received the written disclosures and the letter from each of Ernst & Young LLP and Deloitte & Touche LLP required by applicable requirements of the PCAOB regarding each firm’s communicationDeloitte’s communications with the Audit Committee concerning independence, and has discussed with each firm theirDeloitte its independence.

In addition, the Audit Committee has met separately with Companycompany management and with each of Ernst & Young LLP and Deloitte & Touche LLP.Deloitte.

Based on the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial statements for 2015, 2016 and 20172022 be included in the Company’scompany’s Annual Report on Form10-K for the year ended December 31, 20172022 for filing with the Securities and Exchange Commission.

AUDIT COMMITTEE

Jacques KerrestNana Banerjee

Michelle McKenna-DoylePierre Liduena

Paul ReillyKathi Love

Marty Patterson

The foregoing Audit Committee report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, and shall not otherwise be deemed filed under these acts, except to the extent we specifically incorporate by reference into such filings.

PROPOSALS TO BE VOTED ON

PROPOSAL NO.Proposal No. 1 – Election of Directors

ELECTION OF DIRECTORS

Because we have not held an annual meeting for the election of directors since our 2015 annual meeting, at the 2018 Annual Meeting, ourOur stockholders are being asked to elect (A) three Class III directors to serve for terms expiring at our 2019 annual meeting of stockholders, (B) twothe four nominees named in this proxy statement as Class I directors to serve for terms expiring at our 20202026 annual meeting of stockholders, and (C) three Class II directors to serve for terms expiring at our 2021 annual meeting of stockholders, in each case, to hold office until their respective successors have been duly elected and qualified.

Our Nominating and Governance Committee recommended, and our Board of Directors has nominated, the following individualsNana Banerjee, David Kline, Kathi Love and Brian Wendling for election at the 20182023 Annual Meeting. Each of thethese individuals listed below are presently directorsis currently a director of the Company.company. All have agreed to serve if elected, and we have no reason to believe that any nominee will be unable or unwilling to serve. As previously announced, Dr. Gian Fulgoni is retiring from the Board and is not standing forre-election at the 2018 Annual Meeting.

Class III

Class I

Class II

Dale FullerWesley NicholsWilliam Livek
Jacques KerrestPaul ReillyBrent Rosenthal
Michelle McKenna-DoyleBryan Wiener

Shares represented by the accompanying proxy will be voted for the election of the nominees recommended by the Board of Directors unless the proxy is marked in such a manner so as to withhold authority to vote. If any nominee is unable or unexpectedly declines to serve as a director, the Board of Directors may designate another nominee to fill the vacancy, and the proxy will be voted for that nominee. Alternatively, the Board may reduce the size of the Board, or the proxies may vote just for the remaining nominees, leaving a vacancy that the Board may fill at a later date. Proxies cannot be voted for more than the eightfour named nominees.

The section of this proxy statement titled “Directors, Director Nominees, Executive Officers and Corporate Governance Directors, Director Nominees and Executive Officers” on pages [•]-[•] of this proxy statement contains more information about the experience, qualifications, attributes and skills that caused our Nominating and Governance Committee and our Board of Directors to determine that these nominees should serve as directors of comScore.Comscore.

Required Vote

The nominees receiving the highest number of affirmative “FOR” votes with respect to each class shall be elected as directors. Abstentions and brokernon-votes will have no effect on the outcome of this proposal.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” THE ELECTION OF EACH OF THE ABOVEMENTIONED NOMINEES AS DIRECTORS PURSUANT TO PROPOSAL NO. 1.

PROPOSAL NO.Proposal No. 2 – Advisory Vote to Approve Named Executive Officer Compensation

ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION

We are seeking the advisory,non-binding approval of our stockholders with respect to the compensation paid to our named executive officers as disclosed in this proxy statement.

The objectiveOur executive compensation programs are designed to align our executive officers’ interests with those of our compensation programs forstockholders, promote the achievement of our employees, including our executive officers, is tofinancial, strategic and operating objectives, attract and retain top talent, and to ensure that the total compensation paid is fair and reasonable relative to the competitive nature of our industry. Our compensation programs are designedprioritize a strong, ethical corporate culture. We seek to motivate and reward employeesour executive officers for achievement of positive business results and to promote and enforce accountability. Overall, we seek to maintain a performance-oriented culture with compensation opportunities that reward our executive officers when we achieve or exceed our goalsOur Board and objectives, while putting a significant portion of their target total direct compensation opportunities at risk in the eventCompensation Committee believe that our goalscommitment to these responsible compensation practices justifies a vote by stockholders “FOR” the resolution approving the compensation of our executives as disclosed in this proxy statement. We value input from our stockholders, and objectives are not achieved.

Our Compensation Committee has generally been guided by the following goals and principleswe regularly consider investor feedback in establishing compensation arrangements for our executive officers:

Further Align Stockholder Interests and Promote Achievement of Strategic Objectives.

Promote Achievement of Financial Goals.

Reward Superior Performance.

Attract and Retain Top Talent.

While the Compensation Committee continued to be guided by these principles when addressing executive compensation matters during the Audit Committee investigation and subsequent restatement and audit process, the unique and challenging circumstances we encountered in 2016 and 2017 also influenced the design of compensation arrangements for our executive officers as we sought to maintain normal business operations during a period of significant uncertainty. These unique and challenging circumstances led to a more individualized, situational approach to executive compensation in 2016 and 2017, with decisions driven more by specific hiring and retention needs than by a holistic evaluation ofevaluating our executive compensation program and corporate performance for the respective year.

Following the Audit Committee investigation, our Board of Directors and the Compensation Committee determined that ensuring our executive officers prioritize and maintain a “tone at the top” that emphasizes a strong, ethical corporate culture – as well as rigorous compliance and internal controls – is an additional principle that should guide our executive compensation actions and decisions. The Compensation Committee included these objectives in its evaluation of our executive compensation program for 2017.programs.

This proposal gives you, as a stockholder, the opportunity to express your views on the compensation of our named executive officers as disclosed in this proxy statement. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we are asking stockholders to approve the following resolution:

“RESOLVED, that the compensation paid to the Company’scompany’s named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC that apply to smaller reporting companies, including the Compensation Discussion and Analysis, compensation tables and related narrative discussion included in this proxy statement, is hereby APPROVED.”

Required Vote

You may vote for or against this Proposal No. 2, or you may abstain. Approval of this proposal requires the affirmative vote (“FOR”) of a majority of the shares present or represented by proxy at the 20182023 Annual Meeting and entitled to vote thereon. Abstentions will have the same effect as a vote against this proposal. Brokernon-votes will have no effect on the outcome of this proposal. Because this vote is advisory, it will not be binding upon our Board of Directors.Board. However, our Board of Directors and our Compensation Committee will consider the outcome of the vote, along with other relevant factors, in evaluating our executive compensation program.programs.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” PROPOSAL NO. 2.

PROPOSAL NO.Proposal No. 3 – Ratification of Appointment of Independent Registered Public Accounting Firm

ADVISORY VOTE ON FREQUENCY OF VOTE TOOur Audit Committee has appointed Deloitte & Touche LLP (“Deloitte”) as our independent registered public accounting firm for the year ending December 31, 2023. The Audit Committee’s selection followed a competitive proposal process and is expected to result in lower audit fees in 2023 compared to prior years.

APPROVE NAMED EXECUTIVE OFFICER COMPENSATIONDeloitte has served as our independent audit firm since 2017 and audited our financial statements for the fiscal year ended December 31, 2022. For more information about services Deloitte provided to us, as well as our procedures for approving such services, see the section of this proxy statement titled “Principal Accountant Fees and Services.” A representative of Deloitte is expected to be present at our 2023 Annual Meeting and will have an opportunity to make a statement and respond to appropriate questions from stockholders.

We are seekingRatification of the advisory,non-binding recommendationappointment of Deloitte as our independent registered public accounting firm is not required by our bylaws or other applicable legal requirements. Our Board is submitting the appointment of Deloitte to our stockholders regarding how often we should presentfor ratification as a matter of good corporate practice. If our stockholders withfail to ratify the opportunityappointment, the Audit Committee will reconsider whether to vote to approveretain the compensation paid to our named executive officers. Youfirm; however, the Audit Committee may, vote to have such vote held every year, every two years, or every three years, or you may abstain.

Our stockholders voted on a similar proposal in 2011, with a majority voting to hold thesay-on-pay vote every year. Weits discretion, continue to believeretain Deloitte. Even if the appointment is ratified, the Audit Committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that thesay-on-pay vote shouldsuch a change would be conducted every year so thatin the best interests of the company and our stockholders are afforded the opportunity to express their views annually on our executive compensation program.stockholders.

Required Vote

The frequency option (i.e., every year, every two years or every three years) that receives the affirmative vote (“FOR”) of a majority of the shares present or represented by proxy at the 20182023 Annual Meeting and entitled to vote on this proposal will be deemedis required to beratify the preferenceappointment of Deloitte as our stockholders.independent registered public accounting firm for the year ending December 31, 2023. Abstentions will have the same effect as a vote against this proposal. Brokernon-votes will have no effect on the outcome of this proposal. Because this vote is advisory, it will not be binding upon our Board of Directors. However, our Board of Directors and our Compensation Committee will consider the outcome of the vote, along with other relevant factors, in making future decisions regarding the frequency of futuresay-on-pay votes as they deem appropriate.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE FOR A FREQUENCY OF “EVERY YEAR” FOR“FOR” PROPOSAL NO. 3.

PROPOSAL NO.Proposal No. 4

APPROVAL OF THE COMSCORE, INC. 2018 EQUITY AND INCENTIVE COMPENSATION PLAN

Overview

We are asking stockholders – Approval of an Amendment to approve the comScore, Inc. 2018 Equity and Incentive Compensation Plan (as Amended and Restated Effective as of July 9, 2020)

Overview

The use of equity-based awards under our 2018 Equity and Incentive Compensation Plan (the “2018 Plan”). On has been a key component of our compensation program. The ability to grant equity-based awards is critical to attracting and retaining highly qualified individuals. The Board believes that it is in the best interests of the company and our stockholders for those individuals to have an ownership interest in the company in recognition of their present and potential contributions and to align their interests with those of our stockholders.

The Board has determined that the current number of shares of our Common Stock available for grants under the 2018 Plan is not sufficient to meet the objectives of our compensation program going forward. Accordingly, on April [•], 2018,10, 2023, upon recommendation by theour Compensation Committee, the Board of Directors approved and adopted, subject to the approval of the stockholders of the Companycompany at the 20182023 Annual Meeting, an amendment to the 2018 Plan.Plan (the “Second Amendment”) to increase the number of shares of our Common Stock available for grant by 10,000,000. No other changes to the 2018 Plan were approved by the Board.

TheYou are being asked to approve the Second Amendment, and the Board of Directors is recommending that the Company’scompany’s stockholders vote in favor of the Second Amendment. If approved by our stockholders, the Second Amendment will become effective as of the date of the 2023 Annual Meeting. If the Second Amendment is not approved by our stockholders, then the 2018 Plan which will succeedremain in effect in its present form. Whether the Second Amendment is approved by our stockholders or not, each award granted under the 2018 Plan prior to the date of the 2023 Annual Meeting will continue to be subject to the terms and provisions applicable to such award under the 2018 Plan as in effect immediately prior to the effective date of the Second Amendment.

At the 2018 annual meeting, the stockholders of the company approved the 2018 Plan, and 10,650,000 shares of our Common Stock were reserved for issuance thereunder. At the 2020 annual meeting, the stockholders of the company approved an amendment and restatement of the 2018 Plan, effective as of July 9, 2020, to increase the number of shares of our Common Stock available for grant under the 2018 Plan by 9,600,000 shares and to make other ministerial changes to the 2018 Plan. At the 2022 annual meeting, the stockholders of the company approved the first amendment to the 2018 Plan, effective as of June 15, 2022, to increase the number of shares of our Common Stock available for grant under the 2018 Plan by 7,600,000 shares.

The 2018 Plan succeeded our 2007 Equity Incentive Plan, as amended and restated (the “2007 Plan”). The 2007 Plan expired in accordance with its terms on March 2, 2017, and no further grants may be made thereunder. In addition, no further grants will be made under the Rentrak Corporation Amended and Restated 2005 Stock Incentive Plan and the Rentrak Corporation 2011 Incentive Plan (together, with the Rentrak Corporation Amended and Restated 2005 Stock Incentive Plan, the “Rentrak Plans”), which we assumed in connection with our merger with Rentrak Corporation in 2016. However, outstanding awards under the 2007 Plan and the Rentrak Plans will generally continue in effect in accordance with their terms.

The 2018 Plan, as modified by the Second Amendment (the “Amended 2018 Plan”), will continue to afford the Compensation Committee the ability to design compensatory awards that are responsive to the Company’scompany’s needs and includes authorization for a variety of awards designed to advance the interests and long-term success of the Companycompany by encouraging stock ownership among employees of the Companycompany and its subsidiaries, certain consultants to the Companycompany and its subsidiaries, andnon-employee directors of the Company. You are being asked to approve the 2018 Plan.company.

Stockholder approval of the Second Amendment would increase the number of shares of Common Stock that the company may issue under the 2018 Plan would constitute approvalby 10,000,000 shares. After taking into account this increase and subject to adjustment as provided in the Amended 2018 Plan, the total number of up to 10,650,000 shares of our Common Stock availableauthorized for issuance under the Amended 2018 Plan will equal 37,850,000, including past awards under the 2018 Plan. However, the actual dilutive effect of awards under the Amended 2018 Plan as described below and inis significantly less due to the 2018 Plan. If“fungible” model of the 2018 Plan is approved by stockholders, it will be effectiveand our emphasis on granting full-value shares, as of the date of the 2018 Annual Meeting. If the 2018 Plan is not approved by our stockholders, no awards will be made under the 2018 Plan.described below.

The actual text of the 2018 PlanSecond Amendment is attached to this proxy statement asAnnex A.A. The following description of the 2018 PlanSecond Amendment is only a summary of its principal terms and provisions and is qualified by reference to the actual text as set forth inAnnex A.A.

Why We Believe You Should Vote for this Proposal

The Amended 2018 Plan authorizes the Compensation Committee to provide cash awards and equity-based compensation in the form of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”),RSUs, performance shares, performance units, dividend equivalents, and certain other awards, including those denominated or payable in, or otherwise based on, shares of Common Stock, for the purpose of providing ournon-employee directors, employees of the Companycompany and its subsidiaries,non-employee directors and certain consultants of the Companycompany and its subsidiaries, incentives and/or rewards for performance. Some of the key features of the Amended 2018 Plan that reflect our commitment to effective management of equity and incentive compensation are set forth below in this subsection.

We believe our future success depends in part on our ability to attract, motivate, and retain high qualityhigh-quality employees and directors and that the ability to provide equity-based and incentive-based awards under the Amended 2018 Plan is critical to achieving this success. We would be at a severe competitive disadvantage if we could not use equity-based awards to recruit and compensate our employees and directors. The use of Common Stock as part of our compensation program is also important because equity-based awards are an essential component of our compensation program for key employees, as they help link compensation with long-term stockholder value creation and reward participants based on service and/or performance.

In 2022, 2021 and 2020, we granted awards covering 3,306,592 shares, 4,592,614 shares and 684,570 shares, respectively, of our Common Stock. Our “burn rate” (which represents the rate at which our equity award grants diluted our stockholders) for each of 2022, 2021 and 2020 was 3.57%, 5.68% and 0.96%, respectively, for a three-year average burn rate of 3.40%. We define burn rate as the sum of (i) the total number of full-value shares (including time-based and performance-based RSUs) granted during a fiscal year and (ii) the total number of stock options and SARs granted during a fiscal year, expressed as a percentage of the weighted average basic common shares outstanding as of the fiscal year-end.

As of March 31, 2023, there were 92,359,528 shares of Common Stock outstanding. Based on the closing price of our Common Stock on March 31, 2023 of $1.23 per share, the aggregate market value as of March 31, 2023 of the new shares of Common Stock requested under the Second Amendment, assuming all available shares were awarded as stock option or SAR awards (10,000,000), would be $12,300,000. (The actual value delivered under stock option or SAR awards would depend on increases in our stock price over the exercise price of the awards.) If all available shares were awarded as full-value awards, the aggregate market value of the new shares (5,000,000) as of March 31, 2023 would be $6,150,000.

The Amended 2018 Plan is a flexible authorization plan, often referred to as a “fungible share plan.” Due to the 2018 Plan’s fungible share ratio, each stock option or SAR counts as one share against the plan reserve, and each full-value share (such as RSUs) counts as two shares against the plan reserve; furthermore, performance-based RSUs are counted at maximum performance at the time of grant. While this formula causes the number of shares available for grant to be depleted more rapidly than would occur without the fungible share ratio (requiring a greater number of shares to be approved by our stockholders with each proposal), the actual number of shares ultimately delivered under the 2018 Plan to awardees upon vesting is 1:1, regardless of the type of award. Accordingly, the actual dilutive effect of the share pool is significantly reduced. This is particularly pronounced due to our historical practice of emphasizing full-value shares, including performance-based awards, over stock option and SAR awards. Over the past three fiscal years (2020-2022) combined, we have granted a total of 7,585,776 full-value shares and 998,000 stock options. We have not granted any SARs.

Based on current projections, we anticipate that the number of shares remaining available under the 2018 Plan is insufficient to cover anticipated employee and non-employee director awards through the end of fiscal year 2023.

If we are unable to adequately provide equity compensation to incentivize our employees or provide equity grants as part of compensation to our non-employee directors, we may lose key personnel, which would be detrimental to our operations. If the Second Amendment is not approved, we may be compelled to increase significantly the cash component of our employee and director compensation programs, which approach may not necessarily align employee and director compensation interests with the investment interests of our stockholders. Replacing equity awards with cash also would increase cash compensation expense and use cash that could be better utilized for other purposes, including reinvestment in our businesses or return to our stockholders.

The following includes aggregated information regarding our view of the overhang associated with the 2007 Plan and the Rentrak Plans and the potential dilution associated with the 2018 Plan. This information is as of March 30, 2018. As of that date, there were approximately 55,017,670 shares of Common Stock outstanding:

Outstanding full-value awards (RSUs): 288,126 shares (approximately 0.52% of our outstanding Common Stock);

Outstanding stock options and stock appreciation rights (“SARs”): 3,530,502 shares (approximately 6.42% of our outstanding Common Stock) (outstanding stock options and SARs have a weighted average exercise price of $30.21 and a weighted average remaining term of 1.78 years);

In summary, total shares of Common Stock subject to outstanding awards, as described above (full-value awards, stock options and SARs): 3,818,628 shares (approximately 6.94% of our outstanding Common Stock);

The total number of shares of Common Stock subject to outstanding awards (3,818,628 shares) represents a current, fully diluted overhang percentage of 6.49% (in other words, the potential dilution of our stockholders represented by the 2007 Plan and the Rentrak Plans);

Proposed shares of Common Stock available for awards under the 2018 Plan: 10,650,000 shares (approximately 19.36% of our outstanding Common Stock – this percentage reflects the simple dilution of our stockholders that would occur if the 2018 Plan is approved and all available shares under the 2018 plan were awarded as stock option or SAR awards (not full-value awards)). If all available shares were awarded as full-value awards, the simple dilution would be 9.68%; and

The total shares of Common Stock subject to outstanding awards as of March 30, 2018 (3,818,628 shares), plus the proposed shares of Common Stock available for future awards under the 2018 Plan (10,650,000 shares, assuming all available shares were awarded as stock option or SAR awards), represent a total, fully diluted overhang of 14,468,628 shares (20.82%) under the 2018 Plan. If all available shares were awarded as full-value awards, the total, fully diluted overhang would be 14.25%.

Based on the closing bid price of our Common Stock on the OTC Pink Tier on March 29, 2018 of $24.07 per share, the aggregate market value as of March 30, 2018 of the new shares of Common Stock requested under the 2018 Plan, assuming all available shares were awarded as stock option or SAR awards (10,650,000), was $256.3 million. If all available shares were awarded as full-value awards, the aggregate market value of new shares (5,325,000) as of March 30, 2018 would be $128.2 million.business.

In determining the number of additional shares to request for approval under the 2018 Plan,Second Amendment, our management team worked with Meridian Compensation Partners, LLC and the Compensation Committee and its independent compensation consultant to evaluate a number of factors, including our recent share usage, current stock price, future needs and criteria expected to be utilized by institutional proxy advisory firms in evaluating our proposal for the 2018 Plan.dilution considerations.

If the 2018 PlanSecond Amendment is approved, we intend to utilizeuse the shares authorized under the 2018 PlanSecond Amendment to continue our practice of incentivizing key individuals through equity grants. We currently anticipate that the shares requested in connection with the approval of the 2018 PlanSecond Amendment will last for about fourapproximately one to two years, based on our historic grant rates, estimated future grant rates, and theour approximate current share price, but could last for a shorter or longer period of time if actual practice does not match historic rates or if our future plans or share price change materially. As noted below, our Compensation Committee retains full discretion under the Amended 2018 Plan to determine the number and amountsize of awards to be granted under the Amended 2018 Plan, subject to the terms of the Amended 2018 Plan.

As a result of our delay in filing our periodic reports with the SEC prior to the filing of the 201710-K, we have been unable to use our registration statement on FormS-8 to make equity grants to our employees or directors since February 2016. Further, as noted above, the 2007 Plan expired and became unavailable for future equity awards on March 2, 2017. As of March 30, 2018, we anticipate granting equity awards under the 2018 Plan to our employees andnon-employee directors, as further described below under “New Plan Benefits”, including awards which were

recommended for employees andnon-employee directors in 2016, 2017 and 2018, but have not yet been granted as of March 30, 2018. Generally, these awards, if granted, are expected to vest at the time that they otherwise would have vested if they were granted when initially recommended; for some awards, this will result in the award being fully vested at the time of grant.

Our equity compensation practices are intended to be competitive and consistent with market practices.

practice. In evaluating this proposal, stockholders should consider all of the information in this proposal.

Information on Equity Compensation Plans as of March 31, 2023

The information included in this proxy statement and our Annual Report on Form 10-K for the fiscal year ending December 31, 2022 is updated by the following information regarding all existing equity compensation plans as of March 31, 2023 (except as noted otherwise):

Total shares underlying outstanding stock options (1)

2,241,980

Weighted-average exercise price of outstanding stock options

$2.40

Weighted-average remaining contractual life of outstanding stock options

7.55 years

Total shares underlying outstanding full-value awards (2)

7,182,468

Total shares of common stock outstanding as of March 31, 2023

92,359,528

Total shares available for grant (3)

337,321

(1)

No SARs were outstanding as of March 31, 2023.

(2)

Reflects (i) all shares subject to time-based RSUs and deferred stock units that were outstanding as of March 31, 2023, and (ii) the maximum number of shares subject to performance-based RSUs that were outstanding as of March 31, 2023. If actual performance under the performance-based RSUs falls below the maximum level for these awards, fewer shares would be issued. Includes 451,977 shares subject to an outstanding time-based RSU award that was granted as an inducement award.

(3)

Reflects (i) 158,489 shares available for grant under the 2018 Plan as of March 31, 2023, and (ii) 178,832 shares available for grant under the Shareablee, Inc. 2013 Stock Option/Stock Issuance Plan (the “Shareablee Plan”) (which we assumed in our acquisition of Shareablee, Inc. in December 2021) as of March 31, 2023. Assumes the maximum number of shares subject to outstanding performance-based RSUs is no longer available for issuance. As described above, under the 2018 Plan’s fungible share ratio, each stock option or SAR counts as one share against the plan reserve and each full-value share counts as two shares against the plan reserve, with performance-based RSUs counted at maximum performance. If actual performance under the performance-based RSUs falls below the maximum level for these awards, a greater number of shares would be available for issuance under the 2018 Plan.

Summary of the Changes to the 2018 Plan HighlightsIncluded in the Second Amendment

ReasonableThe Second Amendment will amend the 2018 Plan Limits. Subjectand will allow us to adjustmentgrant equity-based awards to our employees, officers, non-employee directors, and the applicable Common Stock counting provisionscertain contractors, as described in more detail below.

The Second Amendment will increase the number of shares of Common Stock available for issuance under the 2018 Plan (including as awards of Incentive Stock Options, as defined below) by 10,000,000 shares of our

Common Stock. After taking into account this increase and subject to adjustment as provided in the Amended 2018 Plan, the total number of shares of Common Stock authorized for issuance under the Amended 2018 Plan (including as awards of Incentive Stock Options) will equal 37,850,000, including past awards under the 2018 Plan. As described above, the actual dilutive effect of awards under the Amended 2018 Plan is significantly less due to the fungible share ratio and our emphasis on granting full-value shares. The Second Amendment makes no other changes to the 2018 Plan.

This description does not purport to be complete and is qualified in its entirety by the full text of the proposed Second Amendment, which is included as Annex A hereto. If our stockholders approve this proposal, we intend to file, pursuant to the Securities Act of 1933, a registration statement on Form S-8 to register additional shares available for delivery under the Amended 2018 Plan.

Share Increase

Currently, the 2018 Plan is the only active stockholder-approved plan that we use to grant equity-based compensation awards. (The Shareablee Plan was assumed in our acquisition of Shareablee, Inc. in December 2021, was not approved by our stockholders, and may not be used for awards to individuals who were our employees prior to the acquisition.) As of March 31, 2023, there were 158,489 shares remaining available for issuance under the 2018 Plan (the “Available Shares”). If the Second Amendment is approved by our stockholders, an additional 10,000,000 shares would be reserved for issuance under the Amended 2018 Plan (the “New Shares”), with the maximum number of shares available for issuance under the Amended 2018 Plan following the date of stockholder approval being equal to (i) 10,158,489 (which is the sum of the Available Shares plus the New Shares), minus (ii) the sum of (a) one share for every share subject to a stock option or appreciation right granted under the 2018 Plan after March 31, 2023 and prior to the 2023 Annual Meeting and (b) two shares for every one share subject to other awards that are granted under the 2018 Plan after March 31, 2023 and prior to the 2023 Annual Meeting, plus (iii) any shares that again become available after March 31, 2023 for awards under the 2018 Plan are limitedor the Amended 2018 Plan (pursuant to 10,650,000 shares. Thesethe share recycling provisions of the 2018 Plan, as described under “Limited Share Recycling Provisions” below).

The shares issued under the Amended 2018 Plan may be shares of original issuance, treasury shares, or a combination of the two.

TheHighlights of the Amended 2018 Plan also provides that, subject to adjustment as applicable and

Flexible Authorization Plan: The Amended 2018 Plan is a flexible authorization plan. Under the applicable Common Stock counting provisions as described in theAmended 2018 Plan:

Plan, the aggregate number of shares of Common Stock actually issuedavailable for issuance will be reduced by (1) one share of Common Stock for every one share of Common Stock subject to an award of stock options or transferred uponSARs granted under the exercise of Incentive Stock Options (as defined below) will not exceed 10,650,000Amended 2018 Plan, and (2) two shares of Common Stock; and

nonon-employee director will beStock for every one share of Common Stock subject to an award other than of stock options or SARs granted in any one calendar year, compensation for such service having an aggregate maximum value (measured at the date of grant as applicable and calculating the value of any awards under the Amended 2018 Plan based on the grant date fair value for financial reporting purposes) in excess of $900,000.
Plan.

Allowances for Conversion Awards and Assumed Plans.: Shares of Common Stock issued or transferred under awards granted under the Amended 2018 Plan in substitution for or conversion of, or in connection with an assumption of, stock options, SARs, restricted stock, RSUs, or other stock or stock-based awards held by awardees of an entity engaging in a corporate acquisition or merger transaction with us or any of our subsidiaries will not count against (or be added to) the aggregate share limit or other Amended 2018 Plan limits described above. Additionally, shares available under certain plans that we or our subsidiaries may assume in connection with corporate transactions from another entity may be available for certain awards under the Amended 2018 Plan, under circumstances further described in the Amended 2018 Plan, but will not count against the aggregate share limit or other Amended 2018 Plan limits described above.

Limited Share Recycling Provisions. Subject to certain exceptions described in the 2018 Plan, if any award granted under the 2018 Plan (in whole or in part) is canceled or forfeited, expires, is settled for cash, or is unearned, the shares of Common Stock subject to such award will, to the extent of such cancellation, forfeiture, expiration, cash settlement, or unearned amount, again be available under the 2018 Plan at a rate of one share for every one share subject to stock option or SAR awards and two shares for every one share subject to awards other than stock options or SARs. Notwithstanding anything to the contrary contained in the 2018 Plan: (1) shares of Common Stock withheld by us, tendered or otherwise used in payment of the exercise price of a stock option granted under the 2018 Plan will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the 2018 Plan, (2) shares of Common Stock withheld by us, tendered or otherwise used to satisfy tax withholding with respect to awards other than as described in (3) below will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the 2018 Plan, (3) shares of Common Stock withheld by us, tendered or otherwise used prior to the tenth anniversary of the effective date of the 2018 Plan to satisfy tax withholding with respect to awards other than stock options or SARs will be added back (but only to the extent such withholding did not exceed the minimum amounts of tax required to be withheld) to the aggregate number of shares of Common Stock available under the 2018 Plan, and (4) shares of Common Stock reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of stock options granted under the 2018 Plan will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the 2018 Plan. Further, all shares of Common Stock covered by stock-settled SARs that are exercised and settled in shares, whether or not all shares of Common Stock covered by the SARs are actually issued to the participant upon exercise, will not be added back to the aggregate number of shares available under the 2018 Plan. If a participant elects to give up the right to receive compensation in exchange for shares of Common Stock based on fair market value, such shares of Common Stock will not count against the aggregate number of shares available under the 2018 Plan.

No Minimum Vesting Periods. The 2018 Plan does not provide for any minimum vesting periods.

No Repricing Without Stockholder Approval.: The repricing of stock options and SARs (outside of certain corporate transactions or adjustment events described in the Amended 2018 Plan or in connection with a “change in control”) is prohibited without stockholder approval under the Amended 2018 Plan.

Change in Control Definition.: The Amended 2018 Plan includes a definition of “change in control,” which is described below.

Exercise or Base Price Limitation.: The Amended 2018 Plan also provides that, except with respect to certain converted, assumed or substituted awards as described in the Amended 2018 Plan, no stock options or SARs will be granted with an exercise or base price less than the fair market value of a share of Common Stock on the date of grant.

Code Section 162(m)

Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”) generally disallows a deduction for certain compensation paid to certain executive officers (and, beginning in 2018, certainand former executive officers)officers to the extent that compensation to a covered employee exceeds $1 million for such year. Compensation qualifying for a performance-based exception as “qualified performance-based compensation” under Section 162(m) of the Code has historically was not been subject to the deduction limit if the compensation satisfiessatisfied the requirements of Section 162(m) of the Code. This exception has now beenwas repealed, effective for taxable years beginning after December 31, 2017, unless certain transition relief for certain compensation arrangements in place as of November 2, 2017 iswas available. To be clear, stockholders are not being asked to approve the 2018 PlanSecond Amendment (or any of its provisions) for purposes of Section 162(m) of the Code or the performance-based exception. Currently, the CompanyThe company does not anticipate that it would be able to make any future grants under the Amended 2018 Plan that will be intended to qualify for the performance-based exception.

Summary of Other Material Terms of the Amended 2018 Plan

Administration: The Amended 2018 Plan will generally be administered by the Compensation Committee (or its successor), or any other committee of the Board of Directors designated by the Board of Directors to administer the Amended 2018 Plan. References to the “Committee” in this proposal refer to the Compensation Committee or such other committee designated by the Board, of Directors, as applicable. The Committee may, from time to time, delegate all or any part of its authority under the Amended 2018 Plan to a subcommittee. Any interpretation, construction and determination by the Committee of any provision of the Amended 2018 Plan, or of any agreement, notification or document evidencing the grant of awards under the Amended 2018 Plan, will be final and conclusive. To the extent permitted by applicable law, the Committee may delegate to one or more of its members or to one or more officers, or to one or more agents or advisors of the Company,company, such administrative duties or powers as it deems advisable. In addition, the Committee may by resolution, subject to certain restrictions set forth in the Amended 2018 Plan, authorize one or more officers of the Companycompany to (1) designate employees to be recipients of awards under the Amended 2018 Plan, and (2) determine the size of such awards. However, the Committee may not delegate such responsibilities to officers for awards granted tonon-employee directors or certain employees who are subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).Act. The Committee is authorized to take appropriate action under the Amended 2018 Plan subject to the express limitations contained in the Amended 2018 Plan.

Eligibility: Any person who is selected by the Committee to receive benefits under the Amended 2018 Plan and who is at that time an employee of the Companycompany or any of its subsidiaries (including a person who has agreed to commence serving in such capacity within 90 days of the date of grant) is eligible to participate in the Amended 2018 Plan. In addition, certain consultants (provided that such persons satisfy the FormS-8 definition of “employee”), andnon-employee directorsmembers of the Company,Board, may also be selected by the Committee to participate in the Amended 2018 Plan. As of March 30, 2018, there were31, 2023, approximately 8501,365 employees, five180 consultants, and eight10 non-employee directorsmembers of the Company expectedBoard would be eligible to participate in the Amended 2018 Plan. The basis for participation in the Amended 2018 Plan by eligible persons is the selection of such persons by the Committee in its discretion.

Shares Available for AwardsLimited Share Recycling Provisions: Subject to certain exceptions described in the Amended 2018 Plan, if any award granted under the 2018 Plan: Subject to adjustment as described in or the Amended 2018 Plan and(in whole or in part) is canceled or forfeited,

expires, is settled for cash, or is unearned, the 2018 Plan share counting rules, the number of shares of Common Stock available under the 2018 Plan for awards of:

stock options or SARs;

restricted stock;

RSUs;

performance shares or performance units;

other stock-based awards under the 2018 Plan; or

dividend equivalents paid with respect to awards under the 2018 Plan;

will not exceed, in the aggregate, 10,650,000 shares of Common Stock,plus any shares of Common Stock that become available under the 2018 Plan as a result of forfeiture, cancellation, expiration, cash settlement or less-than-maximum earning of awards.

Share Counting: The aggregate number of shares of Common Stock available under the 2018 Plan will be reduced by (1) one share of Common Stock for every one share of Common Stock subject to ansuch award will, to the extent of stock optionssuch cancellation, forfeiture, expiration, cash settlement, or SARs grantedunearned amount, again be available under the Amended 2018 Plan and (2) two sharesat a rate of Common Stockone share for every one share of Common Stock subject to an awardstock option or SAR awards and two shares for every one share subject to awards other than of stock options or SARs granted under the 2018 Plan. Additionally, if,SARs. If, after December 31, 2017, any shares of Common Stock subject to an award granted under the 2007 Plan are forfeited, or an award granted under the 2007 Plan (in whole or in part) is canceledcancelled or forfeited, expires, is settled infor cash, or is unearned, the shares of Common Stock subject to such award will, to the extent of such cancellation, forfeiture, expiration, cash settlement, or unearned amount, be available for awards under the 2018 Plan ator Amended 2018 Plan, as applicable (at a rate of one share of Common Stock for every one share of Common Stock subject to such award.award). Notwithstanding anything to the contrary contained in the Amended 2018 Plan: (1) shares of Common Stock withheld by us, tendered or otherwise used in payment of the exercise price of a stock option or the base price of an SAR granted under the 2018 Plan or the Amended 2018 Plan will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the Amended 2018 Plan, (2) shares of Common Stock withheld by us, tendered or otherwise used to satisfy tax withholding with respect to awards (whether granted under the 2018 Plan or the Amended 2018 Plan) other than as described in (3) below will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the Amended 2018 Plan, (3) shares of Common Stock withheld by us, tendered or otherwise used prior to the expiration of the Amended 2018 Plan to satisfy tax withholding with respect to awards (whether granted under the 2018 Plan or the Amended 2018 Plan) other than stock options or SARs will be added back (but only to the extent such withholding did not exceed the minimum amounts of tax required to be withheld) to the aggregate number of shares of Common Stock available under the Amended 2018 Plan, and (4) shares of Common Stock reacquired by the company on the open market or otherwise using cash proceeds from the exercise of stock options (whether granted under the 2018 Plan or the Amended 2018 Plan) will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the Amended 2018 Plan. Further, all shares of Common Stock covered by stock-settled SARs (whether granted under the 2018 Plan or the Amended 2018 Plan) that are exercised and settled in shares, whether or not all shares of Common Stock covered by the SARs are actually issued to the participant upon exercise, will not be added back to the aggregate number of shares available under the Amended 2018 Plan. If a participant elects to give up the right to receive compensation in exchange for shares of Common Stock based on fair market value, such shares of Common Stock will not count against the aggregate number of shares available under the Amended 2018 Plan.

Types of Awards Underand Award Limits under the Amended 2018 Plan: Pursuant to the Amended 2018 Plan, the Companycompany may grant cash awards and stock options (including stock options intended to be “incentive stock options” as defined in Section 422 of the Code (“Incentive Stock Options”)), SARs, restricted stock, RSUs, performance shares, performance units, cash incentive awards, and certain other awards based on or related to shares of our Common Stock.The Amended 2018 Plan provides that, subject to adjustment and the applicable Common Stock counting provisions, the aggregate number of shares of Common Stock actually issued or transferred upon the exercise of Incentive Stock Options will not exceed 37,850,000 shares of Common Stock. Further, no non-employee director will be granted, in any one calendar year, compensation for such service having an aggregate maximum value (measured at the date of grant as applicable and calculating the value of any awards under the Amended 2018 Plan based on the grant date fair value for financial reporting purposes) in excess of $900,000.

Generally, each grant of an award under the Amended 2018 Plan will be evidenced by an award agreement, certificate, resolution or other type or form of writing or other evidence approved by the Committee (an “Evidence of Award”), which will contain such terms and provisions as the Committee may determine, consistent with the Amended 2018 Plan. A brief description of the types of awards which may be granted under the Amended 2018 Plan is set forth below.

Stock Options: A stock option is a right to purchase shares of Common Stock upon exercise of the stock option. Stock options granted to an employee under the Amended 2018 Plan may consist of either an Incentive Stock Option, anon-qualified stock option that is not intended to be an “incentive stock option” under Section 422 of

the Code, or a combination of both. Incentive Stock Options may only be granted to employees of the Companycompany or certain of our related corporations. Except with respect to awards issued in substitution for, in conversion of, or in connection with an assumption of stock options held by awardees of an entity engaging in a corporate acquisition or merger with us or any of our subsidiaries, Incentive Stock Options andnon-qualified stock options must have an exercise price per share that is not less than the fair market value of a share of Common Stock on the date of grant. The term of a stock option may not extend more than 10 years from the date of grant. The Committee may provide in an Evidence of Award for the automatic exercise of a stock option.

Each grant of a stock option will specify the applicable terms of the stock option, including the number of shares of Common Stock subject to the stock option and the required period or periods of the participant’s continuous service, if any, before any stock option or portion of a stock option will become exercisable. Any grant of stock options may specify management objectives that must be achieved as a condition to the exercise of the stock options. Stock options may provide for continued vesting or the earlier exercise of the stock options, including in the event of retirement, death or disability of the participant or in the event of a change in control.

Each grant will specify whether the consideration to be paid in satisfaction of the exercise price will be payable: (1) in cash, by check acceptable to the Company,company, or by wire transfer of immediately available funds; (2) by the actual or constructive transfer to the Companycompany of shares of Common Stock owned by the participant with a value at the time of exercise that is equal to the total exercise price; (3) subject to any conditions or limitations established by the Committee, by a net exercise arrangement pursuant to which the Companycompany will withhold shares of Common Stock otherwise issuable upon exercise of a stock option; (4) by a combination of the foregoing methods; or (5) by such other methods as may be approved by the Committee. To the extent permitted by law, any grant may provide for deferred payment of the exercise price from the proceeds of a sale through a bank or broker of some or all of the shares to which the exercise relates. Stock options granted under the Amended 2018 Plan may not provide for dividends or dividend equivalents.

Appreciation Rights: The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the granting of SARs. A SAR is a right to receive from us an amount equal to 100%, or such lesser percentage as the Committee may determine, of the spread between the base price and the value of shares of our Common Stock on the date of exercise.

Each grant of SARs will specify the period or periods of continuous service, if any, by the participant with the Companycompany or any subsidiary that is necessary before the SARs or installments of such SARs will become exercisable. Any grant of SARs may specify management objectives that must be achieved as a condition of the exercise of such SARs. SARs may provide for continued vesting or earlier exercise, including in the case of retirement, death or disability of the participant or in the event of a change in control. A SAR may be paid in cash, shares of Common Stock or any combination of the two.

Except with respect to awards issued in substitution for, in conversion of, or in connection with an assumption of SARs held by awardees of an entity engaging in a corporate acquisition or merger with us or any of our subsidiaries, the base price of a SAR may not be less than the fair market value of a share of Common Stock on the date of grant. The term of a SAR may not extend more than 10 years from the date of grant. The Committee may provide in an Evidence of Award for the automatic exercise of a SAR. SARs granted under the Amended 2018 Plan may not provide for dividends or dividend equivalents.

Restricted Stock: Restricted stock constitutes an immediate transfer of the ownership of shares of Common Stock to the participant in consideration of the performance of services, entitling such participant to dividend, voting and other ownership rights, subject to the substantial risk of forfeiture and restrictions on transfer determined by the Committee for a period of time determined by the Committee or until certain management objectives specified by the Committee are achieved. Each such grant or sale of restricted stock may be made without additional consideration or in consideration of a payment by the participant that is less than the fair market value per share of Common Stock on the date of grant.

Any grant of restricted stock may specify management objectives that, if achieved, will result in termination or early termination of the restrictions applicable to the restricted stock. Any grant of restricted stock will require that any and all dividends or distributions paid on restricted stock that remains subject to a substantial risk of forfeiture be automatically deferred and/or reinvested in additional restricted stock, which will be subject to the same restrictions as the underlying restricted stock. Any such dividends or other distributions on restricted stock will be deferred until, and paid contingent upon, the vesting of such restricted stock. Restricted stock may provide for continued vesting or the earlier termination of restrictions on such restricted stock, including in the event of retirement, death or disability of the participant or in the event of a change in control.

RSUs: RSUs awarded under the Amended 2018 Plan constitute an agreement by the Companycompany to deliver shares of Common Stock, cash, or a combination of the two, to the participant in the future in consideration of the performance of services, but subject to the fulfillment of such conditions (which may include the achievement of management objectives) during the restriction period as the Committee may specify. Each grant or sale of RSUs may be made without additional consideration or in consideration of a payment by the participant that is less than the fair market value of shares of our Common Stock on the date of grant.

RSUs may provide for continued vesting or the earlier lapse or other modification of the restriction period, including in the event of retirement, death or disability of the participant or in the event of a change in control. During the restriction period applicable to RSUs, the participant will have no right to transfer any rights under the award and will have no rights of ownership in the shares of Common Stock underlying the RSUs and no right to vote them. Rights to dividend equivalents may be extended to and made part of any RSU award at the discretion of and on the terms determined by the Committee, on a deferred and contingent basis, either in cash or in additional shares of Common Stock, but dividend equivalents or other distributions on shares of Common Stock under the RSUs will be deferred until and paid contingent upon vesting of such RSUs. Each grant or sale of RSUs will specify the time and manner of payment of the RSUs that have been earned. AAn RSU may be paid in cash, shares of Common Stock or any combination of the two.

Cash Incentive Awards, Performance Shares, and Performance Units: Performance shares, performance units and cash incentive awards may also be granted to participants under the Amended 2018 Plan. A performance share is a bookkeeping entry that records the equivalent of one share of Common Stock, and a performance unit is a bookkeeping entry that records a unit equivalent to $1.00 or such other value as determined by the Committee. Each grant will specify the number or amount of performance shares or performance units, or the amount payable with respect to a cash incentive award being awarded, which number or amount may be subject to adjustment to reflect changes in compensation or other factors.

These awards, when granted under the Amended 2018 Plan, generally become payable to participants based on the achievement of specified management objectives and upon such terms and conditions as the Committee determines at the time of grant. Each grant may specify with respect to the management objectives a minimum acceptable level or levels of achievement and may set forth a formula for determining the number of performance shares or performance units, or the amount payable with respect to a cash incentive award, that will be earned if performance is at or above the minimum or threshold level or levels, or is at or above the target level or levels but falls short of maximum achievement. Each grant will specify the time and manner of payment of a cash incentive award, performance shares or performance units that have been earned. Any grant may specify that the amount payable with respect to such grant may be paid by the Companycompany in cash, in shares of Common Stock, in restricted stock or RSUs, or in any combination thereof.

Any grant of performance shares or performance units may provide for the payment of dividend equivalents in cash or in additional shares of Common Stock, subject to deferral and payment on a contingent basis based on the participant’s earning and vesting of the performance shares or performance units, as applicable, with respect to which such dividend equivalents are paid.

The performance period with respect to each cash incentive award or grant of performance shares or performance units will be a period of time determined by the Committee and within which the management objectives relating

to such award are to be achieved. The performance period may be subject to continued vesting or earlier lapse or modification, including in the event of retirement, death or disability of the participant or in the event of a change in control.

Other Awards: Subject to applicable law and applicable share limits under the Amended 2018 Plan, the Committee may grant to any participant shares of Common Stock or such other awards (“Other Awards”) that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, shares of Common Stock or factors that may influence the value of such shares of Common Stock, including, without limitation, convertible or exchangeable debt securities, other rights convertible or exchangeable into shares of Common Stock, purchase rights for shares of Common Stock, awards with value and payment contingent upon performance of the Companycompany or specified subsidiaries, affiliates or other business units or any other factors designated by the Committee, and awards valued by reference to the book value of the shares of Common Stock or the value of securities of, or the performance of the subsidiaries, affiliates or other business units of the Company.company. The terms and conditions of any such awards will be determined by the Committee. Shares of Common Stock delivered under an award in the nature of a purchase right granted under the Amended 2018 Plan will be purchased for such consideration, paid for at such time, by such methods, and in such forms, including, without limitation, shares of Common Stock, other awards, notes or other property, as the Committee determines.

In addition, the Committee may grant cash awards, as an element of or supplement to any other awards granted under the Amended 2018 Plan. The Committee may also authorize the grant of shares of Common Stock as a bonus or may authorize the grant of other awards in lieu of obligations of the Companycompany or a subsidiary to pay cash or deliver other property under the Amended 2018 Plan or under other plans or compensatory arrangements, subject to terms determined by the Committee in a manner thanthat complies with Section 409A of the Code.

Other Awards may provide for the earning or vesting of, or earlier elimination of restrictions applicable to, such awards, including in the event of the retirement, death or disability of the participant or in the event of a change in control. The Committee may provide for the payment of dividends or dividend equivalents on Other Awards in cash or in additional shares of Common Stock, subject to deferral and payment on a contingent basis based on the participant’s earning and vesting of the Other Awards with respect to which such dividends or dividend equivalents are paid.

Change in Control: The Amended 2018 Plan includes a definition of “change in control.” In general, except as may be otherwise prescribed by the Committee with respect to an award under the Amended 2018 Plan, a change in control will be deemed to have occurred if, in general (subject to certain limitations and as further described in the Amended 2018 Plan): (1) a person or group becomes the beneficial owner of 50% or more of either the then-outstanding Common Stock or the combined voting power of the then-outstanding voting securities of the Companycompany entitled to vote generally in the election of directors; (2) individuals who constitute the Board of Directors as of the effective date of the Amended 2018 Plan cease for any reason to constitute at least a majority of the Board, of Directors, unless their replacements are approved as described in the Amended 2018 Plan (subject to certain exceptions); (3) the Companycompany closes a reorganization, merger, statutory share exchange or consolidation or similar transaction involving usthe company or any of our subsidiaries, a sale or other disposition of all or substantially all of our assets, or the acquisition of assets or securities of another entity by usthe company or a subsidiary, as further described in the Amended 2018 Plan (subject to certain exceptions); or (4) the Company’scompany’s stockholders approve a complete liquidation or dissolution of the Company.company.

Management Objectives: The Amended 2018 Plan provides that any of the awards set forth above may be granted subject to the achievement of specified management objectives. Management objectives are defined as the measurable performance objective or objectives established pursuant to the Amended 2018 Plan for participants who have received grants of performance shares, performance units or cash incentive awards or, when so determined by the Committee, stock options, SARs, restricted stock, RSUs, dividend equivalents or Other Awards, all as determined by the Committee. The management objectives may be based upon, but will not be limited to, one or more of the following performance criteria: earnings, cash flow, cash value added performance, stockholder return and/or value, revenues or revenue growth, operating profits (including earnings

before interest, taxes, depreciation and/or amortization or variations thereof), net profits, earnings per share, stock price, cost reduction goals, debt ratios, financial return ratios, profit return and margins, market share, working capital, return on capital, safety, employee engagement, employee satisfaction, and other cultural improvement goals. The Committee may select one criterion or multiple criteria for measuring performance. Management objectives may be measured on company, subsidiary, business unit, business group, or corporate department performance, or on any combination thereof. Further, a management objective may be based on comparative performance with other companies or other external measures of the selected objective.

Additionally, if the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company,company, or the manner in which it conducts its business, or other events or circumstances render the management objectives unsuitable, the Committee may in its discretion modify such management objectives or the acceptable levels of achievement, in whole or in part, as the Committee deems appropriate and equitable.

Transferability of Awards: Except as otherwise provided by the Committee, no stock option, SAR, restricted stock, RSU, performance share, performance unit, cash incentive award, Other Award or dividend equivalents paid with respect to awards made under the Amended 2018 Plan will be transferrable by a participant except by will or the laws of descent and distribution. In no event will any such award granted under the Amended 2018 Plan be transferred for value. Except as otherwise determined by the Committee, stock options and SARs will be exercisable during the participant’s lifetime only by him or her or, in the event of the participant’s legal incapacity to do so, by his or her guardian or legal representative acting on behalf of the participant in a fiduciary capacity under state law or court supervision.

Minimum Holding Periods:The Committee may specify on the grant date that all or part of the shares of Common Stock that are subject to awards under the Amended 2018 Plan will be subject to further restrictions on transfer, including minimum holding periods. In 2022, all full-value awards granted to our Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and non-employee directors provided that the distribution of any shares that vest under such awards will be deferred until the earlier of the grantee’s separation from service or a change in control of the company.

Adjustments; Corporate Transactions: The Committee will make or provide for such adjustments in: (1) the number of and kind of shares of Common Stock covered by outstanding stock options, SARs, restricted stock, RSUs, performance shares and performance units granted under the Amended 2018 Plan; (2) if applicable, the number of and kind of shares of Common Stock covered by Other Awards granted pursuant to the Amended 2018 Plan; (3) the exercise price or base price provided in outstanding stock options and SARs, respectively; (4) cash incentive awards; and (5) other award terms, as the Committee in its sole discretion exercised in good faith determines to be equitably required in order to prevent dilution or enlargement of the rights of participants that otherwise would result from (a) any extraordinary cash dividend, stock dividend, stock split, combination of shares, recapitalization or other change in the capital structure of the Company;company; (b) any merger, consolidation,spin-off,spin-out,split-off,split-up, reorganization, partial or complete liquidation or other distribution of assets, issuance of rights or warrants to purchase securities; or (c) any other corporate transaction or event having an effect similar to any of the foregoing.

In the event of any such transaction or event, or in the event of a change in control of the Company,company, the Committee may provide in substitution for any or all outstanding awards under the Amended 2018 Plan such alternative consideration (including cash), if any, as it may in good faith determine to be equitable under the circumstances and will require in connection therewith the surrender of all awards so replaced in a manner that complies with Section 409A of the Code. In addition, for each stock option or SAR with an exercise price or base price, respectively, greater than the consideration offered in connection with any such transaction or event or change in control of the Company,company, the Committee may in its discretion elect to cancel such stock option or SAR without any payment to the person holding such stock option or SAR. The Committee will make or provide for such adjustments to the numbers of shares of Common Stock available under the Amended 2018 Plan and the share limits of the Amended 2018 Plan as the Committee in its sole discretion may in good faith determine to be appropriate in connection with such transaction or event. However, any adjustment to the limit on the number of

shares of Common Stock that may be issued upon exercise of Incentive Stock Options will be made only if and to the extent such adjustment would not cause any option intended to qualify as an Incentive Stock Option to fail to so qualify.

Prohibition on Repricing: Except in connection with certain corporate transactions or changes in the capital structure of the Companycompany or in connection with a change in control, the terms of outstanding awards may not be amended to (1) reduce the exercise price or base price of outstanding stock options or SARs, respectively, or (2) cancel outstanding “underwater” stock options or SARs (including following a participant’s voluntary surrender of “underwater” stock options or SARs) in exchange for cash, other awards or stock options or SARs with an exercise price or base price, as applicable, that is less than the exercise price or base price of the original stock options or SARs, as applicable, without stockholder approval. The Amended 2018 Plan specifically provides that this provision is intended to prohibit the repricing of “underwater” stock options and SARs and that it may not be amended without approval by our stockholders.

Detrimental Activity and Recapture: Any Evidence of Award may reference a clawback policy of the Companycompany or provide for the cancellation or forfeiture and repayment to us of any gain related to an award, or other provisions intended to have a similar effect, upon such terms and conditions as may be determined by the Committee from time to time, if any participant, either during employment or other service with us or a subsidiary or within a specified period after such employment or service, engages in any detrimental activity, as described in the applicable Evidence of Award or such clawback policy. In addition, any Evidence of Award or such clawback policy may provide for cancellation or forfeiture of an award or the forfeiture and repayment of any shares of Common Stock issued under and/or any other benefit related to an award, or other provisions intended to have a similar effect, upon such terms and conditions as may be required by the Committee or under Section 10D of the Exchange Act and any applicable rules and regulations promulgated by the Securities and Exchange CommissionSEC or any national securities exchange or national securities association on which the shares of Common Stock may be traded. For information about our clawback policy, see “Directors, Director Nominees, Executive Officers and Corporate Governance – Clawback Policy” above.

Grants toNon-U.S. Based Participants: In order to facilitate the making of any grant or combination of grants under the Amended 2018 Plan, the Committee may provide for such special terms for awards to participants who are foreign nationals, who are employed by the Companycompany or any of its subsidiaries outside of the United States of America or who provide services to the Companycompany or any of its subsidiaries under an agreement with a foreign nation or agency, as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. The Committee may approve such supplements to, or amendments, restatements or alternative versions of, the Amended 2018 Plan (includingsub-plans) as it may consider necessary or appropriate for such purposes, provided that no such special terms, supplements, amendments or restatements will include any provisions that are inconsistent with the terms of the Amended 2018 Plan as then in effect unless the Amended 2018 Plan could have been amended to eliminate such inconsistency without further approval by our stockholders.

Withholding: To the extent the Companycompany is required to withhold federal, state, local or foreign taxes or other amounts in connection with any payment made or benefit realized by a participant or other person under the Amended 2018 Plan, and the amounts available to us for such withholding are insufficient, it will be a condition to the receipt of such payment or the realization of such benefit that the participant or such other person make arrangements satisfactory to the Companycompany for payment of the balance of such taxes or other amounts required to be withheld, which arrangements, in the discretion of the Committee, may include relinquishment of a portion of such benefit. If a participant’s benefit is to be received in the form of shares of Common Stock, and such participant fails to make arrangements for the payment of taxes or other amounts, then, unless otherwise determined by the Committee, we will withhold shares of Common Stock having a value equal to the amount required to be withheld. When a participant is required to pay the Companycompany an amount required to be withheld under applicable income, employment, tax or other laws, the participant may elect, unless otherwise determined by the Committee, to satisfy the obligation, in whole or in part, by having withheld, from the shares required to be delivered to the participant, shares of Common Stock having a value equal to the amount required to be

withheld or by delivering to us other shares of Common Stock held by such participant. The shares used for tax or other withholding will be valued at an amount equal to the fair market value of such shares of Common Stock on the date the benefit is to be included in the participant’s income. In no event will the fair market value of the shares of Common Stock to be withheld and delivered pursuant to the Amended 2018 Plan exceed the minimum amount required to be withheld, unless (i) an additional amount can be withheld and not result in adverse accounting consequences, (ii) such additional withholding amount is authorized by the Committee, and (iii) the total amount withheld does not exceed the participant’s estimated tax obligations attributable to the applicable transaction. Participants will also make such arrangements as the Companycompany may require for the payment of any withholding tax or other obligation that may arise in connection with the disposition of shares of Common Stock acquired upon the exercise of stock options.

No Right to Continued Employment: The Amended 2018 Plan does not confer upon any participant any right with respect to continuance of employment or service with the Companycompany or any of its subsidiaries.

Effective Date of the 2018 PlanSecond Amendment: The 2018 PlanSecond Amendment will become effective on the date it is approved by the Company’scompany’s stockholders.

Amendment and Termination of the Amended 2018 Plan:Plan: The Board of Directors generally may amend the Amended 2018 Plan from time to time in whole or in part. However, if any amendment, for purposes of applicable stock exchange rules (and except as permitted under the adjustment provisions of the Amended 2018 Plan) (1) would materially increase the benefits accruing to participants under the Amended 2018 Plan, (2) would materially increase the number of securities which may be issued under the Amended 2018 Plan, (3) would materially modify the requirements for participation in the Amended 2018 Plan, or (4) must otherwise be approved by our stockholders in order to comply with applicable law or theNasdaq rules, of the Nasdaq Stock Market, or, if the shares of Common Stock are not traded on the Nasdaq, Stock Market, the principal national securities exchange upon which the shares of Common Stock are traded or quoted, all as determined by the Board, of Directors, then such amendment will be subject to stockholder approval and will not be effective unless and until such approval has been obtained.

Further, subject to the Amended 2018 Plan’s prohibition on repricing, the Committee generally may amend the terms of any award prospectively or retroactively. Except in the case of certain adjustments permitted under the Amended 2018 Plan, no such amendment may be made that would materially impair the rights of any participant without his or her consent. If permitted by Section 409A of the Code and subject to certain other limitations set forth in the Amended 2018 Plan, including in the case of termination of employment or service, or in the case of unforeseeable emergency or other circumstances or in the event of a change in control, the Committee may provide for continued vesting or accelerate the vesting of certain awards granted under the Amended 2018 Plan.

The Board of Directors may, in its discretion, terminate the Amended 2018 Plan at any time. Termination of the Amended 2018 Plan will not affect the rights of participants or their successors under any awards outstanding and not exercised in full on the date of termination. No grant will be made under the Amended 2018 Plan more than 10 yearson or after May 30, 2028, the effectivetenth anniversary of the date of the 2018 Plan was approved by the company’s stockholders, but all grants made on or prior to such date will continue in effect thereafter subject to their terms and the terms of the Amended 2018 Plan.

Stock Plan Benefits

The terms and number of awards to be granted in the future under the Amended 2018 Plan are to be determined in the discretion of the Committee. Because no such determinations have been made, the benefits or amounts that will be received by or allocated to the company’s executive officers, directors or other eligible employees cannot be determined at this time, although the company intends to make awards to such groups under the Amended 2018 Plan consistent with its existing compensation practices. Therefore, the New Plan Benefits Table is not provided.

As discussed above, we anticipate granting equityThe following table sets forth, for each of our named executive officers, each person who has been granted 5% or more of the total amount of awards ingranted under the 2018 Plan, and certain groups, the number of shares of our

Common Stock that are subject to outstanding stock option grants under the 2018 Plan as of March 31, 2023. No other person has been granted 5% or more of the total amount of awards granted under the 2018 Plan, and no stock option awards have been granted under the 2018 Plan to our employees andany associate of a non-employee directors, which awards were recommended for employees andnon-employee directors in 2016, 2017 and 2018, but were not yet granted as of March 30, 2018. Generally, these awards, if granted, are expected to vest at the time that they otherwise would have vested if they were granted when initially recommended; for some awards, this will result in the award being fully vested at the time of grant. These anticipated awards, which will not be made in the event that stockholders do not approve this Proposal No. 4, are summarized in the following table:

New Plan Benefitsdirector, nominee or executive officer.

2018 Plan Stock Options

 

Name and Position  Dollar Value ($)(1)   Number
of Units (1)
 

William Livek

President and Executive Vice Chairman

  $    —      —   

Gian Fulgoni

Former Chief Executive Officer

    $4,000,000    166,183 

Gregory Fink

Chief Financial Officer

    $800,000    33,237 

David Kay

Former Interim Chief Financial Officer

     —      —   

David Chemerow

Former Chief Financial Officer

     —      —   

Carol DiBattiste

General Counsel & Chief Compliance, Privacy and People Officer

    $1,000,000    41,546 

Christiana Lin

Former Executive Vice President, General Counsel and Chief Privacy Officer

     —  ��   —   

Michael Brown

Former Chief Technology Officer

     —      —   

Executive Group (six persons)

    $4,362,302    181,234 

Non-Executive Director Group (eight persons, including Dr. Fulgoni)

    $5,176,422    215,057 

Non-Executive Officer Employee Group (825 persons)

    $37,532,303    1,559,298 
Number of Shares of
Common Stock
Subject to 2018 Plan
Stock Options

Jon Carpenter

500,000

Bill Livek

300,000

Mary Margaret Curry

160,000

Greg Dale

160,000

All current executive officers as a group

820,000

All current non-executive directors as a group (1)

300,000

All current non-executive employees, including all current officers who are not executive officers, as a group

228,000

 

(1)For those recommended

Includes Nana Banerjee, David Kline, Kathi Love and Brian Wendling, who are current directors nominated for election at the 2023 Annual Meeting. Dr. Banerjee, Messrs. Kline and Wendling and Ms. Love do not hold any outstanding stock option awards that are currently denominated in dollars,under the number of units is calculated as the total dollar value divided by the closing bid price of our Common Stock on the OTC Pink Tier on March 29, 2018 which was $24.07 per share. For those recommended awards that are currently denominated in shares, the dollar value is calculated as the number of shares multiplied by $24.07.Plan.

The amounts in the “Number of Units” column in the table above represent the number of RSUs or unrestricted shares of Common Stock expected to be granted to each of the indicated individuals and groups in the event that the 2018 Plan is approved by stockholders. This data is as of March 30, 2018 and includes only amounts determinable as of such date.

U.S. Federal Income Tax Consequences

The following is a brief summary of certain of the U.S. federal income tax consequences of certain transactions under the Amended 2018 Plan based on federal income tax laws currently in effect. This summary, which is presented for the information of stockholders considering how to vote on this proposal and not for Amended 2018 Plan participants, is not intended to be complete and does not describe federal taxes other than income taxes (such as Medicare and Social Security taxes), or state, local or foreign tax consequences.

Tax Consequences to Participants

Restricted Stock.: The recipient of restricted stock generally will be subject to tax at ordinary income rates on the fair market value of the restricted stock (reduced by any amount paid by the recipient for such restricted stock) at such time as the shares of restricted stock are no longer subject to forfeiture or restrictions on transfer for purposes of Section 83 of the Code (“Restrictions”). However, a recipient who so elects under Section 83(b) of the Code within 30 days of the date of transfer of the shares will have taxable ordinary income on the date of transfer of the shares equal to the excess of the fair market value of such shares (determined without regard to the Restrictions) over the purchase price, if any, of such restricted stock. If a Section 83(b) election has not been made, any dividends received with respect to restricted stock that are subject to the Restrictions generally will be treated as compensation that is taxable as ordinary income to the recipient.

Performance Shares, Performance Units and Cash Incentive Awards.: No income generally will be recognized upon the grant of performance shares, performance units or cash incentive awards. Upon payment in respect of theearn-out of performance shares, performance units or cash incentive awards, the recipient generally will be required to include as taxable ordinary income in the year of receipt an amount equal to the amount of cash received and the fair market value of any unrestricted shares of Common Stock received.

Nonqualified Stock Options.Options: In general:

 

no income will be recognized by an optionee at the time anon-qualified stock option is granted;

 

at the time of exercise of anon-qualified stock option, ordinary income will be recognized by the optionee in an amount equal to the difference between the option price paid for the shares and the fair market value of the shares, if unrestricted, on the date of exercise; and

at the time of sale of shares acquired pursuant to the exercise of anon-qualified stock option, appreciation (or depreciation) in value of the shares after the date of exercise will be treated as either short-term or long-term capital gain (or loss) depending on how long the shares have been held.

Incentive Stock Options.Options: No income generally will be recognized by an optionee upon the grant or exercise of an Incentive Stock Option. If shares of Common Stock are issued to the optionee pursuant to the exercise of an Incentive Stock Option, and if no disqualifying disposition of such shares is made by such optionee within two years after the date of grant or within one year after the transfer of such shares to the optionee, then upon sale of such shares, any amount realized in excess of the option price will be taxed to the optionee as a long-term capital gain and any loss sustained will be a long-term capital loss.

If shares of Common Stock acquired upon the exercise of an Incentive Stock Option are disposed of prior to the expiration of either holding period described above, the optionee generally will recognize ordinary income in the year of disposition in an amount equal to the excess (if any) of the fair market value of such shares at the time of exercise (or, if less, the amount realized on the disposition of such shares if a sale or exchange) over the exercise price paid for such shares. Any further gain (or loss) realized by the participant generally will be taxed as short-term or long-term capital gain (or loss) depending on the holding period.

SARs.: No income will be recognized by a participant in connection with the grant of a SAR. When the SAR is exercised, the participant normally will be required to include as taxable ordinary income in the year of exercise an amount equal to the amount of cash received and the fair market value of any unrestricted shares of Common Stock received on the exercise.

RSUs.RSUs: No income generally will be recognized upon the award of RSUs. The recipient of an RSU award generally will be subject to tax at ordinary income rates on the fair market value of unrestricted shares of Common Stock on the date that such shares are transferred to the participant under the award (reduced by any amount paid by the participant for such RSUs), and the capital gains/loss holding period for such shares will also commence on such date.

Tax Consequences to the Company or its Subsidiaries

To the extent that a participant recognizes ordinary income in the circumstances described above, the Companycompany or the subsidiary for which the participant performs services will be entitled to a corresponding deduction provided that, among other things, the income meets the test of reasonableness, is an ordinary and necessary business expense, is not an “excess parachute payment” within the meaning of Section 280G of the Code and is not disallowed by the $1 million deduction limitation on certain executive compensation under Section 162(m) of the Code.

Registration with the SEC

We intend to file a Registration Statement on FormS-8 relating to the issuance of shares of Common Stock under the Amended 2018 Plan with the SEC pursuant to the Securities Act of 1933, as amended, as soon as practicable after approval of the 2018 PlanSecond Amendment by our stockholders.

Equity Compensation Plan Information

The closing price of a share of our Common Stock as reported by Nasdaq on March 31, 2023 was $1.23. The following table summarizes our equity compensation plans as of December 31, 2017:2022:

 

Plan Category  Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options,
Warrants and
Rights
(a)
   Weighted-
Average
Exercise
Price of
Outstanding
Options,
Warrants
and Rights
(b)
   Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
(c)
   Number of Securities
to be Issued Upon
Exercise of
Outstanding Options,
Warrants and Rights
(a) (1)
   Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights
(b) (2)
   Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column
(a)) (c) (3)
 

Equity compensation plans approved by security holders

   4,310,414   $30.21    —      5,575,147   $3.22    5,693,104 

Equity compensation plans not approved by security holders(4)

   —      —      —      1,362,197   $1.16    176,435 
  

 

   

 

   

 

 

Total

   4,310,414   $30.21    —      6,937,344   $2.42    5,869,539 
  

 

   

 

   

 

 

In March 2017, the 2007 Plan reached the end of itsten-year term and expired. On April [•], 2018, upon recommendation of the Compensation Committee, our Board approved and adopted, subject to the approval of the Company’s stockholders at the 2018 Annual Meeting, the 2018 Plan. As of December 31, 2017, the Company had 5,951,055 shares that would have been available for future issuance under the 2007 Plan had it not expired.

(1)

This column reflects (i) all shares subject to time-based RSUs and deferred stock units that were outstanding as of December 31, 2022, (ii) the maximum number of shares subject to performance-based RSUs that were outstanding as of December 31, 2022, and (iii) all shares subject to outstanding stock options as of December 31, 2022. If actual performance under the performance-based RSUs falls below the maximum level for these awards, fewer shares would be issued.

(2)

The weighted average exercise price reflected in this column is calculated based solely on the exercise prices of outstanding options and does not take into account time-based RSUs, deferred stock units or performance-based RSUs, which do not have an exercise price.

(3)

This column reflects the total number of shares remaining available for issuance as of December 31, 2022, assuming the maximum number of shares subject to outstanding performance-based RSUs is no longer available for issuance. If actual performance under these performance-based RSUs falls below the maximum level for these awards, a greater number of shares would be available for issuance.

(4)

Equity compensation plans not approved by security holders comprise (i) the Shareablee Plan, with 910,220 shares underlying outstanding awards reflected in column (a) and 176,435 shares remaining available for future awards reflected in column (c), and (ii) an outstanding inducement award of time-based RSUs covering 451,977 shares reflected in column (a).

Required Vote

You may vote for or against this Proposal No. 4, or you may abstain. Approval of this proposal requires the affirmative vote (“FOR”) of a majority of the shares present or represented by proxy at the 20182023 Annual Meeting and entitled to vote thereon. Abstentions will have the same effect as a vote against this proposal. Brokernon-votes will have no effect on the outcome of this proposal.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” PROPOSAL NO. 4.

PROPOSAL NO.Proposal No. 5 – Adoption of the Certificate of Designations Amendment

APPROVAL OF AN AMENDMENT TO THE COMSCORE, INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER

The Board of Directors has declared advisable and directed that there be submitted to the stockholders at the 20182023 Annual Meeting a proposed amendment (the “Amendment”)proposal to Article IV of the comScore, Inc.amend our Amended and Restated Certificate of Incorporation by amending the Certificate of Designations of the Series B Preferred Stock (the “Charter”“Certificate of Designations”) to (i) permit us to pay annual dividends on the Series B Preferred Stock in the form of cash, shares of Common Stock, additional shares of Series B Preferred Stock, or a combination thereof, in accordance with the Certificate of Designations Amendment and as elected by the Disinterested Directors, and (ii) make certain other clarifying and conforming changes to the Certificate of Designations, including with respect to intended tax treatment.

The chart below provides a comparison between the key features of the payment structure for annual dividends based on the current Certificate of Designations as compared to the proposed Certificate of Designations Amendment, subject to the terms and conditions of the Certificate of Designations and the Certificate of Designations Amendment, respectively.

Current Dividend Payment Structure under the Certificate of Designations

Proposed Dividend Payment Structure under the Certificate of Designations Amendment

Annual dividends may be paid on the Series B Preferred Stock in the form of cash.

Annual dividends may be paid on the Series B Preferred Stock in the form of:

•   cash;

•   shares of Common Stock;

•   shares of Series B Preferred Stock; or

•   a combination of cash, shares of Common Stock, and/or shares of Series B Preferred Stock

in each case in accordance with the terms of the Certificate of Designations Amendment and as elected by the Disinterested Directors.

The Certificate of Designations Amendment provides that would increase(a) if the Current Market Price (as defined in the Certificate of Designations Amendment) as of the date that the Board declares Annual Dividends (as defined in the Certificate of Designations), which shall be no more than 15 days prior to the close of business on June 15 of each year (the “Dividend Declaration Date”) is below $2.00, we will pay all Accrued Dividends (as defined in the Certificate of Designations) on each share of Series B Preferred Stock in cash (to the extent not prohibited by Section 170 of the Delaware General Corporation Law (“DGCL”)), shares of Common Stock, or any combination thereof, (b) if the Current Market Price as of the Dividend Declaration Date is at or above $2.00 but does not exceed $2.4719, we will pay all Accrued Dividends in cash (to the extent not prohibited by Section 170 of the DGCL), shares of Common Stock, shares of Series B Preferred Stock, or any combination thereof, or (c) if the Current Market Price as of the Dividend Declaration Date is above $2.4719, we will pay all Accrued Dividends in cash (to the extent not prohibited by Section 170 of the DGCL), shares of Series B Preferred Stock, or any combination thereof. The form of payment of all Accrued Dividends will be determined by the Disinterested Directors in their sole discretion.

If the Disinterested Directors elect to pay Accrued Dividends in shares of Common Stock, the number of shares to be paid will be determined based on the Current Market Price as of the Dividend Declaration Date or such higher price (resulting in the issuance of fewer shares) as otherwise agreed by the Disinterested Directors and each holder of Series B Preferred Stock and as further described in the Certificate of Designations Amendment. If the Disinterested Directors elect to pay Accrued Dividends in shares of Series B Preferred Stock, the number of shares to be paid will be determined based on the Purchase Price (as defined in the Certificate of Designations), which is currently $2.4719, as further described in the Certificate of Designations Amendment. Shares of Common Stock or Series B Preferred Stock paid in satisfaction of Accrued Dividends will be rounded down to the nearest whole number such that no fractional shares will be issued.

If the Certificate of Designations Amendment is approved, we will be required to reserve and keep available out of the authorized and unissued Common Stock and Series B Preferred Stock, a number of such shares as from time to time may be issuable in connection with payment of Accrued Dividends. The Certificate of Designations Amendment also provides that we will use reasonable best efforts to maintain the listing on the Nasdaq Global Select Market of such number of shares of Common Stock authorized for issuance thereunderas from 100,000,000time to 150,000,000. The additionaltime may be issued in connection with payment of Accrued Dividends. Any shares of Common Stock and Series B Preferred Stock issued as payment of Accrued Dividends will be duly authorized, validly issued, fully paid and nonassessable and will not be subject to preemptive rights or subscription rights of any stockholder of the company.

The Certificate of Designations Amendment would also increase the number of authorized shares of Series B Preferred Stock from 82,527,609 to 100,000,000 to allow for payment of accrued dividends in the form of Series B Preferred Stock, if approved for issuance pursuantelected by the Disinterested Directors. In addition, the Certificate of Designations Amendment would make certain conforming changes to the approvalCertificate of Designations and clarify the Amendment,company’s rights to deduct and withhold taxes on all applicable payments, actual or deemed, including by a set off with respect to future distributions. It also would be identical in termsclarify the company’s obligations to pay for certain transfer taxes on the issuance of, or conversion of Series B Preferred Stock into, shares of Common Stock currentlyand clarify the scope of the intended tax treatment, by specifying the times and/or circumstances under which the company should reevaluate such tax treatment with respect to actual or deemed distributions on Series B Preferred Stock.

Adoption of the Certificate of Designations Amendment is conditioned on (i) adoption of the Certificate of Incorporation Amendment, which would increase (a) the total number of shares of stock authorized for issuance from 365,000,000 to 380,000,000 and (b) the number of shares of preferred stock authorized for issuance from 90,000,000 to 105,000,000 shares and (ii) approval by our stockholders, in accordance with Nasdaq Listing Rule 5635(d), of the issuance of Common Stock and/or Series B Preferred Stock as annual dividends on the Series B Preferred Stock, as further described under the Charter.Proposal No. 7 (the “Share Issuance”).

The Form of Certificate of Designations Amendment attached asAnnex B hereto and incorporated herein by reference reflects the changes that would be implemented to our Charterthe Certificate of Designations if the Certificate of Designations Amendment is approved.

Purpose of and Effects of the Proposed Amendment

In connection with the Company’s growth in recent periods through both acquisitions and organically, including the January 2016 merger with Rentrak Corporation, as well as the Company’s proposed settlement of certain litigation matters and the Company’s January 2018 financing arrangement involving the issuance of senior secured convertible notes, the Company has issued or reserved for issuance a significant number of shares of Common Stock.

In addition, due to our delay in filing periodic reports with the SEC prior to the filing of our 2017 10-K, we have been unable to use our registration statement on Form S-8 to grant equity awards to our directors and employees since February 2016. Further, in March 2017, our 2007 Equity Incentive Plan reached the end of its ten-year term and expired. As described under Proposal No. 4, we are asking our stockholders to approve the 2018 Equity and Incentive Plan at the 2018 Annual Meeting, and if so approved, we expect to grant additional equity awards. As of March 30, 2018, in accordance with our compensation program for employees and directors, we anticipate making equity awards having an aggregate value of approximately $47.1 million upon approvalPurpose of the 2018 Equity and Incentive Plan. These awards were recommended for employees and directors in 2016, 2017 and 2018 but were not granted as of March 30, 2018. Based on the closing bid price of our Common Stock on the OTC Pink Tier on March 29, 2018, $24.07 per share, we expect to award approximately 1,956,000 shares of Common Stock in connection with the employee and director equity awards known as of March 30, 2018. The actual number of shares of Common Stock issued will be based upon the prevailing trading price of our Common Stock at the time the grants are actually made.Proposed Amendment

The CharterCertificate of Designations currently authorizes the issuance of up to 100,000,000 shares of Common Stock. As of April 13, 2018 and, to the extent applicable, based on the closing bid price of our Common Stock on the OTC Pink Tier on such date, the Company had [●] shares of Common Stock issued and outstanding, [●] shares of Common Stock underlying outstanding equity awards, [●] shares of Common Stock subject to issuance in pending litigation settlements, and [●] shares of Common Stock reserved for issuance upon potential conversion of, and payment of interestAccrued Dividends on the Company’s outstanding senior secured convertible notes,Series B Preferred Stock solely in addition to the shares expected to be issued pursuant to awards recommended for employees and directors in 2016, 2017 and 2018 as described above. As of such date, [●] shares of Common Stock were also held as treasury shares. For certain of these items, including pending litigation settlements and recommended awards for employees and directors, the actual number of shares issued will be based upon the prevailing trading price of our Common Stock at the time of issuance – meaning that any decrease in the trading price of our Common Stock will increase the number of shares needed to deliver the prescribed value. Moreover, these estimates do not include any shares for incentive awards to employees and directors for performance in 2018 or future years.

Furthermore, and as previously disclosed, the Company has the right to conduct a rights offering for up to $150.0 million in aggregate principal amount of senior secured convertible notes. If we were to issue $150.0 million in aggregate principal amount of such convertible notes, the terms of which would be substantially similar to the Company’s outstanding senior secured convertible notes, up to 5,357,143 shares of Common Stock would be issuable upon conversion thereof, and interest thereon would also be payable, at our option, through the issuance of additional shares of Common Stock.

As a result of the foregoing, the Company does not believe that the number of currently authorized shares of Common Stock available for future issuance provides comScore with the necessary flexibility to be able to continue to grow the Company and its operations in 2018 and future years. We believe that the Amendment would provide the Company with sufficient shares of Common Stock for future issuance to meet its needs for the foreseeable future, including in connection with the above-mentioned litigation settlements, convertible notes, pending and contemplated employee and director awards, and potential rights offering of senior secured convertible notes.

cash. The principal purpose of the Certificate of Designations Amendment is to increasepermit the numberpayment of Accrued Dividends in the form of cash, shares of Common Stock, available for future issuance, including for future financing transactions, directorshares of Series B Preferred Stock, or a combination thereof, in accordance with the Certificate of Designations Amendment and employee compensation plans, and other general corporate purposes. In addition, from time to time, the Company may engage in discussions concerning possible acquisitions that could involve the issuance of securitiesas elected by the Company. Market conditions,Disinterested Directors, and to make certain other clarifying and conforming changes in our financial condition or other circumstances could result in a determinationto the Certificate of Designations, including with respect to intended tax treatment. This will provide the company with more flexibility with respect to the payment of Accrued Dividends, including the ability to retain cash for operational purposes if determined advisable by the Company inDisinterested Directors. Based on the futureterms of the Certificate of Designations Amendment, the tax treatment of the Series B Preferred Stock under Section 305(b)(4) of the Code is not expected to materially change.

The adoption of the Certificate of Designations Amendment is conditioned upon the adoption of the Certificate of Incorporation Amendment and the approval of the Share Issuance, as described above.

Effects of the Proposed Amendment

If the Certificate of Designations Amendment is adopted, it would allow us to issue additional shares of Common Stock or securities convertibleSeries B Preferred Stock as payment for Accrued Dividends on the Series B Preferred Stock, in accordance with the Certificate of Designations Amendment and as elected by the Disinterested Directors. Our Series B Preferred Stock is entitled to certain rights under the Certificate of Designations, including, under certain circumstances, the ability to convert into shares of Common Stock.

If approved, the increased number of authorized shares Any issuance of Common Stock or

Series B Preferred Stock as payment for Accrued Dividends could cause a significant reduction in the percentage interests of our current stockholders in voting power, liquidation value, book and market value, and future earnings (if any). Such issuances could dilute, and thereby reduce, each existing stockholder’s proportionate ownership in our Common Stock. For more information on the Series B Preferred Stock, see Exhibit 4.10 to our Annual Report on Form 10-K filed with the SEC on March 2, 2023.

Additionally, the holders of our Series B Preferred Stock are entitled to certain rights under the Certificate of Designations and the SHA that are tied to their ownership of Series B Preferred Stock and Common Stock, including any shares issued as payment for Accrued Dividends in accordance with the Certificate of Designations Amendment. For more information on the rights of the holders of Series B Preferred Stock under the SHA, please see our Current Report on Form 8-K filed with the SEC on March 15, 2021 and the SHA, which is filed as an exhibit to our Annual Report on Form 10-K filed with the SEC on March 2, 2023. If the Certificate of Designations Amendment is adopted, we may negotiate an amendment to the SHA to reflect the Certificate of Designations Amendment and such other changes as are agreed upon by the parties to the SHA.

The Certificate of Designations Amendment specifies certain circumstances under which the intended tax treatment of Series B Preferred Stock as common stock for the purposes of Section 305(b)(4) of the Code may be reevaluated. If the tax treatment of Series B Preferred Stock were to change such that it would be availabletreated as preferred stock for issuance from time to time for suchthe purposes and consideration asof Section 305(b)(4) of the BoardCode, a distribution of Directors may determine tostock made on Series B Preferred Stock could be appropriate. Notaxable.

If the Certificate of Designations Amendment is adopted, no further vote of our stockholders would be required for the issuancepayment of theseAccrued Dividends in the form of cash, shares of Common Stock, shares of Preferred Stock, or a combination thereof, except as providedmay be required under the rules of any national securities exchange or automated quotation system on which our securities are listed.

We currently do not have any plans with respect to the Common Stock mayform of payment for Accrued Dividends. The form of payment for Accrued Dividends will be listed or quoted. The availabilitydetermined by the Disinterested Directors in their sole discretion on each Dividend Declaration Date in accordance with the Certificate of additional shares for issuance, withoutDesignations Amendment, based on the delay and expense of obtaining the approval of stockholders at a special meeting, will provide the Company greater flexibility in acting upon proposed transactions or for other appropriate purposes.

Future issuances of Common Stock would increase the number of shares of Common Stock issued and outstanding, thereby decreasing the percentage ownership in comScore (for voting, distributions and all other purposes) represented by existing shares of Common Stock. The availability for issuancecircumstances of the additional shares of Common Stockcompany at the time and issuance thereof may be viewed as having the effect of discouraging an unsolicited attempt by another person or entity to acquire control of comScore.taking into account all relevant factors.

If the Certificate of Designations Amendment is approvedand the Certificate of Incorporation Amendment are adopted by our stockholders at the 20182023 Annual Meeting, the Company expectswe expect that athe Certificate of Designations Amendment, in the form attached hereto asAnnex B,, would be filed with the Secretary of State of the State of Delaware as soon as practicable after the 20182023 Annual Meeting. Without any further action on the part of our stockholders, the Certificate of Designations Amendment would become effective on the date of any such filing. Prior to any such filing, the Board of Directors reserves the right to delay or abandon the Certificate of Designations Amendment at its discretion.

Adoption of the Certificate of Incorporation Amendment and Share Issuance as a Condition to Adoption of the Certificate of Designations Amendment

Adoption of the Certificate of Designations Amendment is conditioned upon adoption of the Certificate of Incorporation Amendment and approval of the Share Issuance. If the Certificate of Incorporation Amendment and the Share Issuance are not approved by our stockholders, the Certificate of Designations Amendment cannot be effected. See the section entitled “Proposal No. 6 – Adoption of the Certificate of Incorporation Amendment” and the section entitled “Proposal No. 7 – Approval of the Share Issuance.”

Required Vote

You may vote for or against this Proposal No. 5, or you may abstain. Approval of this proposal requires the affirmative vote (“FOR”) of (i) the holders of a majority of the outstanding shares of Common Stock.Stock and Series B Preferred Stock (on an as-converted basis) entitled to vote thereon and (ii) the holders of at least 75% of

the outstanding shares of Series B Preferred Stock entitled to vote thereon, voting as a separate class. Abstentions and brokernon-votes will have the same effect of a voteas votes against this proposal.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” PROPOSAL NO. 5.

PROPOSAL NO.Proposal No. 6 – Adoption of the Certificate of Incorporation Amendment

RATIFICATION OF APPOINTMENT OFThe Board has declared advisable and directed that there be submitted to the stockholders at the 2023 Annual Meeting a proposed amendment (the “Certificate of Incorporation Amendment”) of the comScore, Inc. Amended and Restated Certificate of Incorporation (as amended, the “A&R Certificate of Incorporation”) that would authorize additional shares of preferred stock in order to permit us to issue additional Series B Preferred Stock and other preferred stock and pay annual dividends in the form of Series B Preferred Stock, if elected by our Disinterested Directors, as further described under “Proposal No. 5 – Adoption of the Certificate of Designations Amendment.” The Certificate of Incorporation Amendment would increase (i) the total number of shares of stock authorized for issuance from 365,000,000 to 380,000,000 and (ii) the number of shares of preferred stock authorized for issuance from 90,000,000 to 105,000,000.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMThe Form of Certificate of Amendment attached as Annex C hereto reflects the changes that would be implemented to our A&R Certificate of Incorporation if the Certificate of Incorporation Amendment is approved.

Our Audit Committee has appointed Deloitte & Touche LLPPurpose of and Effects of the Proposed Amendment

The A&R Certificate of Incorporation currently authorizes the issuance of up to 365,000,000 shares of stock, composed of 275,000,000 shares of Common Stock and 90,000,000 shares of preferred stock. As of March 31, 2023, the company had 92,359,528 shares of Common Stock issued and outstanding and 82,527,609 shares of preferred stock issued and outstanding. As of such date, there were:

9,424,448 shares of Common Stock underlying outstanding equity awards (based on maximum achievement, if applicable);

337,321 shares of Common Stock reserved for issuance pursuant to the company’s equity incentive plans, excluding outstanding equity awards;

5,457,026 shares of Common Stock reserved for issuance in connection with the company’s outstanding warrants;

87,255,753 shares of Common Stock reserved for issuance in connection with the conversion of Series B Preferred Stock (including Accrued Dividends through March 31, 2023);

7,133,182 shares of Common Stock reserved for payment of deferred consideration related to our acquisition of Shareablee (representing the maximum number of shares issuable if we elect to pay such consideration in Common Stock);

6,764,796 shares of Common Stock held as treasury shares; and

82,527,609 shares of preferred stock designated as Series B Preferred Stock.

Assuming Proposal No. 5 is approved by our independent registered public accounting firmstockholders, our Disinterested Directors will have the ability to elect (in their discretion) whether to pay annual dividends on the Series B Preferred Stock in the form of additional shares of Series B Preferred Stock, shares of Common Stock, cash or a combination thereof, as contemplated by Proposal No. 5.

The principal purpose of the Certificate of Incorporation Amendment is to increase the total number of shares of stock and the number of shares of preferred stock authorized for future issuance, in order to enable the Disinterested Directors to elect a form of payment for Accrued Dividends from the options described above. The issuance of Common Stock or Series B Preferred Stock as payment for Accrued Dividends in accordance with the Certificate of Designations Amendment could cause a significant reduction in the percentage interests of our current stockholders in voting power, liquidation value, book and market value, and future earnings (if any). Such issuances could dilute, and thereby reduce, each existing stockholder’s proportionate ownership in our Common Stock.

The Certificate of Incorporation Amendment will also provide the company with flexibility to issue additional shares of Series B Preferred Stock and other preferred stock in connection with other transactions, although we have no current intention to do so. As noted above, the A&R Certificate of Incorporation, as amended by the Certificate of Incorporation Amendment, would authorize the issuance of up to 380,000,000 total shares of stock, including 105,000,000 shares of preferred stock.

If approved, the increased number of authorized shares of preferred stock would be available for issuance from time to time for such purposes and consideration as the Board may determine to be appropriate. No further vote of our stockholders would be required for the year ending December 31, 2018. Deloitte & Touche LLP has servedissuance of these shares of preferred stock, except as our independent audit firm since 2017 and audited our financial statementsmay be required under the Certificate of Designations for the fiscal year ended December 31, 2017.Series B Preferred Stock and the rules of any national securities exchange or automated quotation system on which our securities are listed.

If the Certificate of Incorporation Amendment is adopted by our stockholders at the 2023 Annual Meeting, we expect that a Certificate of Amendment, in the form attached hereto as Annex C, would be filed with the Secretary of State of the State of Delaware as soon as practicable after the 2023 Annual Meeting. Without any further action on the part of our stockholders, the Certificate of Incorporation Amendment would become effective on the date of any such filing. Prior to any such filing, the Board reserves the right to delay or abandon the Certificate of Incorporation Amendment at its discretion.

Except for the potential payment of Accrued Dividends in the form of additional shares of Series B Preferred Stock as contemplated by Proposal No. 5 (if so elected by the Disinterested Directors), we currently do not have any plans, arrangements or understandings with respect to the issuance of the additional shares of preferred stock authorized by the Certificate of Incorporation Amendment. For more information about services Deloitte & Touche LLP providedon the Series B Preferred Stock, see Exhibit 4.10 to us, as well as our procedures for approving such services, see “Principal Accounting FeesAnnual Report on Form 10-K filed with the SEC on March 2, 2023. Depending on the particular terms of any class or series of preferred stock, holders of a newly created class of preferred stock could have significant voting and Services —Pre-Approval Policiesliquidation rights and Procedures”the right to representation on page [•] of this proxy statement. A representative of Deloitte & Touche LLP is expected to be present at our 2018 Annual Meeting and will have an opportunity to make a statement and respond to appropriate questions from stockholders.

RatificationBoard. In addition, the approval of the appointmentholders of Deloitte & Touche LLPpreferred stock, voting as our independent registered public accounting firma class or as a series, could be required for the taking of certain corporate actions, such as mergers.

Consequences of Non-Adoption of the Certificate of Incorporation Amendment

Adoption of the Certificate of Incorporation Amendment is a condition to the Certificate of Designations Amendment. If the Certificate of Incorporation Amendment is not requiredadopted by our bylaws or other applicable legal requirements. However, our Boardstockholders, the Certificate of Directors is submittingDesignations Amendment cannot be effected. See the appointment of Deloitte & Touche LLP to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to ratify the appointment, the Audit Committee will reconsider whether to retain the firm. Even if the appointment is ratified, the Audit Committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interestssection entitled “Proposal No. 5 – Adoption of the Company and our stockholders.Certificate of Designations Amendment.”

Required Vote

TheYou may vote for or against this Proposal No. 6, or you may abstain. Approval of this proposal requires the affirmative vote (“FOR”) of (i) the holders of a majority of the outstanding shares present or represented by proxy at the 2018 Annual Meetingof Common Stock and Series B Preferred Stock (on an as-converted basis) entitled to vote is requiredthereon and (ii) the holders of at least 75% of the outstanding shares of Series B Preferred Stock entitled to ratify the appointment of Deloitte & Touche LLPvote thereon, voting as our independent registered public accounting firm for the year ending December 31, 2018.a separate class. Abstentions and broker non-votes will have the same effect as a votevotes against this proposal. Brokernon-votes will have no effect on the outcome of this proposal.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” PROPOSAL NO. 6.

Proposal No. 7 – Approval of the Share Issuance

Our Common Stock is listed on Nasdaq, and as such, we are subject to the listing rules and regulations of Nasdaq (“Nasdaq Listing Rules”). Nasdaq Listing Rule 5635(d) requires stockholder approval in connection with a transaction other than a public offering involving the sale, issuance, or potential issuance by the company of common stock (or securities convertible into or exchangeable for common stock) equal to 20% or more of the common stock or 20% or more of the voting power outstanding before the issuance (each separately, a “20% Issuance”) for a price that is less than the lower of (i) the closing price of the common stock immediately preceding the signing of the binding agreement for the issuance of such securities; or (ii) the average closing price of the common stock for the five trading days immediately preceding the signing of the binding agreement (the “Minimum Price”).

As further described under Proposal No. 5, the Certificate of Designations Amendment would permit us to pay annual dividends on the Series B Preferred Stock in the form of cash, shares of Common Stock, shares of Series B Preferred Stock, or a combination thereof, in accordance with the Certificate of Designations Amendment and as elected by the Disinterested Directors.

If the Disinterested Directors are permitted to and elect to pay Accrued Dividends in shares of Common Stock, the number of shares of Common Stock to be paid will be equal to the quotient of (a) the amount of Accrued Dividends to be paid in shares of Common Stock divided by (b) the Current Market Price as of the Dividend Declaration Date or such higher price (resulting in the issuance of fewer shares of Common Stock) as otherwise agreed by the Disinterested Directors and each holder of Series B Preferred Stock. If the Disinterested Directors elect to pay Accrued Dividends in shares of Series B Preferred Stock, the number of shares of Series B Preferred Stock to be paid shall be equal to the quotient of (a) the amount of Accrued Dividends to be paid in shares of Series B Preferred Stock divided by (b) $2.4719. Under the Certificate of Designations Amendment, “Current Market Price” is defined as the arithmetic average of the VWAP per share of Common Stock for each of the ten (10) consecutive full Trading Days (as defined in the Certificate of Designations) ending on and including the Trading Day immediately preceding the Dividend Declaration Date. Under the Certificate of Designations, the “VWAP” per share of Common Stock on any Trading Day means the per share volume-weighted average price as displayed under the heading Bloomberg VWAP on Bloomberg (or, if Bloomberg ceases to publish such price, any successor service reasonably chosen by the company) page “SCOR <equity> AQR” (or its equivalent successor if such page is not available) in respect of the period from the open of trading on the relevant Trading Day until the close of trading on such Trading Day (or if such volume-weighted average price is unavailable, the market price of one share of Common Stock on such Trading Day determined, using a volume-weighted average method, by an Independent Financial Advisor (as defined in the Certificate of Designations) retained for such purpose by the company). There is no specific cap on the number of shares of Common Stock or Series B Preferred Stock that can be issued as Accrued Dividends under the Certificate of Designations Amendment, other than limits on authorized shares under the A&R Certificate of Incorporation, as amended. For more information on the Certificate of Designations Amendment, see the section entitled “Proposal No. 5 – Adoption of the Certificate of Designations Amendment.”

We cannot predict the Current Market Price of our Common Stock on any future date, nor can we predict the future decisions of the Disinterested Directors with respect to the payment of Accrued Dividends, or whether the holders of the Series B Preferred Stock will convert their shares into Common Stock, or whether the Series B Preferred Stock will be mandatorily converted or redeemed in accordance with the Certificate of Designations, and therefore we cannot predict the number of shares of Common Stock or Series B Preferred Stock that could be issued in connection with the payment of dividends on the Series B Preferred Stock in the future. Under certain circumstances, it is possible that the future issuance of Common Stock or Series B Preferred Stock as payment for Accrued Dividends could result in the issuance (or potential issuance upon conversion of the shares of Series B Preferred Stock) of 20% or more of our Common Stock outstanding at the time of issuance at a price below the Minimum Price, measured as of the date of adoption of the Certificate of Designations Amendment, which would constitute a 20% Issuance under Nasdaq Listing Rule 5635(d).

The issuance of Common Stock or Series B Preferred Stock as payment for Accrued Dividends could cause a significant reduction in the percentage interests of our current stockholders in voting power, liquidation value, book and market value, and future earnings (if any). Such issuances could dilute, and thereby reduce, each existing stockholder’s proportionate ownership in our Common Stock.

Given the foregoing, we are seeking stockholder approval under this Proposal No. 7 to comply with Nasdaq Listing Rule 5635(d), to issue more than 20% of outstanding Common Stock in connection with payments of Accrued Dividends on the Series B Preferred Stock if elected by the Disinterested Directors.

Purpose of and Effects of the Proposal

The principal purpose of this Proposal No. 7 is to comply with Nasdaq Listing Rules in the event that we issue shares of Common Stock or Series B Preferred Stock as payment for Accrued Dividends pursuant to the Certificate of Designations Amendment, if approved under Proposal No. 5. As described further under Proposal No. 5, the principal purpose of the Certificate of Designations Amendment is to permit the payment of Accrued Dividends on the Series B Preferred Stock in the form of cash, shares of Common Stock, shares of Series B Preferred Stock, or a combination thereof, in each case in accordance with the Certificate of Designations Amendment and as elected by the Disinterested Directors. For more information on the purpose of the Certificate of Designations Amendment, see the section entitled “Proposal No. 5 – Adoption of the Certificate of Designations Amendment – Purpose of and Effects of the Proposed Amendment.”

If the Certificate of Designations Amendment and the Certificate of Incorporation Amendment are approved, we could, if elected by the Disinterested Directors, issue shares of Common Stock or Series B Preferred Stock as payment for Accrued Dividends on the Series B Preferred Stock, as described above and in accordance with the Certificate of Designations Amendment, and thereby could increase the number of shares of Common Stock or Series B Preferred Stock outstanding. As a result, our existing stockholders could incur dilution of their percentage interests in voting power, liquidation value, book and market value, and future earnings (if any). No assurance can be given that any shares of Common Stock or Series B Preferred Stock will be issued pursuant to the Certificate of Designations Amendment.

Because various factors are outside of our control, such as the number of shares of Series B Preferred Stock outstanding at any given time and the Current Market Price of our Common Stock on future Dividend Declaration Dates, the magnitude of the dilutive effect cannot be determined at this time.

Consequences of Non-Approval of the Share Issuance

Approval of the Share Issuance is necessary to effectuate the Certificate of Designations Amendment in a manner compliant with Nasdaq Listing Rules. We are required to comply with Nasdaq Listing Rules in order to maintain the listing of our Common Stock with Nasdaq. Additionally, approval of the Share Issuance is a condition to adoption of the Certificate of Designations Amendment. If the Share Issuance is not approved and the Certificate of Incorporation Amendment is not adopted by our stockholders, the Certificate of Designations Amendment cannot be effected. See the section entitled “Proposal No. 5 – Adoption of the Certificate of Designations Amendment.”

Required Vote

You may vote for or against this Proposal No. 7, or you may abstain. Approval of this proposal requires the affirmative vote (“FOR”) of a majority of the shares present or represented by proxy at the 2023 Annual Meeting and entitled to vote thereon. Abstentions will have the same effect as a vote against this proposal. Broker “non-votes” will have no effect on the outcome of this Proposal.

Recommendation of Our Board of Directors

OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” PROPOSAL NO. 7.

OTHER INFORMATION

Other Matters to be Presented at the Annual Meeting

We do not know of any matters to be presented at our 20182023 Annual Meeting other than those described in this proxy statement. If any other matters are properly brought before the annual meeting, proxies will be voted in accordance with the best judgment of the person or persons voting the proxies.

Security Holder Communication with Board Members

Any holder of our common stockCommon Stock or Series B Preferred Stock may contact the Board, of Directors, a committee of the Board of Directors or a specified individual director by writing to the attention of the Board of Directors (or a specified individual director or committee) and sending such communication to the attention of our Corporate Secretary at our executive offices as identified in this proxy statement. Each communication from a stockholder should include the following information in order to permit us to confirm your status as a security holder and enable us to send a response if deemed appropriate:

 

the name, mailing address and telephone number of the security holder sending the communication;

 

the number and type of our securities owned by such security holder; and

 

if the security holder is not a record owner of our securities, the name of the record owner of our securities beneficially owned by the security holder.

Our Corporate Secretary will forward all appropriate communications to the Board, of Directors, the applicable Committeecommittee of the Board of Directors or individual members of the Board of Directors as specified in the communication. Our Corporate Secretary may, but is not required to, review all correspondence addressed to the Board, of Directors, a committee of the Board of Directors or any individual member of the Board, of Directors, for any inappropriate correspondence more suitably directed to management.

Annex A

COMSCORE, INC.Second Amendment to the

comScore, Inc.

Amended and Restated

2018 EQUITY AND INCENTIVE COMPENSATION PLANEquity and Incentive Compensation Plan

1.Purpose.THIS SECOND AMENDMENTThe purpose of this Plan is to attract and retainnon-employee Directors, Employees and certain consultants (the “Second Amendment”) to the CompanycomScore, Inc. Amended and its Subsidiaries,Restated 2018 Equity and to provide to such persons incentives and rewards for service and/Incentive Compensation Plan (as amended, modified or performance.

2.Definitions.As used in this Plan:

(a) “Appreciation Right” means a right granted pursuant toSection 5 of this Plan.

(b) “Base Price” means the price to be used as the basis for determining the Spread upon the exercise of an Appreciation Right.

(c) “Board” means the Board of Directors of the Company.

(d) “Cash Incentive Award” means a cash award granted pursuant toSection 8 of this Plan.

(e) “Change in Control” has the meaning set forth inSection 12 of this Plan.

(f) “Code” means the Internal Revenue Code of 1986, as amendedsupplemented from time to time.time, the “Plan”) was adopted by comScore, Inc.’s (the “Company’s”) board of directors (the “Board”) on April 10, 2023, to be effective June 15, 2023 (the “Second AmendmentEffective Date”).

(g) “Committee” meansW I T N E S S E T H:

WHEREAS, the Compensation CommitteeofCompany previously adopted the Board (or its successor(s)), or any other committeePlan, under which the Company is authorized to grant equity-based incentive awards to certain employees and service providers of the Company;

WHEREAS, the Company’s Board designatedhas determined that it is desirable to amend the Plan, effective as of the Second Amendment Effective Date and subject to approval by the Board to administer this Plan pursuant toSection 10 of this Plan.

(h) “Common Stock” means the common stock, par value $0.001 per share,stockholders of the Company, or any security intoto increase the maximum number of shares for which such common stockAwards may be changed by reason of any transaction or eventgranted under the Plan; and

WHEREAS, Section 18 of the type referredPlan provides that the Board may amend the Plan from time to time, subject to approval by the stockholders of the Company as required by applicable law.

NOW, THEREFORE, the Plan shall be amended as of the Second Amendment Effective Date, subject to approval by the Company’s stockholders, as set forth below:

1.

Section 3(a)(i) of the Plan shall be deleted in its entirety and replaced with the following:

Subject to adjustment as provided in Section 11 of this Plan.

(i) “Company” means comScore, Inc., a Delaware corporation,Plan and its successors.

(j) “Datethe share counting rules set forth in Section 3(b) of Grant” meansthis Plan, the date providednumber of shares of Common Stock available under this Plan for by the Committee on which a grantawards of (A) Option Rights or Appreciation Rights, (B) Restricted Stock, (C) Restricted Stock Units, (D) Performance Shares or Performance Units, Cash Incentive Awards, or other(E) awards contemplated bySection 9 of this Plan, or a grant or sale of Restricted Stock, Restricted Stock Units, or other(F) dividend equivalents paid with respect to awards contemplated bySection 9 ofmade under this Plan, will become effective (which dateor (G) awards corresponding to those described in the preceding clauses (A) through (F) that were made under the Prior Plan will not be earlier than the date on which the Committee takes action with respect thereto).

(k) “Director” means a member of the Board.

(l) “Effective Date” means the date this Plan is approved by the Stockholders.

(m) “Employee” means any person, including officers and Directors, employed by the Company or any Subsidiary. Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company or any Subsidiary.

(n) “Evidence of Award” means an agreement, certificate, resolution or other type or form of writing or other evidence approved by the Committee that sets forth the terms and conditions of the awards granted under this Plan. An Evidence of Award may be in an electronic medium, may be limited to notation on the books and records of the Company and, unless otherwise determined by the Committee, need not be signed by a representative of the Company or a Participant.

(o) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time.

(p) “Incentive Stock Option” means an Option Right that is intended to qualify as an “incentive stock option” under Section 422 of the Code or any successor provision.

(q) “Management Objectives” means the measurable performance objective or objectives established pursuant to this Plan for Participants who have received grants of Performance Shares, Performance Units or Cash Incentive Awards or, when so determined by the Committee, Option Rights, Appreciation Rights, Restricted Stock, Restricted Stock Units, dividend equivalents or other awards pursuant to this Plan. If the Committee determines that a changeexceed in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances render the Management Objectives unsuitable, the Committee may in its discretion modify such Management Objectives or the acceptable levels of achievement, in whole or in part, as the Committee deems appropriate and equitable.

(r) “Market Value per Share” means, as of any particular date, if the Common Stock is listed on any established stock exchange or traded on any established market, and unless otherwise determined by the Committee, the closing price of a share of Common Stock as quoted on such exchange or market on the date of determination, as reported in a source the Committee deems reliable. If there is no closing price for the Common Stock on the particular date, then the Market Value per Share will be the closing price on the last preceding date for which such quotation exists. If there is no regular public trading market for theaggregate 37,850,000 shares of Common Stock, then the Market Value per Share shallStock. Such shares may be the fair market value as determined in good faith by the Committee. The Committee is authorized to adopt another fair market value pricing method provided such method is stated in the applicable Evidence of Award and is in compliance with the fair market value pricing rules set forth in Section 409A of the Code.

(s) “Optionee” means the optionee named in an Evidence of Award evidencing an outstanding Option Right.

(t) “Option Price” means the purchase price payable on exercise of an Option Right.

(u) “Option Right” means the right to purchase shares of Common Stock upon exercise of an award granted pursuant toSection 4 of this Plan.

(v) “Participant” means a person who is selected by the Committee to receive benefits under this Plan and who is at the time (i) an Employee, including a person who has agreed to commence serving in such capacity within 90 days of the Date of Grant, (ii) a consultant (provided that such person satisfies the FormS-8 definition of “employee”),original issuance or (iii) anon-employee Director.

(w) “Performance Period” means, in respect of a Cash Incentive Award, Performance Share or Performance Unit, a period of time established pursuant toSection 8 of this Plan within which the Management Objectives relating to such Cash Incentive Award, Performance Share or Performance Unit are to be achieved.

(x) “Performance Share” means a bookkeeping entry that records the equivalent of one share of Common Stock awarded pursuant toSection 8 of this Plan.

(y) “Performance Unit” means a bookkeeping entry awarded pursuant toSection 8 of this Plan that records a unit equivalent to $1.00 or such other value as is determined by the Committee.

(z) “Person” means any individual, entity, or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act).

(aa) “Plan” means this comScore, Inc. 2018 Equity and Incentive Compensation Plan, as may be amended or amended and restated from time to time.

(bb) “Predecessor Plan” means the comScore, Inc. 2007 Equity Incentive Plan, as amended and restated from time to time.

(cc) “Restricted Stock” meanstreasury shares of Common Stock granted or sold pursuant toSection 6 of this Plan as to which neither the substantial risk of forfeiture nor the prohibition on transfers has expired.

(dd) “Restricted Stock Units” means an award made pursuant toSection 7 of this Plan of the right to receive shares of Common Stock, cash or a combination thereof at the end of the applicable Restriction Period.

(ee) “Restriction Period” means the period of time during which Restricted Stock Units are subject to restrictions, as provided inSection 7 of this Plan.

(ff) “Spread” means the excess of the Market Value per Share on the date when an Appreciation Right is exercised over the Base Price provided for with respect to the Appreciation Right.

(gg) “Stockholder” means an individual or entity that owns one or more shares of Common Stock.

(hh) “Subsidiary” means a corporation, company or other entity (i) more than 50% of whose outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) are, or (ii) which does not have outstanding shares or securities (as may be the case in a partnership, joint venture, limited liability company, unincorporated association or other similar entity), but more than 50% of whose ownership interest representing the right generally to make decisions for such other entity is, now or hereafter, owned or controlled, directly or indirectly, by the Company;provided,however, that for purposes of determining whether any person may be a Participant for purposes of any grant of Incentive Stock Options, “Subsidiary” means any corporation in which the Company at the time owns or controls, directly or indirectly, more than 50% of the total combined Voting Power represented by all classes of stock issued by such corporation.

(ii) “Voting Power” means, at any time, the combined voting power of the then-outstanding securities entitled to vote generally in the election of Directors in the case of the Company or members of the board of directors or similar body in the case of another entity.

3.Shares Available Under this Plan.

(a)Maximum Shares Available Under this Plan.foregoing.

 

2.(i)Subject to adjustment as provided in

Section 11 of this Plan and the share counting rules set forth inSection 3(b) of this Plan, the number of shares of Common Stock available under this Plan for awards of (A) Option Rights or Appreciation Rights, (B) Restricted Stock, (C) Restricted Stock Units, (D) Performance Shares or Performance Units, (E) awards contemplated bySection 9 of this Plan, or (F) dividend equivalents paid with respect to awards made under this Plan will not exceed in the aggregate 10,650,000 shares of Common Stock. Such shares may be shares of original issuance or treasury shares or a combination 3(c) of the foregoing.Plan shall be deleted in its entirety and replaced with the following:

(ii)The aggregate number of shares of Common Stock available underSection 3(a)(i) of this Plan will be reduced by (A) one share of Common Stock for every one share of Common Stock subject to an award of Option Rights or Appreciation Rights granted under this Plan, and (B) two shares of Common Stock for every one share of Common Stock subject to an award other than of Option Rights or Appreciation Rights granted under this Plan.

(b)Share Counting Rules.

(i)Except as provided inSection 22 of this Plan, if any award granted under this Plan (in whole or in part) is cancelled or forfeited, expires, is settled for cash, or is unearned, the shares of Common Stock subject to such award will, to the extent of such cancellation, forfeiture, expiration, cash settlement, or unearned amount, again be available underSection 3(a)(i) above (at a rate of one share of Common Stock for every one share of Common Stock subject to awards of Option Rights or Appreciation Rights and two shares of Common Stock for every one share of Common Stock subject to awards other than of Option Rights or Appreciation Rights).

(ii)If, after December 31, 2017, any shares of Common Stock subject to an award granted under the Predecessor Plan are forfeited, or an award granted under the Predecessor Plan (in whole or in part) is cancelled or forfeited, expires, is settled for cash, or is unearned, the shares of Common Stock subject to such award will, to the extent of such cancellation, forfeiture, expiration, cash settlement, or unearned amount, be available for awards under this Plan (at a rate of one share of Common Stock for every one share of Common Stock subject to such award).

(iii)Notwithstanding anything to the contrary contained in this Plan: (A) shares of Common Stock withheld by the Company, tendered or otherwise used in payment of the Option Price of an Option Right will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available underSection 3(a)(i) of this Plan; (B) shares of Common Stock withheld by the Company, tendered or otherwise used to satisfy tax withholding with respect to awards other than as described in clause (C) will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under Section 3(a)(i) of this Plan; (C) shares of Common Stock withheld by the Company, tendered or otherwise used prior to the tenth anniversary of the Effective Date to satisfy tax withholding with respect to awards other than Option Rights or Appreciation Rights shall be added back (but only to the extent such withholding did not exceed the minimum amounts of tax required to be withheld) to the aggregate number of shares of Common Stock available underSection 3(a)(i) of this Plan; (D) shares of Common Stock subject to an Appreciation Right that are not actually issued in connection with the settlement of such Appreciation Right on the exercise thereof, will not be added back to the aggregate number of shares of Common Stock available under Section 3(a)(i) of this Plan; and (E) shares of Common Stock reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of Option Rights will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under Section 3(a)(i) of this Plan.

(iv)If, under this Plan, a Participant has elected to give up the right to receive compensation in exchange for shares of Common Stock based on fair market value, such shares of Common Stock will not count against the aggregate limit underSection 3(a)(i) of this Plan.

(c)Limit on Incentive Stock Options. Notwithstanding anything to the contrary contained in this Plan, and subject to adjustment as provided inSection 11 of this Plan, the aggregate number of shares of Common Stock actually issued or transferred by the Company upon the exercise of Incentive Stock Options (whether granted under this Plan or the Prior Plan) will not exceed 10,650,00037,850,000 shares of Common Stock.

(d)Individual Director Limit. Notwithstanding anythingNOW, THEREFORE, be it further provided that, except as set forth above, the Plan shall continue to read in its current state.

IN WITNESS WHEREOF, the contrary contained inCompany has caused the execution of this Plan,Second Amendment by its duly authorized officer, effective as of the Second Amendment Effective Date and subject to adjustmentapproval of the Company’s stockholders.

COMSCORE, INC.

By:

/s/ Ashley Wright

Name:

Ashley Wright

Title:

Secretary

Date:

April 10, 2023

Annex B

Amendment to the

Certificate of Designations of

Series B Convertible Preferred Stock,

Par Value $0.001,

of comScore, Inc.

COMSCORE, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Section 242 thereof, hereby certifies that the following resolutions amending the rights of the Series B Convertible Preferred Stock (the “Series B Preferred Stock”) (a) were duly adopted by the Board of Directors of the Corporation (the “Board of Directors”) pursuant to authority conferred upon the Board of Directors by the provisions of the Amended and Restated Certificate of Incorporation of the Corporation, as providedamended (the “Certificate of Incorporation”), and the Amended and Restated Bylaws of the Corporation (the “Bylaws”), at a duly held meeting of the Board of Directors held on April 10, 2023, and (b) were consented to by (i) the holders of at least a majority of the outstanding shares of common stock of the Corporation, par value $0.001 per share, and the Series B Preferred Stock (on an as-converted basis and in accordance with the terms of the Certificate of Designations (as defined below)), and (ii) the holders of at least 75% of the outstanding shares of Series B Preferred Stock, in each case, at a duly held meeting on June 15, 2023.

RESOLVED, that effective upon the filing of this Certificate of Amendment to the Certificate of Designations of Series B Convertible Preferred Stock (this “Certificate of Amendment”), the Certificate of Designations of Series B Convertible Preferred Stock dated and filed with the Delaware Secretary of State on March 10, 2021 (the “Certificate of Designations”), is hereby amended as follows:

1.

The first paragraph of the preamble is hereby amended and restated in its entirety to read as follows:

That, the Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, as filed with the Secretary of State of the State of Delaware on June 15, 2023 (the “Certificate of Amendment”), authorizes the issuance of 380,000,000 shares of capital stock, consisting of 275,000,000 shares of Common Stock, par value $0.001 per share (“Common Stock”), and 105,000,000 shares of Preferred Stock, par value $0.001 per share (“Preferred Stock”).

2.

The defined terms “Accrued Dividends” and “Current Market Price” are hereby amended and restated in their entirety to read as follows:

Accrued Dividends” means, as of any date, with respect to any share of Series B Preferred Stock, all Annual Dividends that have accrued on such share pursuant to Section 114(b) and Section 4(c), whether or not declared, but that have not, as of this Plan,such date, been paid in no event willcash, shares of Common Stock, shares of Series B Preferred Stock, or anynon-employee Director in any one calendar year be granted compensation for such service having an aggregate maximum value (measured at the Date combination thereof.

Current Market Price” per share of GrantCommon Stock, as applicable, and calculating the value of any awards under this Plan baseddate of determination, means the arithmetic average of the VWAP per share of Common Stock for each of the ten (10) consecutive full Trading Days ending on and including the grant date fair value for financial reporting purposes)Trading Day immediately preceding such day, and solely with respect to such term’s use in excessSection 10 hereof, appropriately adjusted to take into account the occurrence during such period of $900,000.any event described in Section 10.

4.

3.

Section 1 of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

SECTION 1 Option Rights.Designation and Number of Shares. The Committee may,shares of such series of Preferred Stock shall be designated as “Series B Convertible Preferred Stock” (the “Series B Preferred Stock”). The number of authorized shares constituting the Series B Preferred Stock shall be 100,000,000. That number from time to time may be increased or decreased (but not below the number of shares of Series B Preferred Stock then outstanding) by further resolution duly adopted by the Board, or any duly

authorized committee thereof, and upon such terms and conditions as it may determine, authorizeby the grantingfiling of a certificate pursuant to Participants of Option Rights. Each such grant may utilize any or allthe provisions of the authorizations,DGCL stating that such increase or decrease, as applicable, has been so authorized. The Company shall not have the authority to issue fractional shares of Series B Preferred Stock.

4.

Section 4(b)(i) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(b) Accrual of Annual Dividends.

(i) Dividends on each share of Series B Preferred Stock (A) shall be cumulative and willaccrue and accumulate on a daily basis from and including the Issuance Date of such share, whether or not declared and whether or not the Company has funds legally available to make payment thereof, at a rate equal to the Dividend Rate as further specified below, and compound annually on each Dividend Payment Date (to the extent not paid on such Dividend Payment Date), and (B) shall be payable annually in arrears, subject to allthe next sentence, on the Dividend Payment Date (such dividends, “Annual Dividends”). The Company shall, with respect to each Dividend Payment Date, declare (such date of declaration, which shall be no more than 15 days prior to the Dividend Record Date, the “Dividend Declaration Date”) and pay, unless prohibited by Section 170 of the requirements, containedDGCL, the Annual Dividends on such Dividend Payment Date.

5.

Section 4(c) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(c) Payment of Annual Dividend.

(i) With respect to any Dividend Payment Date, if (a) the Current Market Price as of the Dividend Declaration Date is below $2.00, the Company will pay all Accrued Dividends on each share of Series B Preferred Stock in cash (to the extent not prohibited by Section 170 of the DGCL), shares of Common Stock, or any combination thereof, (b) the Current Market Price as of the Dividend Declaration Date is at or above $2.00 but does not exceed $2.4719, the Company will pay all Accrued Dividends in cash (to the extent not prohibited by Section 170 of the DGCL), shares of Common Stock, shares of Series B Preferred Stock, or any combination thereof, or (c) the Current Market Price as of the Dividend Declaration Date is above $2.4719, the Company will pay all Accrued Dividends in cash (to the extent not prohibited by Section 170 of the DGCL), shares of Series B Preferred Stock, or any combination thereof, in each case, in the following provisions:

(a) Each grant will specifydiscretion of a committee of the Board composed of directors that have not been designated by, and are not affiliated with, any Holder (the “Disinterested Directors”). If, in accordance with the preceding sentence, the Company is permitted and elects to pay any Accrued Dividends in shares of Common Stock, the number of shares of Common Stock to which it pertains subjectbe paid shall be equal to the limitations set forthquotient of (a) the amount of Accrued Dividends to be paid inSection 3 of this Plan.

(b) Each grant will specify an Option Price per share of Common Stock, which (except with respect to awards underSection 22 of this Plan) may not be less than the Market Value per Share on the Date of Grant.

(c) Each grant will specify whether the Option Price will be payable (i) in cash, by check acceptable to the Company or by wire transfer of immediately available funds, (ii) by the actual or constructive transfer to the Company of shares of Common Stock owneddivided by (b) the Current Market Price as of the Dividend Declaration Date or such higher price (resulting in the issuance of fewer shares of Common Stock) as otherwise agreed by the Optionee having a value atDisinterested Directors and each Holder. If, in accordance with the timefirst sentence of exercisethis Section 4(c)(i), the Company is permitted and elects to pay any Accrued Dividends in shares of Series B Preferred Stock, the number of shares of Series B Preferred Stock to be paid shall be equal to the total Option Price, (iii) subjectquotient of (a) the amount of Accrued Dividends to any conditions or limitations established by the Committee, by the withholding ofbe paid in shares of CommonSeries B Preferred Stock otherwise issuable upon exercisedivided by (b) the Purchase Price. If, in accordance with the first sentence of an Option Right pursuant to a “net exercise” arrangement (it being understood that, solely for purposes of determining the number of treasury shares held bythis Section 4(c)(i), the Company the shares of Common Stock so withheld will not be treated as issuedis permitted and acquired by the Company upon such exercise), (iv) by a combination of such methods of payment, or (v) by such other methods as may be approved by the Committee.

(d) To the extent permitted by law,elects to pay any grant may provide for deferred payment of the Option Price from the proceeds of sale through a bank or broker on a date satisfactory to the Company of some or all of the shares of Common Stock to which such exercise relates.

(e) Successive grants may be made to the same Participant whether or not any Option Rights previously granted to such Participant remain unexercised.

(f) Each grant will specify the period or periods of continuous service by the Optionee with the Company or any Subsidiary, if any, that is necessary before any Option Rights or installments thereof will become exercisable. Option Rights may provide for continued vesting or the earlier exercise of such Option Rights, including in the event of the retirement, death or disability of a Participant or in the event of a Change in Control.

(g) Any grant of Option Rights may specify Management Objectives that must be achieved as a condition to the exercise of such rights.

(h) Option Rights granted under this Plan may be (i) options, including Incentive Stock Options, that are intended to qualify under particular provisions of the Code, (ii) options that are not intended to so qualify, or (iii) combinations of the foregoing. Incentive Stock Options may only be granted to Participants who meet the definition of “employees” under Section 3401(c) of the Code.

(i) No Option Right will be exercisable more than 10 years from the Date of Grant. The Committee may provide in any Evidence of Award for the automatic exercise of an Option Right upon such terms and conditions as established by the Committee.

(j) Option Rights granted under this Plan may not provide for any dividends or dividend equivalents thereon.

(k) Each grant of Option Rights will be evidenced by an Evidence of Award. Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.

5.Appreciation Rights.

(a) The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the granting to any Participant of Appreciation Rights. An Appreciation Right will be the right of the Participant to receive from the Company an amount determined by the Committee, which will be expressed as a percentage of the Spread (not exceeding 100%) at the time of exercise.

(b) Each grant of Appreciation Rights may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:

(i)Each grant may specify that the amount payable on exercise of an Appreciation Right will be paid by the Company in cash, shares of Common Stock or any combination thereof.

(ii)Any grant may specify that the amount payable on exercise of an Appreciation Right may not exceed a maximum specified by the Committee on the Date of Grant.

(iii)Any grant may specify waiting periods before exercise and permissible exercise dates or periods.

(iv)Each grant will specify the period or periods of continuous service by the Participant with the Company or any Subsidiary, if any, that is necessary before the Appreciation Rights or installments thereof will become exercisable. Appreciation Rights may provide for continued vesting or the earlier exercise of such Appreciation Rights, including in the event of the retirement, death or disability of a Participant or in the event of a Change in Control.

(v)Any grant of Appreciation Rights may specify Management Objectives that must be achieved as a condition of the exercise of such Appreciation Rights.

(vi)Appreciation Rights granted under this Plan may not provide for any dividends or dividend equivalents thereon.

(vii)Successive grants of Appreciation Rights may be made to the same Participant regardless of whether any Appreciation Rights previously granted to the Participant remain unexercised.

(viii)Each grant of Appreciation Rights will be evidenced by an Evidence of Award. Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.

(c)Also, regarding Appreciation Rights:

(i)Each grant will specify in respect of each Appreciation Right a Base Price, which (except with respect to awards underSection 22 of this Plan) may not be less than the Market Value per Share on the Date of Grant; and

(ii)No Appreciation Right granted under this Plan may be exercised more than 10 years from the Date of Grant. The Committee may provide in any Evidence of Award for the automatic exercise of an Appreciation Right upon such terms and conditions as established by the Committee.

6.Restricted Stock. The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the grant or sale of Restricted Stock to Participants. Each such grant or sale may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:

(a) Each such grant or sale will constitute an immediate transfer of the ownership of shares of Common Stock to the Participant in consideration of the performance of services, entitling such Participant to voting, dividend and other ownership rights, but subject to the substantial risk of forfeiture and restrictions on transfer hereinafter described.

(b) Each such grant or sale may be made without additional consideration or in consideration of a payment by such Participant that is less than the Market Value per Share on the Date of Grant.

(c) Each such grant or sale will provide that the Restricted Stock covered by such grant or sale will be subject to a “substantial risk of forfeiture” within the meaning of Section 83 of the Code for a period to be determined by the Committee on the Date of Grant or until achievement of Management Objectives referred to inSection 6(e) of this Plan.

(d) Each such grant or sale will provide that during or after the period for which such substantial risk of forfeiture is to continue, the transferability of the Restricted Stock will be prohibited or restricted in the manner and to the extent prescribed by the Committee on the Date of Grant (which restrictions may include rights of repurchase or first refusal of the Company or provisions subjecting the Restricted Stock to a continuing substantial risk of forfeiture while held by any transferee).

(e) Any grant of Restricted Stock may specify Management Objectives that, if achieved, will result in termination or early termination of the restrictions applicable to such Restricted Stock.

(f) Notwithstanding anything to the contrary contained in this Plan, Restricted Stock may provide for continued vesting or the earlier termination of restrictions on such Restricted Stock, including in the event of the retirement, death or disability of a Participant or in the event of a Change in Control.

(g) Any such grant or sale of Restricted Stock will require that any and all dividends or other distributions paid thereon during the period of such restrictions be automatically deferred and/or reinvested in additional Restricted Stock, which will be subject to the same restrictions as the underlying award. For the avoidance of doubt, any such dividends or other distributions on Restricted Stock will be deferred until, and paid contingent upon, the vesting of such Restricted Stock.

(h) Each grant or sale of Restricted Stock will be evidenced by an Evidence of Award. Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve. Unless otherwise directed by the Committee, (i) all certificates representing Restricted Stock will be held in custody by the Company until all restrictions thereon will have lapsed, together with a stock power or powers executed by the Participant in whose name such certificates are registered, endorsed in blank and covering such shares or (ii) all Restricted Stock will be held at the Company’s transfer agent in book entry form with appropriate restrictions relating to the transfer of such Restricted Stock.

7.Restricted Stock Units. The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the granting or sale of Restricted Stock Units to Participants. Each such grant or sale may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:

(a) Each such grant or sale will constitute the agreement by the Company to deliver shares of Common Stock or cash, or a combination thereof, to the Participant in the future in consideration of the performance of services, but subject to the fulfillment of such conditions (which may include the achievement of Management Objectives) during the Restriction Period as the Committee may specify.

(b) Each such grant or sale may be made without additional consideration or in consideration of a payment by such Participant that is less than the Market Value per Share on the Date of Grant.

(c) Notwithstanding anything to the contrary contained in this Plan, Restricted Stock Units may provide for continued vesting or the earlier lapse or other modification of the Restriction Period, including in the event of the retirement, death or disability of a Participant or in the event of a Change in Control.

(d) During the Restriction Period, the Participant will have no right to transfer any rights under his or her award and will have no rights of ownership in the shares of Common Stock deliverable upon payment of the Restricted Stock Units and will have no right to vote them, but the Committee may, at or after the Date of Grant, authorize the payment of dividend equivalents on such Restricted Stock Units on a deferred and contingent basis, either in cash or in additional shares of Common Stock;provided,however, that dividend equivalents or other distributions on shares of Common Stock underlying Restricted Stock Units will be deferred until and paid contingent upon the vesting of such Restricted Stock Units.

(e) Each grant or sale of Restricted Stock Units will specify the time and manner of payment of the Restricted Stock Units that have been earned. Each grant or sale will specify that the amount payable with respect thereto will be paid by the CompanyAccrued Dividends in shares of Common Stock or cash, or a combination thereof.

(f) Each grant or sale of RestrictedSeries B Preferred Stock, Units will be evidenced by an Evidence of Award. Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.

8.Cash Incentive Awards, Performance Shares and Performance Units. The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the granting of Cash Incentive Awards, Performance Shares and Performance Units. Each such grant may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:

(a) Each grant will specify the number or amount of Performance Shares or Performance Units, or amount payable with respect to a Cash Incentive Award, to which it pertains, which number or amount may be subject to adjustment to reflect changes in compensation or other factors.

(b) The Performance Period with respect to each Cash Incentive Award or grant of Performance Shares or Performance Units will be such period of time as will be determined by the Committee, which may be subject to continued vesting or earlier lapse or other modification, including in the event of the retirement, death or disability of a Participant or in the event of a Change in Control.

(c) Each grant of a Cash Incentive Award, Performance Shares or Performance Units will specify Management Objectives which, if achieved, will result in payment or early payment of the award, and each grant may specify in respect of such specified Management Objectives a minimum acceptable level or levels of achievement and may set forth

a formula for determining the number of Performance Shares or Performance Units, or amount payable with respect to a Cash Incentive Award, that will be earned if performance is at or above the minimum or threshold level or levels, or is at or above the target level or levels, but falls short of maximum achievement of the specified Management Objectives.

(d) Each grant will specify the time and manner of payment of a Cash Incentive Award, Performance Shares or Performance Units that have been earned. Any grant may specify that the amount payable with respect thereto may be paid by the Company in cash, inno fractional shares of Common Stock in Restrictedor Series B Preferred Stock or Restricted Stock Units or inshall be issued to any combination thereof.

(e) Any grant of a Cash Incentive Award, Performance Shares or Performance Units may specify thatHolder and the amount payable orCompany shall round down to the nearest whole number of shares of Common Stock Restrictedor Series B Preferred Stock payable to such Holder. At least ten Trading Days before each Dividend Payment Date, the Company shall have notified the Holders whether it intends, as determined by the Disinterested Directors, to pay Accrued Dividends in cash, Common Stock, Series B Preferred Stock or Restricteda combination thereof. The Company shall promptly notify the Holders at any time the Company shall become able or unable, as

the case may be, to legally pay Annual Dividends in cash pursuant to Section 170 of the DGCL. If the Company fails to declare and pay a full Annual Dividend on the Series B Preferred Stock Unitson any Dividend Payment Date, then any Annual Dividends otherwise payable on such Dividend Payment Date on the Series B Preferred Stock shall continue to accrue and cumulate at a Dividend Rate of 9.5% per annum, until such failure is cured, for the period from and including the first Dividend Payment Date upon which the Company fails to pay a full Annual Dividend on the Series B Preferred Stock through but not including the day upon which the Company pays in accordance with respect thereto may not exceed a maximum specifiedthis Section 4(c) all Annual Dividends on the Series B Preferred Stock that are then in arrears.

(ii) Dividends shall be paid pro rata (based on the number of shares of Series B Preferred Stock held by the Committee onHolder) to the DateHolders of Grant.

(f)shares of Series B Preferred Stock entitled thereto (for the avoidance of doubt, taking into account any differences in Issuance Date). The Committee may, on the Date of Grant of Performance Shares or Performance Units, providerecord date for the payment of dividend equivalents toAnnual Dividends that are declared and paid on each Dividend Payment Date will be the holder thereof either in cash or in additional sharesclose of business on June 15 of each year (the “Dividend Record Date”).

(iii) The Company shall at all times reserve and keep available out of its authorized and unissued Common Stock subject in all cases to deferral and payment on a contingent basis based on the Participant’s earning and vesting of the Performance Shares or Performance Units, as applicable, with respect to whichSeries B Preferred Stock such dividend equivalents are paid.

(g) Each grant of a Cash Incentive Award, Performance Shares or Performance Units will be evidenced by an Evidence of Award. Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.

9.Other Awards.

(a) Subject to applicable law and the applicable limits set forth inSection 3 of this Plan, the Committee may authorize the grant to any Participantnumber of shares of Common Stock or such other awards that mayand Series B Preferred Stock as shall from time to time be denominated or payableissuable in valued in whole or in part by referenceconnection with the payment of Accrued Dividends. The Company shall use its reasonable best efforts to or otherwise basedmaintain the listing on or relating to, shares of Common Stock or factors that may influence the valueNASDAQ of such shares, including, without limitation, convertible or exchangeable debt securities, other rights convertible or exchangeable into shares of Common Stock, purchase rights for shares of Common Stock, awards with value and payment contingent upon performance of the Company or specified Subsidiaries, affiliates or other business units thereof or any other factors designated by the Committee, and awards valued by reference to the book value of the shares of Common Stock or the value of securities of, or the performance of specified Subsidiaries or affiliates or other business units of the Company. The Committee will determine the terms and conditions of such awards. Shares of Common Stock delivered pursuant to an award in the nature of a purchase right granted under thisSection 9 will be purchased for such consideration, paid for at such time, by such methods, and in such forms, including, without limitation, shares of Common Stock, other awards, notes or other property, as the Committee determines.

(b) Cash awards, as an element of or supplement to any other award granted under this Plan, may also be granted pursuant to thisSection 9.

(c) The Committee may authorize the grantnumber of shares of Common Stock as a bonus, or may authorize the grant of other awardsshall from time to time be issuable in lieu of obligations of the Company or a Subsidiary to pay cash or deliver other property under this Plan or under other plans or compensatory arrangements, subject to such terms as will be determined by the Committee in a manner that compliesconnection with Section 409A of the Code.

(d) The Committee may, at or after the Date of Grant, authorize the payment of dividends or dividend equivalents on awards granted under thisSection 9 on a deferred and contingent basis, either in cash or in additional shares of Common Stock;provided,however, that dividend equivalents or other distributions onAccrued Dividends. Any shares of Common Stock underlying awards grantedand Series B Preferred Stock issued upon the payment of Accrued Dividends shall be duly authorized, validly issued, fully paid and nonassessable and will not be subject to preemptive rights or subscription rights of any stockholder of the Company.

6.

Section 4(d) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(d) Priority of Dividends. So long as any shares of Series B Preferred Stock remain outstanding, unless full Annual Dividends on all outstanding shares of Series B Preferred Stock that have accrued from and including the Issuance Date have been declared and paid in cash, shares of Common Stock, shares of Series B Preferred Stock, or any combination thereof, or have been or contemporaneously are declared and a sum sufficient for the payment of those Annual Dividends has been or is set aside for the benefit of the Holders, the Company may not declare any dividend on, or make any distributions relating to, Junior Stock or Parity Stock, or redeem, purchase, acquire (either directly or through any Subsidiary) or make a liquidation payment relating to, any Junior Stock or Parity Stock, other than:

(i) purchases, redemptions or other acquisitions of shares of Junior Stock in accordance with any employment contract, benefit plan or other similar arrangement with or for the benefit of current or former employees, officers, directors or consultants;

(ii) purchases of fractional interests in shares of Parity Stock or Junior Stock pursuant to the conversion or exchange provisions of such Parity Stock or Junior Stock or the security being converted or exchanged;

(iii) payment of any dividends or distributions in respect of Junior Stock where the dividend or distribution is in the form of the same stock or rights to purchase the same stock as that on which the dividend is being paid; or

(iv) any dividend in kind in connection with the implementation of a shareholders’ rights or similar plan, or the redemption or repurchase of any rights under thisSection 9any such plan.

Notwithstanding the foregoing, for so long as any shares of Series B Preferred Stock remain outstanding, if Annual Dividends are not declared and paid in full upon the shares of Series B Preferred

Stock and any Parity Stock, all Annual Dividends declared upon shares of Series B Preferred Stock and any Parity Stock will be deferred untildeclared on a proportional basis so that the amount of Annual Dividends declared per share will bear to each other the same ratio that all accrued and paid contingent uponunpaid Annual Dividends as of the earningend of the most recent Dividend Payment Period per share of Series B Preferred Stock and vestingaccrued and unpaid Annual Dividends as of such awards.the end of the most recent dividend period per share of any Parity Stock bear to each other.

(e) The Evidence

7.

Section 7(a) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(a) At any time after the five (5) year anniversary of Award will specify the timeOriginal Issuance Date, if (i) the Closing Price of the Common Stock was greater than the Mandatory Conversion Price (A) for at least twenty (20) Trading Days in any period of thirty (30) consecutive Trading Days ending on, and termsincluding, the Trading Day immediately preceding the date of deliverythe Notice of Mandatory Conversion (such thirty (30) consecutive Trading Day period, the “Trading Period”) and (B) on the last Trading Day of the Trading Period and (ii) the pro rata share of an award granted under thisSection 9.

(f) Notwithstanding anything to the contrary containedaggregate of $100,000,000 in this Plan, awards under thisSection 9 may provide for the earning Annual Dividends and/or vesting of, or earlier elimination of restrictions applicable to, such award, including in the event of the retirement, death or disability of a Participant or in the event of a Change in Control.

10.Administration of this Plan.

(a) This Plan will be administered by the Committee. The Committee may from time to time delegate all or any part of its authority under this Plan to a subcommittee thereof. To the extent of any such delegation, references in this Plan to the Committee will be deemed to be references to such subcommittee.

(b) The interpretation and construction by the Committee of any provision of this Plan or of any Evidence of Award (or related documents) and any determination by the Committee pursuant to any provision of this Plan or of any such agreement, notification or document will be final and conclusive. No member of the Committee shall be liable for any such action or determination made in good faith. In addition, the Committee is authorized to take any action it determines in its sole discretion to be appropriate subject only to the express limitations contained in this Plan, and no authorization in any Plan section or other provision of this Plan is intended or may be deemed to constitute a limitation on the authority of the Committee.

(c) To the extent permitted by law, the Committee may delegate to one or more of its members, to one or more officers of the Company, or to one or more agents or advisors, such administrative duties or powers as it may deem advisable, and the Committee, the subcommittee, or any person to whom duties or powers haveSpecial Dividends has been delegated as aforesaid, may employ one or more persons to render advicepaid with respect to any responsibilityeach share of Series B Preferred Stock (including, for the Committee, the subcommittee or such person may have under this Plan. The Committee may, by resolution, authorize one or more officersavoidance of the Company to do one or bothdoubt, shares of the following on the same basisSeries B Preferred Stock issued as the Committee: (i) designate employees to be recipients of awards under this Plan; and

(ii) determine the size of any such awards;provided,however, that (A) the Committee will not delegate such responsibilities to any such officerpayment for awards granted to an employee who is an officer, Director, or more than 10% “beneficial owner” (as such term is defined in Rule13d-3 promulgated under the Exchange Act) of any class of the Company’s equity securities that is registered pursuant to Section 12 of the Exchange Act, as determined by the CommitteeAccrued Dividends in accordance with Section 16 4(c)) that remains outstanding, the Company may elect to convert (a “Mandatory Conversion”) all, but not less than all, of the Exchange Act; (B)outstanding shares of Series B Preferred Stock into shares of Common Stock (the date selected by the resolution providingCompany for any Mandatory Conversion pursuant to this Section 7(a) and in accordance with Section 7(b) below, the “Mandatory Conversion Date”); provided that the Company may not elect or consummate a Mandatory Conversion if any Investor Party holds or would hold upon such authorizationMandatory Conversion (or any earlier conversion following the date of the related Notice of Mandatory Conversion) shares of Common Stock that are Registrable Securities (as defined in the Registration Rights Agreement) unless as of the date of such Notice of Mandatory Conversion and as of the Mandatory Conversion Date there is an Available Registration Statement covering resale of such shares of Common Stock by the Investor Parties. In the case of a Mandatory Conversion, each share of Series B Preferred Stock then outstanding shall set forth the totalbe converted into (A) a whole number of shares of Common Stock such officer(s) may grant; and (C)at the officer(s) will report periodically to the Committee regarding the nature and scopeConversion Rate plus (B) cash in lieu of the awards granted pursuant to the authority delegated.fractional shares as set out in Section 10(h).

11.Adjustments. The Committee shall make

8.

Section 12(b)(iii) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(iii) any increase or provide for such adjustmentsdecrease in the number of and kind of shares of Common Stock covered by outstanding Option Rights, Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units granted hereunder and, if applicable, in the number of and kind of shares of Common Stock covered by other awards granted pursuant toSection 9 of this Plan, in the Option Price and Base Price provided in outstanding Option Rights and Appreciation Rights, respectively, in Cash Incentive Awards, and in other award terms, as the Committee, in its sole discretion, exercised in good faith, determines is equitably required to prevent dilution or enlargement of the rights of Participants that otherwise would result from (a) any extraordinary cash dividend, stock dividend, stock split, combination of shares, recapitalization or other change in the capital structure of the Company, (b) any merger, consolidation,spin-off,split-off,spin-out,split-up, reorganization, partial or complete liquidation or other distribution of assets, issuance of rights or warrants to purchase securities, or (c) any other corporate transaction or event having an effect similar to any of the foregoing. Moreover, in the event of any such transaction or event or in the event of a Change in Control, the Committee may provide in substitution for any or all outstanding awards under this Plan such alternative consideration (including cash), if any, as it, in good faith, may determine to be equitable in the circumstances and shallrequire in connection therewith the surrender of all awards so replaced in a manner that complies with Section 409A of the Code. In addition, for each Option Right or Appreciation Right with an Option Price or Base Price, respectively, greater than the consideration offered in connection with any such transaction or event or Change in Control, the Committee may in its discretion elect to cancel such Option Right or Appreciation Right without any payment to the Person holding such Option Right or Appreciation Right. The Committee shall also make or provide for such adjustments in theauthorized number of shares of CommonSeries B Preferred Stock specifiedor issuance of shares of Series B Preferred Stock after the Issuance Date other than additional shares of Series B Preferred Stock issued as payment for Accrued Dividends in accordance with Section 34(c).

9.

Section 18(a) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(a) Withholding. The Company agrees that, provided that a Holder delivers to the Company a properly executed IRS Form W-9 certifying as to the complete exemption from backup withholding of this Plan as the Committee inHolder (or, if the Holder is a disregarded entity for U.S. federal income tax purposes, its sole discretion, exercised in good faith, determines is appropriateregarded owner), under current law the Company (including any paying agent of the Company) shall not be required to, reflectand shall not, deduct or withhold taxes on any transactionpayments or deemed payments to any such Holder. In the event described in thisSection 11;provided,however, that any such adjustmentHolder fails to deliver to the number specifiedCompany such properly executed IRS Form W-9, the Company reasonably believes that a previously delivered IRS Form W-9 is no longer accurate and/or valid, or there is a change inSection 3(c) law that affects the withholding obligations of this Plan willthe Company, the Company and its paying agent shall be entitled to deduct or withhold on all applicable payments or deemed payments made only ifto the relevant Holder and shall be entitled to set off with respect to any future distributions, such tax amounts as the Company reasonably determines are required to be

deducted or withheld therefrom under any provision of applicable law (and, to the extent that such adjustment would not cause any Option Right intendedamounts are paid to qualify as an Incentive Stock Option to fail to so qualify.

12.Changethe relevant taxing authority in Control. Foraccordance with applicable law, such amounts will be treated for all purposes of this Plan, except as may be otherwise prescribed by the Committee with respect to an award made under this Plan, a “Change in Control” will be deemed to have occurred upon the occurrence (after the Effective Date)Certificate of any of the following events:

(a) any Person becomes the beneficial owner (within the meaning of Rule13d-3 promulgated under the Exchange Act) of 50% or more of either (i) the then-outstanding Common Stock (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of Directors (the “Outstanding Company Voting Securities”);provided,however, that, for purposes of this definition, the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from the Company, (B) any acquisition by the Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (D) any acquisition pursuant to a transaction that complies withSections 12(c)(i),(c)(ii) and(c)(iii) below;

(b) individuals who, as of the Effective Date, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board;provided,however, that any individual becoming a Director subsequent to the Effective Date whose election, or nomination for election by the Stockholders, was approved by a vote of a majority of the Directors then comprising the Incumbent Board (either by specific vote or by approval of the proxy statement of the Company in which such individual is named as a nominee for Director, without objection to such nomination) shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of Directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board;

(c) consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its Subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or securities of another entity by the Company or any of its Subsidiaries (each, a “Business Combination”), in each case unless, following such Business Combination, (i) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for anon-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for anon-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (ii) no Person (excluding any entity resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, 50% or more of, respectively, the then-outstanding shares of common stock (or, for anon-corporate entity, equivalent securities) of the entity resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such entity, except to the extent that such ownership existed prior to the Business Combination, and (iii) at least a majority of the members of the board of directors (or, for anon-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or

(d) approval by the Stockholders of a complete liquidation or dissolution of the Company.

13.Detrimental Activity and Recapture Provisions. Any Evidence of Award may reference a clawback policy of the Company or provide for the cancellation or forfeiture of an award or the forfeiture and repayment to the Company of any gain related to an award, or other provisions intended to have a similar effect, upon such terms and conditions as may be determined by the Committee from time to time, if a Participant, either (a) during employment or other service with the Company or a Subsidiary, or (b) within a specified period after termination of such employment or service, engages in any detrimental activity, as described in the applicable Evidence of Award or such clawback policy. In addition, notwithstanding anything in this Plan to the contrary, any Evidence of Award or such clawback policy may also provide for the cancellation or forfeiture of an award or the forfeiture and repayment to the Company of any shares of Common Stock issued under and/or any other benefit related to an award, or other provisions intended to have a similar effect, upon such terms and conditions as may be required by the Committee or under Section 10D of the Exchange Act and any applicable rules or regulations promulgated by the Securities and Exchange Commission or any national securities exchange or national securities association on which the shares of Common Stock may be traded.

14.Non-U.S. Participants. In order to facilitate the making of any grant or combination of grants under this Plan, the Committee may provide for such special terms for awards to Participants who are foreign nationals or who are employed by the Company or any Subsidiary outside of the United States of America or who provide services to the Company or any Subsidiary under an agreement with a foreign nation or agency, as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements to or amendments, restatements or alternative versions of this Plan (includingsub-plans) as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of this Plan as in effect for any other purpose, and the secretary or other appropriate officer of the Company may certify any such documentDesignations as having been approved and adoptedpaid to the Person in the same manner as this Plan. Norespect of which such special terms, supplements, amendments or restatements, however, will include any provisions withholding was made); provided, that are inconsistent with the terms of this Plan as then in effect unless this Plan could have been amended to eliminate such inconsistency without further approval by the Stockholders.

15.Transferability.

(a) Except as otherwise determined by the Committee, no Option Right, Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Share, Performance Unit, Cash Incentive Award, award contemplated bySection 9 of this Plan or dividend equivalents paid with respect to awards made under this Plan will be transferable by the Participant except by will or the laws of descent and distribution. In no event will any such award granted under this Plan be transferred for value. Except as otherwise determined by the Committee, Option Rights and Appreciation Rights will be exercisable during the Participant’s lifetime only by him or her or, in the event of the Participant’s legal incapacity to do so, by his or her guardian or legal representative acting on behalf of the Participant in a fiduciary capacity under state law or court supervision.

(b) The Committee may specify on the Date of Grant that part or all of the shares of Common Stock that are (i) to be issued or transferred byif the Company upon the exercise of Option Rights or Appreciation Rights, upon the termination of the Restriction Period applicable to Restricted Stock Units or upon payment under any grant of Performance Shares or Performance Units or (ii) no longer subject to the substantial risk of forfeiture and restrictions on transfer referred to inSection 6 of this Plan, will be subject to further restrictions on transfer, including minimum holding periods.

16.Withholding Taxes. To the extent that the Company is required to withhold federal, state, local or foreign taxes or other amounts in connection with any payment made or benefit realized by a Participant or other Person under this Plan, and the amounts available to the Company for such withholding are insufficient, it will be a condition to the receipt of such payment or the realization of such benefit that the Participant or such other Person make arrangements satisfactory to the Company for payment of the balance of such taxes or other amounts required to be withheld, which arrangements (in the discretion of the Committee) may include relinquishment of a portion of such benefit. If a Participant’s benefit is to be received in the form of shares of Common Stock, and such Participant fails to make arrangements for the payment of taxes or other amounts, then, unless otherwise determined by the Committee, the Company will withhold shares of Common Stock having a value equal to the amount required to be withheld. Notwithstanding the foregoing, when a Participant is required to pay the Company an amount required to be withheld under applicable income, employment, tax or other laws, the Participant may elect, unless otherwise determined by the Committee, to satisfy the obligation, in whole or in part, by having withheld, from the shares of Common Stock required to be delivered to the Participant, shares of Common Stock having a value equal to the amount required to be withheld or by delivering to the Company other shares of Common Stock held by such Participant. The shares of Common Stock used for tax or other withholding will be valued at an amount equal to the fair market value of such shares of Common Stock on the date the benefit is to be included in Participant’s income. In no event will the fair market value of the shares of Common Stock to be withheld and delivered pursuant to thisSection 16 exceed the minimum amount required to be withheld, unless (i) an additional amount can be withheld and not result in adverse accounting consequences, (ii) such additional withholding amount is authorized by the Committee, and (iii) the total amount withheld does not exceed the Participant’s estimated tax obligations attributable to the applicable transaction. Participants will also make such arrangements as the Company may require for the payment of any withholding tax or other obligation that may arise in connection with the disposition of shares of Common Stock acquired upon the exercise of Option Rights.

17.Compliance with Section 409A of the Code.

(a) To the extent applicable, it is intended that this Plan and any grants made hereunder comply with the provisions of Section 409A of the Code, so that the income inclusion provisions of Section 409A(a)(1) of the Code do not apply to the Participants. This Plan and any grants made hereunder will be administered in a manner consistent with this intent. Any reference in this Plan to Section 409A of the Code will also include any regulations or any other formal guidance promulgated with respect to such section by the U.S. Department of the Treasury or the Internal Revenue Service.

(b) Neither a Participant nor any of a Participant’s creditors or beneficiaries will have the right to subject any deferred compensation (within the meaning of Section 409A of the Code) payable under this Plan and grants hereunder to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment. Except as permitted under Section 409A of the Code, any deferred compensation (within the meaning of Section 409A of the Code) payable to a Participant or for a Participant’s benefit under this Plan and grants hereunder may not be reduced by, or offset against, any amount owed by a Participant to the Company or any of its Subsidiaries.

(c) If, at the time of a Participant’s separation from service (within the meaning of Section 409A of the Code), (i) the Participant will be a specified employee (within the meaning of Section 409A of the Code and using the identification methodology selected by the Company from time to time) and (ii) the Company makes a good faith determinationdetermines that an amount payable hereunder constitutes deferred compensation (within the meaning of Section 409A of the Code) the payment of which is required to be delayed pursuant to thesix-month delay rule set forth in Section 409A of the Code in order to avoid taxesdeducted or penalties under Section 409A of the Code, then the Company will not pay such amountwithheld on the otherwise scheduledany payment date but will instead pay it, without interest, on the first business day of the seventh month after such separation from service.

(d) Solelyor deemed payment with respect to any award that constitutes nonqualified deferred compensation subject to Section 409A of the Code and that is payable on account of a Change in Control (including any installments or stream of payments that are accelerated on account of a Change in Control), a Change in Control shall occur only if such event also constitutes a “change in the ownership,” “change in effective control,” and/or a “change in the ownership of a substantial portion of assets” ofHolder, the Company as those terms are defined under Treasury Regulation§1.409A-3(i)(5), but onlyshall provide reasonable prior notice to the extent necessarysuch Holder in writing of its intent to establish a timededuct or withhold taxes on such payment and form of payment that complieswill reasonably cooperate with Section 409A of the Code, without altering the definition of Changesuch Holder in Control forobtaining any purpose in respectavailable exemption or reduction of such award.withholding.

(e) Notwithstanding

10.

Section 18(b) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(b) Transfer Taxes. The Company shall pay any provisionand all stock transfer, documentary, stamp and similar taxes due upon the issuance of this Plan and grants hereunder to the contrary, in light of the uncertainty with respect to the proper application of Section 409A of the Code, the Company reserves the right to make amendments to this Plan and grants hereunder as the Company deems necessary or desirable to avoid the imposition of taxes or penalties under Section 409A of the Code. In any case, a Participant will be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on a Participant or for a Participant’s account in connection with this Plan and grants hereunder (including any taxes and penalties under Section 409A of the Code), and neither the Company nor any of its affiliates will have any obligation to indemnify or otherwise hold a Participant harmless from any or all of such taxes or penalties.

18.Amendments.

(a) The Board may at any time and from time to time amend this Plan in whole or in part;provided,however, that if an amendment to this Plan, for purposes of applicable stock exchange rules and except as permitted underSection 11 of this Plan, (i) would materially increase the benefits accruing to Participants under this Plan, (ii) would materially increase the number of securities which may be issued under this Plan, (iii) would materially modify the requirements for participation in this Plan, or (iv) must otherwise be approved by the Stockholders in order to comply with applicable law or the rules of the NASDAQ Stock Market or, if the shares of CommonSeries B Preferred Stock are not traded on the NASDAQ Stock Market, the principal national securities exchange upon which the shares of Common Stock are traded or quoted, all as determined by the Board, then, such amendment will be subject to Stockholder approval and will not be effective unless and until such approval has been obtained.

(b) Except in connection with a corporate transaction or event described inSection 11 of this Plan or in connection with a Change in Control, the terms of outstanding awards may not be amended to reduce the Option Price of outstanding Option Rights or the Base Price of outstanding Appreciation Rights, or cancel outstanding “underwater” Option Rights or Appreciation Rights (including following a Participant’s voluntary surrender of “underwater” Option Rights or Appreciation Rights) in exchange for cash, other awards or Option Rights or Appreciation Rights with an Option Price or Base Price, as applicable, that is less than the Option Price of the original Option Rights or Base Price of the original Appreciation Rights, as applicable, without Stockholder approval. ThisSection 18(b) is intended to prohibit the repricing of “underwater” Option Rights and Appreciation Rights and will not be construed to prohibit the adjustments provided for inSection 11 of this Plan. Notwithstanding any provision of this Plan to the contrary, thisSection 18(b) may not be amended without approval by the Stockholders.

(c) If permitted by Section 409A of the Code, but subject to the paragraph that follows, including in the case of termination of employment or service, or in the case of unforeseeable emergency or other circumstances or in the event of a Change in Control, to the extent a Participant holds an Option Right or Appreciation Right not immediately exercisable in full, or any Restricted Stock as to which the substantial risk of forfeiture or the prohibition or restriction on transfer has not lapsed, or any Restricted Stock Units as to which the Restriction Period has not been completed, or any Cash Incentive Awards, Performance Shares or Performance Units which have not been fully earned, or any dividend equivalents or other awards made pursuant toSection 9 of this Plan subject to any vesting schedule or transfer restriction, or who holds shares of Common Stock subject to any transfer restriction imposed pursuant toSection 15(b) of this Plan, the Committee may, in its sole discretion, provide for continued vesting or accelerate the time at which such Option Right, Appreciation Right or other award may be exercised or the time at which such substantial risk of forfeiture or prohibition or restriction on transfer will lapse or the time when such Restriction Period will end or the time at which such Cash Incentive Awards, Performance Shares or Performance Units will be deemed to have been fully earned or the time when such transfer restriction will terminate or may waive any other limitation or requirement under any such award.

(d) Subject toSection 18(b) of this Plan, the Committee may amend the terms of any award theretofore granted under this Plan prospectively or retroactively. Except for adjustments made pursuant toSection 11 of this Plan, no such amendment will materially impair the rights of any Participant without his or her consent. The Board may, in its discretion, terminate this Plan at any time. Termination of this Plan will not affect the rights of Participants or their successors under any awards outstanding hereunder and not exercised in full on the date of termination.

19.Governing Law. This Plan and all grants and awards and actions taken hereunder will be governed by and construed in accordance with the internal substantive laws of the State of Delaware.

20.Effective Date/Termination. This Plan will be effective as of the Effective Date. No grants will be made on or after the Effective Date under the Predecessor Plan, provided that outstanding awards granted under the Predecessor Plan will continue unaffected following the Effective Date. No grant will be made under this Plan on or after the tenth anniversary of the Effective Date, but all grants made prior to such date will continue in effect thereafter subject to the terms thereof and of this Plan. For clarification purposes, the terms and conditions of this Plan shall not apply to or otherwise impact previously granted and outstanding awards under the Predecessor Plan.

21.Miscellaneous Provisions.

(a) The Company will not be required to issue any fractional shares of Common Stock pursuant to this Plan. The Committee may provide for the elimination of fractions or for the settlement of fractions in cash.

(b) This Plan will not confer upon any Participant any right with respect to continuance of employment or other service with the Company or any Subsidiary, nor will it interfere in any way with any right the Company or any Subsidiary would otherwise have to terminate such Participant’s employment or other service at any time.

(c) Except with respect toSection 21(e) of this Plan, to the extent that any provision of this Plan would prevent any Option Right that was intended to qualify as an Incentive Stock Option from qualifying as such, that provision will be null and void with respect to such Option Right. Such provision, however, will remain in effect for other Option Rights and there will be no further effect on any provision of this Plan.

(d) No award under this Plan may be exercised by the holder thereof if such exercise, and the receipt of cash or stock thereunder, would be, in the opinion of counsel selected by the Company, contrary to law or the regulations of any duly constituted authority having jurisdiction over this Plan.

(e) Absence on leave approved by a duly constituted officer of the Company or any of its Subsidiaries will not be considered interruption or termination of service of any employee for any purposes of this Plan or awards granted hereunder.

(f) No Participant will have any rights as a Stockholder with respect to any shares of Common Stock subject to awards granted to him or her under this Plan prior to the date as of which he or she is actually recorded as the holder of such shares of Common Stock upon the stock records of the Company.

(g) The Committee may condition the grant of any award or combination of awards authorized under this Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or a Subsidiary to the Participant.

(h) Except with respect to Option Rights and Appreciation Rights, the Committee may permit Participants to elect to defer the issuance of shares of Common Stock under this Plan pursuant hereto. However, in the case of conversion of Series B Preferred Stock, the Company shall not be required to pay any such rules, procedurestax that may be payable in respect of any transfer involved in the issuance or programsdelivery of shares of Series B Preferred Stock or Common Stock to a beneficial owner other than the initial beneficial owner of Series B Preferred Stock, and shall not be required to make any such issuance, delivery or payment unless and until the Person requesting such issuance, delivery or payment has paid to the Company the amount of any such tax or has established, to the satisfaction of the Company, that such tax has been paid or is not payable.

11.

Section 18(c) of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

(c) Tax Treatment. It is intended that, as it may establishof the date of the Certificate of Amendment, (i) the Series B Preferred Stock shall not be treated as “preferred stock” for purposes of this PlanSection 305 of the Code and which are intended to complythe Treasury Regulations promulgated thereunder, and (ii) as a consequence, neither the Annual Dividends nor the Special Dividend accruing on the Series B Preferred Stock nor any difference between the purchase price paid for the Series B Preferred Stock and the Liquidation Preference thereof will, by reason of Section 305(b)(4) of the Code or Treasury Regulations Section 1.305-5, be treated as a distribution of property until paid in cash. The Company and Holders (and their respective affiliates) shall file all tax returns in a manner consistent with the requirements of Section 409Aforegoing intended tax treatment and shall not take any tax position that is inconsistent with such intended tax treatment except in connection with, or as required by, any of the Code. The Committee also may provide that deferred issuancesfollowing: (v) a change in applicable facts and settlements circumstances as to whether the Series B Preferred Stock has a “real and meaningful probability” of participating in the earnings and growth of the Company at the time of distribution, as determined by the Company pursuant to Treasury regulations section 1.305-5(a)), (w) a change in relevant law occurring after the Original Issuance Date, (x) after the Original Issuance Date, the promulgation of relevant final U.S. Treasury Regulations addressing instruments similar to the Series B Preferred Stock (from and after the effective date of such regulations), (y) an amendment to the terms of this Certificate of Designations or (z) a “determination” within the meaning of section 1313(a) of the Code.

12.

Section 19 of the Certificate of Designations is hereby amended and restated in its entirety to read as follows:

SECTION 19 Notices. All notices referred to herein shall be in writing and, unless otherwise specified herein, all notices hereunder shall be deemed to have been given upon (i) acknowledgment of receipt, if sent via e-mail or (ii) the earlier of receipt thereof or three (3) Business Days after the mailing thereof if sent by registered or certified mail with postage prepaid, or by private courier service, in each case, addressed: (i) if to the Company, to its office at comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 (Attention: Ashley Wright), Email:                , (ii) if to any Holder, to such Holder at the address of such Holder as listed in the stock record books of the Company (which may

include the creditingrecords of dividend equivalentsthe Transfer Agent) or interest on(iii) to such other address as the deferral amounts.

(i) If any provision of this Plan is or becomes invalid or unenforceable in any jurisdiction, or would disqualify this PlanCompany or any award under any law deemed applicablesuch Holder, as the case may be, shall have designated by notice similarly given.

RESOLVED FURTHER, that the Certificate of Designations as amended by the Committee, such provision will be construed or deemed amended or limited in scope to conform to applicable laws or, in the discretionCertificate of the Committee, it will be stricken and the remainder of this Plan willAmendment shall remain in full force and effect. Notwithstanding anything ineffect except as expressly amended hereby.

IN WITNESS WHEREOF, the Company has caused this Plan or an Evidence of AwardAmendment to the contrary, nothing inCertificate of Designations to be executed this Plan or in an Evidence15th day of Award prevents a Participant from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding possible legal violations, and for purpose of clarity a Participant is not prohibited from providing information voluntarily to the Securities and Exchange Commission pursuant to Section 21F of the Exchange Act.June 2023.

22.Stock-Based Awards in Substitution for Awards Granted by Another Company. Notwithstanding anything in this Plan to the contrary:

COMSCORE, INC.
By:

Name:

Title:

(a) Awards may be granted under this Plan in substitution for or in conversion of, or in connection with an assumption of, stock options, stock appreciation rights, restricted stock, restricted stock units or other stock or stock-based awards held by awardees of an entity engaging in a corporate acquisition or merger transaction with the Company or any Subsidiary. Any conversion, substitution or assumption will be effective as of the close of the merger or acquisition, and, to the extent applicable, will be conducted in a manner that complies with Section 409A of the Code. The awards so granted may reflect the original terms of the awards being assumed or substituted or converted for and need not comply with other specific terms of this Plan, and may account for shares of Common Stock substituted for the securities covered by the original awards and the number of shares subject to the original awards, as well as any exercise or purchase prices applicable to the original awards, adjusted to account for differences in stock prices in connection with the transaction.

(b) In the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary merges has shares available under apre-existing plan previously approved by stockholders and not adopted in contemplation of such acquisition or merger, the shares available for grant pursuant to the terms of such plan (as adjusted, to the extent appropriate, to reflect such acquisition or merger) may be used for awards made after such acquisition or merger under this Plan;provided,however, that awards using such available shares may not be made after the date awards or grants could have been made under the terms of thepre-existing plan absent the acquisition or merger, and may only be made to individuals who were not employees or directors of the Company or any Subsidiary prior to such acquisition or merger.

(c) Any shares of Common Stock that are issued or transferred by, or that are subject to any awards that are granted by, or become obligations of, the Company underSections 22(a) or 22(b) of this Plan will not reduce the shares of Common Stock available for issuance or transfer under this Plan or otherwise count against the limits contained inSection 3 of this Plan. In addition, no shares of Common Stock subject to an award that is granted by, or becomes an obligation of, the Company underSections 22(a) or22(b) of this Plan, will be added to the aggregate limit contained inSection 3(a)(i) of this Plan.

Annex BC

CERTIFICATE OF AMENDMENT OFCertificate of Amendment of

AMENDED AND RESTATEDAmended and Restated

CERTIFICATE OF INCORPORATIONCertificate of Incorporation

OF COMSCORE, INC.of comScore, Inc.

comScore, Inc. (the “Corporation”Corporation), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

FIRST: That at a meeting of the Board of Directors (the “Board”Board) of the Corporation, resolutions were duly adopted setting forth a proposed amendment (the “Amendment”Amendment) of the Amended and Restated Certificate of Incorporation of the Corporation, declaring the Amendment to be advisable and submitting the Amendment at a meeting of the stockholders of the Corporation for consideration thereof.

SECOND: That thereafter, pursuant to resolutions of the Board, an annual meeting of stockholders of the Corporation was duly called and held on May 30, 2018,June 15, 2023, upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware and at which meeting the necessary number of shares as required by statute and the Amended and Restated Certificate of Incorporation of the Corporation were voted in favor of approval of the Amendment.

THIRD: This Amendment amends the provisions of the Amended and Restated Certificate of Incorporation of the Corporation.

FOURTH: That Section A.1 of Article IV of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended and restated in full as follows:

A.Capital Stock.

1. This Corporation is authorized to issue two classes of stock, to be designated, respectively, “Common Stock” and “Preferred Stock.” The total number of shares which the Corporation is authorized to issue is One Hundred and Fifty-Five Million (155,000,000)380,000,000 shares. One Hundred and Fifty Million (150,000,000)275,000,000 shares shall be Common Stock, par value $0.001 per share, and Five Million (5,000,000)105,000,000 shares shall be Preferred Stock, par value $0.001 per share.

FOURTHFIFTH: That the Amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

SIXTH: All other provisions of the Amended and Restated Certificate of Incorporation of the Corporation shall remain in full force and effect.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by an authorized officer of the Corporation this ___15th day of _______, 2018.June 2023.

 

By: 

     

Name: Carol A. DiBattisteName:
Title: General Counsel & Chief Compliance, Privacy and People OfficerTitle:

LOGOAnnex D

annual meetingReconciliation of stockholdersNon-GAAP Financial Measure

The following table presents a reconciliation of comscore, inc. May 30, 2018 PROXY VOTING INSTRUCTIONSGAAP net loss to non-GAAP adjusted EBITDA for the period presented:

   Year Ended
December 31, 2022
 
(In thousands)  (Unaudited) 

GAAP net loss

  $(66,561
  

 

 

 

Amortization of intangible assets

   27,096 

Depreciation

   16,828 

Income tax provision

   1,724 

Interest expense, net

   915 

Amortization expense of finance leases

   2,364 
  

 

 

 

EBITDA

   (17,634
  

 

 

 

Adjustments:

  

Stock-based compensation expense

   8,178 

Loss on extinguishment of debt

    

Amortization of cloud-computing implementation costs

   1,435 

Change in fair value of contingent consideration liability

   2,558 

Impairment of right-of-use and long-lived assets

   156 

Impairment of goodwill

   46,300 

Restructuring

   5,810 

Loss on asset disposition

   7 

Other (income) expense, net (1)

   (9,802
  

 

 

 

Non-GAAP adjusted EBITDA

  $ 37,008 
  

 

 

 

(1)

Adjustments to other (income) expense, net reflect non-cash changes in the fair value of warrants liability, financing derivatives, and interest make-whole derivative included in other (income) expense, net on our Consolidated Statements of Operations and Comprehensive Loss. For additional information, see our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 2, 2023.

LOGO

SCAN TO VIEW MATERIALS & VOTE w COMSCORE, INC. 11950 DEMOCRACY DR., SUITE 600 VOTE BY INTERNET RESTON, VA 20190 Before The Meeting - Access “www.voteproxy.com” and follow the on-screen instructionsGo to www.proxyvote.com or scan the QR code withBarcode above Use the Internet to transmit your smartphone.voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on June 14, 2023. Have your proxy card availablein hand when you access the web page. TELEPHONE - Call toll-free 1-800-PROXIES (1-800-776-9437) in the United States or 1-718-921-8500 from foreign countries from any touch-tone telephonesite and follow the instructions. Haveinstructions to obtain your proxy card available when you call. Vote online/phone until 11:59 PM EST the day before the meeting. MAIL - Sign, daterecords and mail your proxy card in the envelope provided as soon as possible.to create an electronic voting instruction form. VOTE IN PERSON - You may vote yourthe shares in person by attending the Special2023 Annual Meeting. GO GREEN - e-Consent makes it easyDirections to go paperless. With e-Consent,attend the Annual Meeting where you may vote in person can quickly accessbe found under the “Locations” section of the Company’s website at www.comscore.com. VOTE BY PHONE—1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on June 14, 2023. Have your proxy material, statementscard in hand when you call and other eligible documents online, while reducing costs, clutterthen follow the instructions. VOTE BY MAIL Mark, sign and paper waste. Enroll today via www.astfinancial.com to enjoy online access. Company Number Account Number Please detach along perforated linedate your proxy card and mailreturn it in the postage-paid envelope we have provided IF you are not voting via telephone or the Internet. THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS Areturn it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, “FOR” THE ELECTION OF ALL OF THE NOMINEES FOR PROPOSAL 1, “FOR” PROPOSAL 2, FOR A FREQUENCY OF “EVERY YEAR” FOR PROPOSAL 3, “FOR” PROPOSAL 4, “FOR” PROPOSAL 5 AND “FOR” PROPOSAL 6. PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTEBLOCKS BELOW IN BLUE OR BLACK INK AS SHOWN HERE. 1. Election of Directors:FOLLOWS: V13469-P91505 KEEP THIS PORTION FOR ALL NOMINEES WITHHOLD AUTHORITY FOR ALL NOMINEES FOR ALL EXCEPT (See instruction below) NOMINEES: Class III O Dale Fuller O Jacques Kerrest O Michelle McKenna-Doyle Class I O Wesley Nichols O Paul Reilly Class II O William Livek O Brent Rosenthal O Bryan Wiener 2. To approve, on a non-binding advisory basis, the compensation paid to our named executive officers. FOR AGAINST ABSTAIN 3. To recommend, on a non-binding advisory basis, whether the advisory vote on executive compensation should occur every year, every two years or every three years. EVERY YEAR EVERY TWO YEARS EVERY THREE YEARS ABSTAIN INSTRUCTIONS:YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY COMSCORE, INC. For Withhold For All To withhold authority to vote for any individual All All Except nominee(s), mark “FOR ALL EXCEPT”“For All Except” and fill inwrite the circle next to each nomineeThe Board of Directors recommends you wish to withhold, as shown here: 4. To approvevote FOR the comScore, Inc. 2018 Equity and Incentive Compensation Plan. FOR AGAINST ABSTAIN


LOGO

5. TO APPROVE AN AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY’S COMMON STOCK, PAR VALUE $0.001 PER SHARE, FROM 100,000,000 SHARES TO 150,000,000 SHARES. FOR AGAINST ABSTAIN 6. TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2018. FOR AGAINST ABSTAIN TO CHANGE THE ADDRESS ON YOUR ACCOUNT, PLEASE CHECK THE BOX AT RIGHT AND INDICATE YOUR NEW ADDRESS IN THE ADDRESS SPACE ABOVE. PLEASE NOTE THAT CHANGES TO THE REGISTERED NAME(S) ON THE ACCOUNT MAY NOT BE SUBMITTED VIA THIS METHOD. THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN, IF NO SPECIFICATION IS MADE, THIS PROXY WILL BE VOTED “FOR” THE PROPOSALS HEREIN AND AS SAID PROXIES DEEM ADVISABLE IN THEIR DISCRETION ON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING OR MAY OTHERWISE BE ALLOWED TO BE CONSIDERED AT THE MEETING. IN ORDER TO ASSURE YOUR REPRESENTATION AT THE ANNUAL MEETING OF STOCKHOLDERS, PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY IN THE ENCLOSED ENVELOPE. SIGNATURE OF STOCKHOLDER DATE: SIGNATURE OF STOCKHOLDER DATE: NOTE: PLEASE SIGN EXACTLY AS YOUR NAME OR NAMES APPEAR ON THIS PROXY. WHEN SHARES ARE HELD JOINTLY, EACH HOLDER SHOULD SIGN. WHEN SIGNING AS EXECUTOR, ADMINISTRATOR, ATTORNEY, TRUSTEE OR GUARDIAN, PLEASE GIVE FULL TITLE AS SUCH. IF THE SIGNER IS A CORPORATION, PLEASE SIGN FULL CORPORATE NAME BY DULY AUTHORIZED OFFICER, GIVING FULL TITLE AS SUCH. IF SIGNER IS A PARTNERSHIP, PLEASE SIGN IN PARTNERSHIP NAME BY AUTHORIZED PERSON.


LOGO

annual meetingnumber(s) of stockholders of comscore, inc. MAY 30, 2018 GO GREENE-CONSENT MAKES IT EASY TO GO PAPERLESS. WITHE-CONSENT, YOU CAN QUICKLY ACCESS YOUR PROXY MATERIAL, STATEMENTS AND OTHER ELIGIBLE DOCUMENTS ONLINE, WHILE REDUCING COSTS, CLUTTER AND PAPER WASTE. ENROLL TODAY VIA WWW.ASTFINANCIAL.COM TO ENJOY ONLINE ACCESS. NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS: THE NOTICE OF MEETING, PROXY STATEMENT AND PROXY CARD ARE AVAILABLE AT HTTP://WWW.ASTPROXYPORTAL.COM/25890 PLEASE SIGN, DATE AND MAIL YOUR PROXY CARD IN THE ENVELOPE PROVIDED AS SOON AS POSSIBLE. †“ PLEASE DETACH ALONG PERFORATED LINE AND MAIL IN THE ENVELOPE PROVIDED. †“ THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE ELECTION OF ALL OF THE NOMINEES FOR PROPOSAL 1, “FOR” PROPOSAL 2, FOR A FREQUENCY OF “EVERY YEAR” FOR PROPOSAL 3, “FOR” PROPOSAL 4, “FOR” PROPOSAL 5 AND “FOR” PROPOSAL 6. PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE. ☒the nominee(s) on the line below. following: 1. Election of Directors: ☐ ☐ ☐ Nominees: 01) Nana Banerjee 02) David Kline 03) Kathi Love 04) Brian Wendling The Board of Directors recommends you vote FOR ALL NOMINEES WITHHOLD AUTHORITY FOR ALL NOMINEES FOR ALL EXCEPT (See instruction below) NOMINEES: Class III O Dale Fuller O Jacques Kerrest O Michelle McKenna-Doyle Class I O Wesley Nichols O Paul Reilly Class II O William Livek O Brent Rosenthal O Bryan Wienerthe following proposals: For Against Abstain 2. To approve,The approval, on anon-binding advisory basis, of the compensation paid to ourthe company’s named executive officers. FOR AGAINST ABSTAINofficers ☐ ☐ ☐ 3. To recommend, on anon-binding advisory basis, whether the advisory vote on executive compensation should occur every year, every two years or every three years. EVERY YEAR EVERY TWO YEARS EVERY THREE YEARS ABSTAIN INSTRUCTIONS: To withhold authority to vote for any individual nominee(s), mark “FOR ALL EXCEPT” and fill in the circle next to each nominee you wish to withhold, as shown here: • 4. To approve the comScore, Inc. 2018 Equity and Incentive Compensation Plan. FOR AGAINST ABSTAIN 5. To approve an amendment to the Company’s Amended and Restated CertificateThe ratification of Incorporation to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share, from 100,000,000 shares to 150,000,000 shares. FOR AGAINST ABSTAIN 6. To ratify the appointment of Deloitte & Touche LLP as the Company’scompany’s independent registered public accounting firm for the fiscal year ending December 31, 2018. FOR AGAINST ABSTAIN


LOGO

To change2023 ☐ ☐ ☐ 4. The approval of an amendment to the addressAmended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company’s common stock available for grant by 10,000,000 ☐ ☐ ☐ 5. The adoption of an amendment to the Certificate of Designations of the Series B Convertible Preferred Stock (“Series B Preferred Stock”) to (i) permit ☐ ☐ ☐ the company to pay annual dividends on your account, please check the box at right and indicate your new addressSeries B Preferred Stock in the address space above. Please note thatform of cash, shares of common stock, additional shares of Series B Preferred Stock, or a combination thereof, in each case in accordance with the amendment and as elected by members of the Board of Directors who have not been designated by, and are not affiliated with, any holder of Series B Preferred Stock (the “Disinterested Directors”), and (ii) make certain other clarifying and conforming changes to the registered name(s)Certificate of Designations, including with respect to tax treatment 6. The adoption of an amendment to the Amended and Restated Certificate of Incorporation to authorize additional shares of preferred stock in order to ☐ ☐ ☐ permit the company to issue additional shares of Series B Preferred Stock and other preferred stock and pay annual dividends in the form of Series B Preferred Stock in accordance with the Certificate of Designations amendment and if elected by the Disinterested Directors 7. The approval, in accordance with Nasdaq Listing Rule 5635(d), of the issuance of common stock or Series B Preferred Stock as annual dividends on the accountSeries B Preferred Stock in accordance with the Certificate of Designations amendment and if elected by the Disinterested Directors ☐ ☐ ☐ Note: In their discretion, the proxies may notvote on such other matters as may properly come before the meeting or may otherwise be submitted via this method. THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN, IF NO SPECIFICATION IS MADE, THIS PROXY WILL BE VOTED “FOR” THE PROPOSALS HEREIN AND AS SAID PROXIES DEEM ADVISABLE IN THEIR DISCRETION ON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING OR MAY OTHERWISE BE ALLOWED TO BE CONSIDERED AT THE MEETING. IN ORDER TO ASSURE YOUR REPRESENTATION AT THE ANNUAL MEETING OF STOCKHOLDERS, PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY IN THE ENCLOSED ENVELOPE. Signature of Stockholder Date: Signature of Stockholder Date: Note:allowed to be considered at the meeting. Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign.name(s) appear(s) hereon. When signing as attorney, executor, administrator, attorney, trustee or guardian,other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If the signer is a corporation please sign full corporate name by duly authorized officer, giving full title as such. If signer is aor partnership, please sign in full corporate or partnership name by an authorized person.officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date


LOGOLOGO

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OFImportant Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. V13470-P91505 COMSCORE, INC. FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 30, 2018Annual Meeting of Stockholders June 15, 2023 10:00 AM, EDT This proxy is solicited by the Board of Directors The undersignedstockholder(s) hereby appoints Gregory Finkappoint(s) Mary Margaret Curry and Carol DiBattiste,Ashley Wright, or either of them, as proxies, andattorneys-in-fact, each with fullthe power of substitutionto appoint his/her substitute, and revocationhereby authorize(s) them to each, forrepresent and in the name of the undersigned with all the powers the undersigned would possess if personally present, to vote, the shares of Common Stock of the Company of the undersigned as indicated on the proposals referred todesignated on the reverse side hereofof this ballot, all of the shares of common stock and Series B Convertible Preferred Stock of COMSCORE, INC. that the stockholder(s) is/are entitled to vote at the 20182023 Annual Meeting of StockholdersCOMSCORE, INC. to be held on May 30, 2018 at [•] ET at the Hyatt Regency Reston,Carr Workplaces, located at 1800 Presidents1818 Library Street, Suite 500, Reston, Virginia 20190 at 10:00 AM, EDT on June 15, 2023, and at any adjournmentsadjournment or postponements thereof, andpostponement thereof. This proxy, when properly executed, will be voted in their or his or her discretion upon any other matter which may properly come before said meeting. (Continuedthe manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors’ recommendations. Continued and to be signed on reverse side


LOGO

Your Vote Counts! COMSCORE, INC. 2023 Annual Meeting Vote by June 14, 2023 11:59 PM ET COMSCORE, INC. 11950 DEMOCRACY DR., SUITE 600 RESTON, VA 20190 V13472-P91505 You invested in COMSCORE, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the Annual Meeting to be held on June 15, 2023. Get informed before you vote View the Notice and Proxy Statement and Form 10-K online OR request a free paper or email copy of the material(s) before June 1, 2023. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote in Person at the Annual Meeting* June 15, 2023 10:00 AM, EDT Carr Workplaces 1818 Library Street, Suite 500 Reston, Virginia 20190 *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. V1.1


LOGO

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming Annual Meeting. Please follow the instructions on the reverse side.side to vote these important matters. Voting Items The Board Recommends 1. Election of Directors: Nominees: For 01) Nana Banerjee 02) David Kline 03) Kathi Love 04) Brian Wendling 2. The approval, on a non-binding advisory basis, of the compensation paid to the company’s named executive officers For 3. The ratification of the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 For 4. The approval of an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company’s common stock available for grant by 10,000,000 For 5. The adoption of an amendment to the Certificate of Designations of the Series B Convertible Preferred Stock (“Series B Preferred Stock”) to (i) permit the company to pay annual dividends on Series B Preferred Stock in the form of cash, shares of common stock, additional shares of Series B Preferred Stock, or a combination thereof, in each case in accordance with the amendment and as elected by members of the Board of Directors who have not been For designated by, and are not affiliated with, any holder of Series B Preferred Stock (the “Disinterested Directors”), and (ii) make certain other clarifying and conforming changes to the Certificate of Designations, including with respect to tax treatment 6. The adoption of an amendment to the Amended and Restated Certificate of Incorporation to authorize additional shares of preferred stock in order to permit the company to issue additional shares of Series B Preferred Stock and other For preferred stock and pay annual dividends in the form of Series B Preferred Stock in accordance with the Certificate of Designations amendment and if elected by the Disinterested Directors 7. The approval, in accordance with Nasdaq Listing Rule 5635(d), of the issuance of common stock or Series B Preferred For Stock as annual dividends on the Series B Preferred Stock in accordance with the Certificate of Designations amendment and if elected by the Disinterested Directors Note: In their discretion, the proxies may vote on such other matters as may properly come before the meeting or may otherwise be allowed to be considered at the meeting. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V13473-P91505